| 1510 |
Book
AHFS Formulary service 2000 Bethesda - 3546 p |
|
2000 |
| 604 |
Manufacturer
Baxter 1998 |
Stabilité des médicaments dans l'Intermate® SV50, 100, 200
|
1998 |
| 753 |
Manufacturer
Hospira 2016 |
Topotecan (Topotecan Hospira®) - Summary of Product Characteristics
|
2016 |
| 754 |
Manufacturer
Merck Sharp & Dohme 2019 |
Infliximab (Remicade®) – Summary of Product Characteristics
|
2019 |
| 755 |
Manufacturer
MSD France 2016 |
Pancuronium (Pavulon®) - Résumé des caractéristiques du produit
|
2016 |
| 1509 |
Manufacturer
Norgine 2014 |
Dantrolene sodium (Dantrium®) - Summary of Product Characteristics
|
2014 |
| 1910 |
Manufacturer
Baxter 2002 |
Compatibility of imiglucerase (personal communication)
|
2002 |
| 1911 |
Manufacturer
Janssen-Cilag Ltd 2016 |
Bortezomib (Velcade®) - Summary of Product Characteristics
|
2016 |
| 1912 |
Manufacturer
Merck Sharp Dohme 2016 |
Ertapenem (Invanz®) - Summary of Product Characteristics
|
2016 |
| 1913 |
Manufacturer
Pfizer Europe 2020 |
Gemtuzumab ozogamicin (Mylotarg® - Summary of Product Characteristics)
|
2020 |
| 1914 |
Manufacturer
Eli Lilly 2016 |
Pemetrexed (Alimta®) - Summary of Product Characteristics
|
2016 |
| 1915 |
Manufacturer
Genzyme 2010 |
Imiglucerase (Cerezyme®) -Summary of product Characteristics
|
2010 |
| 1956 |
Manufacturer
Hospira UK Limited 2015 |
Paclitaxel - Summary of Product Characteristics
|
2015 |
| 2093 |
Manufacturer
Shionogi B.V. 2020 |
Cefiderocol (Fetcroja®)- Summary of Product Characteristics
|
2020 |
| 1512 |
Manufacturer
Beacon Pharmaceuticals Ltd 2015 |
Tirofiban (Aggrastat®) - Summary of Product Characteristics
|
2015 |
| 1513 |
Manufacturer
Monarch Pharmaceuticals Ireland 2006 |
Quinupristine / dalfopristine (Synercid®) - Résumé des caractéristiques du produit
|
2006 |
| 1514 |
Manufacturer
Novartis Pharmaceuticals UK Ltd 2015 |
Verteporfin (Visudyne®) – Summary of Product Characteristics
|
2015 |
| 1516 |
Manufacturer
Mercury Pharmaceuticals Limited 2012 |
Ropivacaine (Naropeine®) - Summary of Product Characteristics
|
2012 |
| 1517 |
Manufacturer
Sanofi-Aventis 2015 |
Rasburicase (Fasturtec®) - Summary of Product Characteristics
|
2015 |
| 1518 |
Manufacturer
Hospira UK Ltd 2013 |
Raltitrexed (Tomudex®) - Summary of Product Characteristics
|
2013 |
| 1519 |
Manufacturer
Merck Sharp Dohme 2015 |
Caspofungine (Cancidas®) - Summary of Product Characteristics
|
2015 |
| 1520 |
Manufacturer
B Braun 2001 |
Etude de stabilité des médicaments en Ecoflac®
|
2001 |
| 1522 |
Manufacturer
Maco Pharma 2001 |
Macoflex N®
|
2001 |
| 2197 |
Manufacturer
Medac 2003 |
Treosulfan injection : details about handling and stability.
|
2003 |
| 2199 |
Manufacturer
Mundipharma 2007 |
Chlorhydrate d'oxycodone (Oxynorm®)– Résumé des caractéristiques du produits
|
2007 |
| 2212 |
Manufacturer
Actavis UK Ltd 2015 |
Reteplase (Rapilysin®) - Summary of Product Characteristics
|
2015 |
| 2220 |
Manufacturer
Merck Serono 2015 |
Cétuximab (Erbitux®) - Dossier scientifique
|
2015 |
| 2226 |
Manufacturer
Pfizer Ltd 2016 |
Temsirolimus (Torisel®) - Summary of Product Characteristics
|
2016 |
| 2238 |
Manufacturer
Baxter 2018 |
Clinomel - Résumé des caractéristiques du produit
|
2018 |
| 4084 |
Manufacturer
Accord Health Care 2017 |
Cisplatine - Résumé des caractéristiques du produits
|
2017 |
| 2240 |
Manufacturer
Janssen Pharmaceuticals 2019 |
Décitabine (Dacogen®) - Summary of Product caracteristics
|
2019 |
| 2255 |
Manufacturer
Ebewe Pharma 2007 |
Stability of Alexan "Ebewe" infusion solutions.
|
2007 |
| 2295 |
Manufacturer
Merck Sharp Dohme 2013 |
Fosaprepitant (Emend®) - Summary of Product Characteristics
|
2013 |
| 2256 |
Manufacturer
Ebewe Pharma 2007 |
Stability of doxorubicin "Ebewe" infusion solutions.
|
2007 |
| 2257 |
Manufacturer
Ebewe Pharma 2007 |
Stability of epirubicin "Ebewe" infusion solutions.
|
2007 |
| 2258 |
Manufacturer
Ebewe Pharma 2007 |
Stability of oxaliplatin "Ebewe" lyophilisate after reconstitution.
|
2007 |
| 2259 |
Manufacturer
Ebewe Pharma 2007 |
Stability of oxaliplatin "Ebewe" lyophilisate infusion solutions.
|
2007 |
| 2260 |
Manufacturer
Ebewe Pharma 2007 |
Stability of vinorelbin "Ebewe" infusion solutions.
|
2007 |
| 2271 |
Manufacturer
Novartis 2006 |
Daptomycine (Cubicin®) Résumé des caractéristiques du produits
|
2006 |
| 2272 |
Manufacturer
Genzyme 2006 |
Clofarabine (Evoltra®) – Résumé des caractéristiques du produits
|
2006 |
| 2276 |
Manufacturer
Pharma Mar SA 2015 |
Trabectedine (Yondelis®) - Summary of Product Characteristics
|
2015 |
| 2277 |
Manufacturer
GlaxoSmithKline 2008 |
Argatroban - Summary of Product Characteristics
|
2008 |
| 2284 |
Manufacturer
Astra Zenaca 2007 |
Esomeprazole sodium (Nexium IV®) – Summary of Product Characteristics
|
2007 |
| 2288 |
Manufacturer
Cephalon 2008 |
Bendamustine hydrochloride (Treanda®) – Summary of Product Characteristics
|
2008 |
| 2296 |
Manufacturer
Eumedica 2017 |
Témocilline (Negaban®) - Résumé des caractéristiques du produit
|
2017 |
| 2302 |
Manufacturer
Lettre AFFSAPS 30 November 2008 2008 ; 61, 5: 356-357. |
Ceftriaxone et incompatibilités physico-chimiques, particulièrement avec les solutions contenant des sels de calcium.
|
2008 |
| 2328 |
Manufacturer
Organon 2009 |
Sugammadex (Bridion®) – Résumé des caractéristiques du produits
|
2009 |
| 2332 |
Manufacturer
Janssen-Cilag 2009 |
Doripenem (Doribax®) - Laboratoire informations
|
2009 |
| 2343 |
Manufacturer
Fresenius Biotech 2009 |
Catumaxomab (Removab®)
|
2009 |
| 2344 |
Manufacturer
Ebewe Pharma 2009 |
Stabilité physico-chimique de la gamme oncologie Ebewe Pharma France après dilution.
|
2009 |
| 2348 |
Manufacturer
Alexion Europe SAS 2007 |
Eculizumab (Soliris®) – Summary of Product Characteristics
|
2007 |
| 2838 |
Manufacturer
Pierre Fabre 2010 |
Vinflunine (Javlor®) – Résumé des caractéristiques du produits
|
2010 |
| 2864 |
Manufacturer
Astellas Pharma 2015 |
Isavuconazonium (Cresemba®) - Summary of Product Characteristics
|
2015 |
| 2902 |
Manufacturer
Forrest Pharmaceuticals 2015 |
Ceftazidime - avibactam (Avycaz®) - Summary of Product Characteristics
|
2015 |
| 2990 |
Manufacturer
Roche 2014 |
Trastuzumab Emtansine (Kadcyla®) - Summary of Product Characteristics.
|
2014 |
| 3077 |
Manufacturer
Roche 2019 |
Trastuzumab (Herceptin®) – Summary of Product Characteristics
|
2019 |
| 3084 |
Manufacturer
Bristol Myers Squibb 2009 |
Ixabepilone (Ixempra®) – Summary of Product Characteristics
|
2009 |
| 3109 |
Manufacturer
Bayer Schering Pharma 2010 |
Moxifloxacine (Izilox®) -Notice information
|
2010 |
| 3113 |
Book
Compendium Suisse des m?dicaments 2010 |
Herceptin
|
2010 |
| 3117 |
Manufacturer
Merck Sharp Dohme 2009 |
Temozolomide (Temodal ®) - Summary of Product Characteristics
|
2009 |
| 3128 |
Manufacturer
Prostrakan 2013 |
Mitomycine (Amétycine®) - Résumé Caractéristiques du Produit
|
2013 |
| 3129 |
Manufacturer
Pfizer 2008 |
Irinotécan (Campto®) – Résumé des caractéristiques du produits
|
2008 |
| 3130 |
Manufacturer
Sanofi Avantis France 2009 |
Docétaxel (Taxotere®) – Résumé des caractéristiques du produits
|
2009 |
| 3138 |
Manufacturer
GlaxoSmithKline 2009 |
Ofatumumab (Arzerra®) - Summary of Product Characteristics
|
2009 |
| 3142 |
Manufacturer
SP Europe 2010 |
Doxorubicin hydrochloride liposome (Caelyx®) - Summary of Product Characteristics
|
2010 |
| 3143 |
Manufacturer
Teva Laboratoire 2015 |
Doxorubicin hydrochloride liposome (Myocet®) - Summary of Product Characteristics
|
2015 |
| 3144 |
Manufacturer
Ortho Biotech 2010 |
Doxorubicin liposome (Doxil®) - Product Information
|
2010 |
| 3157 |
Manufacturer
Celgene Europe Limited 2015 |
Paclitaxel albumin (Abraxane®) - Summary of Product Characteristics
|
2015 |
| 3158 |
Manufacturer
Astellas Pharma GmbH 2014 |
Bendamustine (Levact®) - Summary of Product Characteristics
|
2014 |
| 3162 |
Manufacturer
Bayer HealthCare 2010 |
Moxifloxacine (Izilox®) - Résumé des caractéristiques du produits
|
2010 |
| 3184 |
Manufacturer
CP Pharmaceuticals 2005 |
Hyaluronidase (Hyalase®) - Summary of Product characteristics.
|
2005 |
| 3236 |
Manufacturer
Celgene 2011 |
Azacitidine (Vidaza®) - Résumé des caractéristiques du produit
|
2011 |
| 3237 |
Manufacturer
Sanofi Aventis France 2011 |
Cabazitaxel (Jevtana®) - Résumé des caractéristiques du produit.
|
2011 |
| 3250 |
Manufacturer
Eisai Ltd 2011 |
Eribulin (Halaven®) - Summary of Product Characteristics.
|
2011 |
| 3260 |
Manufacturer
Astellas Pharma Europe 2011 |
Telavancin (Vibativ®) - Summary of Products characteristics
|
2011 |
| 3261 |
Manufacturer
Bristol Myers Squibb 2011 |
Belatacept (Nulojix®) – Résumé des caractéristiques du produit
|
2011 |
| 3295 |
Manufacturer
LFB Biom?dicaments 2018 |
Argatroban - Résumé Caractéristiques du Produit
|
2018 |
| 3314 |
Manufacturer
Bristol Myers Squibb 2011 |
Carmustine (Bicnu®) – Résumé des caractéristiques du produits
|
2011 |
| 3320 |
Manufacturer
CTI Life Sciences Limited 2012 |
Pixantrone (Pixuvri®) - Summary of Product Characteristics
|
2012 |
| 3332 |
Manufacturer
Pfizer 2012 |
Tigecycline (Tigacyl®) - Summary of Product characteristics
|
2012 |
| 3348 |
Manufacturer
Amgen 2016 |
Carfilzomib (Kyprolis®) - Résumé des caractéristiques du produit
|
2016 |
| 3352 |
Manufacturer
Bristol Myers Squibb 2011 |
Ipilimumab (Yervoy®) - Summary of Product Characteristics
|
2011 |
| 3369 |
Manufacturer
MEDAC France 2011 |
Levofolinate de sodium Medac - Résumé des caractéristiques du produits
|
2011 |
| 3398 |
Manufacturer
Gilead Science (France) 2013 |
Amphotéricine B (Ambisome®) - Résumé des caractéristiques du produit
|
2013 |
| 3432 |
Manufacturer
Celgene Corporation 2020 |
Romidepsin (Istodax®) - Summary of Product Characteristics
|
2020 |
| 3474 |
Manufacturer
Accord Healthcare Limited 2009 |
Fluorouracil - Summary of Product Characteristics
|
2009 |
| 3495 |
Manufacturer
Takeda 2013 |
Brentuximab (Adcetris®) - Summary of Product Characteristics
|
2013 |
| 3496 |
Manufacturer
Actavis 2009 |
Gemcitabin Actavis solution - Stability Study
|
2009 |
| 3501 |
Manufacturer
Pfizer 2011 |
Ketamine hydrochloride (Ketalar®) - Summary of Product Characteristics
|
2011 |
| 3502 |
Manufacturer
Astra Zeneca 2012 |
Propofol (Diprivan®) - Summary of Products Characteristics
|
2012 |
| 3503 |
Manufacturer
Hameln Pharmaceuticals 2012 |
Fentanyl - Summary of product Characteristics
|
2012 |
| 3504 |
Manufacturer
Pfizer 2012 |
Parecoxib (Dynastat®) - Summary of Product Characteristics
|
2012 |
| 3507 |
Manufacturer
AbbVie 2013 |
Chirocaine - Summary of Product Characteristics
|
2013 |
| 3508 |
Manufacturer
Sanofi Aventis Group 2013 |
Aflibercept (Zaltrap®) - Summary of Product characteristics
|
2013 |
| 3519 |
Manufacturer
Glaxo Smith Kline 2011 |
Remifentanil hydrochloride(Ultiva®) - Summary of Product Characteristics
|
2011 |
| 3520 |
Manufacturer
Sanofi 2011 |
Cidomycin - Summary of product Chracteristics.
|
2011 |
| 3521 |
Manufacturer
Beacon Pharmaceuticals 2012 |
Tramadol® - Summary of Product Characteristics.
|
2012 |
| 3522 |
Manufacturer
Actavis 2013 |
Flucloxacillin - Summary of Product Characteristics.
|
2013 |
| 3523 |
Manufacturer
Roche 2018 |
Ceftriaxone (Rocephin®) - Summary of Product Characteristics.
|
2018 |
| 3524 |
Manufacturer
Sanofi 2013 |
Amiodarone hydrochloride (Cordarone®) - Summary of Product Characteristics.
|
2013 |
| 3525 |
Manufacturer
AMCO Amdipharm Mercury 2012 |
Pethidine hydrochloride - Summary of product Characteristics
|
2012 |
| 3526 |
Manufacturer
Pharmacia 2010 |
Clindamycin (Dalacin®) - Summary of Product Characteristics
|
2010 |
| 3527 |
Manufacturer
Glaxo Smith Kline 2018 |
Amoxicillin (Amoxil®) – Summary of Product Characteristics
|
2018 |
| 3528 |
Manufacturer
Essential generics 2012 |
Ampicillin sodium – Summary of Product Characteristics
|
2012 |
| 3529 |
Manufacturer
Hospira 2013 |
Ciprofloxacin – Summary of Product Characteristics
|
2013 |
| 3530 |
Manufacturer
Hospira 2013 |
Imipenem/Cilastatin – Summary of Product Characteristics
|
2013 |
| 3531 |
Manufacturer
Wockhardt 2014 |
Morphine sulphate 10 mg/mL injection BP – Summary of Product Characteristics
|
2014 |
| 3539 |
Manufacturer
The Medecines Company 2013 |
Bivalirudin (Angiox®) - Summary of Product Characteristics.
|
2013 |
| 3540 |
Manufacturer
Wockhardt 2010 |
Heparin sodium - Summary of Product Characteristics.
|
2010 |
| 3541 |
Manufacturer
Sanofi 2011 |
Rifampicin (Rifadin®) – Summary of Product Characteristics
|
2011 |
| 3543 |
Manufacturer
Wockhardt 2013 |
Ceftazidime – Summary of Product Characteristics
|
2013 |
| 3544 |
Manufacturer
Pfizer 2006 |
Cefoperazone (Cefobid®) - Summary of Product Characteristics
|
2006 |
| 3545 |
Manufacturer
Mylan SAS 2009 |
Amoxicilline / acide clavulanique - Résumé des caractéristiques du produit
|
2009 |
| 3546 |
Manufacturer
Panpharma SA 2007 |
Cefamandole Flavelab - Résumé des caractéristiques du produit
|
2007 |
| 3547 |
Manufacturer
Sanofi-Aventis France 2011 |
Aztréonam (Azactam®) - Résumé des caractéristiques du produit
|
2011 |
| 3548 |
Manufacturer
Bristol Myers Squibb 2007 |
Cefepime (Maxipime®) - Summary of Product caracteristics.
|
2007 |
| 3549 |
Manufacturer
B Braun 2012 |
Amikacine B Braun - Résumé des caractéristiques du produit.
|
2012 |
| 3559 |
Manufacturer
Sanofi Aventis France 2013 |
Pentamidine diiséthionate (Pentacarinat®) - Résumé des caractéristiques du produit
|
2013 |
| 3560 |
Manufacturer
Pharmacia 2013 |
Linezolid (Zyvox®) - Summary of Product Characteristics
|
2013 |
| 3562 |
Manufacturer
Sanofi 2014 |
Ofloxacin (Tarivid®) - Summary of Product Characteristics
|
2014 |
| 3563 |
Manufacturer
Sanofi Aventis France 2013 |
Spiramycine adipate (Rovamycine®) - Résumé des caractéristiques du produit
|
2013 |
| 3564 |
Manufacturer
B Braun 2012 |
Rocuronium B Braun - Résumé des caractéristiques du produit.
|
2012 |
| 3565 |
Manufacturer
Aguettant 2008 |
Flumazenil Aguettant - Résumé des caractéristiques du produit.
|
2008 |
| 3566 |
Manufacturer
Pfizer 2013 |
Voriconazole (Vfend®) - Summary of Product characteristics.
|
2013 |
| 3567 |
Manufacturer
Pfizer 2020 |
Anidulafungin (Ecalta®) - Summary of Product Characteristics.
|
2020 |
| 3573 |
Manufacturer
Astellas 2013 |
Micafungin (Mycamine®) – Summary of Product Characteristics
|
2013 |
| 3574 |
Manufacturer
Accord Healthcare France SAS 2013 |
Ondansetron - Résumé des caractéristiques du produit
|
2013 |
| 3575 |
Manufacturer
Prostrakan 2013 |
Mitomycine (Ametycine®) - Résumé des caractéristiques du produit
|
2013 |
| 3576 |
Manufacturer
Prostrakan 2012 |
Amsacrine (Amsalyo®) - Résumé des caractéristiques du produit
|
2012 |
| 3577 |
Manufacturer
Galen Limited |
Daunorubicine (Daunoxome®) - Résumé des caractéristiques du produit
|
|
| 3578 |
Manufacturer
Accord Healthcare 2011 |
Cisplatin - Summary of Product Characteristics
|
2011 |
| 3579 |
Manufacturer
Janssen Cilag 2005 |
Cladribine Janssen Cilag - Résumé des caractéristiques du produit
|
2005 |
| 3580 |
Manufacturer
Accord Healthcare France 2016 |
Cytarabine Accord - Résumé des caractéristiques du produit
|
2016 |
| 3581 |
Manufacturer
Clinigen Healthcare 2013 |
Dexrazoxane (Cardioxane®) - Résumé des caractéristiques du produit
|
2013 |
| 3583 |
Manufacturer
Roche 2013 |
Sulfaméthoxazole triméthoprime (Bactrim®) - Résumé des caractéristiques du produit
|
2013 |
| 3584 |
Manufacturer
Aspen Pharma 2013 |
Melphalan (Alkéran®) - Résumé des caractéristiques du produit
|
2013 |
| 3585 |
Manufacturer
Genus Pharmaceuticals 2008 |
Benzylpenicillin sodium - Summary of Product Characteristics
|
2008 |
| 3586 |
Manufacturer
Actavis France 2010 |
Piperacilline tazobactam Actavis® - Résumé des caractéristiques du produit
|
2010 |
| 3587 |
Manufacturer
GlaxoSmithKline 2014 |
Ticarcilline/acide clavulanique (Timentin®) - Summary of Product Characteristics
|
2014 |
| 3588 |
Manufacturer
Sandoz 2011 |
Vancomycine (Vancocin®) - Résumé des caractéristiques du produit
|
2011 |
| 3589 |
Manufacturer
PanPharma 2013 |
Oxacilline PanPharma – Résumé des caractéristiques du produits
|
2013 |
| 3590 |
Manufacturer
Dakota Pharm 2011 |
Piperacilline - Résumé des caractéristiques du produit
|
2011 |
| 3591 |
Manufacturer
Bristol Myers Squibb 2011 |
Amphotericine B (Fungizone®) - Résumé des caractéristiques du produit
|
2011 |
| 3592 |
Manufacturer
Sandoz 2008 |
Cimetidine - Résumé des caractéristiques du produit
|
2008 |
| 3593 |
Manufacturer
Beacon Pharmaceuticals 2011 |
Ketorolac trometamol (Ketorolac®) - Summary of Product Characteristics
|
2011 |
| 3594 |
Manufacturer
Zentiva 2013 |
Metronidazole (Flagyl®) - Summary of Product Characteristics
|
2013 |
| 3595 |
Manufacturer
Hospira 2009 |
Aciclovir - Summary of Product Characteristics
|
2009 |
| 3596 |
Manufacturer
Sanofi 2014 |
Chlorpromazine (Largactil®) - Summary of Product Characteristics
|
2014 |
| 3597 |
Manufacturer
AstraZeneca 2013 |
Terbutaline sulfate (Bricanil®) - Summary of Product Characteristics
|
2013 |
| 3598 |
Manufacturer
Clinigen Healthcare Ltd 2016 |
Amifostine (Ethyol®) - Résumé des caractéristiques du produit
|
2016 |
| 3599 |
Manufacturer
Amco Amdipharm Mercry 2013 |
Glycopyrrolate Injection U.S.P. - Summary of Product Characteristics
|
2013 |
| 3600 |
Manufacturer
UCB Pharma SA 2009 |
Hydroxyzine (Atarax®) - Résumé des caractéristiques du produit
|
2009 |
| 3601 |
Manufacturer
Actavis 2012 |
Cisatracurium Actavis - Résumé des Caractéristiques du Produit
|
2012 |
| 3602 |
Manufacturer
Baxter SAS 2013 |
Mesna (Uromitexan®)- Summary of Product Characteristics
|
2013 |
| 3603 |
Manufacturer
Adienne Pharma Biotech 2011 |
Thiotepa (Tepadina®) - Summary of Product Characteristics
|
2011 |
| 3604 |
Manufacturer
Sanofi Aventis France 2012 |
Daunorubicine (Cérubidine®) - Résumé des caractéristiques du produit
|
2012 |
| 3605 |
Manufacturer
Lipomed 2010 |
Dacarbazine (Dacarbazine Lipomed®) - Résumé des caractéristiques du produit
|
2010 |
| 3606 |
Manufacturer
Wokhardt 2013 |
Dobutamine - Summary of Product Characteristics
|
2013 |
| 3607 |
Manufacturer
AOP Orphan Pharmaceuticals AG 2013 |
Esmolol hydrochloride for injection - Summary of Product Characteristics
|
2013 |
| 3609 |
Manufacturer
Aspen Pharma 2013 |
Labetalol (Trandate®) - Summary of Product Characteristics
|
2013 |
| 3612 |
Manufacturer
Amdipharm Mercury Company 2012 |
Doxapram (Dopram) - Summary of Product Characteristics
|
2012 |
| 3613 |
Manufacturer
Primius Lab 2013 |
Dihydralazine (Nepressol®) - Résumé des caractéristiques du produit
|
2013 |
| 3614 |
Manufacturer
American Regent Inc 2013 |
Nicardipine Injection - Summary of Product Characteristics
|
2013 |
| 3615 |
Manufacturer
Archimeded Pharma 2012 |
Apomorphine (Apomorphine Archimedes®) - Résumé des caractéristiques du produit
|
2012 |
| 3616 |
Manufacturer
Boehringer Ingelheim 2012 |
Altéplase (Actilyse®) - Résumé des caractéristiques du produit
|
2012 |
| 3617 |
Manufacturer
Wockhardt 2011 |
Hyaluronidase (Hyalase®) - Summary of Product Characteristics
|
2011 |
| 3618 |
Manufacturer
Amgen 2014 |
Filgrastim (Neupogen®) - Summary of Product Characteristics
|
2014 |
| 3619 |
Manufacturer
Wockhardt 2016 |
Pamidronate (Pamidronate Actavis®) - Summary of Product Characteristics
|
2016 |
| 3620 |
Manufacturer
Beacon Pharmaceuticals 2012 |
Phenylephrine - Summary of Product Characteristics
|
2012 |
| 3621 |
Manufacturer
Renaudin 2008 |
Phosphate dipotassique - Résumé des caractéristiques du produit
|
2008 |
| 3625 |
Manufacturer
CSL Behring 2013 |
Streptokinase (Streptase®) - Summary of Product Characteristics
|
2013 |
| 3626 |
Manufacturer
Astellas Pharma 2014 |
Tacrolimus (Prograf®) - Résumé des Caractéristiques du Produit
|
2014 |
| 3627 |
Manufacturer
Boeringer Ingelheim 2013 |
Tenecteplase (Metalyse®) - Summary of Product Characteristics
|
2013 |
| 3629 |
Manufacturer
Actavis UK 2014 |
Atracurium (Atracurium solution for injection/infusion®) - Summary of Product Characteristics
|
2014 |
| 3630 |
Manufacturer
Merck Sharp Dohme 2012 |
Vecuronium (Norcuron®) - Summary of Product Characteristics
|
2012 |
| 3631 |
Manufacturer
Aguettant 2016 |
Suxamethonium (Suxamethonium Aguettant®) - Résumé des caractéristiques du produit
|
2016 |
| 3632 |
Manufacturer
Hospira 2017 |
Epirubicine (Epirubicine Hospira®) - Summary of Product Characteristics
|
2017 |
| 3634 |
Manufacturer
Accord Healthcare 2011 |
Oxaliplatine (Oxaliplatine Accord®) - Résumé des caractéristiques du produit
|
2011 |
| 3635 |
Manufacturer
Novartis Pharmaceuticals UK Ltd 2015 |
Aldesleukine (Proleukin®) - Summary of Product Characteristics
|
2015 |
| 3637 |
Manufacturer
Hameln Pharmaceuticals 2014 |
Methotrexate (Methotrexate solution for injection®) - Summary of Product Characteristics
|
2014 |
| 3638 |
Manufacturer
Hospira 2010 |
Dopamin (Dopamine 40 mg/mL sterile concentrate®) - Summary of Product Characteristics
|
2010 |
| 3639 |
Manufacturer
Wockhardt 2013 |
Furosemide - Summary of Product Characteristics
|
2013 |
| 3640 |
Manufacturer
Hospira 2013 |
Mitoxantrone - Summary of Product Characteristics
|
2013 |
| 3641 |
Manufacturer
Pierre Fabre 2011 |
Vinorelbine (Navelbine®) - Summary of Product Characteristics
|
2011 |
| 3642 |
Manufacturer
International Medication System (UK) 2013 |
Epinephrine - Résumé des Caractéristiques du Produit
|
2013 |
| 3643 |
Manufacturer
Sanofi 2015 |
Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics
|
2015 |
| 3644 |
Manufacturer
Hameln Pharmaceuticals 2010 |
Calcium gluconate® - Summary of Product Characteristics
|
2010 |
| 3645 |
Manufacturer
Accord Healthcare 2014 |
Doxorubicin - Summary of Product Characteristics
|
2014 |
| 3646 |
Manufacturer
Sanofi Aventis France 2013 |
Bléomycine sulfate (Bléomycine Bellon®) - Résumé des caractéristiques du produit
|
2013 |
| 3647 |
Manufacturer
Roche 2019 |
Trastuzumab (Herceptin® 600 mg for subcutaneous injection) - Summary of Product Characteristics
|
2019 |
| 3653 |
Manufacturer
Laboratoire Léo 2013 |
Bumétanide (Burinex®) - Résumé des caractéristiques du produit
|
2013 |
| 3654 |
Manufacturer
Keocyt 2012 |
Streptozocine (Zanosar®) - Résumé des caractéristiques du produit
|
2012 |
| 3655 |
Manufacturer
Bristol Myers Squibb 2016 |
Etoposide phosphate (Etopophos®) - Résumé des caractéristiques du produit
|
2016 |
| 3656 |
Manufacturer
Sanofi Aventis France 2014 |
Teicoplanine (Targocid®) - Résumé des caractéristiques du produit
|
2014 |
| 3658 |
Manufacturer
Sandoz 2014 |
Omeprazole - Summary of Product Characteristics.
|
2014 |
| 3659 |
Manufacturer
AstraZeneca 2016 |
Propofol (Diprivan®) - Résumé des caractéristiques du produit
|
2016 |
| 3660 |
Manufacturer
Hospira 2016 |
Isoprenaline (Isuprel®) - Résumé des caractéristiques du produit
|
2016 |
| 3661 |
Manufacturer
Laboratoire L?o 2012 |
Fusidate de sodium (Fucidine®) - Résumé des caractéristiques du produit
|
2012 |
| 3662 |
Manufacturer
Clinigen 2014 |
Foscavir (Foscarnet®) - Summary of Product Characteristics
|
2014 |
| 3663 |
Manufacturer
Panpharma 2011 |
Fosfomycine (Fosfomycine Panpharma®) - Résumé des caractéristiques du produit
|
2011 |
| 3668 |
Manufacturer
Hospira 2015 |
Dexamethasone - Summary of Product Characteristics
|
2015 |
| 3671 |
Manufacturer
Teva UK Ltd 2016 |
Deferoxamine - Résumé des caractéristiques du produit
|
2016 |
| 3672 |
Manufacturer
Mylan SAS 2016 |
Nalbuphine Mylan - Résumé des caractéristiques du produit
|
2016 |
| 3674 |
Manufacturer
PanPharma 2016 |
Erythromycin lactobionate - Summary of Product Characteristics
|
2016 |
| 3675 |
Manufacturer
Archimedes Pharma UK Ltd 2015 |
Thiopental sodium - Summary of Product Characteristics
|
2015 |
| 3676 |
Manufacturer
Hospira 2014 |
Atracurium bésilate (Atracurium Hospira®) - Résumé des caractéristiques du produit
|
2014 |
| 3677 |
Manufacturer
Sanofi Aventis France 2008 |
Cefpirome (Cefrom®) - Résumé des caractéristiques du produit
|
2008 |
| 3683 |
Manufacturer
Aguettant 2014 |
Baclofen - Résumé des caractéristiques du produit
|
2014 |
| 3684 |
Manufacturer
Laboratoire Léo 2012 |
Bumétanide (Burinex®) - Résumé des caractéristiques du produit
|
2012 |
| 3686 |
Manufacturer
Eusapharma 2013 |
L asparaginase (Kidrolase®) - Résumé des caractéristiques du produit
|
2013 |
| 3687 |
Manufacturer
Stravencon 2013 |
Cefuroxime sodium - Summary of Product Characteristics
|
2013 |
| 3701 |
Manufacturer
Gentium SPa 2014 |
Defibrotide (Defitelio®) - Summary of Product Characteristics
|
2014 |
| 3711 |
Manufacturer
Takeda 2015 |
Vedolizumab (Entyvio®) - Summary of Product Characteristics
|
2015 |
| 3718 |
Manufacturer
Bayer Healthcare Corporation 2012 |
Conivaptan (Vaprisol®) - Summary of Product Characteristics
|
2012 |
| 3721 |
Manufacturer
Spectrum Pharmaceuticals 2014 |
Belinostat (Beleodaq®) - Summary of Product Characteristics
|
2014 |
| 3752 |
Manufacturer
Durata Therapeutics Holding 2014 |
Dalbavancin (Dalvance®) - Summary of Product Characteristics
|
2014 |
| 3753 |
Manufacturer
Cubist Pharmaceuticals 2014 |
Tedizolid phosphate (Sivextro®) - Summary of Product Characteristics
|
2014 |
| 3768 |
Manufacturer
Roche Products Limited 2014 |
Obinutuzumab (Gazyvaro®) - Summary of Product Characteristics
|
2014 |
| 3769 |
Manufacturer
B Braun laboratoire 2014 |
Paracatamol (Paracetamol B Braun®) - Résumé des caractéristiques du produit
|
2014 |
| 3770 |
Manufacturer
Eclat Pharmaceuticals 2014 |
Phenylephrine hydrochloride (Vazculep®) - Summary of Product Characteristics
|
2014 |
| 3771 |
Manufacturer
Merck Sharp Dohme 2017 |
Pembrolizumab (Keytruda®) - Summary of Product Characteristics
|
2017 |
| 3772 |
Manufacturer
Janssen Biotech 2017 |
Siltuximab (Sylvant®) - Summary of Product Characteristics
|
2017 |
| 3773 |
Manufacturer
Eli Lilly 2014 |
Ramicirumab (Cyramza®) - Summary of Product Characteristics
|
2014 |
| 3774 |
Manufacturer
Amgen 2016 |
Blinatumomab - (Blincyto®) - Summary of Product Characteristics
|
2016 |
| 3775 |
Manufacturer
Talon Therapeutics 2014 |
Vincristine sulfate liposome (Marqibo®) - Summary of Product Characteristics
|
2014 |
| 3776 |
Manufacturer
Teva Pharmaceuticals 2014 |
Omecetaxine (Synribo®) - Summary of Product Characteristics
|
2014 |
| 3787 |
Manufacturer
The Medicines Company 2016 |
Oritavancin diphosphate (Orbactiv®) - Summary of Product Characteristics
|
2016 |
| 3803 |
Manufacturer
Laboratoires Merck Sharp & Dohme Chibret 2020 |
Ceftolozane / tazobactam (Zerbaxa®) - Summary of Product Characteristics
|
2020 |
| 3838 |
Manufacturer
Martindale Pharmaceuticals Ltd 2007 |
Magnesium Sulphate - Summary of Product Characteristics
|
2007 |
| 3883 |
Manufacturer
Arrow 2016 |
Ceftazidime - Résumé des caractéristiques du produit
|
2016 |
| 3920 |
Manufacturer
Fresenius Kabi 2018 |
Levofloxacine - Résumé Caractéristique du Produit
|
2018 |
| 3930 |
Manufacturer
Serb laboratoire 2013 |
Indocyanine (Infracyanine®) - Résumé des caractéristiques du produit
|
2013 |
| 3931 |
Manufacturer
Pfizer Laboratoire 2016 |
Trimébutine (Débridat®) - Résumé des caractéristiques du produit
|
2016 |
| 3932 |
Manufacturer
Serb Laboratoire 2015 |
Hydroxocobalamine (Cyanokit®) - Résumé des caractéristiques du produit
|
2015 |
| 3933 |
Manufacturer
Teva Laboratoire 2015 |
Acide zolédronique - (Acide zoledronique Teva Pharma) - Résumé des caractéristiques du produit
|
2015 |
| 3934 |
Manufacturer
GlaxoSmithKline Laboratoire 2016 |
Eptifibatide (Integrilin®) - Résumé des caractéristiques du produit
|
2016 |
| 3935 |
Manufacturer
Sanofi Laboratoire 2016 |
Insuline glulisine (Insulines Sanofi Apidra®) - Résumé des caractéristiques du produit
|
2016 |
| 3936 |
Manufacturer
GlaxoSmithKline Laboratoire 2016 |
Bélimumab (Benlysta®) – Résumé des caractéristiques du produits
|
2016 |
| 3938 |
Manufacturer
Lilly S.A 2016 |
Necitumumab (Portrazza®) – Résumé des caractéristiques du produits
|
2016 |
| 3941 |
Manufacturer
Concordia International 2017 |
Nicardipine - Summary of Product Characteristics
|
2017 |
| 3968 |
Manufacturer
Fresenius Kabi 2015 |
Ringer lactate - Résumé des Caractéristiques du Produit
|
2015 |
| 4009 |
Manufacturer
Panpharma 2017 |
Droperidol - Résumé des Caractéristiques du Produit
|
2017 |
| 4065 |
Manufacturer
Mylan 2018 |
Urapidil (Eupressyl® - résumé des caractéristiques du produit)
|
2018 |
| 4068 |
Manufacturer
2018 Biogen Idec Ltd |
Natalizumab (Tysabri®) - Summary of Product Characteristics
|
2018 |
| 4086 |
Manufacturer
Novartis Pharma 2017 |
Octréotide - (Sandostatine®)- Résumé des caractéristiques du produit
|
2017 |
| 4153 |
Manufacturer
Orphan Europe (UF) Limited 2014 |
Dactinomycin (Cosmegen Lyovac®) - Summary of Product Characteristics
|
2014 |
| 4154 |
Manufacturer
Accord Health Care 2018 |
Bleomycin sulfate- Summary of Product Characteristics
|
2018 |
| 4173 |
Manufacturer
Baxalta Innovations GmbH 2018 |
Pegaspargase (Oncaspar®) - Résumé des Caractéristiques du Produit
|
2018 |
| 4190 |
Manufacturer
Janssen 2018 |
Daratumumab (Darzalex®) - Summary of Product Characteristics.
|
2018 |
| 4355 |
Manufacturer
Jazz Pharmaceuticals UK 2019 |
Daunorubicine/cytarabine liposomale (Vyxeos®) - Summary of Product Characteristics
|
2019 |
| 4380 |
Manufacturer
Merck Sharp & Dohme Limited 2019 |
Posaconazole (Noxafil®) - Summary of Product Characteristics
|
2019 |
| 4467 |
Manufacturer
Roche Products Limited 2020 |
Avastin - Summary of Product Characteristics
|
2020 |
| 4471 |
Manufacturer
Kyowa Kirin Pharma 2019 |
Amétycine 10 mg poudre pour solution injectable - Résumé des caractéristiques du produit - Oct 10, 2019
|
2019 |
| 4474 |
Manufacturer
Merck 2023 |
Avelumab (Bavencio®) - Summary of Product Characteristics
|
2023 |
| 4480 |
Manufacturer
Jazz Pharmaceuticals UK. 2020 |
Erwinase, Lyophilisate for solution for injection.
|
2020 |
| 4482 |
Manufacturer
Cipla USA 2020 |
ZEMDRI (plazomicin) injection, Highlights of Prescribing Information, Cipla USA, Revised: 1/2020
|
2020 |
| 4503 |
Manufacturer
RIEMSER Pharma GmbH 2018 |
Ziconotide (Prialt®) - Summary of Product Characteristics
|
2018 |
| 4532 |
Manufacturer
Roche Products Limited 2021 |
Atezolizumab (Tecentriq®) - Summary of Product Characteristics
|
2021 |
| 4571 |
Manufacturer
Orion Pharma 2010 |
Levosimendan (Simdax 2.5 mg/ml) - Summary of Product Characteristics
|
2010 |
| 4589 |
Manufacturer
Mylan 2021 |
Pemetrexed Mylan - Résumé des caractéristiques du produit
|
2021 |
| 4608 |
Manufacturer
Astra Zeneca 2021 |
Durvalumab (Imfinzi - Summery of Product Characteristics, updated August 2021)
|
2021 |
| 4617 |
Manufacturer
Sanofi Genzyme 2021 |
Isatuximab - SARCLISA 20mg/mL concentrate for solution for infusion - Summary of Product Characteristics - updated 16 August 2021
|
2021 |
| 4629 |
Manufacturer
2021 Sandoz |
Pemetrexed Sandoz - Summary of Product Characteristics (SmPc)
|
2021 |
| 4650 |
Manufacturer
Advanz Pharma 2021 |
Ceftobiprole (Zevtera 500 mg powder for concentrate for solution for infusion.) Summary of Product Characteristics, Advanz Pharma updated 4 aug 2021.
|
2021 |
| 4652 |
Manufacturer
Bristol Myers Squibb Pharmaceuticals 2022 |
Nivolumab (Opdivo®) - Summary of Product Characteristics
|
2022 |
| 4726 |
Manufacturer
Mylan 2023 |
Arsenic trioxide Mylan - Résumé des caractéristiques du produit
|
2023 |
| 4665 |
Manufacturer
Sanofi Aventis 2021 |
LEMTRADA 12 mg concentrate for solution for infusion - Summary of Product Characteristics. Updated 24-Sep-2021
|
2021 |
| 4686 |
Manufacturer
Roche Products Ltd. 2022 |
Pertuzumab (Perjeta®) - Summary of Product Characteristics.
|
2022 |
| 4700 |
Manufacturer
AS Kalceks 2022 |
Esketamine 25 mg/mL solution for injection/infusion. - Summary of Product Characteristics
|
2022 |
| 4709 |
Manufacturer
Tetraphase Pharmaceuticals. 2021 |
XERAVA® (eravacycline) for injection, for intravenous use. HIGHLIGHTS OF PRESCRIBING INFORMATION.
|
2021 |
| 4717 |
Manufacturer
2022 Daiichi Sankyo Europe Gmb |
Enhertu®- Résumé des caractéristiques du produit
|
2022 |
| 4720 |
Manufacturer
Paratek Pharmaceuticals 2021 |
Nuzyra (amadacycline - Full prescribing infomation. Paratek Pharmaceuticals updated May 2021.
|
2021 |
| 4740 |
Manufacturer
Roche Products Limited 2021 |
MabThera 500 mg concentrate for solution for infusion. Summary of Product Characteristics Updated 07-Oct-2021
|
2021 |
| 4744 |
Manufacturer
2023 |
Stability Report of Extended SB8 Opened Vial (400 mg) Stability.
|
2023 |
| 4785 |
Manufacturer
Janssen-Cilag International NV 2023 |
Darzalex 1800 mg solution for injection - Summary of Product characteristics.
|
2023 |
| 3875 |
Journal
EJHP 2016 ; 23: 4: 213-218. |
Development and stability study of glibenclamide oral liquid paediatric formulations for the treatment of permanent neonatal diabetes mellitus.
Estevez P, Boscolo O, Quiroga E, Penuto R.F, Buontempo F, Tripodi V, Lucangioli S. |
2016 |
| 3373 |
Journal
J R Soc Med Sh Rep 2011 ; 2: 58. |
Precipitation of thiopental with muscle relaxants: a potential hazard.
Khan S, Stannard N, Greijn J. |
2011 |
| 4031 |
Journal
Int J Pharm Compound 2017 ;21 , 5 : 426-429 |
Stability of Dalteparin 1,000 Unit/mL in 0.9% Sodium Chloride for Injection in Polypropylene Syringes.
Kirkham K, Munson J, McCluskey S, Graner K. |
2017 |
| 3291 |
Journal
Acta Pol Pharm 2012 ; 69, 1: 95-105. |
Physical and chemical properties and stability of sodium cefazolin in buffered eye drops determined with HPLC method.
Kodym A, Bilski P, Domanska A, Lukasz Helminiak, Jablonska M, Jachymska A. |
2012 |
| 2437 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 659-662. |
Stability of epinephrine hydrochloride in an extemporaneously compounded topical anesthetic solution of lidocaine, racepinephrine, and tetracaine
Larson TA, Uden DL, Schilling CG. |
1996 |
| 4396 |
Journal
GaBI Journal 2020 ; 9, 1: |
Stability of the trastuzumab biosimilar ABP 980 compared to reference product after intravenous bag preparation, transport and storage at various temperatures, concentrations and stress conditions.
Lueras A, Polozova A, Asbury D, Hippenmeyer J, Litowski J, Goss M, Breslin P, Crampton S. |
2020 |
| 3880 |
Journal
Int J Pharm Compound 2016 ; 20, 4 : 338-342 |
Stability of Ampicillin in Normal Saline and Buffered Normal Saline.
Maher M, Jensen Kara J,Lee David, Nix David E |
2016 |
| 2388 |
Journal
Am J Health-Syst Pharm 2003 ; 60: 75-77. |
Stability of tiagabine in two oral liquid vehicles
Nahata MC, Morosco RS. |
2003 |
| 4702 |
Journal
EJOP 2022 ; 5: 2. |
Physicochemical stability of pemetrexed diarginine at 25 mg/mL in partially-used vials and at 3 and 12 mg/mL diluted in dextrose 5% or in sodium chloride 0.9% in polyolefin bags.
Nisse Y-E, Sobalak N, Vigneron J, Demoré B. |
2022 |
| 3785 |
Journal
J Pain Palliat Care Pharm 2014 ;,28, 4: 367?370. |
Formulation and Stability of an Extemporaneously Compounded Oral Solution of Chlorpromazine HCl
Prohotsky D.L, . Juba K.M, Zhao F. |
2014 |
| 2476 |
Journal
Am J Hosp Pharm 1986 ; 43: 1489-1491. |
Formulation and stability of diazepam suspension compounded from tablets
Strom JG, Jr, Kalu AU. |
1986 |
| 3881 |
Journal
Int J Pharm Compound 2016 ; 20, 4 : 343-346 |
Physical and Chemical Stability of Urapidil in 0.9% Sodium Chloride in Elastomeric Infusion Pump.
Tomasello C, Leggieri A, Rabbia F, Veglio F, Baietto L,Fulcheri C, De Nicol? A, De Perri G, D'Avolio A. |
2016 |
| 2324 |
Journal
Int J Pharm 2009 ; 369, 1-2 : 30-37 |
Investigation into the sorption of nitroglycerin and diazepam into PVC tubes and alternative tube materials during application
Treleano A, Wolz G, Brandsch R, Welle F. |
2009 |
| 4412 |
Journal
J Pediatr Pharmacol Ther 2014 ;19,1:25–29. |
Chiral Stability of an Extemporaneously Prepared Clopidogrel Bisulfate Oral Suspension.
Tynes C.R, Livingston B, Patel H, Arnold J.J. |
2014 |
| 3825 |
Journal
J Pharm Pract and Res 2015 ; 496: 421-431. |
Evaluation of the physicochemical and functional stability of diluted REMSIMA(R) upon extended storage—A study compliant with NHS (UK) guidance.
Young B.L, Ali Khan M, Chapman T.J, Parry R,. Connolly M.A, Watts A.G. |
2015 |
| 3782 |
Journal
Int J Pharm 2014 , 477, 1-2 : 32-38. |
Study of quality and stability of ursodeoxycholic acid formulations for oral pediatric administration
A. Santove?a, E. S?nchez-Negr?n, L. Charola, M. Llabr?s, J.B. Fari?a |
2014 |
| 2002 |
Journal
Am J Health-Syst Pharm 2005 ; 62: 1299-1302. |
Compatibility of tramadol hydrochloride injection with selected drugs and solutions.
Abanmy NO, Zaghloul IY, Radwan MA. |
2005 |
| 2453 |
Journal
Am J Health-Syst Pharm 1997 ; 54: 1301-1303. |
Stability of pentoxifylline in an extemporaneously prepared oral suspension
Abdel-Rahman S, Nahata MC. |
1997 |
| 2382 |
Journal
Am J Health-Syst Pharm 1999 ; 56: 547-550. |
Stability of fumagillin in an extemporaneously prepared ophthalmic solution
Abdel-Rahman SM, Nahata MC. |
1999 |
| 2417 |
Journal
Am J Health-Syst Pharm 1999 ; 56: 243-245. |
Stability of terbinafine hydrochloride in an extemporaneously prepared oral suspension at 25 and 4 degrees C
Abdel-Rahman SM, Nahata MC. |
1999 |
| 2982 |
Journal
J Ped Pharm Pract 1998 ; 3: 115-118. |
Stability of itraconazole in an extemporaneously suspension.
Abdel-Rahman SM, Nahata MC. |
1998 |
| 2828 |
Journal
J Clin Pharm Ther 2008 ; 33, 3: 263-271. |
Evaluation of the stability of morphine sulphate in combination with Instillagel®.
Abdelmageed R, Labyad N, Watson DG, Pournamdari M, Cable CG, Stanley E. |
2008 |
| 2783 |
Journal
Int J Pharm 2015 ; 486; 1-2: 367-369. |
Stability of colistimethate sodium in a disposable elastomeric infusion device.
Abdulla A,.van Leeuwen R.W.F, de Vries Schultink A.H.M,.Koch B.C.P. |
2015 |
| 2383 |
Journal
Am J Health-Syst Pharm 2009 ; 66: 1105-1109. |
Stability of zonisamide in extemporaneously compounded oral suspensions
Abobo CV, Wei B, Liang D. |
2009 |
| 124 |
Journal
Int Pharm J 1993 ; 7: 14-19. |
An in vitro interaction between promethazine hydrochloride and chloroquine phosphate.
Abubakar AA, Mustapha A, Wambebe OC. |
1993 |
| 107 |
Journal
J Pharm Biomed Anal 2001 ; 25: 861-869. |
Stability of stored methacholine solutions: study of hydrolysis kinetic by IP-LC.
Acar V, Houri JJ, Le Hoang MD, Pradeau D, Guyon F. |
2001 |
| 2560 |
Journal
Aust J Hosp Pharm 1994 ; 24: 312-316. |
A short-term stability study of an oral solution of dexamethasone.
Accordino A, Chambers R, Thomson B. |
1994 |
| 2202 |
Journal
Investig Clin Farm 2005 ; 2, 4: 195-203. |
Estabilidad de parecoxib en dilucion con ostros farmacos y administrado en perfusion continua IV para el control del dolor postoperatorio.
Acin Lazaro MP, bono Arino C, martinez Bazan R, manzanares Marin I, Faci Bouthelier A, Velamazan Blocona MJ, Facorro Gaspar E, |
2005 |
| 1647 |
Journal
Anaesthesia 2001 ; 56: 294. |
Physical incompatibility between atracurium and intravenous diclofenac.
Ackland G. |
2001 |
| 3163 |
Journal
EJHP 2010 ; 16, 5: 26-28. |
Physical and chemical stability of Taxotere 1-vial 20mg/mL infusion solution following refrigerated storage.
Acott SR, Hart M. |
2010 |
| 1317 |
Journal
Pharm J 1987 ; 238: 476-478. |
Pharmaceutical aspects of home infusion therapy for cancer patients.
Adams PS, Haines-Hutt RF, Bradford E, Palmer A, Rowland CG. |
1987 |
| 3087 |
Journal
BJID 2008 ; 12, 5: 400-404. |
Treatment of invasive fungal infections: Stability of voriconazole infusion solutions in PVC bags.
Adams, A.I.H., Morimoto, L.N., Meneghini, L.Z., Bergold, A.M. |
2008 |
| 4696 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2022 2022; 7(1): 20220005 |
Physicochemical stability of 20 mg/mL amiodarone hydrochloride oral suspension in SyrSpend® SF PH4 (liquid)
Adoum A, Le P., Faisant S, Legendre P, Lester MA, Boivin PN. |
2022 |
| 3919 |
Journal
Eur J Pharm Sci 2017 ; 96: 449-455. |
Physicochemical stability and compatibility testing of levetiracetam in all-in-one parenteral nutrition admixtures in daily practice.
Aeberhard C, Steuer C, Saxer C, Huber A, Stanga Z, Mühlebach S. |
2017 |
| 2505 |
Journal
Am J Hosp Pharm 1987 ; 44: 2287-2290 |
Stability of cefazolin sodium in various artificial tear solutions and aqueous vehicles
Ahmed I, Day P. |
1987 |
| 2567 |
Journal
Pakistan J Biol Sci 2000 ; 3, 10: 1755-1757. |
Preparation and stability study of diclofenac sodium suppositories.
Ahmed M, Jalil R, Islam MA, Shaheen SM. |
2000 |
| 1300 |
Journal
Hosp Pharm Pract 1992 ; 2: 285-289. |
The stability of drugs in pre-filled syringes: flucloxacillin, ampicillin, cefuroxime, cefotaxime and ceftazidime.
Ahmed ST, Parkinson R. |
1992 |
| 1978 |
Journal
Clin Ther 1992 ; 14, 2: 192-195. |
Comparative sorption of clomipramine, viloxazine and maprotiline hydrochlorides in polyvinylchloride bags and glass vials.
Airaudo C, Bianchi C, Verdier M, Gayte-Sorbier A. |
1992 |
| 3498 |
Journal
Ann Pharmacotherapy 2008 ; 42, 10: 1416-1424. |
Compatibility and aerosol characteristics of formoterol fumarate mixed with other nebulizing solutions.
Akapo S, Gupta J, martinez E, Mccrea C, Ye L, Roach M |
2008 |
| 1921 |
Journal
Drug Stability 1996 ; 1; 141-146. |
Photodegradation reactions of CPT-11, a derivative of campothecion, part ii: photodegradation behaviour of CPT-11 in aqueous solution.
Akimoto K, Kawai A, Ohya K. |
1996 |
| 1920 |
Journal
Drug Stability 1996 ; 1: 118-122. |
Photodegradation reactions of CPT-11, a derivative of campothecion, part i: chemical structure of main degradation products in aqueous solution.
Akimoto K, Kaway A, Ohya K et al. |
1996 |
| 813 |
Journal
Am J Health-Syst Pharm 1999 ; 56: 63-68. |
Stability of milrinone lactate in the presence of 29 critical care drugs and 4 IV solutions.
Akkermann SR, Zhang H, Mullins RE, Yaughn K. |
1999 |
| 2816 |
Journal
J Pharm Biomed Anal 1999 ; 25: 269-275. |
Photodegradation of folic acid in aqueous solution
Aktar J, Khan A, Ahmad I. |
1999 |
| 3274 |
Journal
Intensice Care Medecine 2011 ; 37, 11: 1899. |
Stability of sildenafil (Revatio®) dolutions in dextrose 5%.
Al HadithyF.F.Y, De Goede A.L; Eckhardt M, Hanff L, Koch B.C.P. |
2011 |
| 4141 |
Journal
J Clin Pharm Ther 2018 : 530-535. |
Stability of dobutamine in continuous ambulatory delivery devices.
Al Madfai F, Valah B, Zaidi S.T.R, Wanandy T, Ming M.C, Peterson G.M, Patel R.P. |
2018 |
| 3083 |
Journal
Am J Health-Syst Pharm 2009 ; 66: 1478-1483. |
Stability of extemporaneously prepared voriconazole ophthalmic solution
Al-Badriyeh D, Li J, Stewart K, Kong DCM, Leung L, Davies GE, Robert Fullinfaw R. |
2009 |
| 154 |
Journal
Pharm Res 1990 ; 7: 452-460. |
Chemical stability of pentostatin (NSC-218321), a cytotoxic and immunosuppressant agent.
Al-Razzak LA, Benedetti AE, Waugh WN, Stella VJ. |
1990 |
| 3279 |
Journal
J Clin Pharm Ther 2012 ; 37, 1: 71-73. |
A stability indicating assay for a combination of morphine sulphate with levomepromazine hydrochloride used in palliative care.
Al-Tannak N.F, Cable C.G, McArthur D.A, Watson D.G |
2012 |
| 1380 |
Journal
Am J Hosp Pharm 1984 ; 41: 74. |
Identification of labetolol precipitate.
Alam AS. |
1984 |
| 4106 |
Journal
Can J Hosp Pharm 2018 ;71,2/152-154 |
Stability of Dapsone in Extemporaneously Compounded Oral Suspensions.
Alarie H, Friciu M, Leclair G. |
2018 |
| 36 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 2423-2426. |
Compatibility and activity of aldesleukin (recombinant interleukin-2) in presence of selected drugs during simulated Y-site administration: Evaluation of three methods.
Alex S, Gupta SL, Minor JR, Turcovski-Corrales S, Gallelli JF, Taub D, Piscitelli SC. |
1995 |
| 2657 |
Journal
Int J Pharm Compound 1997 : 60-63. |
Stability of an extemporaneously formulated levothyroxine sodium syrup compounded from commercial tablets.
Alexander KS, Kothapalli MR, Dollimor D. |
1997 |
| 2851 |
Journal
Int J Pharm Compound 2005 ; 9, 1: 82-86. |
Stability of An Extemporaneously Compounded Propylthiouracil Suspension
Alexander KS, Mitra P. |
2005 |
| 3168 |
Journal
Am J Hosp Pharm 1993 ; 50: 683-686. |
Stability of hydralazine hydrochloride syrup compounded from tablets.
Alexander KS, Pudipeddi M, Parker GA. |
1993 |
| 2854 |
Journal
Int J Pharm Compound 1997 ; 1, 3: 195-199. |
The Formulation Development and Stability of Spironolactone Suspension
Alexander KS, Sundar S, White DB, Dollimore D. |
1997 |
| 2663 |
Journal
Int J Pharm Compound 1997 ; 1: 200-205. |
The formulation development and stability of metronidazole suspension.
Alexander KS, Vangala SSKS, Dollimore D. |
1997 |
| 4044 |
Journal
Pharm Sci Communications 2017 ;9:5:28-35 |
Quality assessment and stability study of compounded furosemide syrup.
Alfred-Ugbendo D, Zdoryk O.A, Georgiyants V.A. |
2017 |
| 2396 |
Journal
Am J Health-Syst Pharm 2008 ; 65: 441-447. |
Effect of buffer and antioxidant on stability of a mercaptopurine suspension
Aliabadi HM, Romanick M, Desai S, Lavasanifar A. |
2008 |
| 2433 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 2179-2184. |
Stability of baclofen, captopril, diltiazem hydrochloride, dipyridamole, and flecainide acetate in extemporaneously compounded oral liquids
Allen LV, Jr, Erickson MA, |
1996 |
| 2434 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 1944-1949. |
Stability of acetazolamide, allopurinol, azathioprine, clonazepam, and flucytosine in extemporaneously compounded oral liquids
Allen LV, Jr, Erickson MA, |
1996 |
| 2435 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 2304-2309. |
Stability of labetalol hydrochloride, metoprolol tartrate, verapamil hydrochloride, and spironolactone with hydrochlorothiazide in extemporaneously compounded oral liquids
Allen LV, Jr, Erickson MA, |
1996 |
| 2421 |
Journal
Am J Health-Syst Pharm 1998 ; 55: 1804-1809. |
Stability of bethanechol chloride, pyrazinamide, quinidine sulfate, rifampin, and tetracycline hydrochloride in extemporaneously compounded oral liquids
Allen LV, Jr, MA Erickson |
1998 |
| 2422 |
Journal
Am J Health-Syst Pharm 1998 ; 55: 1915-1920. |
Stability of alprazolam, chloroquine phosphate, cisapride, enalapril maleate, and hydralazine hydrochloride in extemporaneously compounded oral liquids
Allen LV, Jr, Erickson MA, |
1998 |
| 2441 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 2073-2078. |
Stability of ketoconazole, metolazone, metronidazole, procainamide hydrochloride, and spironolactone in extemporaneously compounded oral liquids
Allen LV, Jr, Erickson MA, |
1996 |
| 2443 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 2433-2436. |
Stability of ramipril in water, apple juice, and applesauce
Allen LV, Jr, Stiles ML, Prince SJ, McLaury HJ, Sylvestri MF. |
1995 |
| 730 |
Journal
Am J Hosp Pharm 1977 ; 34: 939-943. |
Compatibility of various admixtures with secondary additives at Y-injection site of intravenous administration sets.
Allen LV, Saul Levinson R, Phisutsinthop D. |
1977 |
| 280 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 2427-2433. |
Stability of cefpirome sulfate in the presence of commonly used intensive care drugs during simulated Y-site injection.
Allen LV, Stiles ML, Prince SJ, Sylvestri MF. |
1995 |
| 222 |
Journal
Am J Hosp Pharm 1990 ; 47: 1572-1574. |
Stability of fentanyl citrate in 0.9% sodium chloride solution in portable infusion pumps.
Allen LV, Stiles ML, Tu YH. |
1990 |
| 217 |
Journal
Am J Hosp Pharm 1993 ; 50: 714-715. |
Stability of bupivacaine hydrochloride, epinephrine hydrochloride, and fentanyl citrate in portable infusion-pump reservoirs.
Allen LV, Stiles ML, Wang DP, Tu YH. |
1993 |
| 1228 |
Journal
Am J Hosp Pharm 1981 ; 38: 380-381. |
Compatibility of various admixtures at Y-injection sites of intravenous administration sets. Part2.
Allen LV, Stiles ML. |
1981 |
| 654 |
Journal
Int J Pharm Compound 1997 ; 1: 123-124. |
Stability of vancomycin hydrochloride in Medication Cassette* reservoirs.
Allen LV. |
1997 |
| 3743 |
Journal
Int J Pharm 1991 ; 69: 197-210. |
The degradation of carboplatin in aqueous solutions containing chloride or other selected nucleophiles.
Allsopp M.A, Sewell G.J, Rowland C.G, Riley C.M, Schowen R.L. |
1991 |
| 4218 |
Journal
EJHP 2020 ; 27, 2: 90-94. |
Assessment of the stability of citrate-buffered flucloxacillin for injection when stored in two commercially available ambulatory elastomeric devices: INfusor LV (Baxter) and Accufuser (Woo Young Medical): a study compliant with the NHS Yellow Cover Document (YCD) requirements.
Allwood M.C,Stonkute D, Wallace A, Wilkinson A-S, Hills T, Jamieson C, |
2020 |
| 1288 |
Journal
Int J Pharm Pract 1994 ; 3: 57-59. |
Stability of injections containing diamorphine and midazolam in plastic syringes.
Allwood MC, Brown PW, Lee M. |
1994 |
| 1263 |
Journal
Int J Pharm Pract 1992 ; 1: 242-244. |
The effect of buffering on the stability of reconstituted benzylpenicillin injection.
Allwood MC, Brown PW. |
1992 |
| 38 |
Journal
Int J Pharm 1996 ; 127: 65-71. |
The extraction of diethylhexylphtalate (DEHP) from polyvinyl chloride components of intravenous infusion containers and administration sets by paclitaxel injection.
Allwood MC, Martin HJ. |
1996 |
| 197 |
Journal
J Clin Pharm Ther 1991 ; 16: 337-340. |
The stability of four catecholamines in 5% glucose infusions.
Allwood MC. |
1991 |
| 1153 |
Journal
Int J Pharm 1992 ; 80: R7-R9. |
The influence of buffering on the stability of erythromycin injection in small-volume infusions.
Allwood MC. |
1992 |
| 1154 |
Journal
Int J Pharm 1990 ; 62: R1-R3. |
The stability of erythromycin injection in small-volume infusions.
Allwood MC. |
1990 |
| 1161 |
Journal
Int J Pharm 1987 ; 39: 183-188. |
Sorption of parenteral nitrates during administration with a syringe pump and extension set.
Allwood MC. |
1987 |
| 1886 |
Journal
Palliative Med 1991 ; 5: 330-333. |
The stability of diamorphine alone and in combinaison with antiemetics in plastic syringes.
Allwood MC. |
1991 |
| 1998 |
Journal
Am J Health-Syst Pharm 1998 55: 1315-1316. |
Fluorouracil precipitate.
Allwood MC. |
1998 |
| 3422 |
Journal
Hosp Pharm 2013 ; 48, 6: 484-488. |
Stability of Diluted Adenosine Solutions in Polyolefin Infusion Bags.
Almagambetova E, Hutchinson D, Blais D.M, Zhao F. |
2013 |
| 4763 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2023 ;8,1 |
Physicochemical stability of urea-containing Mitomycin C preparations in glass vials (1.0 mg/mL) and plastic syringes (2.0, 0.4, 0.2 mg/mL)
Almasi J, Erdnuss F, Thiesen J, Krämer I. |
2023 |
| 4767 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2023 ;8,1 |
Physicochemical stability of durvalumab (Imfinzi® ) concentrate for solution in original vials after first opening.
Almasi K, Thiesen J, Krämer I. |
2023 |
| 1928 |
Journal
J Pain Symptom Manage 2004 ; 28, 3: 268-272. |
Drug stability testing to support clinical feasibility investigations for intrathecal baclofen-clonidine admixture.
Alvarez JC, De Mazancourt Ph, Chartier-Kastler E, Denys P. |
2004 |
| 1223 |
Journal
Am J Hosp Pharm 1980 ; 37: 618. |
Plastic IV container for nitroglycerin.
Amann AH, Baaske DM, Wagenknecht DM. |
1980 |
| 1934 |
Journal
Am J Health-Syst Pharm 2004 ; 61: 1438-1445. |
Compatibility of ketamine hydrochloride and fentanyl citrate in polypropylene syringes.
Ambados F, Brealey J. |
2004 |
| 321 |
Journal
Am J Health-Syst Pharm 1997 ; 54: 205. |
Compatibility of ketamine hydrochloride and meperidine hydrochloride.
Ambados F. |
1997 |
| 980 |
Journal
Aust J Hosp Pharm 1995 ; 25: 352. |
Compatibility of morphine and ketamine for subcutaneous infusion.
Ambados F. |
1995 |
| 2998 |
Journal
J Pharm Technol 1989 ; 5: 202-205. |
Preparation and stability of an oral suspension of dipyridamole.
Ameer B, Callahan RJ, Dragotakes SC et al. |
1989 |
| 3789 |
Journal
Int J Pharm Compound 2015 ; 19, 1: 73-77. |
Physicochemical and Microbiological Stability of Azathioprine in InOrpha Suspending Agent Studied Under Various Conditions.
Amin A, Bourget P, Vidal F, Cartier F, Beauvais R, Do Nascimento Afonso V. |
2015 |
| 3561 |
Journal
Am J Health-Syst Pharm 2015 ; 72:479-482 |
Stability of frozen 1% voriconazole ophthalmic solution.
Amoros-Reboredo P, Bastida-Fernandez C, Guerrero-Molina L, Soy-Muner D, Lopez-Cabezas C. |
2015 |
| 3126 |
Journal
J Pain Symptom Manage 2010 ; 40, 1: 87-94. |
Microbiological and Physicochemical Stability of Oxycodone Hydrochloride Solutions for Patient-Controlled Delivery Systems.
Amri A, Achour AB, Chachaty E, Mercier L, Bourget P, Paci A. |
2010 |
| 1859 |
Journal
Il Farmaco 2002 ; 57: 925-930. |
Physicochemical compatibility between thiocolchicoside injections (Miotens®) and pharmaceutical products frequently used for combined therapy.
Anacardio R, Perilli O, Pagnanelli F, Bartolini S, gentile MM, Mazzeo P, Carlucci G. |
2002 |
| 1847 |
Journal
J Pharm Biomed Anal 2003 ; 32, 6: 1235-1241. |
Physicochemical compatibility between ketoprofen kysine salt injections (Artrosilene®) and pharmaceutical products frequently used for combined therapy by intravenous administration.
Anacardo R, Perilli O, Bartolini S, Gentile MM, Mazzeo P, Carlucci G. |
2003 |
| 2384 |
Journal
Am J Health-Syst Pharm 2002 ; 59: 1267-1270. |
Stability of valganciclovir in an extemporaneously compounded oral liquid
Anaizi NH, Dentinger PJ, Swenson CF. |
2002 |
| 2463 |
Journal
Am J Hosp Pharm 1979 ; 50: 486-488. |
Instability of aqueous captopril solutions
Anaizi NH, Swenson C. |
1979 |
| 2426 |
Journal
Am J Health-Syst Pharm 1997 ; 54: 549-553. |
Stability of acetylcysteine in an extemporaneously compounded ophthalmic solution
Anaizi NH, Swenson CF, Dentinger PJ. |
1997 |
| 2448 |
Journal
Am J Health-Syst Pharm 1998 ; 55: 926-929. |
Stability of mycophenolate mofetil in an extemporaneously compounded oral liquid
Anaizi NH, Swenson CF, Dentinger PJ. |
1998 |
| 4574 |
Journal
Am J Hosp Pharm 2021 ;78,9:825–831 |
Stability of 10-mg/mL and 50-mg/mL ketamine oral solutions.
Ancedy D, Sebti M, Postaire M, Vidal F, Cisternino S. |
2021 |
| 1887 |
Journal
Int J Pharm 1995 ; 123: 229-235. |
Photochemical decomposition of midazolam. IV . Study of pH dependant stability by high-performance liquid chromatography.
Andersin R, Tammilehto S. |
1995 |
| 3571 |
Journal
Hosp Pharm 2014 ; 49, 1: 42-47. |
Physical and Chemical Compatibility of Injectable Acetaminophen During Simulated Y-Site Administration.
Anderson C, Boehme S, Ouellette J, Stidham C, MacKay M. |
2014 |
| 4303 |
Journal
Pharmacy 2015 3, 379-385. |
Stability of Fentanyl Citrate, Hydromorphone Hydrochloride, Ketamine Hydrochloride, Midazolam, Morphine Sulfate, and Pentobarbital Sodium in Polypropylene Syringes.
Anderson C, MacKay M. |
2015 |
| 3299 |
Journal
Am J Health-Syst Pharm 2012 ; 69:595-597. |
Stability of dexmedetomidine 4 µg/mL in polypropylene syringes.
Anderson C.R, Mackay M.W, Holley M, Kay B.A |
2012 |
| 3903 |
Journal
Int J Pharm Compound 2016 ; 20, 5 : 435-437. |
Stability of Sodium Nitroprusside in 5% Dextrose Stored at 4°C in Polypropylene Syringes Protected from Light.
Anderson Collin R, Collins D, Laursen T, Arave T, Helm M. |
2016 |
| 2132 |
Journal
Int J Pharm Compound 2015 ; 19, 4 : 344-347. |
Stability of Diphenhydramine Hydrochloride, Lorazepam, and Dexamethasone Sodium Phosphate in 0.9% Sodium Chloride Stored in Polypropylene Syringes.
Anderson Collin R, Halford Zachery, MacKay Mark. |
2015 |
| 1926 |
Journal
Am J Health-Syst Pharm 2004 ; 61: 394-396. |
Stability of zidovudine with oxytocin in a simulated Y-site injection.
Anderson PL, Miller S, Bushman LR. |
2004 |
| 2207 |
Journal
Am J Health-Syst Pharm 2007 ; 64, 18: 1950-1954. |
Stability of oxaliplatin in infusion bags containing 5% dextrose injection.
Andr? A, Cisternino S, Roy A.L, Chiadmi F, Schlatter J, Agranat P, Fain O, Fontan J.E. |
2007 |
| 2010 |
Journal
Ann Pharmacotherapy 2005 ; 39: 1462-1466. |
Stability of bortezomib 1 mg/ml solution in plastic syringe and glass vial.
André P, Cisternino S, Chiadmi F, Toledano A, Schlatter J, Fain O, Fontan JE. |
2005 |
| 1696 |
Journal
J Pharm Biomed Anal 1999 ; 21: 851-857. |
Photodegradation studies on Atenolol by liquid chromatography.
Andrisano V, Gotti R, Leoni A, Cavrini V. |
1999 |
| 1851 |
Journal
J Pharm Biomed Anal 2001 ; 25, 3-4: 589-597. |
Photostability and phototoxicity studies on diltiazem.
Andrisano V, Hrelia P, Gotti R, Leoni A, Cavrini V. |
2001 |
| 824 |
Journal
Am J Health-Syst Pharm 1998 ; 55: 1602-1605. |
Stability of albumin-free interferon alfa-2b for 42 days.
Appenheimer MM, Schepart BS, Poleon GP, Evans SS. |
1998 |
| 1809 |
Journal
EJHP 2003 ; 3: 34-42. |
Diluted solution of sodium ioxitalamate in paediatrics: A stability and cost effectiveness study.
Arrault XL, Rieutord A, Hassan M, Brion F. |
2003 |
| 1651 |
Journal
J Clin Pharm Ther 2002 ; 27: 205-209. |
Comparison of ceftazidime degradation in glass bottles and plastic bags under various conditions.
Ars?ne M, Favetta P, Favier B, Bureau J. |
2002 |
| 4145 |
Journal
Am J Health-Syst Pharm 2018 ;75,14:1048-1056 |
Physical compatibility of plazomicin with select i.v. drugs during simulated Y-site administration.
Asempa T.E, Avery L.M, Kidd J.M, Kuti J.L, Nicolau D.P. |
2018 |
| 1318 |
Journal
Pharm J 1987 ; 238: 116-118. |
Stability and administration of intravenous Augmentin.
Ashwin J, Lynn B, Taskis CB. |
1987 |
| 796 |
Journal
PDA J Pharm Sci Technol 1996 ; 50: 158-162. |
Photodegradation of furosemide solutions.
Asker AF, Ferdous AJ. |
1996 |
| 3082 |
Journal
J Oncol Pharm Practice 2009 ; 15: 195-200. |
Long-term stability of tramadol chlorhydrate and metoclopramide hydrochloride in dextrose 5% polyolefin bag at 4°C.
Athanasopoulos A, Hecq JD, Vanbeckbergen D, Jamart J, Galanti L. |
2009 |
| 3115 |
Journal
Ann Pharm Fr 2010 ; 68: 157-162. |
Long term stability of the hydrochloride of tramadol and alizapride in dextrose 5% polyolefin bags at 5 +/- 3°C.
Athanasopoulos A, Hecq JD, Vanbeckbergen D, Jamart J, Galanti L. |
2010 |
| 4139 |
Journal
Int J Pharm Compound 2018 ;22,4:326-328 |
Stability of Extemporaneously Prepared Sodium Benzoate Oral Suspensions.
Atkins J.R, Lull M.E, Decker A.S, Hutchinson D.J. |
2018 |
| 3964 |
Journal
Pharmactuel 2017 ; 50,1 : 27-33. |
Compatibilité du citrate de caféine injectable avec plusieurs autres médicaments.
Audet M.A, Forest E, Friciu M, Forest J.M, Leclair G. |
2017 |
| 150 |
Journal
J Pharm Clin 1993 ; 12: 31-35. |
Physicochemical compatibility of methotrexate with co-administered drugs during cancer chemotherapy regimens.
Aujoulat P, Coze C, Braguer D, Raybaud C. |
1993 |
| 3449 |
Journal
Ann Pharmacotherapy 2013 ; 47: 1237-1238. |
Stability of Betaxolol Suspensions in Oral Syringes and Glass Bottles.
Auvity S, Chiadmi F.M, Cisternino S, Fontan J.E, Schlatter J. |
2013 |
| 66 |
Journal
Can J Hosp Pharm 1996 ; 49: 140-145. |
Stability and compatibility of reconstituted hydromorphone with potassium chloride or heparin.
Avelar MA, Walker SE. |
1996 |
| 4434 |
Journal
Clin Ther 2019 ; 41, 10: 2162-2170. |
Assessment of the Physical Compatibility of Eravacycline and Common Parenteral Drugs During Simulated Y-site Administration.
Avery L.M, Chen, I.H, Reyes, S, Nicolau, D.P, Kuti J.L. |
2019 |
| 4698 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2022 |
Y-site compatibility of intravenous medications commonly used in intensive care units : laboratory tests on 75 mixtures involving nine main drugs.
Ayari G, D'Huart E, Vigneron J, Demoré B. |
2022 |
| 1971 |
Journal
Support Care Cancer 2001 |
Physical compatibility and in vivo evaluation of drug mixtures forsubcutaneous infusion to cancer patients in palliative care.
Azuara ML, Sanchez Y, Reyes R, Barcia E. |
2001 |
| 3466 |
Journal
Enferm Intensiva 2011 ;22:78-82. |
Compatibilidad física del bicarbonato sódico con fármacos de uso frecuente en la unidad de cuidados intensivos
B. Ribas Nicolau, E. P?rez Juan, S.M. Amor?s Cerd?, M.J. Ar?valo Rubert, M. Maqueda Palau. |
2011 |
| 708 |
Journal
Am J Hosp Pharm 1980 ; 37: 201-205. |
Nitroglycerin compatibility with intravenous fluid filters containers, and administration sets.
Baaske DM, Amann AH, Wagenknecht DM, Mooers M, Carter JE, Hoyt HJ, Stoll RG. |
1980 |
| 44 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 1701-1705. |
Stability of nicardipine hydrochloride in intravenous solutions.
Baaske DM, DeMay JF, Latona CA, Mirmira S, Sigvardson KW. |
1996 |
| 204 |
Journal
Am J Hosp Pharm 1994 ; 51: 2693-2696. |
Stability of esmolol hydrochloride in intravenous solutions.
Baaske DM, Dyskstra SD, Wagenknecht DM, Karnatz NN. |
1994 |
| 1115 |
Journal
Am J Hosp Pharm 1980 ; 37: 1050-1052. |
Stability of procainamide hydrochloride in dextrose solutions.
Baaske DM, Malick AW, Carter JE. |
1980 |
| 1151 |
Journal
J Chromatogr 1981 ; 212: 339-346. |
High-performance liquid chromatographic determination of sodium nitroprusside.
Baaske DM, Smith MD, Karnatz N, Carter JE. |
1981 |
| 1984 |
Journal
Am J Health-Syst Pharm 2005 ; 62: 182-188. |
Leaching of diethylhexyl phtalate from multilayer tubing into etoposide infusion solutions.
Bagel-Boithias S, Sautou-Miranda V, Bourdeaux D, Tramier V, Boyer A, Chopineau J. |
2005 |
| 315 |
Journal
Am J Health-Syst Pharm 1997 ; 54: 2599-2600. |
Visual compatibility of warfarin sodium injection with selected medications and solutions.
Bahal SM, Lee TJ, McGinnes M, Dobler GL. |
1997 |
| 279 |
Journal
Am J Hosp Pharm 1994 ; 51: 2159-2161. |
Stability of ceftriaxone sodium in injectable solutions stored frozen in syringes.
Bailey LC, Cappel KM, Orosz ST. |
1994 |
| 11 |
Journal
Am J Health-Syst Pharm 1997 ; 54: 424-427. |
Stability of ceftriaxone sodium and metronidazole hydrochloride.
Bailey LC, Orosz ST. |
1997 |
| 259 |
Journal
Am J Hosp Pharm 1993 ; 50: 2092-2094. |
Stability of ceftriaxone sodium in infusion-pump syringes.
Bailey LC, Tang KT, Medwick T. |
1993 |
| 347 |
Journal
Am J Hosp Pharm 1991 ; 48: 2627-2630. |
Effect of syringe filter and IV administration set on delivery of propofol emulsion.
Bailey LC, Tang KT, Rogozinski BA. |
1991 |
| 3125 |
Journal
Int J Pharm Compound 2010 ; 14, 4: 346-349. |
Compatibility and Stability of Cefotaxine, Vancomycin, and Ciprofloxacin in Antibiotic Lock Solutions Containing Heparin.
Baker D S, Waldrop Bruce, Arnold John. |
2010 |
| 341 |
Journal
Am J Hosp Pharm 1985 ; 42: 1352-1355. |
Compatibility of heparin sodium and morphine sulfate.
Baker DE, Yost GS, Craig VL, Campbell RK. |
1985 |
| 3075 |
Journal
EJHP Science 2009 ; 15, 4: 78-82. |
Compatibility and stability of parenteral analgesic admixtures for multimodal analgesia
Balayssac D, Badaroux L, Rodier C, Sautou-Miranda V, Bazin JE, Chopineau J. |
2009 |
| 3818 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2017 ;2, 1:11-16. |
Stability of 25 mg/mL 5-azacitidine suspension kept in fridge after freezing.
Balouzet C, Chanat C, Jobard M, Brandely-Piat M-L, Chast F. |
2017 |
| 3816 |
Poster
SFPO Congress, Nantes, France 2015 |
Stabilité des poches d'azacitidine pour injection intraveineuse (1- 4 et 2,4 mg/mL) conservées à 4°C.
Balouzet C, Chanat C, Jobard M, Brandely-Piat ML, Chast F. |
2015 |
| 1070 |
Journal
Am J Health-Syst Pharm 1999 ; 56: 1891. |
Concentration-dependent incompatibility of vinorelbine tartrate and heparin sodium.
Balthasar JP. |
1999 |
| 1135 |
Journal
Am J Hosp Pharm 1990 ; 47: 2075-2077. |
Visual compatibility of foscarnet with other injectable drugs during simulated Y-site administration.
Baltz JK, Kennedy P, Minor JR, Gallelli J. |
1990 |
| 1338 |
Journal
Am J Hosp Pharm 1985 ; 42: 777-778. |
Compatibility of total nutrient admixtures and secondary cardiovascular medications.
Baptista RJ, Dumas GJ, Bistrian BR, Condella F, Blackburn GL. |
1985 |
| 539 |
Journal
Drug Intell Clin Pharm 1988 ; 22: 592-593. |
Stability and compatibility of cimetidine hydrochloride and aminophylline in dextrose 5% in water injection.
Baptista RJ, Mitrano FP. |
1988 |
| 362 |
Journal
Am J Hosp Pharm 1985 ; 42: 2208-2210. |
Stability of cimetidine hydrochloride in a total nutrient admixture.
Baptista RJ, Palombo JD, Tahan SR, Valicenti AJ, Bistrian BR, Arkin CF, Blackburn GL. |
1985 |
| 1100 |
Journal
Ann Intern Med 1982 ; 97: 619. |
Precipitation of verapamil.
Bar-Or D, Kulig K, Marx JA, Rosen P. |
1982 |
| 3723 |
Journal
Archives de Pédiatrie 1998 ; 5, 10: 1170-1171. |
Stabilité des préparations extemporanées de doxapram (Doprams®) à usage néonatal.
Barb? F, Legagneur H, Boisseau D, Badonnel Y, Boutroy M.J. |
1998 |
| 2732 |
Journal
J Pharm Clin 1999 ; 18: 183-189. |
Stability of vancomycin eye drops.
Barbault S, Aymard G, Feldman D, Pointereau-Bellanger A, Thuillier A. |
1999 |
| 4424 |
Poster
11ème Recontres Convergences Santé Hôpital 2016 |
Etude de stabilité d'une suspension buvable de cloxacilline à usage pédiatrique.
Barbazan C, Le Daré, Lester M-A, Boivin P-N. |
2016 |
| 156 |
Journal
Anticancer Drugs 1995 ; 6: 163-164. |
Addition of heparin in 5-fluorouracil solution for portal vein infusion has no influence on its stability under clinically relevant conditions.
Barberi-Hayob M, Merlin JL, Vigneron M, Conroy T. |
1995 |
| 2176 |
Journal
Support Care Cancer 2007 ; 15: 57-62. |
Tramadol and hyoscine N-butyl bromide combined in infusion solutions: compatibility and stability.
Barcia E, Martin A, Azuara ML, Sanchez Y, Negro S. |
2007 |
| 1966 |
Journal
Support Care Cancer 2005 ; 13, 4: 239-245. |
Stability and compatibility of binary mixtures of morphine hydrochloride with hyoscine-n-butyl bromide.
Barcia E, Reyes R, Azuara L, Sànchez Y, Negro S. |
2005 |
| 1970 |
Journal
Support Care Cancer 2003 ; 11, 2: 107-113. |
Compatibility of haloperidol and hyoscine-N-butyl bromide in mixtures for subcutaneous infusion to cancer patients in palliative care.
Barcia E, Reyes R, Azuara M.L, S?nchez Y, Negro S. |
2003 |
| 3446 |
Poster
SFPO Congress, Mandelieu, France 2013 |
Stabilité physicochimique de solutions diluées d'ipilimumab : résultats préliminaires à 1 mois.
Bardo P, Vieillard V, Astier A, Paul M. |
2013 |
| 3850 |
Journal
Eur J Cancer 2016 ; 58: 8-16. |
Stability of ipilimumab in its original vial after opening allows its use for at least 4 weeks and facilitates pooling of residues.
Bardo-Brouard P, Vieillard V, Shekarian T, Marabelle A, Astier A, Paul M. |
2016 |
| 3456 |
Journal
Curr Med Res Opin 2011 ; 27, 12: 2241-2243. |
Short-term stability of a new generic sodium ferric gluconate in complex with sucrose.
Baribeault D. |
2011 |
| 2141 |
Journal
J Antimicrob Chemother 2003 ; 51: 651-658. |
Stability and compatibility study of cefepime in comparaison with ceftazidime for potential administration by continuous infusion under conditions pertinent to ambulatory treatment of cystic fibrosis patients and to administration in intensive care units.
Barinian N, Chanteux H, Viaene E, Servais H, Tulkens PM. |
2003 |
| 2017 |
Journal
Am J Health-Syst Pharm 2005 ; 62: 1969-1976. |
Visual compatibility of vasopressin with other injectable drugs.
Barker B, Feddema S, Rusho WJ, Dengg R. |
2005 |
| 2705 |
Journal
J Clin Pharm Ther 1994 ; 19, 6: 391-396. |
Stability of caffeine oral formulations for neonatal use.
Barnes AR, Hebron BS, Smith J. |
1994 |
| 2708 |
Journal
J Clin Pharm Ther 1999 ; 24: 299-302 |
Stability of ceftazidime in a viscous eye drop formulation
Barnes AR, Nash R. |
1999 |
| 512 |
Journal
Pharm World Sci 1995 ; 17: 87-92. |
Stability of bupivacaine hydrochloride with diamorphine hydrochloride in an epidural infusion.
Barnes AR, Nash S. |
1995 |
| 961 |
Journal
J Clin Pharm Ther 1990 ; 15: 187-196. |
Chemical stabilities of cefuroxime sodium and metronidazole in an admixture for intravenous infusion.
Barnes AR. |
1990 |
| 2717 |
Journal
J Liquid Chrom 1995 ; 18: 3117-3128. |
Determination of ceftazidime and pyridine by HPLC: application to a viscous eye drop formulation.
Barnes AR. |
1995 |
| 4673 |
Journal
Pharmaceutics 2022 ;14,1:118 |
Physicochemical Stability of a Novel Tacrolimus Ophtalmic Formulation for the Treatment of Ophtalmic Inflammatory Diseases.
Barrieu M, Chennell P, Yessaad M, Bouattour Y, Wasiak M, Jouannet M, Le Basle Y, Sautou V. |
2022 |
| 592 |
Journal
J Pharm Clin 1989 ; 8: 101-106. |
Effects of storage temperature and pH on the stability of cefotaxime in PVC bags.
Barthes D, Fauconneau B, Martin JP, Courtois P. |
1989 |
| 161 |
Journal
Am J Hosp Pharm 1994 ; 51: 2706-2709. |
Stability and compatibility of etoposide in 0.9% sodium chloride injection in three containers.
Barthes DM, Rochard EB, Pouliquen IJ, Rabouan SM, Courtois PY. |
1994 |
| 2530 |
Journal
Int J Pharm Compound 2022 ;26,4:330-335 |
Physicochemical and Microbiological Stability of Vancomycin 10-mg/mL Intravitreal Syringes.
Bartoll A, Bellés Medall M, Peñarrocha J, Escrig L, Clemente R, Azuara J. |
2022 |
| 337 |
Journal
Am J Hosp Pharm 1988 ; 45: 2532-2533. |
Visual compatibility of zidovudine with other drugs during simulated Y-site administration.
Bashaw ED, Amantea MA, Minor JR, Galleli JF. |
1988 |
| 3956 |
Journal
ASAIO Journal 2005 ; 51,6:761-763. |
Prolonged Stability of Stored Vancomycin, Gentamicin, and Heparin for Use in the Antibiotic-Lock Technique.
Bastani B; Amin K; Herr A. |
2005 |
| 2155 |
Journal
Perit Dial Int 1995 ; 15: 72-74. |
Stability of ofloxacin in peritoneal dialysis solutions.
Battista C, Kane MP, Moon DG, Bailie GR. |
1995 |
| 3951 |
Journal
Hemodial Int 2009 ; 13, 3: 322-328. |
Antibiotic lock: In vitro stability of vancomycin and four percent sodium citrate stored in dialysis catheters at 37°C
Battistella M, Walker S, law S, Lok C. |
2009 |
| 3952 |
Journal
Hemodial Int 2010 ; 14, 3 : 322-326. |
Antibiotic lock: In vitro stability of gentamicin and sodium citrate stored in dialysis catheters at 37°C.
Battistella M,. Vercaigne L.M, Cote D,. Lok C.E. |
2010 |
| 2737 |
Journal
J Pharm Pharmacol 1996 ; 48, 1: 22-26. |
Chemical stability of artesunate injection and proposal for its administration by intravenous infusion.
Batty KT, Ilett KF, Timothy Davis ME. |
1996 |
| 33 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 1457-1458. |
Stability of fluorouracil in polypropylene syringes and ethylene vinyl acetate infusion-pump reservoirs.
Baud-Camus F, Crauste-Manciet S, Klein E, Richard L, Brossard D. |
1996 |
| 642 |
Journal
Hosp Pharm 1988 ; 23: 44,49, 59. |
Norepinephrine stability in saline solutions.
Baumgartner TG, Knudsen AK, Dunn AJ, Kilroy RA. |
1988 |
| 3722 |
Journal
Acta Pol Pharm 2014 ; 71, 4: 661-666. |
Stability of cilazapril in pediatric oral suspensions prepared from commercially available tablet dosage forms.
Beata J. Stanisz, Sylwia K. Paszun, Anna Zalewska. |
2014 |
| 1232 |
Journal
Br J Pharm Pract 1987 ; 9: 223-226, 236. |
A physical compatibility study of furosemide & flucloxacillin injections.
Beatson C, Taylor A. |
1987 |
| 3268 |
Journal
Am J Health-Syst Pharm 2012 ;69: 98. |
Physical compatibility of calcium gluconate and magnesium sulfate injections.
Beauregard N, Bertrand N, Dufour A, Blaizel O, Leclair G |
2012 |
| 4274 |
Journal
J Clin Anesth 2016 ; 35: 551-559. |
Stability of suxamethonium in pharmaceutical solution for injection by validated stability-indicating chromatographic method.
Beck W, Kabiche S, Balde I-B, Carret S, Fontan J-E, Cisternino S, Schlatter J. |
2016 |
| 287 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 1912-1914. |
Stability of ceftazidime (with arginine) in an elastomeric infusion device.
Bednar DA, Klutman NE, Henry DW, Fox JL, Strayer AH. |
1995 |
| 531 |
Journal
J Oral Maxillofac Surg 1994 ; 52: 393-396. |
Stability of reconstituted methohexital sodium.
Beeman CS, Dembo J, Bogardus A. |
1994 |
| 3137 |
Journal
Retina 2010 ; 30, 1: 81-84. |
Infliximab stability after reconstitution, dilution, and storage under refrigeration.
Beer PM, Wong SJ, Schartman JP, Kulas KE, Hartman CL, Giganti M, Falk NS. |
2010 |
| 482 |
Journal
J Parenter Sci Technol 1991 ; 45: 108-112. |
Chemical and physical stability of etoposide and teniposide in commonly used infusion fluids.
Beijnen JH, Beijnen-Bandhoe U, Dubbelman AC, Van Gijn R, Underberg WJM. |
1991 |
| 992 |
Journal
Ann Pharmacotherapy 1991 ; 25: 869. |
Visual compatibility of ondansetron and dexamethasone.
Beijnen JH, Koks CHW. |
1991 |
| 408 |
Journal
Am J Hosp Pharm 1986 ; 43: 3022-3027. |
Stability of intravenous admixtures of doxorubicin and vincristine.
Beijnen JH, Neef C, Meuwissen OJAT, Rutten JJMH, Rosing H, Underberg WJM. |
1986 |
| 632 |
Journal
J Parenter Sci Technol 1985 ; 39: 220-222. |
Stability of anthracycline antitumour agents in infusion fluids.
Beijnen JH, Rosing H, De Vries PA, Underberg WJM. |
1985 |
| 1160 |
Journal
Int J Pharm 1986 ; 32: 123-131. |
Aspects of the degradation kinetics of doxorubicin in aqueous solution.
Beijnen JH, van der Houwen OAGJ, Underberg WJM. |
1986 |
| 172 |
Journal
J Parenter Sci Technol 1992 ; 46: 111-116. |
Chemical stability of two sterile, parenteral formulations of cyclophosphamide (Endoxan) after reconstitution and dilution in commonly used infusion fluids.
Beijnen JH, van Gijn R, Challa EE, Kaijser GP, Underberg WJM. |
1992 |
| 684 |
Journal
Ann Pharmacotherapy 1990 ; 24: 1056-1058. |
Chemical stability of suramin in commonly used infusion fluids.
Beijnen JH, Van Gijn R, Horenblas S, Underberg WJM. |
1990 |
| 1827 |
Journal
J Parenter Sci Technol 1990 ; 44: 332-335. |
Chemical stability of the antitumor mitomycin C in solutions for intravesical instillation.
Beijnen JH, Van Gijn R, Underberg WJM. |
1990 |
| 381 |
Journal
J Parenter Sci Technol 1993 ; 47: 166-171. |
Chemical stability of the cardioprotective agent ICRF-187 in infusion fluids.
Beijnen JH, Van Gijn R. |
1993 |
| 481 |
Journal
J Parenter Sci Technol 1989 ; 43: 84-87. |
Stability of vinca alkaloid anticancer drugs in three commonly used infusion fluids.
Beijnen JH, Vendrig DEMM, Underberg WJM. |
1989 |
| 4350 |
Journal
EJHP 2019 ;0:1-5 |
Physicochemical stability of an admixture of lidocaine and ketamine in polypropylene syringe used in opioid-free anaesthesia.
Beiler B, Barraud D, Vigneron J, Demor? B. |
2019 |
| 1501 |
Journal
Int J Pharm 1999 ; 185: 113-121. |
Compatibility of plastics with cytotoxic drug solutions - comparison of polyethylene with other container materials.
Beitz C, Bertsch T, Hannak D, Schrammel W, Einberger C, Wehling M. |
1999 |
| 1691 |
Journal
Krankenhauspharmazie 1999 ; 20: 121-125 |
Stabilität und kompatibilität von zytostatika-zubereitungen mit infusionlösungsbehältern aus polyethylen.
Beitz C, Einberger C, Wehling M. |
1999 |
| 1802 |
Journal
Am J Health-Syst Pharm 2003 ; 60: 193-194. |
Visual compatibility of doxapram hydrochloride with drugs commonly administered via a Y-site in the intensive care nursery.
Bell MS, Nolt DH. |
2003 |
| 19 |
Journal
Am J Hosp Pharm 1986 ; 43: 1444-1453. |
Stability of intravenous admixtures of aztreonam and cefoxitin, gentamicin, metronidazole, or tobramycin.
Bell RG, Lipford LC, Massanari MJ, Riley CM. |
1986 |
| 4087 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2018 ;3,1:31-37 |
Stability of 5 mg/mL Nitrendipine Oral Suspension in SyrSpend® SF PH4.
Bellay R, Bonnaure A.C, Rault P, Pertuisel S, Lester M.A, Boivin P.N. |
2018 |
| 258 |
Journal
Am J Hosp Pharm 1994 ; 51: 901-904. |
Stability of aztreonam and ampicillin sodium-sulbactam sodium in 0.9% sodium chloride injection.
Belliveau PP, Nightingale CH, Quintiliani R. |
1994 |
| 281 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 1561-1563. |
Stability of cefotaxime sodium and metronidazole in 0.9% sodium chloride injection or in ready-to-use metronidazole bags.
Belliveau PP, Nightingale CH, Quintiliani R. |
1995 |
| 238 |
Journal
Am J Hosp Pharm 1993 ; 50: 950-952. |
Stability of metoprolol tartrate in 5% dextrose injection or 0.9% sodium chloride injection.
Belliveau PP, Shea BF, Scavone JM. |
1993 |
| 4455 |
Journal
J Oncol Pharm Practice 2020 online first |
Physical and chemical stability of cytarabine in polypropylene syringes.
Ben Ayed W, Drira C, Ali Soussi M, Ouesleti H, Hamdene B, Khrouf M, Safta F, Fradi I. |
2020 |
| 2281 |
Journal
Int J Pharm Compound 2008 ; 12, 5: 460-462. |
Compatibility and stability of palonosetron hydrochloride with lactated Ringer's, Hetastarch in lactated electrolyte, an mannitol injections during simulated Y-site administration.
Ben M, Kupiec T, Trusley C, Trisel LA. |
2008 |
| 2286 |
Journal
Int J Pharm Compound 2008 ; 12, 4: 368-371. |
Physical and chemical stability of palonosetron hydrochloride with glycopyrrolate and neostigmine during simulated Y-site administration.
Ben M, Trusley C, Kupiec TC, Trissel LA. |
2008 |
| 2214 |
Journal
Int J Pharm Compound 2007 ; 11, 6: 520-524. |
Palonosetron hydrochloride compatibility and stability with three beta-lactam antibiotics during simulated Y-site administration.
Ben M, Trusley C,Kupiec T.C, Trissel L.A. |
2007 |
| 162 |
Journal
Int J Pharm 1994 ; 105: 83-87. |
Compatibility study of methotrexate with PVC bags after repackaging into two types of infusion admixtures.
Benaji B, Dine T, Goudaliez F, Luyckx M, Brunet C, Mallevais ML, Gressier B, Cazin M, Cazin JC. |
1994 |
| 164 |
Journal
J Clin Pharm Ther 1994 ; 19: 95-100. |
Stability and compatibility of cisplatin and carboplatin with PVC infusion bags.
Benaji B, Dine T, Luyckx M, Brunet C, Goudaliez F, Mallevais ML, Cazin M, Gressier B, Cazin JC. |
1994 |
| 385 |
Journal
Am J Hosp Pharm 1988 ; 45: 1117-1118. |
Visual compatibility of amiodarone hydrochloride with various antimicrobial agents during simulated Y-site injection.
Benedict MK, Roche VF, Banakar UV, Hilleman DE. |
1988 |
| 268 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 1850-1851. |
Ciprofloxacin and sodium phosphate not compatible during actual Y-site injection.
Benjamin BE. |
1996 |
| 3473 |
Journal
Int J Pharm 2015 ; 495, 2: 956-962. |
Stability of a highly concentrated solution of epirubicin for conventional transcatheter arterial chemoembolization.
Bennis Y, Savry A, Correard F, Montana M, Sauzet C, Gauthier-Villano L, Pisano P, Pourroy B. |
2015 |
| 1178 |
Journal
Am J Hosp Pharm 1981 ; 38: 1914-1918. |
Stability and compatibility of antitumor agents in glass and plastic containers.
Benvenuto JA, Anderson RW, Kerkof K, Smith RG, Loo TL. |
1981 |
| 2984 |
Journal
EJHP Science 2007 ; 13-67-72. |
The development of a stable oral solution of captopril for paediatric patients.
Berger-Gryllaki M, Podilsky G, Widmer N, Gloor S, Testa B, Pannatier A. |
2007 |
| 1420 |
Journal
J Clin Pharm Ther 1999 ; 24: 125-132. |
Compatibility of tirofiban HCl with dopamine HCl, famotidine, sodium heparin, lidocaine HCl and potassium chloride during simulated Y-site administration.
Bergquist PA, Hunke WA, Reed RA, Manas D, Forsyth RJ, Kenney RR, Cook J, Holahan M. |
1999 |
| 1603 |
Journal
Am J Health-Syst Pharm 2001 ; 58: 1218-1223. |
Stability and compatibility of tirofiban hydrochloride during simulated Y-site administration with other drugs.
Bergquist PA, Manas D, Hunke WA, Reed RA. |
2001 |
| 1071 |
Journal
Am J Health-Syst Pharm 1999 ; 56: 1627-1629. |
Stability of tirofiban hydrochloride in three commonly used IV solutions and polyvinyl chloride administration sets.
Bergquist PA, Zimmermann J, Kenney RR, Han RYH, Hunke WA. |
1999 |
| 3418 |
Journal
Int J Pharm Bio Sci 2013 ; 3, 1: 449-458. |
Chemical stability of bortezomib solutions in original manufacturer vial at room temperature and in syringe at 4°C.
Berruezo garcia J, Espinosa Bosch M, Sanchez Rojas F, Bosch Ojeda C |
2013 |
| 3112 |
Journal
J Antimicrob Chemother 2010 ; 65: 1073-1075 |
Stability of meropenem and doripenem solutions for administration by continuous infusion
Berthoin K, Le Duff, CS , Marchand-Brynaert J, Carryn S, Tulkens PM |
2010 |
| 3542 |
Journal
Am J Health-Syst Pharm 2015 ; 72:390-395 |
Compatibility of cefepime and vancomycin during simulated Y-site administration of prolonged infusion
Berti A.D, Hutson P.R, Schulz L.T, Webb A.P, Rose W.E. |
2015 |
| 4472 |
Journal
Pharmaceutics 2020 ;12, 781 |
Stability of Ophthalmic Atropine Solutions for Child Myopia Control.
Berton B, Chennell P, Yessaad M, Bouattour Y, Jouannet M, Wasiak M, Sautou V. |
2020 |
| 865 |
Journal
Int J Pharm Compound 1998 ; 2: 79-81. |
Physical compatibility and chemical stability of atracurium besylate and midazolam hydrochloride during intravenous coinfusion.
Bhatt-Mehta V, Hirata S. |
1998 |
| 225 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 511-513. |
Stability of fentanyl citrate and midazolam hydrochloride during simulated intravenous coadministration.
Bhatt-Mehta V, Johnson CE, Leininger N, Agarwal M. |
1995 |
| 309 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 192-196. |
Stability of propofol with parenteral nutrient solutions during simulated Y-site injection.
Bhatt-Mehta V, Paglia RE, Rosen DA. |
1995 |
| 232 |
Journal
Am J Hosp Pharm 1993 ; 50: 285-288. |
Stability of midazolam hydrochloride in parenteral nutrient solutions.
Bhatt-Mehta V, Rosen DA, King RS, Marsym CJ. |
1993 |
| 3812 |
Journal
Int J Pharm Compound 2015 ; 19, 5 : 432-436. |
In-use Stability of Ceftaroline Fosamil in Elastomeric Home Infusion Systems and MINI-BAG Plus Containers.
Bhattacharya S, Parekh S, Dedhiya M. |
2015 |
| 896 |
Journal
J Clin Pharm Ther 1992 ; 17: 223-227. |
Sorption studies of dipotassium clorazepate salt (Tranxene®) and midazolam hydrochloride (Hypnovel®) in polyvinyl chloride and glass infusion containers.
Bianchi C, Airaudo CB, Gayte-Sorbier A. |
1992 |
| 2305 |
Journal
Anaesthesia 2008 63, 9: 972-978. |
Stability and compatibility of drug mixtures in an implantable infusion system.
Bianchi F, Ginggen A, Tardy Y. |
2008 |
| 702 |
Journal
J Pharm Clin 1998 ; 17: 145-148. |
Stability of vancomycin in polyolefine or PVC bags and glass vials.
Biellmann-Berlaud V, Willemin JC. |
1998 |
| 21 |
Journal
Am J Hosp Pharm 1986 ; 43: 2803-2809. |
Compatibility of imipenem-cilastatin sodium with commonly used intravenous solutions.
Bigley FP, Forsyth RJ, Henley MW. |
1986 |
| 4256 |
Journal
Pharmaceutics 2019 ;11,190: |
Preparation and Physicochemical Stability of Liquid Oral Dosage Forms Free of Potentially Harmful Excipient Designed for Pediatric Patients.
Binson G, Beuzit K, Migeot V, Marco L, Troussier B, Venisse N, Dupuis A. |
2019 |
| 4211 |
Journal
PlosOne 2019 |
Overcoming stability challenges during continuous intravenous administration of high-dose amoxicillin using portable elastomeric pumps.
Binson G, Grignon C, Le Moal G, Lazaro P, Lelong J, Roblot F, Venisse N, Dupuis A. |
2019 |
| 4492 |
Journal
Int J Antimicrob Agents 2020 |
Preparation and physicochemical stability of 50 mg/ml hydroxychloroquine oral suspension in Syrspend pH4 dry.
Binson G, Venisse N , Sauvaget A , Bacle A , Lazaro P , Dupuis A. |
2020 |
| 4050 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2017 ;2,4:193-201 |
Preparation and physico-chemical stability of dexamethasone oral suspension.
Binson G, Venisse N, Bacle A, Beuzit K, Dupuis A. |
2017 |
| 840 |
Journal
Can J Hosp Pharm 1986 ; 39: 60-66. |
Stability of 5-fluorouracil and flucytosine in parenteral solutions.
Biondi L, Nairn JG. |
1986 |
| 1035 |
Journal
J Parenter Sci Technol 1983 ; 37: 129-132. |
Compatibility of several antibiotics or hydrocortisone when added to metronidazole solution for intravenous infusion.
Bisaillon S, Sarrazin R. |
1983 |
| 1730 |
Journal
Act Pharm Nord 1991 ; 3: 251. |
Chemical compatibility of mitoxantrone and etoposide (VP-16).
Björkman S, Roth B. |
1991 |
| 1009 |
Journal
J Pharm Sci 1988 ; 77: 630-634. |
Studies on the stability of vinblastine sulfate in aqueous solution.
Black J, Buechter DD, Chinn JW, Gard J, Thurston DE. |
1988 |
| 827 |
Journal
Drug Intell Clin Pharm 1988 ; 22: 634-636. |
Stability of vinblastine sulfate when exposed to light.
Black J, Buechter DD, Thurston DE. |
1988 |
| 917 |
Journal
EJHP 1994 ; 4: 12-13. |
Stability of refrigerated and frozen solutions of ondansetron hydrochloride.
Blaise N, Vigneron J, Perrin A, Noirez V, Hoffman MA, Hoffman M. |
1994 |
| 399 |
Journal
Aust J Hosp Pharm 1993 ; 23: 260-262. |
Stability of midazolam in sodium chloride infusion packs.
Bleasel MD, Peterson GM, Jestrimski KW. |
1993 |
| 2020 |
Journal
Can J Hosp Pharm 2005 ; 58: 65-70. |
Effect of freezing on stability of a fortified 5 mg/ml ticarcillin ophtalmic solution.
Blondeel S, Pelloquin A, Pointereau-Bellanger A, Thuillier A, Fernandez C. |
2005 |
| 665 |
Journal
Int J Pharm Compound 2005 ; 9, 4: 323-326. |
Stability of Nebulizer Admixtures.
Blondino, FE, Baker M. |
2005 |
| 2215 |
Journal
Chem Pharm Bull 1984 ; 32, 3: 1113-1119. |
Hydrolysis of succinylcholine chloride in pH range 3.0 to 4.5.
Boehm J.J, Poust R.I. |
1984 |
| 1050 |
Journal
Am J Hosp Pharm 1984 ; 41: 300-302. |
Shelf life of unrefrigerated succinylcholine chloride injection.
Boehm JJ, Dutton DM, Poust RI. |
1984 |
| 1908 |
Journal
J Pain Symptom Manage 2004 ; 28, 1: 4-6. |
Long-term stability of sufentanil citrate with levobupivacaine hydrochloride in 0.9% sodium chloride infusion PVC bags at 4°C.
Boitquin L, Hecq JD, Evrard JM, Vanbeckbergen D, Jamart J, Galanti L. |
2004 |
| 1938 |
Journal
Ann Pharmacotherapy 2004 ; 38: 1836-1839. |
Stability of sufentanil citrate with levobupivacaine hydrochloride in NaCl 0.9% after microwave freeze-thaw treatment.
Boitquin LP, Hecq JD, Vanbeckbergen DF, Jamart J, Galanti LM. |
2004 |
| 4520 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2020 |
Physicochemical stability of compounded midazolam capsules over a one-year storage period.
Boivin P-N, Legendre P, Bonnaure A-C, M-A. |
2020 |
| 4484 |
Journal
Drugs R D 2022 ;22, 95–104 |
In Vitro Stability and Recovery Studies of Pimavanserin in Water and in Different Vehicles Orally Administered.
Bokser A D, Holmes Adegbenle Y, Stoisavljevic V, Norton J C. |
2022 |
| 3190 |
Journal
Advance in Haematology 2009 Article ID 704928, 5 page |
An NMR Study of the Bortezomib Degradation under Clinical Use Conditions.
Bolognese A, Esposito A, Manfra M, Catalano L, Petruzziello F, Martorelli MC, Pagliuca R, Mazzarelli V, Ottiero M, Scalfaro M, |
2009 |
| 3898 |
Journal
EJHP 2016 ;23:288-293 |
Chemical and microbiological stability studies of an aqueous solution of pravastatin sodium salt for drug therapy of the dysphagic patients
Bonacucina G, Logrippo S, Cespi M, Ganzetti R, Casettari L, Sestili M, Perinelli D.R, Ricciutelli M, Marziali A, Polidori C, Pa |
2016 |
| 3019 |
Journal
Curr Med Res Opin 2007 ; 23: 2477-2483. |
Compatibility of arformoterol tartrate inhalation solution with three nebulized drugs.
Bonasia P, Cook C, Cheng Y et al. |
2007 |
| 2803 |
Journal
Respiratory Care 2008 ; 683, 12: 1716-1722. |
Chemical and physical compatibility of levalbuterol inhalation solution concentrate mixed with budesonide, ipratropium bromide, cromolyn sodium or acetylcysteine sodium.
Bonasia PJ, McVicar WK, Williams B, Ong S. |
2008 |
| 2077 |
Journal
Ann Emerg Med 1990 ; 19: 1242-1244. |
Stability of epinephrine in alkalinized solutions.
Bonhomme L, Benhamou D, Comoy E, Preaux N. |
1990 |
| 4077 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2018 |
Physicochemical Stability of 5 mg/mL Pediatric Prednisone Oral Suspensions in Syrspend® SF PH4.
Bonnaure Anne-Claire, Bellay R, Rault P, Lester M.A, Boivin P.N. |
2018 |
| 4104 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2018 |
Formulation of a 3-months Stability Oral Viscous Budesonide Gel and Development of an Indicating Stability HPLC Method.
Bonnet M, Dermu M, Roessle C, Bellaiche M, Abarou T, Vasseur V, Benakouche S, Storme T. |
2018 |
| 4708 |
Journal
Drugs R D 2022 ; 22,3: 225–234 |
Study of the Stability of Sandoz Rituximab Biosimilar Rixathon®/Riximyo® When Subjected for up to 21 Days to Ambient Storage.
Borišek R, Mischo A, Šmid I. |
2022 |
| 4676 |
Poster
EAHP Congress Vienna 2022 |
Assessing the stability of Sandoz rituximab biosimilar after exposure to out-of-fridge conditions for 21 days.
Borišek R, Šmid I. |
2022 |
| 444 |
Journal
Am J Hosp Pharm 1992 ; 49: 2756-2760. |
Stability of an ofloxacin injection in various infusion fluids.
Bornstein M, Kao SH, Mercorelli M, Verma S. |
1992 |
| 626 |
Journal
Am J Hosp Pharm 1982 ; 39: 1495-1498. |
Moxalactam disodium compatibility with intramuscular and intravenous diluents.
Bornstein M, Lo AY, Thomas PN, Wilham WL. |
1982 |
| 1371 |
Journal
Am J Hosp Pharm 1985 ; 42: 2436. |
Crystal formation after reconstituting cefazolin sodium with 0.9% sodium chloride injection.
Bornstein M, Templeton RJ. |
1985 |
| 1882 |
Journal
Ziekenhuisfarmacie 1993 ; 9: 97-101. |
Decrease of sufentanil citrate concentration during formulation and application of an epidural infusion solution.
Bosch EH, Van Doorne H, Brouwers JRBJ, Marskamp A, Meevis RF. |
1993 |
| 3349 |
Journal
Int J Pharm Bio Sci 2012 ; 2, 3: 344-350. |
Chemical stability of bortezomib solutions in original manufacturer vials.
Bosch-Ojeda C, Sanchez-Rojas M.F, Espinosa-Bosch M. |
2012 |
| 183 |
Journal
Am J Hosp Pharm 1992 ; 49: 2223-2225. |
Stability of ondansetron hydrochloride in injectable solutions at -20, 5, and 25°C.
Bosso JA, Prince RA, Fox JL. |
1992 |
| 418 |
Journal
Am J Hosp Pharm 1985 ; 42: 2211-2214. |
Stability of clindamycin phosphate and ceftizoxime sodium, cefoxitine sodium, cefamandole nafate, or cefazolin sodium in two intravenous solutions.
Bosso JA, Townsend RJ. |
1985 |
| 4249 |
Journal
PeerJ 2018 |
Stability of an ophtalmic formulation of polyhexamethylene biguanide in gamma-sterilized and ethylene oxide sterilized low density polyethylene multi dose eyedroppers.
Bouattour Y, Chennell P, Wasiak M, Jouannet M, Sautou V. |
2018 |
| 4671 |
Journal
Int J Antimicrob Agents 2020 ; 56: 106083. |
Voriconazole topical cream formulation: evidence for stability and antifungal activity.
Bouchand C, Nguyen D, Secretan P-H, Vidal F, Guery R, Auvity S, Cohen J.F, Lanternier |
2020 |
| 3948 |
Journal
JPEN 2012 ;30. 416?424. |
Compatibility of Intravenous Medications With Parenteral Nutrition - In Vitro Evaluation.
Bouchoud L, Fonzo-Christe C, Klingm?ller M, Bonnabry P . |
2012 |
| 2012 |
Journal
Am J Health-Syst Pharm 2005 ; 62: 2001-2005. |
Compatibility of ondansetron hydrochloride and methylprednisolone sodium succinate in multilayer polyolefin containers.
Bougouin C, Thelcide C, Crespin-Maillard F, Maillard C, Kinowski JM, Favier M. |
2005 |
| 3992 |
Journal
Int J Pharm 2016 ; 509 : 279:284. |
Formulation and charaterization of 0,1% rapamycin cream for the treatment of Tuberous Sclerosis Complex-related angiofibromas.
Bougueon G, Lagarce F, Martin L, Pailhoriès H, Bastiat G, Vrignaud S. |
2016 |
| 2000 |
Journal
J Pharm Biomed Anal 2005 ; 38: 180-185. |
Quality control and stability study using HPTLC: applications to cyclophosphamide in various pharmaceutical products.
Bouligand J, Storme T, Laville I, Mercier L, Oberlin O, Vassal J, Bourget Ph, Paci A. |
2005 |
| 780 |
Journal
Ann Pharmacotherapy 1996 ; 30: 1037-1038. |
Precipitation of lorazepam infusion.
Boullata J, Gelone SP, Mancano MA, Borenstein MR, Zitterman R. |
1996 |
| 2561 |
Journal
Aust J Hosp Pharm 1994 ; 24: 151-156. |
The stability of an enalapril maleate oral solution prepared from tablets.
Boulton DW, Woods DJ, Fawcett JP. |
1994 |
| 4661 |
Journal
J Pharm Biomed Anal 2022 |
Stability of a high-concentrated aqueous solution of idarubicin stored in a polypropylene syringe for transarterial chemoembolization
Bourcier B, Lagarce R, Lebreton V. |
2022 |
| 1895 |
Journal
J Pharm Biomed Anal 2004 ; 35: 57-64. |
Analysis by liquid chromatography and infrared spectrometry of di(2-ethylhexyl)phtalate released by multilayer infusion tubing.
Bourdeaux D, Sautou-Miranda V, Bagel-Boithias S, Boyer A, Chopineau J. |
2004 |
| 4192 |
Journal
Pediatric Anesthesia 2018 |
Quality control and stability of ketamine, remifentanil and sufentanil syringes in a pediatric operating theater.
Bourdon F, Simon N, Lannoy D, Berneron C, D?caudin B, Reumaux L, Duhamel A, Richart P, Odou P. |
2018 |
| 3757 |
Journal
Antimicrob Agents Chemother 2014 ; 58 : 2849-2855. |
How To Minimize Toxic Exposure to Pyridine during Continuous Infusion of Ceftazidime in Patients with Cystic Fibrosis?
Bourget P, Amin A, Dupont C, Abely M, Desmazes-Dufeu N, Dubus J.C, Jouani B.-L., Merlette C, Nov?-Josserand R, Pages J, Panzo R |
2014 |
| 3755 |
Journal
Int J Pharm Compound 2014 ; 18, 5: 427-431. |
Physicochemical and Microbiological Stabilities of Hydrocortisone in InOrpha Suspending Agent Studied Under Various Condition.
Bourget P, Amin A, Vidal F, Pieyre M, Dosso E.O, Beauvais R, Loeuillet R. |
2014 |
| 2341 |
Poster
Poster ESCP Stockholm May 2005 |
Release of di(2-ethylhexyl)phtalate from polyvinylchloride bags during docetaxel infusions
Bourlon S, Sautou-Miranda V, Dalle M. |
|
| 4719 |
Journal
SAGE Open Medicine 2022 ; 10: 20503121221135568. |
Prepared omadacycline for injection: Nine-day stability and sterility in an elastomeric pump.
Bower J, Wright K, Burdette J. |
2022 |
| 4166 |
Journal
J Clin Pharm Ther 1978 3:211-214 |
Stability of heparin in sodium chloride solution.
Bowie H.M, Haylor V. |
1978 |
| 1165 |
Journal
Int J Pharm 1980 ; 4: 263-265. |
Compatibility of the cephalosporin, cefamandole nafate with injections.
Bowtle WJ, Heasman MJ, Prince AP, Easthope DA. |
1980 |
| 580 |
Journal
Am J Hosp Pharm 1972 ; 29: 687-689. |
Stability of frozen solutions of sodium cephalothin and cephaloridine.
Boylan JC, Simmons JL, Winely CL. |
1972 |
| 1820 |
Journal
J Clin Pharm Ther 2003 ; 28: 471-474. |
Stability of dopamine hydrochloride 0.5 mg/ml in polypropylene syringes.
Braenden JU, Stendal TL, Fagernaes CB. |
2003 |
| 2262 |
Journal
Am J Health-Syst Pharm 2008 ; 65: 1261-1265. |
Compatibility of doripenem with other drugs during simulated Y-site administratioN
Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D. |
2008 |
| 4646 |
Journal
Int J Pharm Compound 2022 ;26,2:150-154 |
Stability Studies of Fludrocortisone Acetate Capsules and Fludrocortisone Acetate Titrated Powders (Powder Triturates).
Brandin T, Wasilewski M, Panuccio C, Bouguergour C, Primas N, Lamy E, Jean C, Bertault-Peres P, Rathelot P, Curti C, Vanelle P. |
2022 |
| 1412 |
Journal
Int J Pharm Compound 1999 ; 3: 64-66. |
Y-site stability of fosphenytoin and sodium phenobarbital.
Brett A, Riggs RM, Webster AA, Benner KW. |
1999 |
| 924 |
Journal
J Pharm Pharmacol 1998 ; 50: 407-411. |
Compatibility of tropisetron with glass and plastics. Stability under different storage conditions.
Brigas F, Sautou-Miranda V, Normand B, Geneve S, Chopineau J. |
1998 |
| 3897 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2016 ;1,2:83-89 |
Stability of Reconstituted and Diluted Mitomycin C Solutions in Polypropylene Syringes and Glass Vials.
Briot T, Truffaut C, Le Quay L, Lebreton A, Lagarce F. |
2016 |
| 1889 |
Journal
Int J Pharm 2015 ; 492 : 137?140. |
Stability of micafungin sodium solutions at different concentrations in glass bottles and syringes.
Briota Th, Vrignaud S, Lagarce F. |
2015 |
| 2138 |
Journal
Eur J Anaesthesiol 2002 ; 19: 295-297. |
Stability of a sufentanil-ropivacaine mixture in a glass and a PVC reservoir.
Brodner G, Ermert T, Van Aken H et al. |
2002 |
| 3949 |
Poster
JFSPH Congress, Bern, Switzerland. 2016 |
Optimisation du processus de préparation des solutions de melphalan destinées à l’administration intra-vitréenne dans le traitement du rétinoblastome et étude de leur stabilité
Brönnimann C, Berger-Gryllaki M, Podilsky G, Sadeghipour F. |
2016 |
| 170 |
Journal
Am J Hosp Pharm 1975 ; 62: 44-45. |
Effect of briefly heating cyclophosphamide solutions.
Brooke D, Scott JA, Bequette RJ. |
1975 |
| 1491 |
Journal
Eur Hosp Pharm 1995 ; 1: 12-14. |
Stability of sufentanil citrate and sufentanil citrate/bupivacaine mixture in portable infusion pump reservoirs.
Brouwers JRBJ, van Doorne H, Meevis RF, Boersma FP. |
1995 |
| 1329 |
Journal
Br J Parent Ther 1986 ; march/april: 42-44. |
Freeze-thaw stability of antibiotics used in an IV additive service.
Brown AF, Harvey DA, Hoddinott DJ, Britton. |
1986 |
| 4582 |
Journal
J Pharm Technol 2021 |
Beyond-Use Dates Assignment for Pharmaceutical Preparations: Example of Low-Dose Amiodarone Capsules.
Brun D, Curti C, Lamy E, Jean C, Bertault-Përez P, Broggi J, Tintori G, Vanelle P. |
2021 |
| 1965 |
Journal
PDA J Pharm Sci Technol 2004 ; 58, 6: 296-308. |
Photostability of sympatomimetic agents in commonly used infusion media in the absence and presence of bisulfite.
Brustugun J, Kristensen S, Tonnesen HH. |
2004 |
| 2089 |
Journal
Pharmazie 2004 ; 59: 457-463. |
Photostability of epinephrine - the influence of bisulfite and degradation products.
Brustugun J, Kristensen S, Tonnesen HH. |
2004 |
| 2827 |
Journal
Am J Health-Syst Pharm 2009 ; 66: 1722-1725. |
Long-term stability of extemporaneously prepared captopril oral liquids in glass bottles
Brustugun J, Lao YE, Fagern?s C, Br?nden J, Kristensen S. |
2009 |
| 3186 |
Journal
Am J Health-Syst Pharm 2011 ; 68:377-378. |
Physical compatibility of 4% sodium citrate with 23.4% sodium chloride, fluconazole, and micafungin.
Bryan Dotson B, Churchwell MD. |
2011 |
| 2720 |
Journal
J Ocular Pharm Ther 2007 ; 23, 3: 292-303. |
Formulation of sirolimus eye drops corneal permeation studies.
Buech G, Bertelmann E, Pleyer U, Siebenbrodt I, Borchert HH. |
2007 |
| 4602 |
Journal
Hosp Pharm 2021 ; 56, 4: 215-220. |
Physical and Chemical Stability of Dexamethasone Sodium Phosphate in Intravenous Admixtures Used to Prevent Chemotherapy-Induced Nausea and Vomiting.
Buga I, Uzoma J.I, Reindel K, Rashid K, Diep T, McCartan P, Zhao F. |
2021 |
| 3786 |
Journal
JAMA Ophtalmology 2014 ; 132, 11: 1372-1373. |
Stability of Melphalan Solution for Intravitreal Injection for Retinoblastoma
Buitrago E, Lagomarsino E; Mato G; Schaiquevich P. |
2014 |
| 673 |
Journal
JPEN 1989 ; 13: 505-509. |
The stability of amikacin, gentamicin, and tobramycin in total nutrient admixtures.
Bullock L, Clark JH, Fitzgerald JF, Glick MR, Hancock BG, Baenziger JC, Black CD. |
1989 |
| 355 |
Journal
Am J Hosp Pharm 1989 ; 46: 2326-2329. |
Stability of famotidine 20 and 50 mg/L in total nutrient admixtures.
Bullock L, Fitzgerald JF, Glick MR. |
1989 |
| 356 |
Journal
Am J Hosp Pharm 1989 ; 46: 2321-2325. |
Stability of famotidine 20 and 40 mg/L and amino acids in total parenteral nutrient solutions.
Bullock LS, Fitzgerald JF, Glick MR, Parks RB, Schnabel JG, Hancock BG. |
1989 |
| 553 |
Journal
Ann Pharmacotherapy 1989 ; 23: 132-135. |
Stability of famotidine in minibags refrigerated and/or frozen.
Bullock LS, Fitzgerald JF, Glick MR. |
1989 |
| 690 |
Journal
Ann Pharmacotherapy 1989 ; 23: 588-590. |
Stability of intravenous famotidine stored in polyvinyl chloride syringes.
Bullock LS, Fitzgerald JF, Mazur HI. |
1989 |
| 359 |
Journal
Am J Hosp Pharm 1985 ; 42: 2683-2687. |
Stability of ranitidine hydrochloride and amino acids in parenteral nutrient solutions.
Bullock LS, Parks RB, Lampasona V, Mullins RE. |
1985 |
| 3167 |
Journal
Farm Hosp 2010 ;34:293-7. |
Carvedilol stability in paediatric oral liquid formulations.
Buontempo F, Bernabeu E, Glisoni RJ, Quiroga E, Bregni C, Chiappetta DA. |
2010 |
| 3407 |
Journal
Farm Hosp 2013 ; 37, 21: 103-110. |
Suspensiones extratemporáneas de clobazam para uso pediátrico preparadas a partir de tabletas disponibles comercialmente y fármaco puro.
Buontempo F, Moretton M.A, E. Quiroga y D. A. Chiappetta. |
2013 |
| 54 |
Journal
J Pharm Clin 1995 ; 14: 26-30. |
Compatibility PVC-psychotropic drugs during an infusion.
Bureau A, Lahet JJ, D?Athis P, Vailleau JL, Cosmidis V, Martin L. |
1995 |
| 1907 |
Journal
Hosp Pharm 2004 ; 39: 554-557. |
Sustaining treatment of coccidioidal meningitidis by extending the stability of amphotericin B.
Burger DE, Caldwell JW. |
2004 |
| 1744 |
Journal
Am J Health-Syst Pharm 1999 ; 56: 384. |
Incompatibility of ceftriaxone sodium with lactated Ringer’s injection.
Burkiewicz JS. |
1999 |
| 151 |
Journal
Am J Hosp Pharm 1994 ; 51: 2704-2706. |
Stability of paclitaxel and fluconazole during simulated Y-site administration.
Burm JP, Choi JS, Jhee SS, Chin A, Ulrich RW, Gill MA. |
1994 |
| 47 |
Journal
Am J Hosp Pharm 1994 ; 51: 1201-1204. |
Stability of paclitaxel with ondansetron or ranitidine hydrochloride during simulated Y site administration.
Burm JP, Jhee SS, Chin A, Moon YSK. |
1994 |
| 3256 |
Journal
EJHP 2011 ; 17, 5: 49-56. |
Stability of Hospira filgrastim following changes to thermal and photic storage conditions.
Burnett B, Radic I. |
2011 |
| 2402 |
Journal
Am J Health-Syst Pharm 2006 ; 63: 2240-2247. |
Stability and viscosity of a flavored omeprazole oral suspension for pediatric use
Burnett JE, Balkin ER. |
2006 |
| 4407 |
Journal
Am J Health-Syst Pharm 2020 ;77,8:649–657. |
Compatibility of treprostinil sodium and dopamine hydrochloride during simulated Y-site administration.
Bustin A, Ramsey Z, Hanna B, Kaushal G. |
2020 |
| 3383 |
Journal
Farm Hosp 2013 ;37,1:4-9 |
Evaluación de la estabilidad de un jarabe de hidrato de cloral al 7% en envases mono y multidosis bajo condiciones ambiente y de refrigeración.
Bustos-Fierro C, Olivera M. E, Manzo P.G, Jimenez-Kairuz A.K. |
2013 |
| 703 |
Journal
Am J Hosp Pharm 1980 ; 37: 935-941. |
Effect of inline filtration on the potency of low-dose drugs.
Butler LD, Munson JM, DeLuca PP. |
1980 |
| 2320 |
Journal
EJHP Science 2009 ; 15, 1: 15-19. |
Effect of freezing, long-term storage and microwave thawing on the stability of sodium folinate.
Cadrobbi J, Hecq J.D, Vanbeckbergen D, Jamart J, Galanti L. |
2009 |
| 2331 |
Journal
Hospital Pharmacy Europe 2009 ; 42 : 30-31. |
Stability of 5-fluorouracil and sodium folinate admixture.
Cadrobbi J, Hecq J.D, Vanbeckbergen D, Jamart J, Galanti L. |
2009 |
| 2111 |
Journal
EJHP Science 2006 ; 12, 3: 57-59. |
Long-term stability of voriconazole 4 mg/ml in dextrose 5% polyvinyl chloride bags at 4°C.
Cadrobbi J, Hecq JD, Lebrun C, Vanbeckbergen D, Jamart J, Galanti L. |
2006 |
| 2204 |
Journal
J Oncol Pharm Practice 2007 ; 13: 99-103. |
Long-term stability of sodium folinate in dextrose 5% polyolefin bags at 4°C.
Cadrobbi J, Hecq JD, Vanbeckbergen D, Jamart J, Galanti L. |
2007 |
| 1399 |
Journal
Pharm J 1987 ; 238: 577. |
Incompatibility of ceftazidime and vancomycin.
Cairns CJ, Robertson J. |
1987 |
| 3488 |
Journal
Farm Hosp 1995 ; 19, 1: 41-44. |
Jarabe de midazolam: Estudio de estabilidad de una solucion oral para uso hospitaliaro.
Caldes R, Ciges S.M, Borras E, Calvelo R, Lisart F. |
1995 |
| 4111 |
Journal
Am J Health-Syst Pharm 2018 ;75,9:231-235 |
Stability of extemporaneously prepared ophtalmic solutions for mydriasis.
Camp N, Nadra J, Hughes S, Gilbert J, Zhao F. |
2018 |
| 4538 |
Journal
Archives of Disease in Childhood 2020 ; 105: 395-397. |
Compatibility of pentoxifylline and parenteral medications.
Campbell A, Petrovski M, Senarathna G, Mukadam ,Strunk T, Batty K. |
2020 |
| 242 |
Journal
Am J Hosp Pharm 1986 ; 43: 917-921. |
Stability of amiodarone hydrochloride in admixtures with other injectable drugs.
Campbell S, Nolan PE, Bliss M, Wood R, Mayersohn M. |
1986 |
| 4357 |
Journal
Nutrition in clinical Practice 2020 ; 35: 967-972. |
Physicochemical Compatibility of Dexmedetomidine With Parenteral Nutrition.
Campos-Baeta, Saavedra-Mitjans M, Garin N, Cardenete J, Cardona D, Riera P. |
2020 |
| 2335 |
Journal
Am J Health-Syst Pharm 2009 ; 66, 8: 727-729 |
Visual compatibility of i.v. medications routinely used in bone marrow transplant recipients
Canann D, Tyler L.S, Barker B, Condie C. |
2009 |
| 357 |
Journal
Am J Hosp Pharm 1988 ; 45: 1100-1102. |
Stability of ranitidine hydrochloride in total nutrient admixtures.
Cano SM, Montoro JB, Pastor C, Pou L, Sabin P. |
1988 |
| 4023 |
Journal
Hosp Pharm 2017 ; 52,7 : 478-482. |
Compounded Apixaban Suspensions for Enteral Feeding Tubes.
Carabello M, Donmez S, Nathan K, Zhao F. |
2017 |
| 3337 |
Journal
EJHP 2012 ; 19: 428-431. |
Stability of bortezomib reconstituted under clinical use conditions in original vials and polypropylene syringes at 4 °C and room temperature.
Carati D, Masini C, Minguzzi M, Petocchi B, Romanazzi C, Rondoni C, Sangiorgi E, Sferra S, Simonetta S, Stancari A, Locchi F, Z |
2012 |
| 1855 |
Journal
J Pharm Biomed Anal 2000 ; 23: 803-817. |
Furosemide assay in pharmaceuticals by Micellar liquid chromatography: study of the stability of the drug.
Carla-Broch S, Esteve-Romero J, Garcia-Alvarez-Coque MC. |
2000 |
| 4147 |
Journal
Minerva Anestesiologica 2014 ;81,3:283-287 |
Stability of generic brands of meropenem reconstituted in isotonic saline.
Carlier M, Stove V, Verstraete A.G, De Waele J.J. |
2014 |
| 2818 |
Journal
J Pharm Biomed Anal 1998 ; 17: 885-890. |
Stability of isoniazid in isoniazid syrup: formation of hydrazine
Carlin A, Gregory N, Simmons J. |
1998 |
| 707 |
Journal
Am J Hosp Pharm 1980 ; 37: 95-98. |
Solubility and stability of phenytoin sodium when mixed with intravenous solutions.
Carmichael RR, Mahoney CD, Jeffrey LP. |
1980 |
| 581 |
Journal
Am J Hosp Pharm 1976 ; 33: 639-641. |
Stability of frozen solutions of cefazolin sodium.
Carone SM, Bornstein M, Coleman DL, Thomas PN, Boylan JC. |
1976 |
| 4316 |
Journal
J Pharm Technol 2006 ;22:95-98. |
Stability of Omeprazole Sodium and Pantoprazole Sodium Diluted for Intravenous Infusion.
Carpenter J.F, McNulty M-A, Dusci L.J, Ilett K.F. |
2006 |
| 3704 |
Journal
Can J Hosp Pharm 2014 ; 67, 3:179-202. |
Stability of Epinephrine at Standard Concentrations
Carr R.R, Decarie D, Ensom M.H.H |
2014 |
| 3154 |
Journal
J Antimicrob Chemother 2010 ; 65, 9: 2045-2046. |
Long-term stability of temocillin in elastomeric pumps for outpatient antibiotic therapy in cystic fibrosis patients.
Carryn S, Couwenbergh N, Tulkens PM |
2010 |
| 829 |
Journal
Int J Pharm 1988 ; 42: 41-46. |
Examination of sorption and photodegradation of amsacrine during storage in intravenous burette administration sets.
Cartwright-Shamoon JM, McElnay JC, D'Arcy PF. |
1988 |
| 2399 |
Journal
Am J Health-Syst Pharm 2007 ; 64: 1513-1515. |
Stability of extemporaneously prepared sodium phenylbutyrate oral suspensions
Caruthers RL, Johnson CE. |
2007 |
| 4097 |
Journal
Pharm Dev Technol 2013 |
Physicochemical stability of captopril and enalapril extemporaneous formulations for pediatric patients.
Casas M, Alvarez J, Lucero M. |
2013 |
| 915 |
Journal
Ann Pharmacotherapy 1994 ; 28: 712-714. |
Stability of ondansetron stored in polypropylene syringes.
Casto DT. |
1994 |
| 4643 |
Journal
EJHP 2021 |
Evaluation of 30-day stability of morphine hydrochloride and clonidine at high and low concentrations in polypropylene syringes.
Catry E, Colsoul M-L, Closset M, Nyssen C, Hubert J, Soumoy L, Bihin B, Jamart J, Hecq J-D, Galanti L. |
2021 |
| 4691 |
Journal
Int J Pharm Compound 2022 ;26,3:248-254 |
Physical and Chemical Stability of Pharmaceutical Preparation of Bumetanide and Scopolamine.
Catry E, Colsoul ML, Closset Me, Hubert J, Soumoy L, Bihin B, Thiry E, Jamart J, Hecq JD, Galanti L. |
2022 |
| 1981 |
Journal
Am J Health-Syst Pharm 2002 ; 59: 2434-2439. |
Stability of i.v. mycophenolate mofetil in 5% dextrose injection in polyvinyl chloride infusion bags.
Certain E, Beteta F, Goudou-Sinha C, Darbord JC, Prognon P, Jacquot C. |
2002 |
| 288 |
Journal
Hosp Pharm 1992 ; 27: 957-958,961-962. |
Visual compatibility of injectable ciprofloxacin lactate with selected injectable drugs during simulated Y-site administration.
Cervenka P, Dejong DJ, Butler BL, Monzingo MD. |
1992 |
| 1611 |
Journal
Am J Health-Syst Pharm 2001 ; 58: 504-506. |
Visual compatibility of amiodarone hydrochloride injection with various intravenous drugs.
Chalmers JR, Bobek MB, Militello MA. |
2001 |
| 3557 |
Journal
Can J Hosp Pharm 2013 ; 66, 5: 310-312 |
Physical Incompatibility between Parenteral Cloxacillin and Vancomycin.
Chan A, Tawfik G, Cheng W. |
2013 |
| 2570 |
Journal
Am J Hosp Pharm 1994 ; 51: 1205-1207. |
Degradation of captopril in solutions compounded from tablets and standard powder.
Chan DS, Sato AK, Claybaugh JR. |
1994 |
| 1807 |
Journal
Can J Hosp Pharm 2003 ; 56, 2: 87-92. |
Stability of dolasetron mesylate in 0.9% sodium chloride and 5% dextrose in water.
Chan J, Walker SE, Law S. |
2003 |
| 2852 |
Journal
Int J Pharm Compound 2004 ; 8, 6: 486-488. |
Stability of Extemporaneous Oral Ribavirin Liquid Preparation
Chan JP, Tong HHY, Chow AHL. |
2004 |
| 2269 |
Journal
Am J Health-Syst Pharm 2008 ; 65, 16: 1545-1551. |
Compatibility of ceftobiprole medocaril with selected drugs during simulated Y-site administration.
Chan P, Bishop A, Kupiec TC, Trissel LA, Gole D, Jimidar IM, Vermeersch H. |
2008 |
| 2247 |
Journal
Int J Pharm Compound 2008 ; 12, 3: 276-278. |
Compatibility of caspofungin acetate injection with other drugs during simulated Y-site coadministration.
Chan P, Heatherly K, Kupiec T.C, Trissel L.A. |
2008 |
| 2005 |
Journal
Am J Health-Syst Pharm 2005 ; 62: 1347-1348. |
Influence of temperature and drug concentration on nafcillin precipitation.
Chan V. |
2005 |
| 94 |
Journal
Am J Hosp Pharm 1990 ; 47: 1970. |
Aztreonam-vancomycin incompatibility.
Chandler SW, Folstad J, Trissel LA. |
1990 |
| 1974 |
Journal
J Pain Symptom Manage 1996 ; 12, 3: 168-171. |
Combined administration of opoids with selected drugs to manage pain and other cancer symptoms initial safety screening for compatibility.
Chandler SW, Trissel LA, Weinstein SM |
1996 |
| 854 |
Journal
J Pharm Pharmacol 1979 ; 31: 853-854. |
The stability of melphalan in the presence of chloride ion.
Chang SY, Evans TL, Alberts DS. |
1979 |
| 2118 |
Journal
J Pain Symptom Manage 2006 ; 32, 1: 90-97. |
Microbiological and physicochemical stability of fentanyl and sufentanil solutions for patient-controlled delivery-systems.
Chapalain-Pargade S, Laville I, Paci A, Chachaty E, Mercier L, Bourget Ph. |
2006 |
| 4416 |
Journal
J Pediatr Pharmacol Ther 2015 ; 20, 3: 197-202. |
Stability of Hydrocortisone Preservative-Free Oral Solutions.
Chappe J, Osman N, Cisternino S, Fontan J-E, Schlatter J. |
2015 |
| 811 |
Journal
Am J Health-Syst Pharm 1998 ; 55: 1296-1298. |
Activity of enoxaparin sodium in tuberculin syringes for 10 days.
Charland SL, Davis DD, Tillman DJ. |
1998 |
| 3731 |
Journal
J Pharm Sci 1978 ; 67, 4: 526-530. |
Thermal and photolytic decomposition of methotrexate in aqueous solutions.
Chatterji D.C, Gallelli J.F. |
1978 |
| 1200 |
Journal
Am J Hosp Pharm 1981 ; 38: 1737-1742. |
Compatibility of netilmycin sulfate injection with commonly used intravenous injections and additives.
Chaudry IA, Bruey KP, Hurlburt LE, Oden EM. |
1981 |
| 3173 |
Poster
SNPHPU Congress France 2010 |
Stability of tetracaine eye-drops
Chaussard M, Bouche V, labat L, Brandely ML, Batista R, Chast F. |
2010 |
| 3761 |
Book
Master en pharmacie - University of Geneva 2014 |
Etude de la stabilité de solutions de prostaglandine E1 à 48 et 72 heures en vue d'une administration parentérale en continu à des patients de néonatalogie.
Chavan E. |
2014 |
| 3780 |
Journal
EJHP 2015 ;22:7-11 |
Stability of an epidural analgesic admixture containing butorphanol tartrate and ropivacaine hydrochloride
Chen F, Peng L, Zhou B, Fang B, Yang Y. |
2015 |
| 4116 |
Journal
Drug Design Dev Ther 2016 ;10:1869-1875 |
Stability of tramadol with three 5-HT3 receptor antagonists in polyolefin bags for patient-controlled delivery systems.
Chen F, Zhu J, Li B, Yuan F, Wang K. |
2016 |
| 3378 |
Journal
Am J Health-Syst Pharm 2013 ; 70:515-519. |
Compatibility of butorphanol and droperidol in 0.9% sodium chloride injection
Chen F-C, Fang B-X, Li P, Yang J-G, Zhou B-H. |
2013 |
| 4034 |
Journal
Afr J Pharm Pharmacol 2012 ;27,6:2055-2060 |
Compatibility and stability of lornoxicam with morphine, tramadol or fentanyl in infusion solutions.
Chen F-C, Fang B-X, Li P, Zheng F, Shi X-Y. |
2012 |
| 3805 |
Journal
Am J Health-Syst Pharm 2015 ; 72:1374-1378. |
Compatibility of butorphanol with granisetron in 0.9% sodium chloride injection packaged in glass bottles or polyolefin bags.
Chen F.C, Xiong H, Liu H.M, Fang B.X, Li P. |
2015 |
| 3475 |
Journal
Am J Health-Syst Pharm 2013 ;70:1966-1970. |
Incompatibility of ciprofloxacin and meropenem injections.
Chen L.Y, Chen J, Waters V, Boodhan S. |
2013 |
| 4559 |
Journal
Drug Design Dev Ther 2020 ;14, 4179-4187. |
Physical Compatibility and Chemical Stability of
Fentanyl and Naloxone Hydrochloride in 0.9% Sodium Chloride Injection Solution for Patient-Controlled Analgesia Administration.
Chen P, Chen F, Lei J, Zhou B. |
2020 |
| 4431 |
Journal
Medicine 2018 ; 97:50(e13698) |
Compatibility and stability of dezocine and tropisetron in 0.9% sodium chloride injection for patient-controlled analgesia administration.
Chen P, Chen F, Zhou B-H. |
2018 |
| 4681 |
Journal
Hosp Pharm 2022 ; 57, 1: 69-75. |
An Exploratory Study of a New Vancomycin Eye Drops Formulation for Extemporaneous Compounding.
Chen P, Mar Z, Giannetti A, Hughes S, Gilbert J, Zhao F. |
2022 |
| 668 |
Journal
Medicine 2015 ; 94(6):e432. |
Stability of Butorphanol–Tropisetron Mixtures in 0.9% Sodium Chloride Injection for Patient-Controlled Analgesia Use.
Chen, Fu-Chao; Shi, Xiao-Ya; Li, Peng; Yang, Jin-Guo; Zhou, Ben-Hong. |
2015 |
| 4487 |
Journal
Pharmaceutics 2020 ; 12, 786. |
Do Ophthalmic Solutions of Amphotericin B Solubilised in 2-Hydroxypropyl- -Cyclodextrins Possess an Extended Physicochemical Stability?
Chennell P, Yessaad M, Abd El Kader F, Jouannet M, Wasiak M, Bouattour Y, Sautou V. |
2020 |
| 125 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 1576-1579. |
Stability of thiopental sodium and propofol in polypropylene syringes at 23 and 4°C.
Chernin EL, Stewart JT, Smiler B. |
1996 |
| 409 |
Journal
Am J Hosp Pharm 1987 ; 44: 124-130. |
Stability of cisplatin, iproplatin, carboplatin, and tetraplatin in commonly used intravenous solutions.
Cheung YW, Cradock JC, Vishnuvajjala BR, Flora KP. |
1987 |
| 1028 |
Journal
Am J Hosp Pharm 1984 ; 41: 1802-1806. |
Stability of cytarabine, methotrexate sodium, and hydrocortisone sodium succinate admixtures.
Cheung YW, Vishnuvajjala BR, Flora KP. |
1984 |
| 1039 |
Journal
Am J Hosp Pharm 1984 ; 41: 1156-1159. |
Stability of azacitidine in infusion fluids.
Cheung YW, Vishnuvajjala BR, Morris NL, Flora KP. |
1984 |
| 152 |
Journal
Pharm Acta Helv 1995 ; 70: 141-148. |
Stability and compatibility of a mixture of the anti-cancer drugs etoposide, cytarabine and daunorubicine for infusion.
Chevrier R, Sautou V, Pinon V, Demecop F, Chopineau J. |
1995 |
| 2970 |
Journal
J Pharm Pharm Sci 2005 ; 8: 322-325. |
Stability of levamisole oral solutions prepared from tablets and powder.
Chiadmi F, Lyer A, Cisternino S et al. |
2005 |
| 396 |
Journal
Am J Hosp Pharm 1989 ; 46: 2057-2058. |
Visual compatibility of ranitidine hydrochloride with commonly used critical-care medications.
Chilvers MR, Lysne JM. |
1989 |
| 1995 |
Journal
Am J Health-Syst Pharm 2005 ; 62: 1073-1074. |
Extended stability of ascorbic acid in 5% dextrose injection and 0.9% sodium chloride injection.
Chin A, Liu S, Ting-Chan J, Gill MA. |
2005 |
| 27 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 1174-1176. |
Stability of granisetron hydrochloride with dexamethasone sodium phosphate for 14 days.
Chin A, Moon YSK, Chung KC, Gill MA. |
1996 |
| 669 |
Journal
Ann Pharmacotherapy 1994 ; 28: 35-36. |
Paclitaxel stability and compatibility in polyolefin containers.
Chin A, Ramakrishnan RR, Yoshimura NN, Jeong EWS, Nii LJ, DiMeglio LS. |
1994 |
| 314 |
Journal
Am J Health-Syst Pharm 1997 ; 54: 64-65. |
Visual compatibility of injectable drugs used in the intensive care unit.
Chiu MF, Schwartz ML. |
1997 |
| 235 |
Journal
Am J Hosp Pharm 1994 ; 51: 2273-2276. |
Stability of piperacillin sodium-tazobactam sodium and ranitidine hydrochloride in 0.9% sodium chloride injection during simulated Y-site administration.
Choi JS, Burm JP, Jhee SS, Chin A, Ulrich RW, Gill MA. |
1994 |
| 4205 |
Journal
J Kor Soc Hosp Pharm 2006 ;23,3:219-224 |
Stability of Carboplatin in normal saline : dependence on initial dilution concentration and storage time.
Choi S, O La H, Kim K, Kim S, Hwangbo S. |
2006 |
| 909 |
Journal
J Informed Pharmacother 2003 ; 13: 100-110. |
Stability of hydrocortisone in extemporaneously compounded suspensions.
Chong G, Decarie D, Ensom M.H.H. |
2003 |
| 306 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 170-173. |
Stability of bupivacaine hydrochloride and hydromorphone hydrochloride during simulated epidural coadministration.
Christen C, Johnson CE, Walters JR. |
1996 |
| 51 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 1541-1543. |
Stability of granisetron hydrochloride in a disposable elastomeric infusion device.
Chung KC, Chin A, Gill MA. |
1995 |
| 16 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 1554-1556. |
Compatibility of ondansetron hydrochloride and piperacillin sodium-tazobactam sodium during simulated Y-site administration.
Chung KC, Moon YSK, Chin A, Ulrich WU, Gill MA. |
1995 |
| 3821 |
Journal
Am J Health-Syst Pharm 2015 ; 72:2182-2188 |
Stability of furosemide and chlorothiazide stored in syringes.
Cies J.J, Moore W.S, Chopra A, Lu G, Mason R.W. |
2015 |
| 2621 |
Journal
Eur J Pharm Biopharm 2003 ; 55: 209-213. |
Stability of fludrocortisone acetate solutions prepared from tablets and powder.
Cisternino S, Schlatter J, Saulnier JL. |
2003 |
| 4470 |
Journal
Critical care 2005 ; 9(Suppl 1) P37 |
Continuous versus intermittent infusion of temocillin in intensive care unit patient.
Claeysoone K, Basma V, Hens R, Van Bambeke F, de Jongh R, Tulkens P. |
2005 |
| 1948 |
Journal
J Pain Symptom Manage 2004 ; 28, 6: 603-611. |
Stability of admixtures containing morphine sulfate, bupivacaine hydrochloride, and clonidine hydrochloride in an implantable infusion system.
Classen AM, Wimbish GH, Kupiec TC. |
2004 |
| 1498 |
Journal
Ann Pharmacotherapy 1996 ; 30: 409-412. |
Amphotericin B formulated in a lipid emulsion.
Cleary JD. |
1996 |
| 4736 |
Journal
J Pharm Biomed Anal 2023 |
An Ultra-High-Performance Chromatography method to study the long term stability of gemcitabine in dose banding conditions.
Closset M, Colsoul ML, Goderniaux N, Bihin B, Jamart J, Onorati S, Soumoy L, Hecq JD, Odou P, Galanti L. |
2023 |
| 4479 |
Journal
J Oncol Pharm Practice 2020 ;27,6:1328-1332 |
Long term stability of an admixture of alizapride and ondansetron in 0.9% sodium chloride solution polyolefin bags stored at 5 +/- 3°C.
Closset M, Goderniaux N, Colsoul M-L, Soumoy L, Bihin B, Jamart J, Odou P, Hecq J-D, galanti L. |
2020 |
| 3911 |
Journal
EJHP 2017 ; 24: 230-234. |
Does an interaction exist between ketamine hydrochloride and Becton Dickinson syringes?
Closset M, Hecq J D, Gonzalez E, Bihin B, Jamart J, L Galanti L. |
2017 |
| 4735 |
Journal
J Oncol Pharm Practice 2023 |
Long-term physicochemical stability of 5-fluorouracil at selected standardised rounded doses in polyolefin bags.
Closset M, Onorati S, Colsoul M-L, Goderniaux N, Bihin B, Jamart J, Soumoy L, Hecq J-D, Odou P, Galanti L. |
2023 |
| 4568 |
Journal
Journal of Chemotherapy 2021 |
Long-term physico-chemical stability of 5-fluorouracile at standardised rounded doses (SRD) in MyFuser® portable infusion pump.
Closset M,Onorati S, Colsoul M.L,Goderniaux N,Bihin B, Jamart J, Soumoy L, Hecq J.D, Odou P, Galanti L. |
2021 |
| 711 |
Journal
Am J Hosp Pharm 1980 ; 37: 492-496. |
Avaibility of diazepam from plastic containers.
Cloyd JC, Vezeau C, Miller KW. |
1980 |
| 2374 |
Journal
Am J Hosp Pharm 1990 ; 47: 147 - 150. |
Stability of cefotaxime in two peritoneal dialysis solutions
CM Paap CM, Nahata MC. |
1990 |
| 4694 |
Journal
PlosOne 2022 |
Stability evaluation of compounded hydroxyurea 100 mg/mL oral liquids using a novel analytical method involving chemical derivatization.
Coache D, Friciu M, Bernine Marcellin R, Bonnemain L, Viau A, Gaëlle Roullin V, Forest J.M, Leclair G. |
2022 |
| 4648 |
Journal
PlosOne 2021 16(11): e0260279. |
Stability evaluation of compounded clonidine hydrochloride oral liquids based on a solidphase extraction HPLC-UV method.
Coache D, Friciu M, Roullin G, Boule M, Forest J-M, Leclair G. |
2021 |
| 2221 |
Journal
Am J Health-Syst Pharm 2007 ; 64, 23: 2480-2482. |
Stability of 70% alcohol solutions in polypropylene syringes for use in ethanol-lock therapy.
Cober M.P, Johnson C.E. |
2007 |
| 3203 |
Journal
Am J Health-Syst Pharm 2011 ; 68:843-845. |
Stability of extemporaneously prepared glycopyrrolate oral suspensions.
Cober MP, Johnson CE, Sudekum D, Penprase K |
2011 |
| 3095 |
Journal
Am J Health-Syst Pharm 2010 ; 67: 287-289. |
Stability of extemporaneously prepared rifaximin oral suspensions.
Cober MP, Johnson CE, Lee J, Currie K. |
2010 |
| 2401 |
Journal
Am J Health-Syst Pharm 2007 ; 64: 644-646. |
Stability of an extemporaneously prepared alcohol-free phenobarbital suspension
Cober MP, Johnson CE. |
2007 |
| 2192 |
Journal
Am J Health-Syst Pharm 2007 ; 64, 13: 1410-1414. |
Physical compatibility and chemical stability of mycophenolate mofetil during simulated Y-site administration with commonly coadministered drugs.
Cochran BG, Sowinski KM, Fausel C, Overholser BR. |
2007 |
| 4770 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2023 ; 8(1): 20220010 |
Use of a liquid chromatography-tandem mass spectrometry method to assess the concentration of epinephrine, norepinephrine, and phenylephrine stored in plastic syringes.
Cohen A.C, Wiseman L, Al Faraj A, Andreou P, Hall R, Neira V.M. |
2023 |
| 763 |
Journal
Cancer Treat Rep 1985 ; 69: 1325-1326. |
Drug precipitation within IV tubing : A potential hazard of chemotherapy administration.
Cohen MH, Jonhson-Early A, Hood MA, McKenzie M, Citron ML, Jaffe N, Krasnow SH. |
1985 |
| 779 |
Journal
J Pharm Pharmacol 1986 ; 38: 51P. |
Stability of diamorphine hydrochloride with haloperidol in prefilled syringes for continuous subcutaneous administration.
Collins AJ, Abethell JA, Holmes SG, Rain R. |
1986 |
| 4248 |
Journal
Hosp Pharm 2019 ; 55, 3: 199-193. |
Long-Term Stability of Lorazepam in Sodium Chloride 0.9% Stored at Different Temperatures in Different Containers.
Colsoul M.L, Breuer A, Goderniaux N, Hecq J.D, Soumoy L, Bihin B, Jamart J, Galanti L. |
2019 |
| 384 |
Journal
Am J Hosp Pharm 1988 ; 45: 630-632. |
Visual compatibility of esmolol hydrochloride and various injectable drugs during simulated Y-site injection.
Colucci RD, Cobuzzi LE, Halpern NA. |
1988 |
| 386 |
Journal
Am J Hosp Pharm 1988 ; 45: 1357-1358. |
Visual compatibility of labetalol hydrochloride injection with various injectable drugs during simulated Y-site injection.
Colucci RD, Cobuzzi LE, Halpern NA. |
1988 |
| 715 |
Journal
Am J Hosp Pharm 1980 ; 37: 677-678. |
Stability of carmustine in the presence of sodium bicarbonate.
Colvin M, Hartner J, Summerfield M. |
1980 |
| 4332 |
Poster
JFSPH 2019 2019 |
Compatibilité de Glycophos® avec d’autres médicaments administrés en perfusion aux soins intensifs (SI).
Compatibilité de Glycophos® avec d’autres médicaments administrés en perfusion aux soins intensifs (SI) |
2019 |
| 427 |
Journal
Am J Hosp Pharm 1986 ; 43: 3027-3030. |
Stability of aqueous solutions of amoxicillin sodium in the frozen and liquid states.
Concannon J, Lovitt H, Ramage M, Tai LH, McDonald C, Sunderland VB. |
1986 |
| 2233 |
Journal
Am J Health-Syst Pharm 2008 ; 65, 5: 454-457. |
Visual compatibility of caspofungin acetate with commonly used drugs during simulated Y-site delivery
Condie C.K, Tyler L.S, Barker B, Canann D.M. |
2008 |
| 342 |
Journal
Am J Hosp Pharm 1985 ; 42: 339-342. |
Stability of an analgesic-sedative combination in glass and plastic single-dose syringes.
Conklin CA, Kerege JF, Christensen JM. |
1985 |
| 1333 |
Journal
J Clin Hosp Pharm 1982 ; 7: 245-250. |
The stability of amoxycillin sodium in intravenous infusion fluids.
Cook B, Hill SA, Lynn B. |
1982 |
| 304 |
Journal
Am J Hosp Pharm 1992 ; 49: 1455-1458. |
Stability, potency, and preservative effectiveness of epoetin alfa after addition of a bacterostatic diluent.
Corbo DC, Suddith RL, Sharma B, Naso RB. |
1992 |
| 138 |
Journal
Am J Health-Syst Pharm 1997 ; 54: 1845-1848. |
Precipitation of fluorouracil in elastomeric infusers with a polyisoprene reservoir and in polypropylene syringes with an elastomeric joint.
Corbrion V, Crauste-Manciet S, Allain P, Brossard D. |
1997 |
| 4517 |
Journal
EJHP 2020 |
Formulation, long-term physicochemical and microbiological stability of 15% topical resorcinol for hidradenitis suppurativa.
Cordero-Ramos J, Merino-Bohórquez V, Delgado-Valverde , Barros-Tornay R, Cameán-Fenández M, Calleja-Hernández M.A. |
2020 |
| 42 |
Journal
Am J Health-Syst Pharm 1997 ; 54: 422-423. |
Stability of bumetanide in 5% dextrose injection.
Cornish LA, Montgomery PA, Johnson CE. |
1997 |
| 3728 |
Journal
Am J Health-Syst Pharm 2014 ; 71: 1288-1291. |
Visual compatibility of defibrotide with selected drugs during simulated Y-site administration.
Correard F, Savry A, Gauthier-Villano L, Pisano P, Pourroy B. |
2014 |
| 1102 |
Journal
Eur J Clin Pharmacol 1981 ; 19: 181-185. |
Availability of isosorbide dinitrate, diazepam and chlormethiazole, from i.v. delivery systems.
Cossum PA, Roberts MS. |
1981 |
| 4121 |
Journal
Int J Pharm Compound 2018 ;22,3:252-256 |
The Use and Utility of Low-dose Naltrexone Capsules for Patients with Fibromyalgia.
Cote B, Ross B, Fortner J, Rao D. |
2018 |
| 3141 |
Journal
Can J Hosp Pharm 2010 ; 63, 4: 304-311. |
Stability of Trisodium Citrate and Gentamicin Solution for Catheter Locks after Storage in Plastic Syringes at Room Temperature.
Cote D, Lok CE, Battistella M, Vercaigne L. |
2010 |
| 4389 |
Journal
Pharmactuel 2019 ;52,4:206-213 |
Compatibilité physique des médicaments administrés en Y aux soins intensifs, en particulier la dexmédétomidine, le lévosimendan et la kétamine.
Côté K, Correal F, Metras M.E, Friciu M, Forest J.M, Leclair G. |
2019 |
| 286 |
Journal
Am J Hosp Pharm 1992 ; 49: 1459-1462. |
Stability of fluconazole and amino acids in parenteral nutrient solutions.
Couch P, Jacobson P, Johnson CE. |
1992 |
| 2730 |
Journal
J Pharm Pract and Res 2015 ; 45: 152-158. |
Evaluation of the physicochemical compatibility of cyclosporin infusion and parenteral nutrition when intravenously administered via the same central line lumen.
Coutsouvelis J, Yao-Da Dong, Witney K, Li W, Corallo C. |
2015 |
| 739 |
Journal
Am J Hosp Pharm 1978 ; 35: 402-406. |
Evaluation of some pharmaceutical aspects of intrathecal methotrexate sodium, cytarabine and hydrocortisone sodium succinate.
Cradock JC, Kleinmann LM, Rahman A. |
1978 |
| 2275 |
Journal
Int J Pharm 1998 ; 173: 221-232. |
Hydrolysis kinetics and stability predictions for a mixture of R and S temocillin isomers.
Craig Dyar S, Notari RE. |
1998 |
| 1075 |
Journal
J Pharm Biomed Anal 1997 ; 16: 199-205. |
Stability and compatibility of topotecan hydrochloride for injection with common infusion solutions and containers.
Craig SB, Bhatt UH, Patel K. |
1997 |
| 4560 |
Journal
J Pediatr Pharmacol Ther 2021 ; 26, 3: 265-270. |
Stability Determination of an Extemporaneously Compounded Ambrisentan Suspension by High Performance Liquid Chromatography Analysis.
Cramer J, Bevry M, Handler S, Tillman K, Abourashed E.A. |
2021 |
| 4477 |
Journal
GaBI Journal 2020 ; 9, 1: 5-13. |
Stability of the trastuzumab biosimilar ABP 980 compared to reference product after intravenous bag preparation, transport and storage at various temperatures, concentration and stress conditions.
Crampton S, Polozoxa A, Asbury D, Lueras A, Breslin P, Hippenmeyer J, Litkowski J,,Goss M. |
2020 |
| 3145 |
Journal
Am J Health-Syst Pharm 2010 ; 67: 1539-1544. |
Stability of doripenem in polyvinyl chloride bags and elastomeric pumps.
Crandon JL, Sutherland C, Nicolau DP. |
2010 |
| 1824 |
Journal
J Clin Pharm Ther 2003 ; 28: 363-369. |
Stability of reconstituted parecoxib for injection with commonly used diluents.
Crane IM, Mulhern MG, Nema S. |
2003 |
| 4108 |
Journal
Am J Health-Syst Pharm 2018 ;75;8:510-512 |
Physical compatibility of levetiracetam injection with heparin, dobutamine, and dopamine.
Cruz K, Chrchwell M, Mauro V, Boddu. |
2018 |
| 3416 |
Journal
Am J Health-Syst Pharm 2013 ; 70: 932-937 |
Physical compatibility of sodium citrate with alcohol and cefepime.
Csaba M, Boddu,S.H.S , Churchwell M.D. |
2013 |
| 1198 |
Journal
Am J Hosp Pharm 1982 ; 39: 1685-1687. |
Compatibility of propranolol hydrochloride injection with intravenous infusion fluids in plastic containers.
Cummings DS, Park MK, Howard B. |
1982 |
| 168 |
Journal
J Pharm Pharmacol 1993 ; 45: 6-9. |
The long term stability of mechlorethamine hydrochloride (Nitrogen Mustard) ointment measured by HPLC.
Cummings J, Maclellan A, Langdon SJ, Smyth JF. |
1993 |
| 2253 |
Journal
J Synchrotron Rad 2001 ; 8: 716-718. |
Carboplatin and oxaliplatin decomposition in chloride medium, monitored by XAS.
Curis E, Provost K, Bouvet D, Nicolis I, Crauste-manciet S, Brossard D, B?nazeth S. |
2001 |
| 2254 |
Journal
New J Chem 2000 ; 24: 1003-1008. |
Carboplatin decomposition in aqueous solution with chloride ions monitored by X-ray absorption spectroscopy.
Curis E, Provost K, Nicolis I, Bouvet D, B?nazeth S, Crauste-Manciet S, Brion F, Brossard D. |
2000 |
| 4326 |
Journal
Pharmazie 2019 ; 74: 357-362. |
Stability studies of antipyocyanic beta-lactam antibiotics used in continuous infusion.
Curti C, Harti Souab K, Lamy E, Mathias F, Bornet C, Guinard B, Fersing C, Primas N, Albanèse J, Vanelle P. |
2019 |
| 4345 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2019 |
Carbidopa Capsules for Insulinoma Diagnostic: Compounding and Stability Study.
Curti C, Mathias F, Savelli M, Garrigue P, Lamy E, Guillet B, Vanelle P. |
2019 |
| 2339 |
Journal
Can J Hosp Pharm 2002 ; 55, 3: 207-211. |
Stability of Trimethoprim in Admixtures of Trimethoprim–Sulfamethoxazole Prepared in Polyvinylchloride Bags and Glass Bottles
Curtis J.M, Edwards D.J. |
2002 |
| 706 |
Journal
Am J Hosp Pharm 1981 ; 38: 231. |
Compatibility of verapamil hydrochloride with other additives.
Cutie MR. |
1981 |
| 1057 |
Journal
Am J Hosp Pharm 1983 ; 40: 1205-1207. |
Compatibility of verapamil hydrochloride injection with commonly used additives.
Cutie MR. |
1983 |
| 1098 |
Journal
Ann Intern Med 1983 ; 98: 672. |
Verapamil precipitation.
Cutie MR. |
1983 |
| 3862 |
Journal
Hosp Pharm 2016 ; 51, 3: 246-251. |
Enzymatic Stability of Alteplase Solution for Injection: Effect of Various Methods of Thawing Frozen Solutions.
Cutshall B.T, Gorman G.S, Freeman M.K ,. Kyle J.A. |
2016 |
| 4118 |
Journal
Drug Design Dev Ther 2016 ;10:1029-1034 |
Stability studies of lincomycin hydrochloride in aqueous solution and intravenous infusion fluids.
Czarniak P, Boddy M, Sunderland B, Hughes J. |
2016 |
| 979 |
Journal
Int Pharm J 1995 ; 9: 57. |
In vitro compatibility of granisetron with selected alkaline drugs.
D'Arcy PF. |
1995 |
| 3275 |
Journal
Am J Health-Syst Pharm 2012 ; 69: 232-240. |
Stability of extemporaneously prepared cytarabine, methotrexate sodium, and methylprednisolone sodium succinate
D'Hondt M, Vangheluwe E, Van Dorpe S, Boonen J, Bauters T, Pelfrene B, Vandenbroucke J, Robays H, De Spiegeleer B |
2012 |
| 4761 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2023 ; 8(1): 20220009 |
Physicochemical stability of Cabazitaxel Zentiva® solution in vials after opening and diluted- solutions in three infusion bags.
D'Huart E, Sacrez M, Vigneron J, Demoré B. |
2023 |
| 4268 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2019 |
Physicochemical Stability of Cefotaxime Sodium in Polypropylene Syringes at High Concentrations for Intensive Care Units.
D'Huart E, Vigneron J, Blaise F, Charmillon A, Demoré B. |
2019 |
| 4348 |
Journal
Can J Hosp Pharm 2019 ;72(5):360-8 |
Physicochemical Stability of Vancomycin at High Concentrations in Polypropylene Syringes.
D'Huart E, Vigneron J, Charmillon A, Clarot I, Demoré B. |
2019 |
| 4250 |
Journal
Ann Pharm Fr 2019 ;77,3:212-221. |
Physicochemical stability of norepinephrine bitartrate in polypropylene syringes at high concentrations for intensive care units.
D'Huart E, Vigneron J, Clarot I, Demoré B. |
2019 |
| 4267 |
Journal
EJHP 2019 |
Physicochemical stability of nefopam and nefopam/droperidol solutions in polypropylene syringes for intensive care units.
D'Huart E, Vigneron J, Clarot I, Demoré B. |
2019 |
| 4254 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2019 ;4,1:29-40 |
Physical Compatibility of Intravenous Drugs Commonly Used in Intensive Care Units: An Observational Study and Physical Compatibility Laboratory Tests on Anti-Infective Drugs
D'Huart E, Vigneron J, Demoré B. |
2019 |
| 4125 |
Journal
EJHP 2020 ; 27, 1: 43-48. |
Physicochemical stability of etoposide diluted at range concentrations between 0.38 and 1.75 mg/mL in polyolefin bags.
D'Huart E, Vigneron J, Lider P, Demoré B. |
2020 |
| 4126 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2018 ;3,3:135-142 |
Physico-Chemical Stability of Sodium Thiosulfate Infusion Solutions in Polyolefin Bags at Room Temperature over a Period of 24 Hours.
D'Huart E, Vigneron J, Ranchon F, Vantard N, Rioufol C, Demor2 B |
2018 |
| 3415 |
Journal
Pharmaceut Anal Acta 2013 ; 4: 205 |
Stability-Indicating HPLC Assay and Stability Study Over Two Years of Morphine Hydrochloride Diluted Solutions in Polypropylene Syringes
d?Hayer B, Vieillard V, Astier A, Paul M |
2013 |
| 1893 |
Journal
Ann Pharmacotherapy 2004 ; 38: 569-573. |
Anti-Xa stability of diluted enoxaparin for use in pediatrics.
Dager WE, Gosselin RC, King JF, Christensen CL, Owings JT, Larkin EC. |
2004 |
| 1221 |
Journal
Am J Hosp Pharm 1980 ; 37: 460,464. |
Visual compatibility of dobutamine with seven parenteral drug products.
Dahlin PA, Paredes SM. |
1980 |
| 2175 |
Journal
J Pharm Clin 2006 ; 25, 3: 147-152. |
Peut-on conditionner les solutions de docétaxel dans des poches en PVC ?
Dalle M, Sautou-Miranda V, Balayssac D, Bourlon S, Bagel S, Chopineau J. |
2006 |
| 1249 |
Journal
Am J Hosp Pharm 1985 ; 42: 595-597. |
Stability of dopamine hydrochloride exposed to blue-light phototherapy.
Dandurand KR, Stennett DJ. |
1985 |
| 4143 |
Journal
EJHP 2016 ; 25, 4 |
Physicochemical stability of oxycodone-ketamine solutions in polypropylene syringe and polyvinyl chloride bag for patient-controlled analgesia use.
Daouphars M, Hervou?t C.H, Bohn P, Martin D, Rouvet J, Basuyau F, Varin R. |
2016 |
| 1505 |
Journal
Eur Hosp Pharm 1997 3,4: 154-6 |
Stability of cladribine in either polyethylene containers or polyvinylchloride bags.
Daouphars M, Vigneron J, Perrin A, Hoffman MA, Hoffman M. |
1997 |
| 239 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 655-658. |
Loss of quinidine gluconate injection in a polyvinyl chloride infusion system.
Darbar D, Dell'Orto S, Wilkinson GR, Roden DM. |
1996 |
| 585 |
Journal
J Clin Pharm Ther 1988 ; 13: 199-205. |
Chemical stabilities of cefaperazone sodium and ceftazidime in 5% dextrose and 0.9% sodium chloride injections.
Das Gupta V, Bethea C, Dela Torre M. |
1988 |
| 600 |
Journal
Am J IV Ther Clin Nut 1984 ; 11: 14-15, 18-19. |
Stability of piperacillin sodium in dextrose 5% and sodium chloride 0.9% injections.
Das Gupta V, Davis DD, Stewart KR. |
1984 |
| 1718 |
Journal
Int J Pharm Compound 2001 ; 5: 230-231. |
Stability of piperacillin sodium after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric use.
Das Gupta V, Ling J. |
2001 |
| 2354 |
Journal
Int J Pharm Compound 2000 ; 4, 5: 396-397. |
Stability of hydrocortisone sodium succinate after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric use.
Das Gupta V, Ling J. |
2000 |
| 652 |
Journal
Int J Pharm Compound 1997 ; 1: 208-209. |
Stability of cefmetazole sodium in 5% dextrose injection and 0.9% sodium chloride injection.
Das Gupta V, Maswoswe J, Bailey R.E, County H. |
1997 |
| 451 |
Journal
Int J Pharm Compound 1997 ; 1: 206-207. |
Stability of ketorolac tromethamine in 5% dextrose injection and 0.9% sodium chloride injections.
Das Gupta V, Maswoswe J, Bailey RE. |
1997 |
| 873 |
Journal
Int J Pharm Compound 1997 ; 1: 435-436. |
Stability of cefepime hydrochloride dextrose in 5% dextrose injection and 0.9% sodium chloride injection.
Das Gupta V, Maswoswe J, Bailey RE. |
1997 |
| 923 |
Journal
Int J Pharm Compound 1998 ; 2: 170-171. |
Stability of indomethacin in 0.9% sodium chloride injection.
Das Gupta V, Maswoswe J. |
1998 |
| 527 |
Journal
J Clin Pharm Ther 1987 ; 12: 339-342. |
Chemical stability of thiopental sodium injection in disposable plastic syringes.
Das Gupta V, Neal Gardner S, Jolowsky CM, Newcomer DR, Stewart KR. |
1987 |
| 567 |
Journal
Can J Hosp Pharm 1989 ; 42: 109-112. |
Stability of clindamycin phophate in dextrose and saline solutions.
Das Gupta V, Parasrampuria J, Bethea C, Wright W. |
1989 |
| 693 |
Journal
J Clin Pharm Ther 1988 ; 13: 329-334. |
Chemical stabilities of famotidine and ranitidine hydrochloride in intravenous admixtures.
Das Gupta V, Parasrampuria J, Bethea C. |
1988 |
| 68 |
Journal
J Clin Pharm Ther 1989 ; 14: 451-456. |
Stability of acyclovir sodium in dextrose and sodium chloride injections.
Das Gupta V, Pramar Y, Bethea C. |
1989 |
| 935 |
Journal
Int J Pharm Compound 1998 ; 2: 322-324. |
Stability of lorazepam in 5% dextrose injection.
Das Gupta V, Pramar Y. |
1998 |
| 2837 |
Journal
Int J Pharm Compound 2005 ; 9, 2: 165-166. |
Chemical Stability of Isoniazid in an Oral Liquid Dosage Form
Das Gupta V, Sood A. |
2005 |
| 1331 |
Journal
J Clin Hosp Pharm 1986 ; 11 : 449-452. |
Chemical stabilities of lignocaine hydrochloride and phenylephrine hydrochloride in aqueous solution.
Das Gupta V, Steward KR. |
1986 |
| 430 |
Journal
Am J Hosp Pharm 1986 ; 43: 1729-1731. |
Stability of vancomycin hydrochloride in 5% dextrose and 0.9% sodium chloride injections.
Das Gupta V, Stewart KR, Nohria S. |
1986 |
| 605 |
Journal
Am J Hosp Pharm 1982 ; 39: 292-294. |
Stability of haloperidol in 5% dextrose injection.
Das Gupta V, Stewart KR. |
1982 |
| 630 |
Journal
J Clin Hosp Pharm 1985 ; 10: 67-72. |
Stability of metronidazole and ten antibiotics when mixed with magnesium sulphate solutions.
Das Gupta V, Stewart KR. |
1985 |
| 631 |
Journal
J Parenter Sci Technol 1985 ; 39: 145-148. |
Chemical stabilities of hydrocortisone sodium succinate and several antibiotics when mixed with metronidazole injection for intravenous infusion.
Das Gupta V, Stewart KR. |
1985 |
| 636 |
Journal
J Clin Hosp Pharm 1986 ; 11: 47-54. |
Stability of cefuroxime sodium in some aqueous buffered solutions and intravenous admixtures.
Das Gupta V, Stewart KR. |
1986 |
| 1045 |
Journal
Am J Hosp Pharm 1984 ; 41: 686-689. |
Stability of dobutamine hydrochloride and verapamil hydrochloride in 0.9% sodium chloride and 5 % dextrose injections.
Das Gupta V, Stewart KR. |
1984 |
| 2513 |
Journal
Am J Hosp Pharm 1987 ; 44: 360-361. |
Stability of propranolol hydrochloride suspension and solution compounded from injection or tablets
Das Gupta V, Stewart KR. |
1987 |
| 1627 |
Journal
Int J Pharm Compound 2001 ; 5: 148-150. |
Chemical stability of methylprednisolone sodium succinate after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes.
Das Gupta V. |
2001 |
| 1628 |
Journal
Int J Pharm Compound 2001 ; 5: 482-484. |
Stability of pentobarbital sodium after reconstitution in 0.9% sodium chloride injection and repackaging in glass and polypropylene syringes.
Das Gupta V. |
2001 |
| 1711 |
Journal
Int J Pharm Compound 2002 ; 6: 234-236. |
Stability of cefotaxime sodium after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric use.
Das Gupta V. |
2002 |
| 593 |
Journal
J Pharm Sci 1984 ; 73: 565-567. |
Stability of cefotaxime sodium as determined by High-Performance Liquid Chromatography.
Das Gupta V. |
1984 |
| 648 |
Journal
Int J Pharm Compound 1997 ; 1: 282-283. |
Stability of mitomycin aqueous solution when stored in tuberculin syringes.
Das Gupta V. |
1997 |
| 649 |
Journal
Int J Pharm Compound 1997 ; 1: 280-281. |
Stability of ceftriaxone sodium when mixed with metronidazole injection.
Das Gupta V. |
1997 |
| 653 |
Journal
Int J Pharm Compound 1997 ; 1: 125-127. |
Quantification of metoprolol tartrate and propranolol hydrochloride in pharmaceutical dosage forms : stability of metoprolol in aqueous mixture.
Das Gupta V. |
1997 |
| 2358 |
Journal
Int J Pharm Compound 2000 ; 4, 6: 482-483. |
Stability of levothyroxine sodium injection in polypropylene syringes.
Das Gupta V. |
2000 |
| 2469 |
Journal
Am J Hosp Pharm 1981 ; 38: 363-364. |
Stability of aqueous suspensions of disulfiram
Das Gupta V. |
1981 |
| 2833 |
Journal
Int J Pharm Compound 2001 ; 5, 6: 480-481. |
Stability of an Oral Liquid Dosage Form of Glycopyrrolate Prepared from Tablets
Das Gupta V. |
2001 |
| 2834 |
Journal
Int J Pharm Compound 2003 ; 7, 5: 386-388. |
Stability of Oral Liquid Dosage Forms of Glycopyrrolate Prepared With the Use of Powder
Das Gupta V. |
2003 |
| 2835 |
Journal
Int J Pharm Compound 2007 ; 11, 3: 259-261. |
Chemical Stability of Hydrocortisone in an Oral Liquid Dosage Form without Suspending Agents
Das Gupta V. |
2007 |
| 2849 |
Journal
Int J Pharm Compound 2005 ; 9, 6: 484-486. |
Chemical Stability of Perphenazine in Oral Liquid Dosage Forms
Das Gupta V. |
2005 |
| 2876 |
Journal
Int J Pharm Compound 2009 ; 13, 5: 438-439. |
Chemical Stability of Scopolamine Hydrobromide Nasal Solution.
Das Gupta V. |
2009 |
| 2877 |
Journal
Int J Pharm Compound 2009 ; 13, 5: 445-446. |
Chemical Stability of Amitriptyline Hydrochloride in Oral Liquid Dosage Forms.
Das Gupta V. |
2009 |
| 1108 |
Journal
Crit Care Med 1983 ; 11: 50-52. |
Loss of nitroglycerin to cardiopulmonay bypass apparatus.
Dasta JF, Jacobi J, Wu LS, Sokoloski T, Beckley P, Reilley TE, Howie MB. |
1983 |
| 4032 |
Poster
EAHP Congress - Paris 2013 |
Stability of frozen ceftazidime in polypropylene syringes for intravitreal injection.
Daul A, Vigneron J, Zenier H, May I, Demor? B. |
2013 |
| 1316 |
Journal
Pharm J 1987 ; 239: 599-601. |
Sodium nitroprusside stability in light-protective administration sets.
Davidson SW, Lyall D. |
1987 |
| 4649 |
Journal
GaBI Journal 2021 ; 10, 4 |
Extended stability of the trastuzumab biosimilar ABP 980 (KANJINTI™) in polyolefin bags and elastomeric devices.
Davies L, Milligan K, Corris M, Clarke I, Dwyer P, Lee S-E, Teraoka J, Crouse-Zeineddini J, Hippenmeyer J. |
2021 |
| 507 |
Journal
Br J Anaesth 1992 ; 68: 414-417. |
Stability of fentanyl, bupivacaine and adrenaline solutions for extradural infusion.
Dawson PJ, Bjorksten AR, Duncan IP, Barnes RK, Beemer GH. |
1992 |
| 4651 |
Journal
Eur J Pedia 2021 ;180,1169–1176. |
Physical compatibility of alprostadil with selected drugs commonly used in the neonatal intensive care units.
De Basagoiti A, Katsumiti A, Abascal S, Bustinza A, López-Giménez L.R, Pascual P, De Miguel M, Campino A. |
2021 |
| 4491 |
Journal
Eur J Pedia 2020 |
Physical compatibility of alprostadil with selected drugs commonly used in the neonatal intensive care units.
De Basagoiti A, Katsumiti A, Abascal S, Bustinza A, López-Giménez L.R, Pilar P, De Miguel M, Campino A. |
2020 |
| 2376 |
Journal
J Sep Sci 2007 ; 30, 12: 1233-1238. |
Chemical stability of midazolam injection by high performance liquid chromatography.
de Diego M, Godoy G, Mennikent S. |
2007 |
| 3319 |
Journal
Int J Pharm 2012 ; 433, 1-2 : 119-120. |
Development and validation of a paediatric oral formulation of clonidine hydrochloride
de Goede A.L, Boedhram R.R, Eckhardt M, Hanff L.M, Koch B.C.P, Vermaat C.H, Vermes A. |
2012 |
| 2231 |
Journal
J Antimicrob Chemother 2008 ; 61, 2: 382-388. |
Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection.
de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S. |
2008 |
| 1147 |
Journal
J Pharm Pharmacol 1991 ; 43: 601-604. |
Influence of intravenous administration set composition on the sorption of isosorbide dinitrate.
De Muynck C, Colardyn F, Remon JP. |
1991 |
| 1148 |
Journal
J Pharm Pharmacol 1988 ; 40: 601-604. |
The sorption of isosorbide dinitrate to intravenous delivery systems.
De Muynck C, Remon JP, Colardyn F. |
1988 |
| 424 |
Journal
Am J Hosp Pharm 1986 ; 43: 1486-1488. |
Stability of pentamidine isethionate in 5% dextrose and 0.9% sodium chloride injections.
De NC, Alam AS, Kapoor JN. |
1986 |
| 3994 |
Journal
Int J Pharm Compound 2017 ; 3: 255-263 |
Stability of Alprazolam, Atropine Sulfate, Glutamine, Levofloxacin, Metoprolol Tartrate, Nitrofurantoin, Ondansetron Hydrochloride, Oxandrolone, Pregabaline, and Riboflavin in SyrSpend SF pH4 Oral Suspensions.
De Oliveira Ferreira A, Polonini H C, Loures da Silva S, Cerqueira de Melo V Augusto, de Andrade L, Fernandes Brand?o Marcos A. |
2017 |
| 3999 |
Journal
Int J Pharm Compound 2017 ; 21:4 :339-346 |
Stability of Acetazolamide, Baclofen, Dipyridamole, Mebeverine Hydrochloride, Propylthiouracil, Quinidine Sulfate, and Topiramate Oral Suspensions in SyrSpend SF PH4.
De Oliveira Ferreira, Polonini H, Loures da Silva S, Buzinari Aglio N.C, Abreu J, Fernandes Brand?o M.A. |
2017 |
| 4403 |
Journal
J Pharm Biomed Anal 2020 ; 179: 112973. |
Stability in clinical use and stress testing of meropenem antibiotic by direct infusion ESI-Q-TOF: Quantitative method and identification of degradation products.
De Souza Barbosa F, Capra Pezzi L, Tsao M, Manoela Dias Macedo S, Franco de Oliveira T, Schapoval EES, Mendez ASL. |
2020 |
| 525 |
Journal
Int J Pharm 1990 ; 65: 49-56. |
A study on the stability of three antineoplastic drugs and on their sorption by IV delivery systems and end-line filters.
De Vroe C, De Muynck C, Remon JP, Samsom M. |
1990 |
| 1462 |
Journal
J Pharm Pharmacol 1989 ; 41: 273-275. |
The availability of diltiazem: a study on the sorption by intravenous delivery systems and on the stability of the drug.
De Vroe C, de Muynck C, Remon JP, Scheldewaert R, Colardyn F. |
1989 |
| 4070 |
Journal
Hosp Pharm 2018 ;53, 2: 73-74. |
Stability of 2 mg/mL Adenosine Solution in Polyvinyl Chloride and Polyolefin Infusion Bags.
DeAngelis M, Ferrara A, Gregory K, Zammit K, Zhao F. |
2018 |
| 1197 |
Journal
Am J Hosp Pharm 1982 ; 39: 1681-1684. |
Stability of trimethoprim-sulfamethoxazole injection in five infusion fluids.
Deans KW, Lang JR, Smith DE. |
1982 |
| 1941 |
Journal
Am J Health-Syst Pharm 2004 ; 61: 1586-1589. |
Potency and stability of frozen urokinase solutions in syringes.
Dedrick SC, Ramirez-Rico J. |
2004 |
| 1341 |
Journal
Pharm J 1983 ; 230: 495-497. |
Stability of an intrathecal morphine injection formulation.
Deeks T, Davis S, Nash S. |
1983 |
| 3149 |
Journal
Diabetes Tech and Ther 2006 ; 8, 3: 358-368. |
In Vitro Stability of Insulin Lispro in Continuous Subcutaneous Insulin Infusion.
DeFelippis MR, Bell MA, Heyob JA, Storms SM. |
2006 |
| 3486 |
Journal
Cardiovasc Intervent Radiol 2013 ; 36: 237-238. |
Incompatibility of contrast medium and trisodium citrate.
Delcour C, Brunnix G. |
2013 |
| 1455 |
Journal
J Pharm Clin 1995 ; 14: 178-179. |
Etude de la stabilité de deux benzamides antiémétiques en poches PVC de chlorure de sodium 0.9% et de glucose 5% sur une période de 5 mois.
Demoré B, Raffy F, Commun N, Vigneron J, Hoffman MA, Hoffman M. |
1995 |
| 1819 |
Journal
J Clin Pharm Ther 2002 ; 27: 139-142. |
Leaching of diethyl hexyl phtalate from polyvinyl chloride bags into intravenous etoposide solution.
Demoré B, Vigneron J, Perrin A, Hoffman MA, Hoffman M. |
2002 |
| 1269 |
Journal
J Clin Pharm Ther 1988 ; 13: 335-340. |
Binding of drugs to end-line filters: a study of four commonly administered drugs in intensive care units.
DeMuynck C, De Vroe C, Remon JP, Colardyn F. |
1988 |
| 414 |
Journal
Am J Hosp Pharm 1989 ; 46: 2500-2505. |
Stability of azacitidine in lactated Ringer’s injection frozen in polypropylene syringes.
Den Hartigh J, Brandenburg HCR, Vermeij P. |
1989 |
| 4314 |
Journal
J Am Pharm Assoc 2017 ; 56, 4: 457-461. |
Effects of Time and Storage Conditions on the Chemical and Microbiologic Stability of Diluted Buprenorphine for Injection.
DenHerder J.M, Reed R.L, Sargent J.L, Bobe G, Stevens J.F, Helen E Diggs H.E. |
2017 |
| 224 |
Journal
Am J Hosp Pharm 1991 ; 48: 515-517. |
Stability of methadone hydrochloride in 0.9% sodium chloride injection in single-dose plastic containers.
Denson DD, Crews JC, Grummich KW, Stirm EJ, Sue CA. |
1991 |
| 2397 |
Journal
Am J Health-Syst Pharm 2007 Dentinger PJ, Swenson CF |
Stability of codeine phosphate in an extemporaneously compounded syrup
Dentinger PJ, Swenson CF. |
2007 |
| 2392 |
Journal
Am J Health-Syst Pharm 2000 ; 57: 1340-1342. |
Stability of famotidine in an extemporaneously compounded oral liquid
Dentinger PJ, Swenson CF, Anaizi NH. |
2000 |
| 2385 |
Journal
Am J Health-Syst Pharm 2002 ; 59: 953-956. |
Stability of pantoprazole in an extemporaneously compounded oral liquid
Dentinger PJ, Swenson CF, Anaizi NH. |
2002 |
| 2408 |
Journal
Am J Health-Syst Pharm 2003 ; 60: 1019-1022. |
Stability of nifedipine in an extemporaneously compounded oral solution
Dentinger PJ, Swenson CF, Anaizi NH. |
2003 |
| 2940 |
Journal
Am J Health-Syst Pharm 2001 ; 58: 1021-1024. |
Stability of amphotericin B in an extemporaneously compounded oral suspension.
Dentinger PJ, Swenson CF, Anaizi NH. |
2001 |
| 3848 |
Thesis
Thèse de doctorat en pharmacie 2014 |
Etude de stabilité d'un collyre à l'amphotéricine B 0,5%.
Dermu Marine. |
2014 |
| 3977 |
Journal
Drugs R D 2015 ;15:253-259. |
Stability of Melphalan in 0,9% Sodium Chloride Solutions Prepared in Polyvinyl Chloride Bags for Intravenous Injection.
Desmaris R.P, Mercier L, Paci A. |
2015 |
| 3470 |
Journal
Support Care Cancer 2012 ; 20: 2501-2509. |
Physical compatibility of binary and tertiary mixtures of morphine and methadone with other drugs for parenteral administration in palliative care.
Destro M, Ottolini L, Vicentini L, Boschetti S. |
2012 |
| 3001 |
Journal
Ann Pharm Fr 2015 ; 73: 108-113. |
Long-term stability of aciclovir in 0.9% NaCl infusion polyolefin bags at 2-8°C after freeze-thaw treatment: A generic product versus the brand name.
Dewulf J, Galanti L, Godet M, Gillet P, Jamart J, Hecq JD. |
2015 |
| 2808 |
Journal
Int J Pharm Compound 2015 ; 19, 3: 268-270. |
Long-term Stability of Cocaine Hydrochloride Aqueous Solution 50 mg/mL (5%) at Room Temperature and at 5°C ± 3°C in Glass Bottles.
Dewulf J, Hecq J.D, Huvelle S, Godet M, Gillet P, Jamart J, Galanti L.M. |
2015 |
| 486 |
Journal
Am J Health-Syst Pharm 1998 ; 55: 602, 604. |
Stability of carboplatin in polyvinyl chloride bags.
Diaz Amador F, Sevilla Azzati E, Herreros de Tajeda y Lopez-Coterilla A. |
1998 |
| 3201 |
Journal
J Pediatr Pharmacol Ther 2006 ; 11:233?6. |
Physical compatibility of alprostadil with commonly used IV solutions and medications in the neonatal intensive care unit.
Dice JE. |
2006 |
| 978 |
Journal
Can J Hosp Pharm 1994 ; 47: 147. |
Methotrexate and cytarabine for intrathecal administration.
Dick DM, Woloschuk DMM. |
1994 |
| 1479 |
Journal
Krankenhauspharmazie 1995 ; 1: 9-12. |
Cefamandolnafat und metronidazol. Chemische stabilität in einer mischung zur intravenösen infusion.
Digel S. |
1995 |
| 2546 |
Journal
Ann Pharmacotherapy 2000 ;34:600-605. |
Stability of suspension formulations of lansoprazole and omeprazole stored in amber-colored plastic oral syringes.
DiGiacinto JL, Olsen KM, BergmanKL, Hoie EB. |
2000 |
| 3996 |
Journal
Int J Pharm Compound 2017 ; 21,3 : 240-241. |
Updated Stability Data of Midazolam, Oseltamivir Phosphate, and Propranolol Hydrochloride in SyrSprend SF and Minoxidil in Espumil.
Dijkers E,Nanhekhan V,Thorissen A. |
2017 |
| 148 |
Journal
Pharm Weekbl [Sci] 1992 ; 14: 365-369. |
Stability and compatibility of four anthracyclines: doxorubicin, epirubicin, daunorubicin and pirarubicin with PVC infusion bags.
Dine T, Cazin JC, Gressier B, Luycks M, Brunet C, Cazin M, Goudaliez F, Mallevais ML, Toraub I. |
1992 |
| 1762 |
Journal
J Pharm Biomed Anal 1998 ; 18: 373-381. |
Stability study of fotemustine in PVC infusion bags and sets under various conditions using a stability-indicating high-performance liquid chromatographic assay.
Dine T, Khalfi F, Gressier B, Luyckx M, Brunet C, Ballester L, Goudaliez F, Kablan J, Cazin M, Cazin JC. |
1998 |
| 40 |
Journal
Pharm Sci Communications 1994 ; 4: 97-101. |
Stability and compatibility studies of four cytostatic agents (fluorouracil, dacarbazine, cyclophosphamide and ifosfamide) with PVC infusion bags.
Dine T, Lebegue S, Benaji B, Gressier B, Segard V, Goudaliez F, Luyckx M, Brunet C, Mallevais ML, Kablan J, Cazin M, Cazin JC. |
1994 |
| 144 |
Journal
Int J Pharm 1991 ; 77: 279-285. |
Stability and compatibility studies of vinblastine, vincristine, vindesine and vinorelbine with PVC infusion bags.
Dine T, Luyckx M, Cazin JC, Goudaliez F, Mallevais ML. |
1991 |
| 573 |
Journal
Drug Intell Clin Pharm 1977 ; 11: 542-548. |
Stability of antibiotic admixtures frozen in minibags.
Dinel BA, Ayotte DL, Behme RJ, Black BL, Whitby JL. |
1977 |
| 394 |
Journal
Am J Hosp Pharm 1989 ; 46: 2333-2335. |
Long-term stability of famotidine 20 mg/L in a total parenteral nutrient solution.
DiStefano JE, Mitrano FP, Baptista RJ, Der MM, Silvestri Ap, Palombo JD, Bistrian BR. |
1989 |
| 64 |
Journal
Am J Hosp Pharm 1992 ; 49: 1672. |
Additional data on visual compatibility of foscarnet sodium with morphine sulfate.
DiStefano JE, Outman WR. |
1992 |
| 4556 |
Journal
J Pharm Technol 2020 ; 36, 4: 126-129. |
The Physical Compatibility of Clinically Used Concentrations of Diltiazem Hydrochloride With Heparin Sodium.
Dobson, S.R, Mauro, V.F, Boddu, S.H.S, Churchwell, M.D. |
2020 |
| 1918 |
Journal
J Pharm Sci 1997 ; 86, 12: 1410-1416. |
Photodegradation of irinotecan (CPT-11) in aqueous solutions : identification of fluorescent products and influence of solution composition.
Dodds HM, Craik DJ, Rivory LP. |
1997 |
| 2143 |
Journal
J Pharm Biomed Anal 1998 ; 17: 785-792. |
The detection of photodegradation products of irinotecan (CPT-11, Campto®, Camptosar®), in clinical studies, using high-performance liquid chromatography/atmospheric pressure chemical ionisation/mass spectrometry.
Dodds HM, Robert J, Rivory LP. |
1998 |
| 1245 |
Journal
JPEN 1989 ; 13: 539-543. |
Insulin adsorption to three-liter ethylen vinyl acetate bags during 24-hour infusion.
Doglietto GB, Bellantone R, Bossola M, Perri V, Ratto C, Pacelli F, Sofo L, Migliore A, Manna R, Crucitti F. |
1989 |
| 1750 |
Journal
Int J Pharm Compound 1998 ; 2: 463-465. |
Chemical stability of meperidine hydrochloride in polypropylene syringes.
Donelly RF, Bushfield TL. |
1998 |
| 2840 |
Journal
Can J Hosp Pharm 2010 ; 63, 1 : 25-30. |
Stability of Diclofenac Sodium Oral suspensions Packaged in Amber Polyvinyl Chloride Bottles.
Donnell RF, Pascuet E, Ma C, Vaillancourt R. |
2010 |
| 3916 |
Journal
Int J Pharm Compound 2016 ; 20, 6 : 514-516. |
Stability of Fentanyl Citrate in Polyolefin Bags.
Donnelly R F. |
2016 |
| 2843 |
Journal
Int J Pharm Compound 2004 ; 8, 6: 489-491. |
Chemical Stability of Methadone Concentrate and Powder Diluted in Orange-Flavored Drink
Donnelly R. |
2004 |
| 4028 |
Journal
Hosp Pharm 2017 ;52,10 :704-708 |
Stability of Procainamide Injection in Clear Glass Vials and Polyvinyl Chloride Bags.
Donnelly R. |
2017 |
| 4164 |
Journal
Int J Pharm Compound 2018 ;22,5:412-416 |
Stability of Tranexamic Acid Mouth Rinse.
Donnelly R. |
2018 |
| 2297 |
Journal
Int J Pharm Compound 2008 ; 11, 6: 550-552 |
Physical compatibility and chemical stability of a concentrated solution of atropine sulfate (2 mg/ml) for use as an antidote in nerve agent casualties.
Donnelly R.F, Corman C. |
2008 |
| 2322 |
Journal
Can J Hosp Pharm 2009 ; 62, 1 |
Physical Compatibility and Chemical Stability of Ketamine–Morphine Mixtures in Polypropylene Syringes.
Donnelly R.F. |
2009 |
| 2345 |
Journal
Can J Hosp Pharm 2009 ; 62, 3: 226-231. |
Stability of aseptically prepared Tazocin solutions in polyvinyl chloride bags.
Donnelly R.F. |
2009 |
| 3263 |
Journal
Can J Hosp Pharm 2011 ; 64, 4: 289-290. |
Stability of buffered lidocaine in glass vials.
Donnelly R.F. |
2011 |
| 3435 |
Journal
Can J Hosp Pharm 2013 ; 66, 3 : 198. |
Stability of Diluted Ketamine Packaged in Glass Vials.
Donnelly R.F. |
2013 |
| 3926 |
Journal
Hosp Pharm 2016 ; 51 ; 11 : 915-921. |
Stability of Levodopa/Carbidopa Rectal Suspensions.
Donnelly R.F. |
2016 |
| 3078 |
Journal
Can J Hosp Pharm 2009 ; 62, 6: 464-468. |
Stability of celecoxib oral suspensions.
Donnelly RF, Pascuet E, Ma C, Vaillancourt R. |
2009 |
| 318 |
Journal
Am J Hosp Pharm 1994 ; 51: 512-514. |
Stability of citrated caffeine injectable solution in glass vials.
Donnelly RF, Tirona RG. |
1994 |
| 3181 |
Journal
Int J Pharm Compound 2011 ; 15, 1: 81-84. |
Stability of venlafaxine immediate-release suspension.
Donnelly RF, Wong K, Goddard R |
2011 |
| 1680 |
Journal
Int J Pharm Compound 2002 ; 6: 468-470. |
Chemical stability of furosemide in minibags and polypropylene syringes.
Donnelly RF. |
2002 |
| 1277 |
Journal
Can J Hosp Pharm 1999 ; 52: 150-155. |
Chemical stability of diphenhydramine hydrochloride in minibags and polypropylene syringes.
Donnelly RF. |
1999 |
| 2031 |
Journal
Int J Pharm Compound 2005 ; 9: 482-483. |
Chemical stability of fentanyl in polypropylene syringes and polyvinylchloride bags.
Donnelly RF. |
2005 |
| 2875 |
Journal
Can J Hosp Pharm 2004 ; 57, 5: 283.287. |
Chemical Stability of 4-Aminopyridine Capsules.
Donnelly RF. |
2004 |
| 3220 |
Journal
Can J Hosp Pharm 2011 , 64, 32: 192-198. |
Stability of Pantoprazole Sodium in Glass Vials, Polyvinyl Chloride Minibags, and Polypropylene Syringes.
Donnelly RF. |
2011 |
| 3230 |
Journal
Can J Hosp Pharm 2011 ; 64, 4: 241-245. |
Stability of Cefazolin Sodium in Polypropylene Syringes and Polyvinylchloride Minibags
Donnelly RF. |
2011 |
| 3231 |
Journal
Can J Hosp Pharm 2011 ; 64, 4 : 252-256. |
Stability of Ciprofloxacin in Polyvinylchloride Minibags.
Donnelly RF. |
2011 |
| 2695 |
Journal
Int J Pharm Compound 2015 ; 19, 3: 248-251. |
Stability of Metronidazole Suspensions.
Donnelly Ronald F, Ying James. |
2015 |
| 2329 |
Journal
Can J Hosp Pharm 2008 ; 61, 6: 426-430. |
Stability of Ketamine-Propofol mixtures for procedural sedation and analgesia in the emergency department.
Donnely R.F, Willman E, Andolfatto G. |
2008 |
| 3131 |
Journal
Can J Hosp Pharm 2010 ; 63, 2: 154-155. |
Physical compatibility of high-concentration bupivacaine with hydromorphone, morphine and fentanyl.
Donnely RF, Wong K, Spencer J. |
2010 |
| 659 |
Journal
Can J Hosp Pharm 1996 ; 49: 62-65. |
Epinephrine stability in plastic syringes and glass vials.
Donnely RF, Yen M. |
1996 |
| 1806 |
Journal
Can J Hosp Pharm 2002 ; 55, 5: 307-312. |
Chemical stability of dimenhydrinate in minibags and polypropylene syringes.
Donnely RF. |
2002 |
| 1931 |
Journal
Can J Hosp Pharm 2004 ; 4: 230-235. |
Physical compatibility and chemical stability of bupivacaine and hydromorphone in polypropylene syringes.
Donnely RF. |
2004 |
| 2172 |
Journal
J Oncol Pharm Practice 2006 ; 12, 4: 211-222. |
Physical and chemical stability of paclitaxel infusions in different container types.
Donyai P, Sewell GJ. |
2006 |
| 485 |
Journal
J Oncol Pharm Practice 1995 ; 1: 19-24. |
Stability of mitomycin C in different infusion fluids: compatibility with heparin and glucocorticosteroids.
Dorr RT, Liddil JD. |
1995 |
| 3122 |
Journal
Am J Health-Syst Pharm 2010 ; 67: 1195-1198. |
Physical compatibility of 4% sodium citrate with selected antimicrobial agents.
Dotson B, Lynn S, Savakis K, Churchwell MD. |
2010 |
| 3669 |
Journal
Ann Pharm Fr 2015 ; 73, 1: 31-36. |
Formulation and stability study of a pediatric 2% phenylephrine hydrochloride eye drop solution
Dreno C, Gicquel T, Harry .M, Tribut O, Aubin F, Brandhonneur N, Dollo G. |
2015 |
| 2076 |
Journal
Ann Emerg Med 2003 ; 42: 9-13. |
Stability and microbiology of inhalant N-acetylcysteine used as an intravenous solution for the treatment of acetaminophen poisoning.
Dribben WH, Porto SM, Jeffords BK. |
2003 |
| 90 |
Journal
Am J Hosp Pharm 1993 ; 50: 2561-2563. |
Stability of nitroglycerin concentrate for injection stored in plastic syringes.
Driver PS, Jarvi EJ, Gratzer PL. |
1993 |
| 2057 |
Journal
J Antimicrob Chemother 2003 ; 51: 849-855. |
Stability and in vitro efficacy of antibiotic-heparin lock solutions potentially useful for treatment of central venous catheter-related sepsis.
Droste JC, Jeraj HA, MacDonald A, Farrington K. |
2003 |
| 1992 |
Journal
J Pharm Clin 1999 ; 18, 3: 251-257. |
Traitement par étoposide oral : présentation adaptée à une meilleure observance pédiatrique hospitalière.
Drouard, VigneronJ, May I. |
1999 |
| 3976 |
Journal
Am J Health-Syst Pharm 2017 ; 74,16 : 1217-1218 |
Visual compatibility of blinatumomab with selected co-administrated drugs during simulated Y-site administration.
Du Repaire T, Vigne P, Guedon A, Gauthier-Villano L, Bertault Peres P, Pourroy B. |
2017 |
| 65 |
Journal
Am J Hosp Pharm 1990 ; 47: 143-146. |
Stability of morphine sulfate in infusion devices and containers for intravenous administration.
Duafala ME, Kleinberg ML, Nacov C, Flora KP, Hines J, Davis K, McDaniel A, Scott D. |
1990 |
| 2810 |
Journal
Antimicrob Agents Chemother 2009 ; 53, 2: 798-799. |
Preparation and stability of voriconazole eye drop solution.
Dupuis A, Tournier N, Le Moal G, Venisse N. |
2009 |
| 2591 |
Journal
Can J Hosp Pharm 1988 ; 41: 121-123. |
Stability of a sotalol hydrochloride oral liquid formulation.
Dupuis LL, James G, Bacola G. |
1988 |
| 2773 |
Journal
Support Care Cancer 2009 ; 17, 6: 701-706. |
Stability of an extemporaneous oral liquid aprepitant formulation.
Dupuis LL, Lingertat-Walsh K, Walker SE. |
2009 |
| 925 |
Journal
Can J Hosp Pharm 1998 ; 51: 55-57. |
Compatibility and stability of propafenone hydrochloride with five critical-care medications.
Dupuis LL, Trope A, Giesbrecht E, Wong B. |
1998 |
| 193 |
Journal
Am J Health-Syst Pharm 1997 ; 54: 1293-1295. |
Stability of propafenone hydrochloride in IV solutions.
Dupuis LL, Wong B, Trope A. |
1997 |
| 3204 |
Journal
Ann Pharmacotherapy 2011 ;45, 4:546. |
Stability of Azacitidine Suspensions.
Duriez A, Vigneron J.H, Zenier H.A, May I, Demoré B.M. |
2011 |
| 4689 |
Journal
Braz J Pharm Sci 2022 ;58: e19175 |
Captopril oral solution for pediatric use: formulation, stability study and palatability assessment in vivo.
Dysarz L.P, Tavares M, Viçosa A.L, Ribeiro M.F, Teixeira R.G.S, Elias S.C, Márcio R. M. |
2022 |
| 1021 |
Journal
J Clin Hosp Pharm 1986 ; 11: 343-348. |
Methotrexate in solutions - A stability test for the hospital pharmacy.
Dyvik O, Grislingaas AL, Tonnesen HH, Karlsen J. |
1986 |
| 3465 |
Journal
Enferm Intensiva 2010 ;21:96-103. |
Compatibilidad visual y física de la furosemida en mezclas intravenosas para perfusión continua.
E. P?rez Juan, M. Maqueda Palau, M. Ar?valo Rubert, B. Ribas Nicolau, S.M. Amor?s Cerd?. |
2010 |
| 3380 |
Journal
Ann Pharmacotherapy 2013 ;47:426-427. |
Incompatibility of Piritramide with Cephalosporins.
Eckle V-S, Heim E, Hahn M, Grasshoff C. |
2013 |
| 835 |
Journal
Int J Pharm 1979 ; 4: 21-26. |
Determination of the stability of mitomycin C by high performance liquid chromatography.
Edwards D, Selkirk AB, Taylor RB. |
1979 |
| 3832 |
Journal
Ann Pharmacotherapy 2016 ; 50: 155-156. |
Stability Studies of Extemporaneously Compounded Clobazam Oral Suspension.
Ei Mon Phyo Lwin, Ellis D, SonY, Turner S, Garg S. |
2016 |
| 2883 |
Journal
Am J Health-Syst Pharm 2009 ; 66, 21: 1929-1933. |
Physicochemical stability of oxaliplatin in 5% dextrose injection stored in polyvinyl chloride, polyethylene, and polypropylene infusion bags.
Eiden C, Philibert L, Bekhtari K, Poujol S, Malosse F, Fr?d?ric Pinguet F. |
2009 |
| 1354 |
Journal
Am J Hosp Pharm 1984 ; 41: 2405-2406. |
Stability of citrated caffeine solutions for injectable and enteral use.
Eisenberg MG, Kang N. |
1984 |
| 1635 |
Journal
Am J Health-Syst Pharm 2002 ; 59: 1351-1356. |
Stability of dacarbazine in amber glass vials and polyvinyl chloride bags.
El Aatmani M, Poujol S, Astre C, Malosse F, Pinguet F. |
2002 |
| 3420 |
Journal
J Oncol Pharm Practice 2014 ; 21, 3: 178-187. |
Stability of an extemporaneously prepared bleomycin-lidocaine-epinephrine intradermal admixture used in dermatology
El Kateb N, Chaussard M, Bellenger P, Petit A, Faure P. |
2014 |
| 4523 |
Journal
Pharm Dev Technol 2021 |
Formulation and stability study of hydroxychloroquine sulfate oral suspensions.
El Mershati S, Thouvenin A , Secretan P-H, De Lonlay P, Tuchmann-Durand C, Cisternino S, Schlatter J. |
2021 |
| 2890 |
Journal
Acta Pharm 2000 ; 50: 219-228. |
Stability and compatibility of thiamine hydrochloride in liquid dosage forms et various temperatures.
El-Khawas M, Boraie NA. |
2000 |
| 1724 |
Journal
Can J Hosp Pharm 2001 ; 54: 102-105. |
Visual compatibility of various injectable neuroleptic agents with benztropine and lorazepam in polypropylene syringes.
Elbe D, Condé C. |
2001 |
| 2789 |
Journal
Bone Marrow Transplantation 2006 ; 37, 8: 781-784. |
Long-term stability of a patient-convenient 1mg/ml suspension of tacrolimus for accurate maintenance of stable therapeutic levels.
Elefante A, Muindi J, West K, Dunford L, Abel S, Paplham P, Brown K, Hahn T, Padmanabhan S, Battiwalla M, McCarthy PL. |
2006 |
| 4418 |
Journal
J Pediatr Pharmacol Ther 2004 ; 9, 4: 254-258. |
Chemical Stability of Extemporaneously Prepared Lorazepam Suspension at Two Temperatures.
Ellaria Lee W-M, Lugo R.A, Rusho W.J, MacKay M, Sweeley J. |
2004 |
| 1503 |
Journal
Am J Hosp Pharm 1983 ; 40: 1002-1006. |
Stability of cimetidine hydrochloride in admixtures after microwave thawing
Elliott GT, McKenzie MW, Curry SH, Pieper JA, Quinn SL. |
1983 |
| 285 |
Journal
Clin Ther 1996 ; 18: 246-255. |
Stability and compatibility of admixtures of intravenous ciprofloxacin and selected drugs.
Elmore RL, Contois ME, Kelly J, Noe A, Poirier A. |
1996 |
| 3490 |
Journal
Ann Pharmacotherapy 2002 ; 36: 423-426. |
Stability of furosemide in human albumin solution.
Elwell R.J, Spencer A.P, Barnes J.F, Wynn J.E, Jones C.E. |
2002 |
| 1945 |
Journal
Ann Pharmacotherapy 2004 ; 38: 2041-2044. |
Stability of cefepime in icodextrin peritoneal dialysis solution.
Elwell RJ, Volino LR, Frye RF. |
2004 |
| 1322 |
Journal
JPEN 1983 ; 7: 156-158. |
In vitro study of inline filtration of medications commonly administered to pediatric cancer patients.
Ennis CE, Merritt RJ, Neff DN. |
1983 |
| 71 |
Journal
Am J Health-Syst Pharm 1997 ; 54: 2204-2206. |
Stability of cidofovir in 0.9% sodium chloride injection for five days.
Ennis RD, Dahl TC. |
1997 |
| 4085 |
Journal
Can J Hosp Pharm 2005 ; 58: 26-30. |
Stability of Thiamine in Extemporaneously Compounded Suspensions.
Ensom M, Decarie D |
2005 |
| 3410 |
Journal
Can J Hosp Pharm 2013 ; 66, 2: 118-124. |
Stability of Propranolol in Extemporaneously Compounded Suspensions
Ensom M.H, Kendrick J, Rudolph S, Decarie D. |
2013 |
| 3826 |
Journal
Can J Hosp Pharm 2015 ; 68, 6: 489-491. |
Stability of Extemporaneously Compounded Naproxen 25 mg/mL Suspension in Glass and Plastic Bottles and Plastic Syringes.
Ensom M.H.H, D?carie D, Lingertat-Walsh K. |
2015 |
| 677 |
Journal
Can J Hosp Pharm 2015 ; 68, 4 : 346-348. |
Stability of Extemporaneously Compounded Levetiracetam in Glass and Plastic Bottles and Plastic Syringes.
Ensom M.H.H, D?carie D. |
2015 |
| 3851 |
Journal
Can J Hosp Pharm 2016 ; 69, 1: 49-51. |
Dexamethasone 1 mg/mL Suspension Prepared from Crushed Tablets: Stability in Glass and Plastic Bottles and Plastic Syringes.
Ensom M.H.H, D?carie D. |
2016 |
| 3153 |
Journal
Can J Hosp Pharm 2010 ; 63, 5: 366-372. |
Stability of Vancomycin 25 mg/mL in Ora-Sweet and Water in Unit-Dose Cups and Plastic Bottles at 4°C and 25°C.
Ensom M.H.H, Decarie D, Lakhani A. |
2010 |
| 2336 |
Journal
Can J Hosp Pharm 2009 ; 62, 2: 112-118. |
Stability of Hydromorphone–Ketamine Solutions in Glass Bottles, Plastic Syringes, and IV Bags for Pediatric Use
Ensom M.H.H, Decarie D, Leung K, MontgomeryC |
2009 |
| 3713 |
Journal
Can J Hosp Pharm 2014 ; 67, 4 : 274-278 |
Stability of Extemporaneously Compounded Dexamethasone in Glass and Plastic Bottles and Plastic Syringes.
Ensom M.H.H, Décarie D. |
2014 |
| 3714 |
Journal
Can J Hosp Pharm 2014 ; 67, 4: 274-280. |
Stability of Extemporaneously Compounded Clonidine in Glass and Plastic Bottles and Plastic Syringes.
Ensom M.H.H, Décarie D. |
2014 |
| 3763 |
Journal
Can J Hosp Pharm 2014 ; 67, 5: |
Stability of Extemporaneously Compounded Pyridoxine in Glass and Plastic Bottles and Plastic Syringes.
Ensom M.H.H, Décarie D. |
2014 |
| 3854 |
Journal
Can J Hosp Pharm 2016 ; 69, 2: 171-173. |
Stability of extemporaneously compounded trimethioprim in glass and plastic bottles and plastic syringes.
Ensom M.H.H, Decarie D. |
2016 |
| 3221 |
Journal
Can J Hosp Pharm 2011 ; 64, 3: 207-211. |
Stability of Levetiracetam in Extemporaneously Compounded Suspensions.
Ensom MHH, Decarie D, Rudolph S. |
2011 |
| 2594 |
Journal
Can J Hosp Pharm 2007 ; 60, 3: 184-191. |
Stability of lansoprazole in extemporaneously compounded suspensions for nasogastric or oral administration.
Ensom MHH, Decarie D, Sheppard I. |
2007 |
| 2857 |
Journal
Can J Hosp Pharm 2002 ; 55, 1: 63-65. |
Stability of Mycophenolate Mofetil in a 1:1 Mixture of Ora-Sweet and Ora-Plus.
Ensom MHH, Decarle D. |
2002 |
| 103 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 1347. |
Incompatibility of cefotetan disodium and promethazine hydrochloride.
Erickson SH, Ulici D. |
1995 |
| 984 |
Journal
Ann Pharmacotherapy 1996 ; 30: 298. |
Amphotericin B is incompatible with lipid emulsions.
Ericsson O, Hallmen AC, Wikstrom I. |
1996 |
| 2906 |
Journal
Farm Hosp 2005 ; 29: 30-36. |
Stability study of an aqueous formulation of captopril at 1 mg/ml.
Escribano Garcia MJ, Torrado Duran S, Torrado Duran JJ. |
2005 |
| 3706 |
Journal
Farm Hosp 2014 ;38, 3:154-161 |
Estudio de estabilidad de oxaliplatino y doxorrubicina para su administración intraperitoneal con hipertermia.
Escudero-Ortiz V, Duart-Duart M.J, P?rez-Ruixo C, P?rez-Ruixo J.J, Valenzuela B. |
2014 |
| 4082 |
Journal
EJHP 2018 ; 25, e2 |
Stability of mixtures of ondansetron and haloperidol stored in infusors at different temperatures.
Espinosa-Bosch M, Sanchez-Rojas F, Bosche-Ojeda C. |
2018 |
| 1885 |
Journal
Pharm World Sci 1999 ; 21: 144-146. |
Long-term stability of morphine and bupivacaine mixture for spinal use.
Essink-Tjebbes CM, Burger DM, Beelen, Wuis EW, Heckster YA. |
1999 |
| 4036 |
Journal
EJHP 2017 ;25,4: 200-203. |
Stability and compatibility of ondansetron with haloperidol in parenteral admixtures.
Estan-Cerezo G, Matoses-Chirivella C, Soriano-Iriga L, Murcia-Lopez A.C, Rodrguez-Lucena F.J, Navarro-Ruiz A. |
2017 |
| 4366 |
Journal
Braz J Pharm Sci 2019 ;55:e17351 |
Midazolam and haloperidol for palliative sedation: physicochemical stability and compatibility of parenteral admixtures.
Estan-Cerezo G, Rodriguez-Lucena F.J, Matoses Chirivella C, Jiminez-Pulido I, Garcia-Monsalve A, Navarro-Ruiz A. |
2019 |
| 3463 |
Journal
Nursing 2011 ; 29 :62-6 |
Fármacos en perfusión continua en la unidad de cuidados intensivos: estudio de compatibilidad.
Eva Perez Juan, Maria Jos? Arévalo Rubert , Silvia Monica Amoros Cerda , Palau M.M, Nicolau B.R. |
2011 |
| 23 |
Journal
Am J Health-Syst Pharm 1997 ; 54: 1065-1068. |
Stability of ondansetron hydrochloride and dexamethasone sodium phosphate in 0.9% sodium chloride and in 5% dextrose injection.
Evrard B, Ceccato A, Gaspard O, Delattre L, Delporte JP. |
1997 |
| 4101 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2018 |
Paediatric formulation: budesonide 0.1 mg/mL viscous oral solution for eosinophilic esophagitis using cyclodextrins.
Ey C, Hosselet C, Villon B, Mar?on F. |
2018 |
| 3988 |
Journal
Am J Health-Syst Pharm 2017 ; 74:13 : 1002-1006 |
Stability of tacrolimus ophthalmic solution.
Ezquer-Garin C, Ferriols-Lisart R, Al?s-Almi?ana M. |
2017 |
| 4299 |
Journal
Biomed Chromatogr 2019 ; 33, 7: e4529. |
Stability of mycophenolate mofetil in polypropylene 5% dextrose infusion bags and chemical compatibility associated with the use of the EQUASHIELD® closed-system transfer device.
Ezquer-Garin C, Ferriols-Lisart R, Alos-Alminana M. |
2019 |
| 4405 |
Journal
Pharmazie 2020 ; 75: 172-176. |
Stability of tedizolid phosphate-sodium rifampicin and tedizolid phosphate-meropenem admixtures in intravenous infusion bags stored at different temperatures
Ezquer-Garin C, Ferriols-Lisart R, Martinez-López LM, Sangrador-Pelluz C, Nicolás-Picó J, Alós-Almiñana M. |
2020 |
| 4298 |
Journal
Biomed Chromatogr 2019 ; 33, 4:e4471 |
Stability and degradation products of imipenem applying High-Resolution Mass Spectrometry: an analytical study focused on solutions for infusion.
Fabio de Souza Barbosa F, Capra Pezzi L, Tsao M, Franco de Oliveira T, Dias Macedo S.M, Schapoval E.E.S, Mendez A.S.L. |
2019 |
| 3725 |
Journal
Dysphagia 2014 |
An investigation into the stability and sterility of citric acid solutions used for cough reflex testing.
Falconer J.R, Wu Z, Lau H, Sue J, Wang L, Pottinger S, Lee E, Alazawi N, Kalllesen M, Gargiulo D.A, Swift S, Svirskis D. |
2014 |
| 4115 |
Journal
Drug Design Dev Ther 2016 ;10:3873-3878 |
Physicochemical stability of ternary admixtures of butorphanol, ketamine, and droperidol in polyolefin bags for patient-controlled analgesia use.
Fang B, Wang L, Gu J, Chen F, Shi X. |
2016 |
| 4301 |
Journal
Oncotarget 2017 ;8, 63: 106249-106257. |
Stability of azasetron-dexamethasone mixture for chemotherapyinduced nausea and vomiting administration.
Fang B-X, Chen F-C, Zhu D, Guo J, Wang L-H. |
2017 |
| 4429 |
Journal
Medicine 2016 ; 95:25(e3824) |
Incompatibilities of lornoxicam with 4 antiemetic medications in polyolefin bags during simulated intravenous administration.
Fang B-X, Li P, Shi X-Y, Chen F.C, Wang L.H. |
2016 |
| 4430 |
Journal
Medicine 2017 96:35(e7979) |
Stability study of dezocine in 0.9% sodium chloride solutions for patient-controlled analgesia administration.
Fang B-X, Wang L-H, Liu H-M, Chen F-C, Liu J. |
2017 |
| 1656 |
Journal
Pharmazie 1994 ; 49: 425-427. |
Stability and compatibility studies of cefaloridine, cefuroxime and ceftazidime with PVC infusion bags.
Faouzi A, Dine T, Luyckx M, Gressier B, Brunet C, Goudaliez F, Mallevais ML, Cazin M, Cazin JC. |
1994 |
| 165 |
Journal
Int J Pharm 1994 ; 105: 89-93. |
Leaching of diethylhexyl phthlate from PVC bags into intravenous teniposide solution.
Faouzi MA, Dine T, Luyckx M, Gressier B, Goudaliez F, Mallevais ML, Brunet C, Cazin M, Cazin JC. |
1994 |
| 1055 |
Journal
Can J Hosp Pharm 1983 ; 36: 43-52. |
Compatibility of antibiotics and other drugs in total parenteral nutrition solutions.
Faragos S. |
1983 |
| 39 |
Journal
J Pharm Clin 1997 ; 16: 45-48. |
Influence of intravenous admixtures on the stability of the new solution of 5-fluorouracil.
Farhang-Asnafi S, Callaert S, Barre J, Tillement JP, Thebault A. |
1997 |
| 1909 |
Journal
J Pharm Clin 2000 ; 19: 248-251. |
Compatibilité et stabilité du mélange bupivacaïne-sufentanil en poche.
Farhang-Asnefi S, Barre J, Callaert S, Boutros A, Causse R, Thebault A. |
2000 |
| 2116 |
Journal
Am J Health-Syst Pharm 2006 ; 63: 906-908. |
Visual compatibility of furosemide with phenylephrine and vasopressine.
Faria CE, Fiumara K, Patel N, Tran DC. |
2006 |
| 1857 |
Journal
J Pharm Biomed Anal 1999 ; 20-521-530. |
Stability of reconstituted solutions of ceftazidime for injections: an HPLC and CE approach.
Farina A, Porra R, Cotichini V, Doldo A. |
1999 |
| 524 |
Journal
Am J Hosp Pharm 1992 ; 49: 1911. |
Visual compatibility of diltiazem with commonly used injectable drugs during simulated Y-site administration.
Farquhar Zanetti LA. |
1992 |
| 1622 |
Journal
Am J Health-Syst Pharm 2001 ; 58: 238-241. |
Stability of carmustine in polyvinyl chloride bags and polyethylene-lined trilayer plastic containers.
Favier M, De Casanove F, Coste A, Cherti N, Bressolle F. |
2001 |
| 4122 |
Journal
Hosp Pharm 2018 ;54,3:190?196 |
Stability of Meropenem After Reconstitution for Administration by Prolonged Infusion.
Fawaz S, Barton S, Whitney L, Swinden J, Nabhani-Gebara S. |
2018 |
| 2538 |
Journal
Ann Pharmacotherapy 1995 ;29:987-990. |
Stability of hydrocortisone oral suspensions prepared from tablets and powder.
Fawcett JP, Boulton DW, Jiang R, Woods DJ. |
1995 |
| 2542 |
Journal
Ann Pharmacotherapy 1997 ;31:1291-1295. |
Formulation and stability of naltrexone oral liquid for rapid withdrawal from methadone.
Fawcett JP, Morgan NC, Woods DJ. |
1997 |
| 2558 |
Journal
Aust J Hosp Pharm 1993 ; 23: 18-21. |
The stability of acetylcysteine eyedrops.
Fawcett JP, Woods DJ, Hayes P. |
1993 |
| 227 |
Journal
Am J Hosp Pharm 1994 ; 51: 2292. |
Compatibility of cyclizine lactate and haloperidol lactate.
Fawcett JP, Woods DJ, Munasiri B, Becket G. |
1994 |
| 1801 |
Journal
Am J Health-Syst Pharm 2003 ; 60: 1271-1272. |
Physical compatibility of vasopressin with medications commonly used in cardiac arrest.
Feddema S, Rusho WJ, Tyler LS, Barker B. |
2003 |
| 2261 |
Journal
Can J Hosp Pharm 2008 ; 61, 3: 191-195. |
Stabilité et compatibilité de l'association ondansétron-méthylprednisolone en solution.
Fernandez C, Pelloquin A, Berthoume M, Bellanger A, Farinotti R. |
2008 |
| 2145 |
Journal
J Clin Pharm Ther 2006 ; 31: 641-643. |
Stability of moxifloxacin injection in peritoneal dialysis solution bags (Dianeal PD1 1.36%® and Dianeal PD1 3.86%®).
Fernandez-Varon E, Marin P, Espuny A, Villamayor L, Escudero E, Carceles C. |
2006 |
| 4074 |
Journal
EJHP 2018 ; 25: 107-110. |
Stability of daptomycin reconstituted vials and infusion solutions.
Ferrandez J, Sanchez R, Diaz D, Diaz M, Estevan M, Garcia T. |
2018 |
| 2087 |
Journal
Pharmactuel 2004 ; 37: 17-20. |
Compatibility of dimenhydrinate injectable by Y administration.
Ferreira E, Forest JM, Hildgen P. |
2004 |
| 1927 |
Journal
EJHP 2004 ; 4: 60-63. |
Stability of ranitidine hydrochloride in different aqueous solutions.
Ferreira MO, Bahia MF, Costa P. |
2004 |
| 3819 |
Journal
J Pharm Biomed Anal 2015 ; 118: 105-112. |
Feasibility of amlodipine besylate, chloroquine phosphate, dapsone, phenytoin, pyridoxine hydrochloride, sulfadiazine, sulfasalazine, tetracycline hydrochloride, trimethoprim and zonisamide in SyrSpend® SF PH4 oral suspensions.
Ferreiraa A.O, Poloninia H.C, Silva S.L, Patricio F.B, Brand?oa M.A.F, Raposoa N.R.B. |
2015 |
| 3989 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2017 ; 2,1: 35 |
Stability of midazolam and noradrenaline stored in cyclic olefin copolymer AT-Closed Vials® and polypropylene syringes during 365 days.
Feutry F, Genay S, Velghe C, Barthélémy C, Décaudin B, Odou, P. |
2017 |
| 1972 |
Journal
Drug Dev Ind Pharm 2016 ; 42, 1: 166-174. |
Stability of 10 mg/mL cefuroxime solution for intracameral injection in commonly used polypropylene syringes and new ready-to-use cyclic olefin copolymer sterile vials using the LC–UV stability-indicating method.
Feutry, F., Simon, N., Genay, S., Lannoy, D., Barthelemy, C., Decaudin, B., Labalette, P., Odou, P. |
2016 |
| 2404 |
Journal
Palliative Med 2000 ; 14: 205-208. |
The compatibility and stability of octreotide acetate in the presence of diamorphine hydrochloride in polypropylene syringes
Fielding H, Kyaterekera , Skellern GG, Tettey JN, McDade JR, ZMsuya Z, Watson DG, Urie J. |
2000 |
| 4079 |
Journal
J Pharm Anal 2017 ; 7, 4: 237-243. |
Formulation, stability testing, and analytical characterization of melatonin-based preparation for clinical trial.
Filali S, Bergamelli C, Tall M.L, Salmon D, Laleye D, Dhelens C, Diouf E, Pivot C, Pirot F. |
2017 |
| 800 |
Journal
Ann Pharmacotherapy 1997 ; 31: 553-559. |
Stability of fosphenytoin sodium with intravenous solutions in glass bottles, polyvinyl chloride bags, and polypropylene syringes.
Fischer JH, Cwik MJ, Luer MS, Sibley CB, Deyo KL. |
1997 |
| 2428 |
Journal
Am J Health-Syst Pharm 1997 ; 54: 1619-1622 |
Stability of sumatriptan succinate in extemporaneously prepared oral liquids
Fish DN, Beall HD, Goodwin SD, Fox JL. |
1997 |
| 2413 |
Journal
Am J Health-Syst Pharm 1999 ; 56: 1957-1960 |
Stability of valacyclovir hydrochloride in extemporaneously prepared oral liquids
Fish DN, Vidaurri VA, Deeter RG. |
1999 |
| 1093 |
Journal
Anesthesiology 1984 ; 61: 347-348. |
Stability of atracurium administered by infusion.
Fisher DM, Canfell, Miller RD. |
1984 |
| 3364 |
Journal
Am J Health-Syst Pharm 2012 ; 69:2130. |
Visual compatibility of micafungin sodium and levofloxacin injections.
Fleischbein E, Montgomery P.A, Zhou C.Z. |
2012 |
| 4131 |
Journal
Hosp Pharm 2019 ;54,1:32-36. |
Physical Compatibility and Chemical Stability of Injectable and Oral Ranitidine.
Fleming K, Donnelly R. |
2019 |
| 50 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 514-516. |
Stability of ondansetron hydrochloride and cyclophosphamide in injectable solutions.
Fleming RA, Olsen DJ, Savage PD, Fox JL. |
1995 |
| 3569 |
Journal
EJHP 2014 ;21:34-38 |
Development of ready-to-use cefuroxime syringes for use in ophthalmology.
Fleury-Souverain S, Sadeghipour F, Bonnabry P. |
2014 |
| 3224 |
Journal
EJHP Science 2011 ; 1: 3-6. |
The stability of soluble insulin in plastic syringes
Fleury-Souverain S, Sigrist T, Griffiths W, Ing H, Matthey B; Sadeghipour F, Bonnabry P. |
2011 |
| 469 |
Journal
Am J Hosp Pharm 1990 ; 47: 1097-1100. |
Compatibility of ketorolac tromethamine injection with common infusion fluids and administration sets.
Floy BJ, Royko CJ, Fleitman JS. |
1990 |
| 3165 |
Journal
Am J Health-Syst Pharm 2011 ; 68: 69-72. |
Stability of extemporaneously prepared acetylcysteine 1% and 10% solutions for treatment of meconium ileus
Fohl AL, Johnson CE, Cober P. |
2011 |
| 4605 |
Journal
Ann Allergy 2012 ; 2:28. |
Impact of physical incompatibility on drug mass flow rates: example of furosemide-midazolam incompatibility.
Foinard A, Décaudin B, Barthélémy C, Debaene B, Odou P. |
2012 |
| 421 |
Journal
Am J Hosp Pharm 1985 ; 42: 839-843. |
Compatibility of clindamycin phosphate with cefotaxim sodium or netilmicin sulfate in small-volume admixtures.
Foley PT, Bosso JA, Bair JN, Townsend RJ. |
1985 |
| 397 |
Journal
Am J Hosp Pharm 1989 ; 46: 125-126. |
Visual compatibility of intravenous famotidine with selected drugs.
Fong PA, Ward J. |
1989 |
| 2949 |
Journal
Pharmazie 2007 ; 62: 519-521. |
Development validation and stability study of pediatric atenolol syrup.
Foppa T, Murakami FS, Silva MAS. |
2007 |
| 336 |
Journal
Am J Hosp Pharm 1987 ; 44: 1408-1409. |
Visual compatibility of acyclovir sodium with commonly used intravenous drugs during simulated Y-site injection.
Forman JK, Lachs JR, Souney PF. |
1987 |
| 404 |
Journal
Am J Hosp Pharm 1987 ; 44: 2298-2299. |
Visual compatibility of midazolam hydrochloride with common preoperative injectable medications.
Forman JK, Souney PF. |
1987 |
| 3766 |
Journal
Pharmactuel 2014 ; 47, 3 : 161-165. |
Compatibilité de l’acétylcystéine injectable lors de son administration en Y avec d’autres médicaments usuels
Forrest J.M, Hildgen P. |
2014 |
| 4465 |
Journal
Am J Health-Syst Pharm 2020 ;77,14:1144-1148 |
Y-site physical compatibility of hydrocortisone continuous infusions with admixtures used in critically ill patients.
Foushee A, Meredith P, Fox Laura, Wilder A. |
2020 |
| 3429 |
Journal
Am J Health-Syst Pharm 2015 ; 72:483-486 |
Physical compatibility of cisatracurium with selected drugs during simulated Y-site administration
Foushee J.A, Fox L.M, Gormley L.R, Lineberger M.S. |
2015 |
| 3879 |
Journal
Int J Pharm Compound 2016 ; 20, 4 : 328-332. |
Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures.
Foushee Jaime A, Meredith Pmichaele, Fox Laura M, Grace Edward E. |
2016 |
| 1103 |
Journal
J Pediatr 1988 ; 112: 813-817. |
Antibiotic stability in a pediatric parenteral alimentation solution.
Fox AS, Boyer KM, Sweeney HM. |
1988 |
| 3379 |
Journal
Am J Health-Syst Pharm 2013 ;70:520-524. |
Physical compatibility of various drugs with neonatal total parenteral nutrient solution during simulated Y-site administration.
Fox L.M, Wilder A.G, Foushee J.A. |
2013 |
| 3859 |
Journal
RRJHCP 2016 ; 1, 3: 31-37. |
Microbiological and Physico-Chemical Stability of Ketamine Solution for Patient-Controlled Analgesia Systems.
Foy G, Poinsignon V, Mercier L, Laurent S, Paci A. |
2016 |
| 612 |
Journal
Am J Hosp Pharm 1982 ; 39: 622-627. |
Stability of cefamandole nafate injection with parenteral solutions and additives.
Frable RA, Klink PR, Engel GL, Mundell EE. |
1982 |
| 3076 |
Journal
Ann Pharm Fr 2009 ; 67: 427-432. |
Effect of freezing, long-term storage and microwave thawing on the stability of a mixture of diclofenac and sodium bicarbonate in glucose 5% polyolefin bags.
François JH, Hecq JD, Vanbeckbergen D, Jamart J, Galanti L. |
2009 |
| 167 |
Journal
Int J Pharm 1994 ; 103: 87-92. |
Adsorption of vincristine, vinblastine, doxorubicin and mitoxantrone to in-line intravenous filters.
Francomb MM, Ford JL, Lee MG. |
1994 |
| 3942 |
Journal
Am J Health-Syst Pharm 2017 ; 74, 5: 280-281. |
Physical compatibility of valproate sodium injection with dobutamine and dopamine.
Frank M.I, Boddu S.H.S, . Mauro V.F,. Churchwell M.D. |
2017 |
| 43 |
Journal
Am J Health-Syst Pharm 1997 ; 54: 1106-1108. |
Stability of caffeine citrate injection in polypropylene syringes at room temperature.
Fraser BD, Berod T, Whitney HAK. |
1997 |
| 230 |
Journal
Am J Hosp Pharm 1994 ; 51: 905-906. |
Visual compatibility of haloperidol lactate with injectable solutions.
Fraser GL, Riker RR. |
1994 |
| 2904 |
Journal
Ann Pharm Fr 2005 ; 63: 162-166. |
Development of an oxybutynin chloride solution: from formulation to quality control.
Fratta A, Bordenave J, Boissinot C, Le Grand J, Esquirol C, Radideau E, Benoit G. |
2005 |
| 1206 |
Journal
Am J Hosp Pharm 1983 ; 40: 564. |
Cefoperazone-aminoglycoside incompatibility.
Frear RS. |
1983 |
| 837 |
Journal
Acta Pharm Suec 1986 ; 23: 115-124. |
Stability of carmustine - kinetics and compatibility during administration.
Fredriksson K, Lundgren P, Landersjo L. |
1986 |
| 2304 |
Journal
Int J Pharm 2005 304; 1-2: 135-144. |
The development and stability assessment of extemporaneous pediatric formulations of Accupril.
Freed A.L, Silbering S.B, Kolodsick K.J, Rossi D, Mahjour M, Kingsmill C.A. |
2005 |
| 3228 |
Journal
Am J Health-Syst Pharm 2011 ;68:1723-1728. |
Stability of levothyroxine injection in glass, polyvinyl chloride, and polyolefin containers
Frenette AJ, MacLean RD, Williamson D, Marsolais P, . Donnelly RF |
2011 |
| 3861 |
Journal
J Pharm Pract and Res 2016 ; 46: 28-33. |
Evaluation of stability of melatonin in extemporaneously compounded oral suspensions.
Friciu M , Savji T , Zaraa S, Leclair G. |
2016 |
| 4406 |
Journal
Can J Hosp Pharm 2020 2020;73(2):141-4 |
Stability of Methadone Hydrochloride for Injection in Saline Solution
Friciu M, Alarie H, Beauchemin M, Forest JM, Leclair G. |
2020 |
| 3892 |
Journal
Can J Hosp Pharm 2016 ; 69, 4 : 329-333. |
Stability of Hydrocortisone, Nifedipine, and Nitroglycerine Compounded Preparations for the Treatment of Anorectal Conditions
Friciu M, Chefson A, Leclair G. |
2016 |
| 4690 |
Journal
Hosp Pharm 2022 ; 57, 2: 294-299. |
Stability of Compounded Digoxin Solution 0.05mg/mL for Injection.
Friciu M, Marcelin R.B, Bédard P, Forest J.M, Leclair G. |
2022 |
| 4639 |
Journal
Can J Hosp Pharm 2021 2021;74(4):344-9 |
Stability of N-Acetylcysteine 60 mg/mL in Extemporaneously Compounded Injectable Solutions.
Friciu M, Monfort A, Dubé P-A, Leclair G. |
2021 |
| 2054 |
Journal
Int J Pharm Compound 2015 ; 19, 4 : 337-339. |
Stability of Prednisone in Oral Mix Suspending Vehicle.
Friciu M, Plourde K, Leclair G, Danapoulos P, Savji T. |
2015 |
| 4308 |
Journal
PlosOne 2017 |
Stability of gabapentin in extemporaneously compounded oral suspensions.
Friciu M, Roullin G, Leclair G. |
2017 |
| 3893 |
Journal
Can J Hosp Pharm 2016 ; 69, 4: 327-329. |
Stability of Extemporaneously Compounded Amlodipine Besylate Oral Suspensions
Friciu M, Zaraa S, Leclair G. |
2016 |
| 3921 |
Journal
Can J Hosp Pharm 2016 ; 69, 6: 505-507. |
Stability of extemporaneously prepared enalapril maleate suspensions in glass bottles and plastic syringes.
Friciu M, Zaraa S, Leclair G. |
2016 |
| 3946 |
Journal
Can J Hosp Pharm 2017 ; 70,1 :51-53. |
Stability of Extemporaneously Compounded Tacrolimus in Glass Bottles and Plastic Syringes
Friciu M, Zaraa S, Leclair G. |
2017 |
| 4313 |
Journal
PlosOne 2017 |
Stability of Diazoxide in Extemporaneously Compounded Oral Suspensions.
Friciu M, Zaraa S, Roullin G, Leclair G. |
2017 |
| 2011 |
Journal
Krankenhauspharmazie 2005 ; 26, 6: 206-210. |
HPLC-stabilitätuntersuchungen zu rekonstituierten Bortezomib-Lösungen.
Friess D, Nguyen HC, Lipp HP. |
2005 |
| 2134 |
Journal
J Pharm Sci 1998 ; 87, 12: 1572-1576. |
Influence of pH, temperature and buffers on cefepime degradation kinetics and stability predictions in aqueous solutions.
Fubara JO, Notari RE. |
1998 |
| 181 |
Journal
Med Sci Monit 2015 ; 21:1138-1145. |
Butorphanol and Ketamine Combined in Infusion Solutions for Patient-Controlled Analgesia Administration: A Long-Term Stability Study.
Fuchao Chen, Hui Xiong, Jinguo Yang, Baoxia Fang, Jun Zhu, Benhong Zhou. |
2015 |
| 1812 |
Journal
Int J Pharm Compound 2000 ; 4, 4: 320-323. |
Stability of 5-fluorouracil in an extemporaneously compounded ophtalmic solution.
Fuhrman LC, Godwin DA, Davis RA. |
2000 |
| 2420 |
Journal
Am J Health-Syst Pharm 1998 ; 55: 1386-1388 |
Stability of vancomycin in an extemporaneously compounded ophthalmic solution
Fuhrman LC, Jr, RT Stroman |
1998 |
| 464 |
Journal
Am J Hosp Pharm 1986 ; 43: 2209-2213. |
Effect of pretreatment with 0.9% sodium chloride or insulin solutions on the delivery of insuline from an infusion system.
Furberg H, Kruse Jensen A, Salbu B. |
1986 |
| 4563 |
Journal
Eur J Pharm Sci 2021 ; 160: 105738. |
Stability study of a compounded oral solution of nicardipine for the treatment of hypertension in children.
Fuss D, Gondé H, Lamoureux F, Pereira T, Colnot M, Buchbinder N, Coquard A, Varin R, Hervouët C. |
2021 |
| 214 |
Journal
Am J Hosp Pharm 1990 ; 47: 1606-1610. |
Stability of ranitidine hydrochloride with eight medications in intravenous admixtures.
Galante LJ, Stewart JT, Warren FW, Edgar JW, Huff AJ. |
1990 |
| 213 |
Journal
Am J Hosp Pharm 1990 ; 47: 1580-1584. |
Stability of ranitidine hydrochloride at dilute concentration in intravenous infusion fluids at room temperature.
Galante LJ, Stewart JT, Warren FW, Johnson SM, Duncan R. |
1990 |
| 2323 |
Journal
Can J Hosp Pharm 2009 ; 62, 1 |
Long-Term Stability of 5-Fluorouracil in 0.9% Sodium Chloride after Freezing, Microwave Thawing, and Refrigeration
Galanti L, Lebitasy M.P, Hecq J.D, Cadrobbi J, Vanbeckbergen D, Jamart J. |
2009 |
| 1608 |
Journal
Int J Pharm Compound 2001 ; 5: 397-400. |
Assessment of the stability of teicoplanin in intravenous infusions.
Galanti LM, Hecq JD, Jeuniau P, Vanbeck D, Jamart J. |
2001 |
| 656 |
Journal
J Clin Pharm Ther 1996 ; 21: 185-189. |
Long-term stability of cefuroxime and cefazolin sodium in intravenous infusions.
Galanti LM, Hecq JD, Vanbeckbergen D, Jamart J. |
1996 |
| 931 |
Journal
J Clin Pharm Ther 1997 ; 22: 353-356. |
Long-term stability of vancomycin hydrochloride in intravenous infusions.
Galanti LM, Hecq JD, Vanbeckbergen D, Jamart J. |
1997 |
| 2760 |
Journal
Pharm Hosp et Clin 2007 ; 42, 171 : 171-176. |
Etude de stabilité d’un collyre à ,6 mg/ml de ticarciline.
Galvez O,Mullot JU, Mullot H, Simon L, Grippi R, Payen C, Bonneau D, Huart B, Gentes P. |
2007 |
| 1600 |
Journal
Am J Health-Syst Pharm 2001 ; 58: 1850-1851. |
Stability of tirofiban hydrochloride in 0.9% sodium chloride injection for 30 days.
Garabito MJ, Jimenez L, Bautista J, Santos-Rubio MD, Perez Rodrigo I. |
2001 |
| 4464 |
Journal
PlosOne 2018 13(1): e0190577. |
Compatibility of intravenous ibuprofen with lipids and parenteral nutrition, for use as a continuous infusion.
Garcia J, Garg A, Song Y, Fotios A, Andersen C, Garg S. |
2018 |
| 1903 |
Journal
Am J Obstet Gynecol 2002 ; 186: 496-498. |
Oxytocin preparation stability in several common obstetric intravenous solutions.
Gard JW, Alexander JM, Bawdon RE, Albrecht JT. |
2002 |
| 738 |
Journal
Am J Hosp Pharm 1978 ; 35: 581-584. |
Intropin (dopamine hydrochloride) intravenous admixture compatibility. Part 3: Stability with miscellaneous additives.
Gardella LA, Kesler H, Amann A, Carter JE. |
1978 |
| 732 |
Journal
Am J Hosp Pharm 1975 ; 32: 575-578. |
Intropin (dopamine hydrochloride) intravenous admixture compatibility. Part 1: Stability with common intravenous fluids.
Gardella LA, Zaroslinski JF, Possley LH. |
1975 |
| 2125 |
Journal
Hospital Pharmacist 2003 ; 10: 354-361. |
Compatibility of an injectable oxycodone formulation with typical diluents, syringes, tubings, infusion bags and drugs for potential co-administration.
Gardiner PR. |
2003 |
| 2886 |
Journal
Int J Pharm Compound 2009 ; 13, 3: 250-253. |
Chemical Stability of Extemporaneously Compounded Omeprazole Formulations: A methods of compounding.
Garg S, Svirskis D, Al-Kabba M, Farhan S, Komeshi M, Lee J, Liu Q, Naidoo S. |
2009 |
| 789 |
Journal
Am J Hosp Pharm 1990 ; 47: 604-606. |
Compatibility of drugs separated by a fluid barrier in a retrograde intravenous infusion system.
Garner SS, Wiest DB. |
1990 |
| 1397 |
Journal
Pharm J 1990 ; 244: 218. |
Dopamine dilutions.
Garner ST, Murdoch JM. |
1990 |
| 2151 |
Journal
Int J Pharm 1995 ; 115: 113-117. |
Stability study of prostaglandin E1 (PGE1) in physiological solutions by liquid chromatography (HPLC).
Gatti R, Gotti R, Cavrini V, Soli M, Bertaccini A, Carparelli F. |
1995 |
| 2655 |
Journal
Int J Pharm 2008 ; 353, 1-2: 1-7. |
Invitro release and stability of an artesunate rectal gel suitable for pediatric use.
Gaudin K, Barbaud A, Boyer C, Langlois MH, Lagueny AML, Dubost JP, Millet P, Fawaz F. |
2008 |
| 4197 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2018 ;3,4:219-226 |
Stability of a 50 mg/mL Ceftazidime Eye-Drops Formulation.
Gautier E, Saillard J, Deshayes C, Vrignaud S, Lagarce F, Briot T. |
2018 |
| 198 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 516-520. |
Visual compatibility of diltiazem injection with various diluents and medications during simulated Y-site injection.
Gayed AA, Kheshary PR, Hinkle RL. |
1995 |
| 2865 |
Journal
Int J Pharm 2001 ; 223: 49-54. |
Stability indicating HPLC method for the estimation of oxycodone and lidocaine in rectal gel
Gebauer MG, McClure AF, Vlahakis TL. |
2001 |
| 3810 |
Journal
Int J Pharm Compound 2015 ; 19, 5 : 420-427. |
Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF.
Geiger C M, Sorenson B, Whaley P. |
2015 |
| 3356 |
Journal
Int J Pharm Compound 2012 ; 16, 6 : 513-515. |
Stability of Propranolol Hydrochloride in SyrSpend SF.
Geiger C M, Voudrie M A, Sorenson B. |
2012 |
| 3436 |
Journal
Int J Pharm Compound 2013 ; 17, 4: 336-338. |
Stability of Captopril in SyrSPend SF.
Geiger C. M, Sorenson B, Whaley P. A. |
2013 |
| 3403 |
Journal
Int J Pharm Compound 2013 ; 17 ; 2 : 165-167. |
Stability of Minoxidil in Espumil Foam Base
Geiger C.M, Sorenson B, Whaley P.A. |
2013 |
| 3437 |
Journal
Int J Pharm Compound 2013 ; 17, 4: 344-346. |
Stability of Midazolam in SyrSpend SF and SyrSpend SF Cherry.
Geiger C.M, Sorenson B, Whaley P.A. |
2013 |
| 2733 |
Journal
J Pharm Clin 1999 ; 18: 179-182. |
Impact of deep-freezing on pefloxacin eye drops stability.
Gellis C, Sautou-Miranda V, Arvouet A. |
1999 |
| 234 |
Journal
J Clin Pharm Ther 1997 ; 22: 257-260. |
Stability of refrigerated and frozen solutions of tropisetron in either polyvinylchloride or polyolefin infusion bags.
Georget S, Vigneron J, Blaise N, Perrin A, Hoffman MA, Hoffman M. |
1997 |
| 4011 |
Journal
EJHP 2016 2016;0:1-11 |
Physicochemical compatibility and emulsion stability of propofol with commonly used analgesics and sedatives in an intensive care unit.
Gersonde F, Eisend S, Haake N, Kunze T. |
2016 |
| 2100 |
Journal
Farm Hosp 1995 ; 19: 38-40. |
Estabilidad fisica y quimica del sulfato magnesico combinado con heparina sodica en solucion salina al 0,9 por 100.
Gervas S, Gosalbez F. |
1995 |
| 3712 |
Journal
Pediatr Crit Care Med 2001 ; 2, 4: 315-317. |
Stability of dopamine and epinephrine solutions up to 84 hours.
Ghanayem N.S, Lee L, Nelson T, Wong S, Gordon G.B, Markdante K et al. |
2001 |
| 4433 |
Journal
Clin Ther 2020 ; 42, 3: 475-485. |
Y-site Administration of Imipenem/Cilastatin/ Relebactam With Common Intravenous Medications
Ghazi I.M, El Nekidy W.S, Sood A, Dulku A, Patel R, Patel K. |
2020 |
| 3827 |
Poster
ASHP Midyear 2015 |
Compatibility of tedizolid phosphate with selected intravenous drugs via simulated Y-site conditions.
Ghazi I.M, Hamada Y, Nicolau D.P. |
2015 |
| 2444 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 2204-2207. |
Stability of cyclosporine in an extemporaneously compounded paste
Ghnassia LT, Yau DF, Kaye KI, Duggin GG. |
1995 |
| 188 |
Journal
Am J Hosp Pharm 1994 ; 51: 2709-2710. |
Visual compatibility of neuroleptics with anticholinergics or antihistamines in polyethylene syringes.
Gibler B, Kim MS, Raleigh F. |
1994 |
| 1649 |
Journal
Aust J Hosp Pharm 1997 ; 27: 470. |
Ticarcillin-potassium clavulanate and vancomycin incompatibility.
Gilbar P, McAllan Z. |
1997 |
| 939 |
Journal
Aust J Hosp Pharm 1994 ; 24: 167-170. |
Visual compatibility of total parenteral nutrition solution (Synthamin 17 Premix*) with selected drugs during simulated Y-site injection.
Gilbar PJ, Groves CF. |
1994 |
| 14 |
Journal
Am J Health-Syst Pharm 1997 ; 54: 1193-1195. |
Compatibility of ciprofloxacin lactate with sodium bicarbonate during simulated Y-site administration.
Gilbert DL, Trissel LA, Martinez JF. |
1997 |
| 3538 |
Journal
Krankenhauspharmazie 2013 ; 11: 524-525. |
Physikalisch-chemische Stabilität einer Metoprolol-Injektionslösung 1 mg/ml, 50 ml.
Gilcher Th, Heeb R M, Krämer I. |
2013 |
| 4584 |
Journal
EJHP 2021 |
Long-term stability of 10 mg/mL dobutamine injectable solutions in 5% dextrose and normal saline solution stored in polypropylene syringes and cyclic-oleofin- copolymer vials.
Gilliot S, Henry H, Carta N, Genay S, Barthélémy C, Décaudin B, Odou P. |
2021 |
| 4201 |
Journal
Am J Health-Syst Pharm 2020 ; 77, 9: 681-689. |
Long-term stability of ready-to-use 1-mg/mL midazolam solution.
Gilliot S, Masse M, Feutry F, Barthélémy C, Décaudin B, Genay S, Odou P. |
2020 |
| 4500 |
Journal
J Pediatr Pharmacol Ther 2020 ;25, 8:723-729. |
Stability of Extemporaneously Prepared Acetazolamide Oral Suspensions at Two Temperatures.
Gillium C, Friciu M, Abatzoglou N, Leclair G. |
2020 |
| 3447 |
Poster
SFPO Congress, Mandelieu, France 2013 |
Etude de la stabilité d’une solution de bortézomib à 2,5 mg/mL par chromatographie liquide à haute performance couplée à un détecteur à barrettes de diodes et à un détecteur évaporatif à diffusion de lumière.
Giovanelli M, Vigneron J, May I, Nicolas A. |
2013 |
| 449 |
Journal
Am J Hosp Pharm 1987 ; 44: 2291-2293. |
Stability of terbutaline sulfate repackaged in disposable plastic syringes.
Glascock JC, DiPiro JT, Cadwallader DE, Perri M. |
1987 |
| 4637 |
Journal
Braz J Pharm Sci 2021 ;57: e18896. |
Evaluation of physicochemical and microbiological stability of liquid preparation from tizanidine hydrochloride tablets - a Hospital concern.
Gobetti C, da Silva Bitencourt, A, Vinícius Ayres M, Peixoto de Freitas A.L, Loureiro Mendez A.S, Garcia C.V. |
2021 |
| 4089 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2018 ;3,1:23-30 |
Stability of Concentrated Solution of Vancomycin Hydrochloride in Syringes for Intensive Care Units.
Godet M, Simar J, Closset M, Hecq J.D, Braibant M, Soumoy L, Gillet P, Jamart J, Bihin B, Galanti L. |
2018 |
| 1601 |
Journal
Hosp Pharm 2001 ; 36: 950-954. |
Stability of a baclofen and clonidine hydrochloride admixture for intrathecal administration.
Godwin DA, Kim NH, Zuniga R. |
2001 |
| 2268 |
Journal
Ann Pharmacotherapy 2008 ; 42, 4: 511-515. |
AntiXa stability of diluted dalteparin for pediatric use.
Goldenberg NA, Jacobson L, Hthaway H, Tripputi M, Primeaux J, Child J. |
2008 |
| 2841 |
Journal
Atencion Pharmaceutica 2009 ; 11, 3: 161-166. |
Estudio de estabilidad de la mezcla ondansetron-dexametasona en cloruro sodico 0,9%.
Gonzalves Navaro M, Carril Aviles M, Borras Almenar C, Romero Crespo I, Jimenez Torres NV. |
2009 |
| 2960 |
Journal
Respiratory Care 1991 ; 36: 1387-1390. |
Stability of albuterol and tobramycin when mixed for aerosol administration.
Gooch MD. |
1991 |
| 1901 |
Journal
J Pain Symptom Manage 2004 ; 27, 5: 471-475. |
The compatibility and stability of midazolam and dexamethasone in infusion solutions.
Good PD, Schneider JJ, Ravenscroft PJ. |
2004 |
| 434 |
Journal
Am J Hosp Pharm 1991 ; 48: 2166-2171. |
Compatibility of ciprofloxacin injection with selected drugs and solutions.
Goodwin SD, Nix DE, Heyd A, Wilton JH. |
1991 |
| 2371 |
Journal
Am J Hosp Pharm 1991 ; 48: 1234 - 1237. |
Stability of dobutamine hydrochloride in peritoneal dialysis solutions
Gora ML, Seth S, Visconti JA, Shields B, Bay W. |
1991 |
| 3971 |
Journal
Int J Pharm Compound 2017 ; 21, 2 : 164-170. |
Development and Application of a High-Performance Liquid Chromatography Stability-Indicating Assay for Beyond-Use Date Determination of Compounded Topical Gels Containing Multiple Active Drugs.
Gorman G, Sokom S, Coward L, Arnold J J. |
2017 |
| 4572 |
Journal
Antibiotics 2021 ; 10, 217. |
Toward Safe Pharmacotherapy: The Interplay between Meropenem and Parenteral Nutrition Admixtures.
Gostynska A, Piwowarczyk L, Nadolna M, Jelinska A, Dettlaff K, Ogrodowczyk M, Popielarz-Brzezinska M, Stawny M. |
2021 |
| 4441 |
Journal
Pharmaceutics 2020 ; 12, 27 |
The Interactions between Ciprofloxacin and Parenteral Nutrition Admixtures.
Gostynska, A, Stawny M, Dettlaff K, Jelinska A. |
2020 |
| 2007 |
Journal
J Pharm Biomed Anal 2005 ; 38: 709-713. |
Migration of diethylhexyl phtalate from PVC into intravenous cyclosporine solutions.
Gotardo MA, Monteiro M. |
2005 |
| 1424 |
Journal
Am J Emerg Med 1999 ; 17: 333-337. |
Prehospital stability of diazepam and lorazepam.
Gottwald MD, Akerd LC, Liu PK, Orsulak PJ, Corry M, Bacchetti P, Fields SM, Loxenstein DH, Alldredge BK. |
1999 |
| 1386 |
Journal
Pharm J 1983 ; 231- 233. |
Antibiotic interactions.
Gove L. |
1983 |
| 2772 |
Journal
South Med J 1993 ; 86: 771-772. |
Stability of midazolam prepared for oral administration
Gragory DF, Koestner JA, Tobias JD. |
1993 |
| 1917 |
Journal
J Pharm Biomed Anal 1997 ; 15: 537- 543. |
Analysis of gentamicin sulfate and a study of its degradation in dextrose solution.
Graham AE, Speicher E, Williamson B. |
1997 |
| 2481 |
Journal
Am J Hosp Pharm 1993 ; 50: 106-108. |
Stability of ondansetron hydrochloride injection in extemporaneously prepared oral solutions
Graham CL, Dukes GE, Fox JL, Kao CF, Hak LJ. |
1993 |
| 333 |
Journal
Ann Pharmacotherapy 1992 ; 26: 768-771. |
Stability of ondansetron in large-volume parenteral solutions.
Graham CL, Dukes GE, Kao CF, Bertch JM, Hak LJ. |
1992 |
| 1454 |
Journal
Am J Health-Syst Pharm 2000 ; 57: 992-995. |
Stability of meropenem in a portable infusion device in a cold pouch.
Grant EM, Zhong MK, Ambrose PG, Nicolau DP, Nightingale CH, Quiniliani R. |
2000 |
| 1722 |
Journal
EJHP 2002 ; 2: 33-40. |
Compatibility of etoposide solution with polyvinyl chloride and low density polyethylene containers and its stability in different storage conditions.
Gras C, Sautou-Miranda V, Bagel-Boithias S, Brigas F, Chopineau J. |
2002 |
| 122 |
Journal
Int J Pharm Pract 1993 ; 2: 39-43. |
Factors affecting the physical and chemical stability of morphine sulphate solutions stored in syringes.
Grassby PF, Hutchings L. |
1993 |
| 1292 |
Journal
Int J Pharm Pract 1995 ; 3: 174-177. |
Stability of epidural opiate solutions in 0.9 per cent sodium chloride infusion bags.
Grassby PF, Roberts DE. |
1995 |
| 4030 |
Journal
Int J Pharm Compound 2017 ; 21, 5 : 430-435 |
Physicochemical Stability of an Oral Suspension of Trimethoprim 20 mg/mL in Combination with Sulfadiazine 200 mg/mL in PCCA Base SuspendIt.
Graves R, Phan K, Bostanian L, Mandal T, Pramar Y. |
2017 |
| 4000 |
Journal
Int J Pharm Compound 2017 ; 21:4 :334-338 |
Stability of Spironolactone Oral Suspension in PCCA Base, SuspendIt.
Graves R, Phan K.V,Bostanian L.A,Mandal T.K, Pramar Y.V. |
2017 |
| 2403 |
Journal
Am J Health-Syst Pharm 2004 ; 61: 1493-1496. |
Stability of nimodipine solution in oral syringes
Green AE, Banks S, Jay M, Hatton J. |
2004 |
| 3006 |
Journal
J Am Acad Dermatol 1987 ; 16: 984-988. |
Anthralin stability in various vehicles.
Green PG, Kennedy CT, Forbes DR. |
1987 |
| 742 |
Journal
Am J Hosp Pharm 1979 ; 36: 38-43. |
Stability of cisplatin in aqueous solution.
Greene RF, Chatterji DC, Hiranaka PK, Gallelli JF. |
1979 |
| 4570 |
Journal
Pharmaceuticals 2019 |
Investigations of Physical Compatibilities of Commonly Used Intravenous Medications with and without Parenteral Nutrition in Pediatric Cardiovascular Intensive Care Unit Patients.
Greenhill K, Hornsby E, Gorman G. |
2019 |
| 3310 |
Journal
Hosp Pharm 2012 ; 47, 5: 367-370. |
Stability of Regular Human Insulin Extemporaneously Prepared in 0.9% Sodium Chloride in a Polyvinyl Chloride Bag.
Greenwood B.C, Chesnick M.A, Szumita P.M, Caryn Belisle C, Cotugno M. |
2012 |
| 1167 |
Journal
Antimicrob Agents Chemother 1987 ; 31: 610-611. |
Instability of vancomycin in infusaid drug pump model 100.
Grennberg RN, Saeed AM, Kennedy DJ, McMillian R. |
1987 |
| 4506 |
Journal
Am J Health-Syst Pharm 2020 ;77,23:1938-1940. |
Physical compatibility of milrinone 1 mg/mL with select cardiovascular medications during simulated Y-site administration.
Griffith S, Stapleton E, Padilla S, Mruk A, Thomas C. |
2020 |
| 2035 |
Journal
EJHP Science 2005 ; 11: 107-110. |
The stability of ready-to-use (RTU) ephedrine hydrochloride in polypropylene syringes for use in maternal hypotension.
Griffiths W, Ing H, Fleury-SouverainS, Kern C, Sadeghipour F, Bonnabry P. |
2005 |
| 233 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 1850. |
Precipitation of lorazepam during infusion by volumetric pump.
Grillo JA, Barie PS. |
1996 |
| 380 |
Journal
Crit Care Med 1995 ; 23: 1061-1066. |
Chemical compatibility of inotropic and vasoactive agents delivered via a multiple line infusion system.
Grillo JA, Gonzalez ER, Ramaiya A, Karnes HT, Wells B. |
1995 |
| 2173 |
Journal
EJHP Science 2006 ; 12, 6: 135-139. |
Chemical stability and microbiological potency of intravenous vancomycin hydrochloride syringes for use in the neonatal intensive care.
Grioffiths W, Favet J, Ing H, Sadeghipour F, Bonnabry P. |
2006 |
| 2820 |
Journal
J Pharm Biomed Anal 2006 ; 42: 362-366. |
Stability of amphotericin B and nystatin in antifungal mouthrinses containing sodium hydrogen carbonate
Groeschke J, Solassol I, Bressolle F, Pinguet F. |
2006 |
| 3839 |
Journal
Current Ther Res 2015 ; 77: 105-110. |
Post-reconstitution Stability of Telavancin with Commonly Used Diluents and Intravenous Infusion Solutions.
Gu Z, Parra C, Wong A, Nguyen A, Cheung R, Catalano T. |
2015 |
| 2006 |
Journal
Hosp Pharm 2015 ; 50, 7: 609-614. |
Stability of Reconstituted Telavancin Drug Product in Frozen Intravenous Bags.
Gu Z, Wong A, Raquinio E, Nguyen A. |
2015 |
| 2217 |
Journal
Ziekenhuisfarmacie 1997 ; 13, 1: 21-23. |
De stabiliteit van clonazepaminjectievloeistof.
Guchelaar H.J, Hartog M.E. |
1997 |
| 4021 |
Journal
J Oncol Pharm Practice 2017 ;25,2: 303-308 |
Long-term stability of ganciclovir in polypropylene containers at room temperature.
Guichard N, Bonnabry P, Rudaz S, Fleury S. |
2017 |
| 4033 |
Journal
Am J Health-Syst Pharm 2017 ;74,22:1887-1894 |
Stability of busulfan solutions in polypropylene syringes and infusion bags as determined with an original assay.
Guichard N, Bonnabry P, Rudaz S, Fleury-Souverain S. |
2017 |
| 3317 |
Poster
APHIF Congress 2009 |
Stabilité de l'infliximab en solutions diluées.
Guirao S, Paul M, Jaccoulet E, Morand K, Astier A. |
2009 |
| 4280 |
Journal
J Pediatr Pharmacol Ther 2019 ; 24, 1: 53-57. |
Sterility and Stability Testing of Preservative-free Albuterol.
Gulley, S.L, Baltzley, S.M, Junkins, A.D, Murray, T.D, Simms, S.F, Sullivan, J.E, Al-Ghananeem A.M, O?Hagan A.R. |
2019 |
| 2185 |
Journal
J Pharm Biomed Anal 2007 ; 43: 1849-1853. |
Study on the compatibility of cefotaxime with tinidazole in glucose injection.
Guo P, Li X, Wan J, You A. |
2007 |
| 2367 |
Journal
Int J Pharm Compound 2005 ; 9, 5: 399-401. |
Chemical stability of hydralazine hydrochloride after reconstitution in 0.9% sodium chloride injection or 5% dextrose injection for infusion.
Gupta V.D. |
2005 |
| 3180 |
Journal
Int J Pharm Compound 2011 ; 15, 1: 78-80. |
Chemical stability of brompheniramine maleate in an oral liquid dosage form.
Gupta VD, Gupta VS. |
2011 |
| 2986 |
Journal
J Clin Pharm Ther 1988 ; 13: 165-169. |
Chemical stabilities of isoetharine hydrochloride, metaproterenol sulphate and terbutaline sulphate after mixing with normal saline for respiratory therapy.
Gupta VD, Parasrampurian J, Gardner SN. |
1988 |
| 1631 |
Journal
Int J Pharm Compound 2008 ; 12, 4: 372-374. |
Chemical stability of perphenazine in two commercially available vehicles for oral liquid dosage forms
Gupta VD. |
2008 |
| 1701 |
Journal
Int J Pharm Compound 2002 ; 6: 395-397. |
Chemical stability of dexamethasone sodium phosphate after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes.
Gupta VD. |
2002 |
| 1714 |
Journal
Int J Pharm Compound 2002 ; 6: 316-317. |
Stability of ketamine hydrochloride injection after reconstitution in water for injection and storage in 1-ml tuberculin polypropylene syringes for pediatric use.
Gupta VD. |
2002 |
| 1813 |
Journal
Int J Pharm Compound 2003 ; 7, 4: 310-312. |
Chemical stability of cefuroxime sodium after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric use.
Gupta VD. |
2003 |
| 1814 |
Journal
Int J Pharm Compound 2003 ; 7, 2: 152-154. |
Chemical stability of cefazolin sodium after reconstituting in 0.9% sodium chloride injection and storage in polypropylene suyringes for padiatric use.
Gupta VD. |
2003 |
| 1891 |
Journal
Int J Pharm Compound 2004 ; 8, 2: 153-155. |
Chemical stability of phenylephrine hydrochloride after reconstitution in 0.9% sodium chloride injection for infusion.
Gupta VD. |
2004 |
| 1933 |
Journal
Int J Pharm Compound 2004 ; 8, 5: 404-406. |
Chemical stability of terbutaline sulfate injection after diluting with 0.9% sodium chloride injection when stored at room temperature in polyvinyl chloride bags.
Gupta VD. |
2004 |
| 1957 |
Journal
Int J Pharm Compound 2005 ; 9, 1: 72-74. |
Chemical stability of metoclopramide hydrochloride injection diluted with 0.9% sodium chloride injection in polypropylene syringes at room temperature.
Gupta VD. |
2005 |
| 2953 |
Journal
J Pharm Sci 1982 ; 71: 585-587. |
Effect of some formulation adjuncts o the stability of benzoyl peroxide.
Gupta VD. |
1982 |
| 3278 |
Journal
Int J Pharm Compound 2012 ; 16, 1: 80-81. |
Chemical Stability of Pentoxifylline in a Topical Cream.
Gupta Vishnu D |
2012 |
| 1372 |
Journal
Int J Pharm Compound 2007 ; 11, 1: 79-81. |
Chemical Stability of Desonide in Ear Drops.
Gupta,VD. |
2007 |
| 1604 |
Journal
Eur Hosp Pharm 2001 ; 7: 11-14. |
Stability of citalopram hydrochloride in polyvinyl chloride bag for I.V. solutions and compatibility in the presence of dipotassium clorazepate.
Gury C, Dolizy I, Aymard N, Sellali Y, Rochet S. |
2001 |
| 1655 |
Journal
Pharmacotherapy 1999 ; 19: 484. |
Stability of intravenous citalopram hydrochloride in either polyvinyl chloride bags or glass containers for infusion therapy, and compatibility with dipotassium clorazepate admixed.
Gury C, Dolizy I, Aymard N, Sellali Y. |
1999 |
| 3346 |
Journal
Krankenhauspharmazie 2012 ; 33: 427-431. |
Stabilität, Qualität und Analytik individueller Noradrenalin-Zubereitungen.
H?llein L, Bennack E, Holzgrabe U. |
2012 |
| 2858 |
Journal
Int J Pharm Compound 2003 ; 7, 6: 485-489. |
Stability of Two Concentrations of Tiagabine in an Extemporaneously Compounded Suspension.
Haase MR, Khan MA, Bonilla J. |
2003 |
| 1734 |
Journal
J Pharm Biomed Anal 1993 ; 11: 723-727. |
The suitability of carboplatin solutions for 14-day continuous infusion by ambulatory pump : an HPLC-dynamic FAB study.
Hadfield JA, McGown AT, Dawson MJ, Thatcher N, Fox BW. |
1993 |
| 146 |
Journal
Clin Ther 1992 ; 14: 821-824. |
Effects of temperature, solution composition, and type of container on the stability and absorption of carmustine.
Hadji-Minaglou-Gonzalvez MF, Gayte-Sorbier A, Airauto CB, Verdier M. |
1992 |
| 319 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 997-999. |
Compatibility of etomidate, thiopental sodium, and propofol injections with drugs commonly administered during induction of anesthesia.
Hadzija BW, Lubarsky DA. |
1995 |
| 2785 |
Journal
Am J Health-Syst Pharm 2005 ; 62, 11: 1192-1194. |
Stability of misoprostol in suppositories.
Hafirassou H, Chaidmi F, Schlatter J, Ratiney R, Fontan JE. |
2005 |
| 278 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 521-523. |
Stability of nafcillin sodium in the presence of lidocaine hydrochloride.
Hagan RL, Carr-Lopez S, Strickland JS. |
1995 |
| 231 |
Journal
Am J Hosp Pharm 1993 ; 50: 2379-2381. |
Stability of midazolam hydrochloride in 5% dextrose injection or 0.9% sodium chloride injection over 30 days.
Hagan RL, Jacobs III LF, Pimsler M, Merritt GJ. |
1993 |
| 30 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 1431-1435. |
Stability of ondansetron hydrochloride and dexamethasone sodium phosphate in infusion bags and syringes for 32 days.
Hagan RL, Mallett MS, Fox JL. |
1996 |
| 957 |
Journal
J Parenter Sci Technol 1990 ; 44: 30-34. |
Stability studies of hydralazine in aqueous solutions.
Halasi S, Nairn JG. |
1990 |
| 104 |
Journal
Am J Health-Syst Pharm 1997 ; 54: 185-189. |
Compatibility of filgrastim with selected antimicrobial drugs during simulated Y-site administration.
Hall PD, Yui D, Lyons S, Bosso JA. |
1997 |
| 1315 |
Journal
Int J Pharm Clin Pharmacol Ther Tox 1989 ; 27: 294-297. |
Visual compatibility of enalaprilat with commonly used critical care medications during simulated Y-site injection.
Halpern NA, Colucci RD, Alicea M, Greenstein R. |
1989 |
| 1490 |
Journal
Int J Pharm Clin Pharmacol Ther Tox 1989 ; 27: 250-254. |
The compatibility of nicardipine hydrochloride injection with various ICU medications during simulated Y-site injection.
Halpern NA, Colucci RD, Alicea M, Greenstein R. |
1989 |
| 3264 |
Poster
AAPS Congress - Washington, October 2011 2011 |
Nalbuphine stability at 1 mg/mL concentration.
Hammer C, Perello L, Dory A, Lev?que D, Ubeaud-S?quier G. |
2011 |
| 504 |
Journal
Sci Tech Pharm 1987 ; 3: 33-40. |
Etude de la stabilité dans des solutions diluées destinées à la perfusion de deux antimitotiques dérivés de la podophyllotoxine : l’étoposide (VP 16), le téniposide (VM 26).
Hamon M, Plas-Remoissenet D, Kubab-Alajati S. |
1987 |
| 3372 |
Journal
Rev Bras Anestesiol 2013 ; 63, 1: 163-166. |
Precipitation in Gallipoli: Sugammadex / Amiodarone & Sugammadex / Dobutamine & Sugammadex / Protamine.
Hanci V, Ali Kiraz H, Ömür D, Ekin S, Uyan B, Yurtlu B.S. |
2013 |
| 348 |
Journal
Am J Hosp Pharm 1985 ; 42: 335-339. |
Effect of a polyethylene-lined administration set on the avaibility of diazepam injection.
Hancock BG, Black CD. |
1985 |
| 4436 |
Journal
Anaesthesiol Intensive Ther 2018 ; 50, 3: 221-225. |
Extended compatibility of fentanyl and ketamine in dextrose 5%.
Hanifah S, Kennedy R.A; Ball P.A. |
2018 |
| 4435 |
Journal
Anaesthesiol Intensive Ther 2020 ; 52, 1: 23-27. |
Compatibility of acetaminophen with central nervous system medications during simulated Y-site injection.
Hanifah S, Nugroho B.H, Chabib L. |
2020 |
| 1980 |
Journal
Act Pharm Nord 1991 ; 3, 3: 131-136. |
Loss of nitroglycerin during passage through two different infusion sets.
Hansen HC, Spillum A. |
1991 |
| 4664 |
Journal
Biomed Chromatogr 2022 ;e5340. |
Stability evaluation of morphine, hydromorphone, metamizole and esketamine containing analgesic mixtures applied for patient-controlled analgesia in hospice and palliative care.
Harder M, Fiegl-Lechner A, Oberacher H, Horvath U.E.I, Schlager A, Jeske M, Kerndler S, Schüllner F, Bonn G.F, Rainer M. |
2022 |
| 1325 |
Journal
JPEN 1982 ; 6: 163-165. |
Compatibility of 5-fluorouracil and total nutrition solutions.
Hardin TC, Clibon U, Page CP, Cruz AB. |
1982 |
| 4378 |
Journal
Perit Dial Int 2020 ; 40, 5: 470-476. |
Stability of ceftolozane and tazobactam in different peritoneal dialysis solutions.
Harmanjeet H, Jani H, Zaidi S.T.R, Wanandy T, Castelino R.L, Sud K, Peterson G.M, Patel R.P. |
2020 |
| 4035 |
Journal
EJHP 2017 ;0:1-5 |
Physicochemical stability of voriconazole in elastomeric devices.
Harmanjeet H, Zaidi S.T.R, Ming L.C, Wanandy T, Patel R.P. |
2017 |
| 3215 |
Journal
EJOP 2011 ; 5,1: 24-27. |
Taxotere 1-vial (docetaxel 20 mg/ml) physical and chemical stability over 28 days in infusion bags containing 0.9% saline solution and 5% glucose solution.
Hart MC, Ahmed W. |
2011 |
| 1964 |
Journal
Am J Health-Syst Pharm 2002 ; 59: 1784-1785. |
Visual compatibility of argatroban with selected drugs.
Hartman CA, Baroletti SA, Churchill WW et al. |
2002 |
| 1944 |
Journal
Am J Health-Syst Pharm 2004 ; 61: 1774. |
Visual compatibility of bivalirudin with selected drugs.
Hartman CA, Faria CE, Mago K. |
2004 |
| 1832 |
Journal
Pharmazie 2003 ; 6 |
Stability of fentanyl/ropivacain preparations for epidural application.
Hartmann M, Knoth H, K?ler W, Meissner W. |
2003 |
| 1735 |
Journal
J Pharm Biomed Anal 1999 ; 21: 577-583. |
Stability of mepiridine in an implantable infusion pump using capillary gas chromatography-mass spectrometry and a deuterated internal standard.
Harvey SC, Toussaint CP, Coe SE, Watson EE, O?Neil MG, Patrick KS. |
1999 |
| 1036 |
Journal
Am J Hosp Pharm 1984 ; 41: 1379-1380. |
Visual compatibility of amiodarone hydrochloride injection with other injectable drugs.
Hasegawa GR, Eder JF. |
1984 |
| 1041 |
Journal
Am J Hosp Pharm 1984 ; 41: 949-951. |
Visual compatibility of dobutamine hydrochloride with other injectable drugs.
Hasegawa GR, Eder JF. |
1984 |
| 1352 |
Journal
Am J Hosp Pharm 1984 ; 41: 2588-2589. |
Dobutamine-heparin mixture inadvisable.
Hasegawa GR, Eder JF. |
1984 |
| 2419 |
Journal
Am J Health-Syst Pharm 1999 ; 56: 333-336. |
Stability of rifabutin in two extemporaneously compounded oral liquids
Haslam JL, Egodage KL, Chen Y, Rajewski RA, Stella V. |
1999 |
| 199 |
Journal
Am J Hosp Pharm 1994 ; 51: 2143-2145. |
Stability of labetalol hydrochloride with selected critical care drugs during simulated Y-site injection.
Hassan E, Leslie J, Martir-Herrero ML. |
1994 |
| 361 |
Journal
Am J Hosp Pharm 1991 ; 48: 1507-1510. |
Stability of nizatidine in total nutrient admixtures.
Hatton J, Holstad SG, Rosenbloom AD, Westrich T, Hirsch J. |
1991 |
| 1396 |
Journal
J Clin Oncol 1993 ; 11: 197. |
Ondansetron compatible with sodium acetate.
Hauser AR, Trissel LA, Martinez JF. |
1993 |
| 4498 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2020 |
Development and validation of a new HPLC method for the analysis of a novel oral suspension formulation of 50 mg/mL ursodesoxycholic acid for newborns.
Hausherr A, Roessle C, Pinet E, Vasseur V, Abarou T, Benakouche S, Bourdon O, Storme T. |
2020 |
| 871 |
Journal
Anesth Analg 1998 ; 86: 208-213. |
The chemical stability and sterility of sodium thiopental after preparation.
Haws JL, Herman N, Clark Y, Bjoraker R, Jones D. |
1998 |
| 1669 |
Journal
Can J Hosp Pharm 1994 ; 47: 9-14. |
The pharmaceutical stability of deferoxamine mesylate.
Hayes DM, Reilly RM, Lee MMC. |
1994 |
| 3033 |
Journal
Eur Respir J 1998 ; 11: 946-948. |
Stability of metacholine chloride solutions under different storage conditions over a 9 months period.
Haynes RD, Beach JR, Rutherford DM et al. |
1998 |
| 2872 |
Journal
Int J Pharm Compound 2009 ; 13, 2: 170-174. |
Stability of Melatonin in an Extemporaneously Compounded Sublingual Solution and Hard Gelatin Capsule.
Haywood A, Burrell A, van Breda K, Testa C, Norris R. |
2009 |
| 2932 |
Journal
J Pharm Pract and Res 2005 ; 35: 181-182. |
Extemporaneous isoniazid mixture: stability implications.
Haywood A, Mangan M, Grant G et al. |
2005 |
| 3981 |
Journal
EJHP 2017 ;24:162?166 |
Compatibility of dexamethasone sodium phosphate with 5-HT3 receptor antagonists in infusion solutions: a comprehensive study
He G, Zeng F, Lei K, Xia S, Deng L, Zhang C, Liu D. |
2017 |
| 3121 |
Journal
Am J Health-Syst Pharm 2010 ; 67: 1191-1194. |
Stability of polymyxin B sulfate diluted in 0.9% sodium chloride injection and stored at 4 or 25 °C
He J, Figueroa DA, Lim TP, Chow DS, Tam VH. |
2010 |
| 3360 |
Journal
Antimicrob Agents Chemother 2012 ; 56:6432-6433. |
Stability of Colistimethate Sodium in Aqueous Solution.
Healan A. M, Gray W, Fuchs E.J, Griffiss J.M, Salata R.A, Blumer J. |
2012 |
| 2683 |
Journal
Int J Pharm Pract 1993 ; 23: 163-167. |
Shelf life of cefuroxime eye-drops when dispensed in artificial tear preparations.
Hebron B, Scott H. |
1993 |
| 3572 |
Journal
Int J Pharm Compound 2014 ; 18, 1 : 78-82. |
Long-term Stability of Morphine Hydrochloride in 0.9% NaCl Infusion Polyolefin Bags After Freeze-thaw Treatment and in Polypropylene Syringes at 5°C ± 3°C.
Hecq J-D, Godet M, Gillet P, Jamart J, Galanti L. |
2014 |
| 1946 |
Journal
Can J Hosp Pharm 2004 ; 57, 5: 276-282. |
Effects of freezing, long-term storage, and microwave thawing on the stability of piperacillin plus tazobactam in 5% dextrose for infusion.
Hecq JD, Berlage V, Vanbeckbergen D, Jamart J, Galanti L. |
2004 |
| 1962 |
Journal
Pharmakon 2004 ; 36, 1: 8-14. |
Long term stability of sufentanyl citrate with levobupivacaine hydrochloride in 0.9% sodium chloride infusion P.V.C bags at 4°C.
Hecq JD, Boitquin L, Evrard JM, Vanbeckbergen D, Jamart J, Galanti L. |
2004 |
| 2124 |
Journal
EJHP Science 2006 ; 12, 4: 72-75. |
Freeze thaw treatment of ketorolac tromethamine in 5% dextrose infusion polyolein bags: effect of drug concentration and microwave power on the long-term stability at 4°C.
Hecq JD, Boitquin L, Lebrun C, Vanbeckbergen D, Evrard JM, Jamart J, Galanti L. |
2006 |
| 2008 |
Journal
Ann Pharmacotherapy 2005 ; 39: 1244-1248. |
Effect of the freezing conditions and microwave thawing power on the stability of cefuroxime in dextrose 5% infusion polyolefin bags at 4°C.
Hecq JD, Boitquin LP, Vanbeckbergen DF, Jamart J, Galanti LM. |
2005 |
| 2015 |
Journal
Ann Pharmacotherapy 2005 39: 1654-1658. |
Effect of freezing, long term storage, and microwave thawing on the stability of ketorolac tromathamine.
Hecq JD, Boitquin LP, Vanbeckbergen DF, Jamart J, Galanti LM. |
2005 |
| 1289 |
Journal
Pharmakon 1998 ; 116: 145-148. |
Etude de stabilité visuelle du chlorhydrate de chlorpromazine, du chlorure de potassium, de la furosémide et de l’héparine sodique en perfusion continue.
Hecq JD, Evrard JM, Gillet P, Grosdent N. |
1998 |
| 2110 |
Journal
EJHP Science 2006 ; 12, 3: 52-56. |
Effect of freezing, long term storage and microwave thawing on the stability of ceftriaxone sodium in 5% dextrose infusion polyolefin bags at 2-8°C.
Hecq JD, Evrard JM, Vanbeckbergen DF, Jamart J, Galanti LM. |
2006 |
| 1958 |
Journal
EJHP Science 2005 ; 11: 23-25. |
Effect of freezing, long-term storage and microwave thawing on the stability of cefuroxime sodium in 5% dextrose infusion polyvinyl chloride bags.
Hecq JD, Schlesser V, Vanbeckbergen D, Jamart J, Galanti L. |
2005 |
| 3402 |
Journal
J Oncol Pharm Practice 2013 ; 19, 1: 65-74. |
Doxorubicin-loaded drug-eluting beads (DC Bead®) for use in transarterial chemoembolization: A stability assessment.
Hecq, J.-D., Lewis, A.L., Vanbeckbergen, D., Athanosopoulos, A., Galanti, L., Jamart, J., Czuczman, P., Chung, T. |
2013 |
| 3397 |
Poster
EAHP Congress Paris 2013 |
Physicochemical stability of ready-to-administer epinephrine injection solutions 20 µg/mL, 50 mL.
Heeb R.M, Krämer I. |
2013 |
| 3445 |
Journal
Krankenhauspharmazie 2013 ; 34, 8: 410-411. |
Aseptische Herstellung applikationsfertiger Adrenalin-Dauerinjektionen 20 µg/ml.
Heeb R.M, Thiesen J, Krämer I. |
2013 |
| 2723 |
Journal
J Ped Hematol Oncol 2004 ; 26: 179-184. |
Chemical and functional analysis of hydroxyurea oral solutions.
Heeney MM, Whorton MR, Howard TA. |
2004 |
| 270 |
Journal
Am J Health-Syst Pharm 1997 ; 54: 1449. |
Precipitation of amphotericin B from IV fat emulsion.
Heide PE. |
1997 |
| 2446 |
Journal
Am J Health-Syst Pharm 1998 ; 55: 1299-1301. |
Content uniformity and stability of nifedipine in extemporaneously compounded oral powders
Helin MM, Kontra KM, Naaranlahti TJ, Wallenius KJ. |
1998 |
| 3401 |
Journal
J Clin Pharm Ther 2013 ;38, 2: 104-108 |
Stability of an epidural analgesic admixture of levobupivacaine, fentanyl and epinephrine.
Helin-Tanninen, M., Lehtonen, M., Naaranlahti, T., Ven?l?inen, T., Pentik?inen, J., Laatikainen, A., Kokki, H. |
2013 |
| 795 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 2338-2339. |
21-day compatibility of hydromorphone hydrochloride and promethazine hydrochloride in a cassette.
Henderson F. |
1996 |
| 2524 |
Journal
Am J Hosp Pharm 1994 ; 51: 2955-2957. |
Stability of mesalamine in rectal suspension diluted with distilled water
Henderson LM, Johnson CE, Berardi RR. |
1994 |
| 4501 |
Journal
BMC Anesthesiology 2020 ;20:283. |
The effect of concentration, reconstitution solution and pH on the stability of a remifentanil hydrochloride and propofol admixture for simultaneous co-infusion.
Henkel E, Vella R, Behan K, Austin D, Kruger P, Fenning A. |
2020 |
| 2386 |
Journal
Am J Health-Syst Pharm 203 ; 60: 687-690. |
Stability of valganciclovir in extemporaneously compounded liquid formulations
Henkin CC, Griener JC, Ten Eick AP. |
203 |
| 646 |
Journal
J Clin Pharm Ther 1999 ; 24: 365-368. |
Stability of methacholine chloride in isotonic sodium chloride using a capillary electrophoresis assay.
Henn S, Monfort P, Vigneron JH, Hoffman MA, Hoffman M. |
1999 |
| 1989 |
Journal
Am J Health-Syst Pharm 2005 ; 62: 506-509. |
Stability of cidofovir in extemporaneously prepared syringes.
Hennere G, Havard L, Bonan B, Prognon P. |
2005 |
| 3958 |
Journal
J Infect Dis 1988 ; 157, 3: 600-601. |
A Dilute Solution of Vancomycin and Heparin Retains Antibacterial and Anticoagulant Activities .
Henrickson K.J; . Powell K.R; . Schwartz C.L. |
1988 |
| 3119 |
Poster
Congrès HOPIPHARM 2010 |
Stabilité de la vincristine sans conservateurs.
Henriet Th, El Kateb N, Jourdan N, Faure P, Bellenger P. |
2010 |
| 53 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 2570-2573. |
Stability of cisplatin and ondansetron hydrochloride in admixtures for continuous infusion.
Henry DW, Marshall JL, Nazzar OD, Fox JL, Leff RD. |
1995 |
| 2477 |
Journal
Am J Hosp Pharm 1986 ; 43: 1492-1495. |
Stability of propranolol hydrochloride suspension compounded from tablets
Henry DW, Repta AJ, Smith FM, White SJ. |
1986 |
| 4567 |
Journal
Pharmaceutics 2021 ;13, 458. |
Addition of Regular Insulin to Ternary Parenteral Nutrition: A Stability Study.
Henry H, Lannoy D, Maboudou P, Seguy D, Dine T, Pigny P, Odou P. |
2021 |
| 791 |
Journal
JPEN 1996 ; 20: 219-220. |
Stability of heparin anticoagulant activity over time in parenteral nutrition solutions.
Hensrud DD, Buritt MF, Hall LG. |
1996 |
| 4728 |
Journal
J Pharm Biomed Anal 2021 ; 203:114209. |
Stability study over time of clinical solutions of ziv-aflibercept prepared in infusion bags using a proper combination of physicochemical and functional strategies.
Hermosilla J, Pérez-Robles R, Salmerón-García A, Casares S, Cabeza J, Navas N. |
2021 |
| 4279 |
Journal
Bio Drugs 2019 ; 33: 193–205. |
Comparative Stability Studies of Different Infliximab and Biosimilar CT-P13 Clinical Solutions by Combined Use of Physicochemical Analytical Techniques and Enzyme-Linked Immunosorbent Assay (ELISA).
Hermosilla J, Sanchez-Martin R, Pérez-Robles R, Salmeron-Garcia A, Casares S, Cabeza J, Cuadros-Rodriguez L, Navas N. |
2019 |
| 1869 |
Journal
J Pain Symptom Manage 2003 ; 25, 5: 464-471. |
Stability and compatibility of morphine-clonidine admixtures in an implantable infusion system.
Hildebrand KR, Elsberry DD, Hassenbusch SJ. |
2003 |
| 1867 |
Journal
J Pain Symptom Manage 2001 ; 22, 6: 1042-1047. |
Stability and compatibility of hydromorphone hydrochloride in an implantable infusion system.
Hildebrand KR, Elsberry DE, Anderson VC. |
2001 |
| 1879 |
Journal
Clin J Pain 2001 : 17: 239-244. |
Stability, compatibility, and safety of intrathecal bupivacaine administered via an implantable delivery system.
Hildebrand KR, Elsberry DE, Deer TR. |
2001 |
| 1990 |
Journal
Krankenhauspharmazie 2000 ; 11: 576-580. |
Treosulfan : chemisch-physikalische stabilität, Hinweise für die pharmazeutisch-onkologische praxis.
Hilger RA, Kredtke S, Barth J. |
2000 |
| 2900 |
Journal
EJHP 2009 ; 15, 5: 32-38. |
Compatibility of an injectable high strength oxycodone formulation with typical diluents, syringes, tubings,infusion bags and drugs for potential co-administration.
Hines S, Pleasance S. |
2009 |
| 4636 |
Journal
J Oncol Pharm Practice 2022 ; |
Design and stability of pediatric oral formulation of imatinib
Hinterlang M, Gendron A, Fleury F, Rieutord A, Vrana A , Schlatter J, Annereau M. |
2022 |
| 4692 |
Journal
The Scientific World Journal 2022 |
Physicochemical Stability Study of Oral Suspension Containing Ruxolitinib in Children with Steroid-Refractory Acute Graft-Versus-Host Disease.
Hinterlang M, Sebti M, Cotteret C, Vidal F, Neven B, Cisternino S, Schlatter J. |
2022 |
| 1175 |
Journal
Am J Hosp Pharm 1981 ; 38: 995-997. |
Insulin adsorption to polyolefin infusion bottles and polyvinyl chloride administration sets.
Hirsch JI, Wood JH, Thomas RB. |
1981 |
| 2547 |
Journal
Ann Pharmacotherapy 2001 ;35:1293-1294. |
Stability of extemporaneously prepared gentamicin ophthalmic solutions.
Ho PC, Soh H, Lim SM, Yow KL. |
2001 |
| 951 |
Journal
PDA J Pharm Sci Technol 1998 ; 52: 129-133. |
Influence of DL methionine and sodium metasulphite on the photostability of vitamin K1.
Ho PC, Wong VK. |
1998 |
| 532 |
Journal
Ann Pharmacotherapy 1996 ; 30: 343-346. |
Lorazepam stability in parenteral solutions for continuous intravenous administration.
Hoey LL, Vance-Bryan K, Clarens DM, Wright DH, Konstantinides FN, Guay DRP. |
1996 |
| 740 |
Journal
Am J Hosp Pharm 1979 ; 36: 1536-1538. |
Stability of refrigerated and frozen solutions of doxorubicin hydrochloride.
Hoffman DM, Grossano DD, Damin LA, Woodcock TM. |
1979 |
| 2317 |
Journal
EJHP Science 2009 ; 15, 1: 3-5. |
Development and stability testing of a concentrated injectable clonidine solution for intrathecal analgesia.
Hollenwaeger M, Borquin Challandes I, Fallab L.C, Schaad N, Zelger G. |
2009 |
| 575 |
Journal
Am J Hosp Pharm 1982 ; 39: 104-108. |
Effect of freezing and microwave thawing on the stability of six antibiotic admixtures in plastic bags.
Holmes CJ, Ausman RK, Kundsin RB, Walter CW. |
1982 |
| 576 |
Journal
Drug Intell Clin Pharm 1980 ; 14: 353-357. |
Activity of antibiotic admixtures subjected to different freeze-thaw treatments.
Holmes CJ, Ausman RK, Walter CW, Kundsin RB. |
1980 |
| 2162 |
Journal
Perit Dial Int 1990 ; 10: 157-160. |
Stability of cotrimoxazole in peritoneal dialysis fluid.
Holmes SE, Aldous S. |
1990 |
| 4419 |
Journal
J Pediatr Pharmacol Ther 2008 ; 13, 3: 155-161. |
Physical Compatibility of Ibuprofen Lysine Injection with Selected Drugs During Simulated Y-site Injection.
Holt R.J, Siegert S.W.K, Krishna A. |
2008 |
| 4655 |
Journal
Am J Health-Syst Pharm 2022 ;79,1:27-33 |
Physical compatibility of Normosol-R with critical care medications used in patients with COVID-19 during simulated Y-site administration.
Holyk A, Lindner A, Lindner S, Shippert B |
2022 |
| 1963 |
Journal
Am J Health-Syst Pharm 2004 ; 61: 2415-2418. |
Compatibility of argatroban with selected cardiovascular agents.
Honisko ME, Fink JM, Militello MA, Mauro VF, Alexander KS. |
2004 |
| 4393 |
Poster
Sunnybrook Health Sciences Centre 2020 |
Chemical Stability of Epinephrine Diluted in 0.9% Sodium Chloride and Stored in Polypropylene (PP) Syringes at 4°C and 25°C.
Hook R, Riss V, Neault A, Ma N, Law S, Walker S.E. |
2020 |
| 4395 |
Poster
Sunnybrook Health Sciences Centre 2020 |
Stability of Morphine Solutions of 20, 40, 100 , 200 and 1,000 µg/mL in Syringes Following Dilution with 0.9% Sodium Chloride or D5W at Room Temperature (25°C).
Hook R, Riss V, Neault A, Ma N, Law S, Walker S.E. |
2020 |
| 4183 |
Poster
Professional Practice Conference - the Canadian So 2018 |
Stability if 4 and 10 mcg/mL Remifentanil Solutions Stored in Syringes at Room Temperature (23°C).
Hook R, Riss V, Scharrer E, Law S, Walker S.E. |
2018 |
| 4216 |
Poster
Sunnybrook 2019 |
Stability of 1.0, 0.2 and 0.025 mg/mL Milrinone Solutions Stored in Syringes at 4ºC and at Room Temperature (25ºC).
Hook R, Riss V, Scharrer E, Robillard J, Law S, Walker SE. |
2019 |
| 1246 |
Journal
Pharm Weekbl [Sci] 1990 ; 12: 188-189. |
Comparison of clonazepam sorption to polyvinyl chloride-coated and polyethylene-coated tubings.
Hooymans PM, Janknegt R, Lohman JJHM. |
1990 |
| 3324 |
Journal
J Pharm Pract and Res 2012 ; 42, 2: 115-117. |
Stability study of a thalidomide suspension.
Hopkins AM, Sharley NA, Tang CD. |
2012 |
| 932 |
Journal
J Clin Pharm Ther 1997 ; 22: 405-410. |
Stability of morphine sulphate in saline under simulated patient administration conditions.
Hor MMS, Chan SY, Yow KL, Lim LY, Chan E, Ho PC. |
1997 |
| 930 |
Journal
J Clin Pharm Ther 1997 ; 22: 339-345. |
Stability of admixtures of pethidine and metoclopramide in aqueous solution, 5% dextrose and 0.9% sodium chloride.
Hor MMS, Chan SY, Yow KL, Lim LY, Chan E. |
1997 |
| 2503 |
Journal
Am J Hosp Pharm 1991 ; 48: 293-295. |
Stability of an extemporaneously compounded terbutaline sulfate oral liquid
Horner RK, Johnson CE. |
1991 |
| 1109 |
Journal
Crit Care Med 1990 ; 18: 858-861. |
Intravenous infusions of nitroprusside, dobutamine, and nitroglycerin are compatible.
Horrow JC, Digregorio J, Barbieri EJ, Rupp E. |
1990 |
| 3648 |
Journal
Am J Health-Syst Pharm 2014 ; 71:669-673. |
Stability of penicillin G sodium diluted with 0.9% sodium chloride injection or 5% dextrose injection and stored in polyvinyl chloride bag containers and elastomeric pump containers.
Hossain M.A, Friciu M, Aubin S, Leclair G. |
2014 |
| 4457 |
Journal
J Obstet Gynaecol Can 2016 ;38,10:936e944. |
Magnocaine: Physical Compatibility and Chemical Stability of Magnesium Sulphate and Lidocaine Hydrochloride in Prefilled Syringes.
Houlihan, S, Decarie, D, Benes, C, Cleve, R, Vidler M, Magee L.A, Ensom M.H.H, vonDadelszen P. |
2016 |
| 1676 |
Journal
Int J Pharm 1997 ; 154: 95-102. |
Compatibility of granisetron towards glass and plastics and its stability under various storage conditions.
Hourcade F, Sautou-Miranda V, Normand B, Laugier M, Picq F, Chopineau J. |
1997 |
| 3254 |
Journal
Am J Health-Syst Pharm 2011 ; 68: 2265-2270. |
Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration
Housman S.T, Tessier P.R, Nicolau D.P, Kuti J.L. |
2011 |
| 2707 |
Journal
J Clin Pharm Ther 1998 ; 23, 1: 41-47. |
Stability of cefazolin sodium eye drops
How TH, Loo WY, Yow KL, Lim LY, Chan EW, Ho PC, Chan SY. |
1998 |
| 855 |
Journal
Cancer Chemother Pharmacol 1992 ; 29: 252-255. |
Suitability of cisplatin solutions for 14-day continuous infusion by ambulatory pump.
Hrubisko M, Mc Gown AT, Prendiville JA, Radford JA, Thatcher N, Fox BW. |
1992 |
| 216 |
Journal
Am J Hosp Pharm 1994 ; 51: 2963. |
Compatibility of hydromorphone hydrochloride with haloperidol lactate and ketorolac tromethamine.
Huang E, Anderson RP. |
1994 |
| 3377 |
Journal
Anaesthesia 1983 ; 38: 601-602. |
Precipitation betwen meptazinol and thiopentone.
Huddy NC, Durcan JJ. |
1983 |
| 2308 |
Journal
Int J Obstet Anesth 2005 ; 14, 4: 284-287. |
Stability of premixed syringes of diamorphine and hyperbaric bupivacaine.
Hudson S.J, Jones M.F, Nolan S, Ellis H, Duncombe R, Alexander-Williams J.M. |
2005 |
| 3485 |
Journal
Anaesthesia 2000 ; 55, 10: 1039-1040. |
Vancomycin causes dangerous precipitation when infused with gelatin fluid.
Huey-Ping Ng, Kwong-Fah Koh, Lai-San Tham. |
2000 |
| 4140 |
Journal
Int J Pharm Compound 2018 ;22,4:340-344 |
Comparative Stability of Vitamin K1 Oral Liquids Prepared in Sterile Water for Injection and Stored in Amber Glass Bottles and Amber Plastic Syringes.
Huffman J, Brown S, Lewis P, Lawson S, Ogle A, Peacock G. |
2018 |
| 4583 |
Journal
Int J Pharm Compound 2021 ;25,3:246-257 |
Prolonged In-use Stability of Diluted Atezolizumab in Commercial Intravenous Bags
Hui A, Yin J, Liu W, Zheng K. |
2021 |
| 3176 |
Poster
16èmes JFSPH, Sion, 18-19 novembre 2010 |
Compatibilité du Remifentanil avec d'autres médicaments injectables : influence du soluté.
Humbert Delaloye V, Berger M, Voirol P, Pannatier A. |
2010 |
| 3177 |
Poster
16èmes JFSPH, Sion, 18-19 novembre 2010 2010 |
Compatibilités physico-chimique entre catécholamines, amiodarone, et/ou nitroprussiate de sodium intraveineux.
Humbert-Delaloye V, Berger M, Pannatier A. |
2010 |
| 3294 |
Journal
EJHP 2012 ; 19: 57-64. |
In vitro compatibility of remifentanil hydrochloride and sufentanil citrate with selected drugs
Humbert-Delaloye V, Berger M, Voirol P, Pannatier A. |
2012 |
| 3381 |
Journal
EJHP 2013 ; 20:110-116. |
In vitro compatibility of various cardioactive drugs during simulated Y-site administration.
Humbert-Delaloye V, Berger-Gryllaki M, Voirol P, Gattlen L, Pannatier A. |
2013 |
| 3781 |
Journal
EJHP 2015 ;22:1 56-58 |
Screening for physicochemical incompatibilities of intravenous drugs in intensive care units: the case of monobasic potassium phosphate and furosemide.
Humbert-Delaloye V, Berger-Gryllaki M, Voirol P, Testa B, Pannatier A |
2015 |
| 2310 |
Journal
EJHP Science 2008 ; 14, 6: 36-38. |
Stability of diluted nadroparin for the treatment of paediatric thrombosis.
Hunfeld N, Ypma P, Westerman E, Leebeck F, Touw D. |
2008 |
| 257 |
Journal
Am J Hosp Pharm 1993 ; 50: 1186-1187. |
Stability of fluconazole in injectable solutions.
Hunt-Fugate AK, Hennessey CK, Kazarian CM. |
1993 |
| 2670 |
Journal
Int J Pharm Compound 1998 ; 2: 394-396. |
Stability of albuterol in continuous nebulization.
Hunter DA, Yoo SD, Fox JL. |
1998 |
| 4640 |
Journal
Hosp Pharm 2021 ; 56, 5: 507–512. |
Stability of Ampicillin in Normal Saline Following Refrigerated Storage and 24-Hour Pump Recirculation.
Huskey M, Lewis P, Brown S.D. |
2021 |
| 1868 |
Journal
Nutr Clin Metab 2003 ; 17: 8-14. |
Stabilité galénique de mélanges commercialisés de nutrition parentérale en présence de médicaments: médicaments dans le mélange.
Husson E, Crauste-Manciet S, Hadj-Salah E, ,Segier JC, Broissard D. |
2003 |
| 93 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 2185-2188. |
Compatibility of cefmetazole sodium with commonly used drugs during Y-site delivery.
Hutchings SR, Rusho WJ, Tyler LS. |
1996 |
| 2394 |
Journal
Am J Health-Syst Pharm 2009 ; 66: 665-667. |
Stability of extemporaneously prepared moxifloxacin oral suspensions
Hutchinson DJ, Johnson CE, Klein KC. |
2009 |
| 2381 |
Journal
Ann Pharmacotherapy 2010 ;44:462-465. |
Stability of Extemporaneously Prepared Rufinamide Oral Suspensions .
Hutchinson DJ, Liou Y, Best R, Zhao F. |
2010 |
| 1022 |
Journal
Drug Intell Clin Pharm 1986 ; 20: 886. |
Heparin and aminoglycosides instability.
Hutchinson SMW. |
1986 |
| 4148 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2018 |
Long-Term Stability Comparison between an Original and a Generic Version of Piperacillin/Tazobactam in Dextrose 5% Infusion Polyolefin Bags at 5+/-3°C after Microwave Freeze-Thaw Treatment.
Huvelle S, Godet M, Galanti L, Closset M, Bihin B, Jamart J, Hecq J.D. |
2018 |
| 3874 |
Journal
Ann Pharm Fr 2016 ; 74: 283-287. |
Long-term stability of ketamine hydrochloride 50 mg/ml injection in 3 ml syringes
Huvelle S, Godet M, Hecq J.D, Gillet P, Bihin B, Jamart J, Galanti L. |
2016 |
| 2988 |
Journal
J Clin Pharm Ther 2007 ; 32: 489-496. |
Compounding of vitamin A, D3, E, and K3 supplements for cystic fibrosis patients: formulation and stability study.
Huyghebaert N, de Beer J, Vervaet C et al. |
2007 |
| 4245 |
Poster
2019 |
Physical Compatibility and Stability of Ascorbic acid Injection in Polyvinyl Chloride Minibags at 4ºC and Room Temperature (25ºC).
Iazetta J, Law S, Adhikari NKJ, Lamontagne F, Kanji S, Walker SE. |
2019 |
| 3759 |
Journal
Yakugaku Zasshi 2014 ; 134, 2: 293-298. |
Examination of the cause of changing solution color by mixing aminophylline and dopamine, the compatibility of which was indicated by the supplier.
Igarashi K, Kawahara M. |
2014 |
| 3333 |
Journal
Am J Health-Syst Pharm 2012 ; 69:1509-1512. |
Stability of infliximab in polyvinyl chloride bags.
Ikeda R, Vermeulen L.C, Lau E, Jiang Z, Saha S, Reichelderfer M, Kolesar J.M. |
2012 |
| 3135 |
Journal
Am J Health-Syst Pharm 2010 ; 67, 3: 223-226. |
Stability of cetuximab and panitumumab in glass vials and polyvinyl chloride bags.
Ikesue H, Vermeulen LC, Hoke R, Kolesar JM. |
2010 |
| 2879 |
Poster
GSASA Congress - Lucerne - Switzerland 2008 |
Compatibilité entre amiodarone, catecholamines et/ou nitroprussiate de sodium, administré en continu par voie veineuse aux soins intensifs adultes.
Imesch G., Humbert-Delaloye V., Berger M., Pannatier A. |
2008 |
| 360 |
Journal
Am J Hosp Pharm 1992 ; 49: 2769-2772. |
Stability of ranitidine hydrochloride with aztreonam, ceftazidime, or piperacillin sodium during simulated Y-site administration.
Inagaki K, Gill MA, Okamoto MP, Takagi J. |
1992 |
| 903 |
Journal
J Parenter Sci Technol 1993 ; 47: 35-39. |
Chemical compatibility of cefmetazole sodium with ranitidine hydrochloride during simulated Y-site administration.
Inagaki K, Gill MA, Okamoto MP, Takagi J. |
1993 |
| 934 |
Journal
Int J Pharm Compound 1998 ; 2: 318-321. |
Compatibility and stability of ranitidine hydrochloride with six cephalosporins during simulated Y-site administration.
Inagaki K, Kambara M, Mizuno M, Okuda J, Gill MA, Nishida M. |
1998 |
| 2355 |
Journal
Int J Pharm Compound 2000 ; 4, 2: 150-153. |
Stability of ranitidine hydrochloride with cefazolin sodium, cefbuperazone sodium, cefoxitin sodium nd cephalotin sodium during simulated Y-site administration.
Inagaki K, Miyamoto Y, Kurata N, Nakane S, Gill M.A, Nishida M. |
2000 |
| 256 |
Journal
Am J Hosp Pharm 1993 ; 50: 1206-1208. |
Stability of fluconazole in commonly used intravenous antibiotic solutions.
Inagaki K, Takagi J, Lor E, Lee KJ, Nii L, Gill MA. |
1993 |
| 4107 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2018 |
Physicochemical Stability of Extemporaneously Prepared Oral Suspension of Fluconazole 50 mg/mL in SuspendIt.
Ip K, Shan A, Carvalho M, Baker S, Banov D. |
2018 |
| 4174 |
Journal
Int J Pharm Compound 2018 ;22,6:504-511 |
Physical and Chemical Stability of Estriol 0.025% to 1% Vaginal Creams (VersaBase).
Ip K, Shan A, Yan W, Banov D. |
2018 |
| 4001 |
Journal
Int J Pharm Compound 2017 ; 21:4 :322-329 |
Physical and Chemical Stability of Budesonide Mucoadhesive Oral Suspensions (MucoLox).
Ip K,Carvalho M,Shan A,Banov D. |
2017 |
| 2104 |
Journal
Farm Hosp 2000 ; 24: 145-150 |
Estudio de la estabilidad de mezclas ciclofosfamida/mesna e ifosfamida/mesna en soluciones intravenosas de gran volumen.
Iriarte Izura MA, Gozalo garcia MJ, Marcotegui Ros F, Nagore Indurain C, Urdaniz Baztan AO. |
2000 |
| 1085 |
Journal
Radiology 1989 ; 173: 91-92. |
Incompatibility of contrast agents with intravascular medications.
Irving HD, Burbridge BE. |
1989 |
| 1863 |
Journal
Journal of clinical anesthesia 1996 ; 8: 329-336. |
Compatibility of propofol, fentanyl,and vecuronium mixtures designed for potential use in anesthesia and patient transport.
Isert PR, Lee D, Naidoo D, Carasso ML, Kennedy RA. |
1996 |
| 467 |
Journal
Am J Hosp Pharm 1991 ; 48: 2442-2443. |
Visual compatibility of indomethacin sodium trihydrate with drugs given to neonates by continuous infusion.
Ishisaka DY, van Vleet J, Marquardt E. |
1991 |
| 255 |
Journal
Am J Hosp Pharm 1994 ; 51: 2290,2292. |
Visual compatibility of fluconazole with drugs given by continuous infusion.
Ishisaka DY. |
1994 |
| 4628 |
Journal
Pharmaceuticals 2021 ; 14, 943. |
Development and Validation of a New Storage Procedure to Extend the In-Use Stability of Azacitidine in Pharmaceutical Formulations.
Iudicello A, Genovese F, Strusi V, Dominici M, Ruozi B. |
2021 |
| 4157 |
Journal
Pediatric Anesthesia 2018 |
Evaluation of the stability and stratification of propofol and ketamine mixtures for pediatric anesthesia.
Izgi M, Basara B, Muderrisoglu A, Yilbas A.A, Uluer M.S, Celebioglu B. |
2018 |
| 2881 |
Poster
SFPO Congress 2009 |
Stabilité d'un anticorps monoclonal d'intérêt thérapeutique après reconstitution: le rituximab.
Jaccoulet E, Guirao S, Morand K, Astier A, Paul M. |
2009 |
| 229 |
Journal
Am J Hosp Pharm 1994 ; 51: 2962-2963. |
Compatibility of haloperidol lactate with benztropine mesylate.
Jackson CW, Cunningham K. |
1994 |
| 2685 |
Journal
Int J Pharm Pract 1995 ; 3: 169-173. |
Stability of ipratropium bromide and salbutamol nebuliser admixtures.
Jacobson GA, Peterson GM. |
1995 |
| 2442 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 189-191. |
Stability of itraconazole in an extemporaneously compounded oral liquid
Jacobson PA, Johnson CE, Walters, JR. |
1995 |
| 2436 |
Journal
Am J Health-Syst Pharm 1997 ; 54: 178-180. |
Stability of tacrolimus in an extemporaneously compounded oral liquid
Jacobson PA, Johnson CE, West NJ, Foster JA. |
1997 |
| 1469 |
Journal
Int J Pharm 1996 ; 128: 283-286. |
Stability and compatibility of 2.5 mg/ml methotrexate solution in plastic syringes over 7 days.
Jacolot A, Arnaud P, Lecompte D, Alamercery S, Caroff E, Naveau C, Guillot T, Bousselet M, Brion F. |
1996 |
| 3717 |
Journal
Am J Health-Syst Pharm 2014 ; 71:1480-1484 |
Stability of ertapenem 100 mg/mL in polypropylene syringes stored at 25, 4, and -20 °C.
Jain J.G, Sutherland C, Nicolau D.P, Kuti J.L. |
2014 |
| 3764 |
Journal
Am J Health-Syst Pharm 2014 2014; 71: 1831-1832. |
Compatibility of argatroban injection with select antiarrhythmic drugs
Jakimczuk P.J, Churchwell M.D, Howard M.S, Mauro V.F, Alexander K.S, Boddu S.H.S. |
2014 |
| 422 |
Journal
Am J Hosp Pharm 1985 ; 42: 1095-1100. |
Stability of intravenous admixtures of aztreonam and ampicillin.
James MJ, Riley CM. |
1985 |
| 419 |
Journal
Am J Hosp Pharm 1985 ; 42: 1984-1986. |
Stability of intravenous admixtures of aztreonam and clindamycin phosphate.
James MJ, Riley CM. |
1985 |
| 4645 |
Journal
JAC Antimicrob Resist 2021 |
Assessment of ceftolozane/tazobactam stability in elastomeric devices and suitability for continuous infusion via outpatient parenteral antimicrobial therapy.
Jamieson C, Drummond F, Hill T, Ozolina L, Gilchrist M, Seaton R.A, Santillo M, Wilkinson A-S, Allwood M.C. |
2021 |
| 4512 |
Journal
EJHP 2020 2020;0:1-5. |
Assessment of the stability of citrate- buffered piperacillin/tazobactam for continuous infusion when stored in two commercially available elastomeric devices for outpatient parenteral antimicrobial chemotherapy: a study compliant with the NHS Yellow Cover Document requirements
Jamieson C,Ozolina L,Seaton RA, Gilchrist M, Hills T, Drummond F, Wilkinson AS. |
2020 |
| 1357 |
Journal
Ann Pharmacotherapy 1989 ; 23: 91-92. |
Quinolones and penicillins incompatibility.
Janknegt R, Schrouff GGM, Hooymans PM, Hermens WJHH, Lohman JJHM. |
1989 |
| 889 |
Journal
Pharm Weekbl [Sci] 1991 ; 13: 207-209. |
Ofloxacin intravenous. Compatibility with other antibacterial agents.
Janknegt R, Stratermans T, Cilissen J, Lohman JJHM, Hooymans PM. |
1991 |
| 1888 |
Journal
Ziekenhuisfarmacie 1986 ; 2: 45-48. |
Compatibility study of midazolam.
Janknegt R, Van den Berg TJ, De Jong M, Oldenhof HGJ, Steenhoek A. |
1986 |
| 4653 |
Journal
EJHP 2021 ; 28: 331-335. |
Development of a sterile morphine hydrogel for the local treatment of painful skin ulcers.
Jansen MMPM, van Waas VPH, Verzijl JM, Burger D. |
2021 |
| 2319 |
Journal
EJHP Science 2009 ; 15, 1: 11-14. |
Chemical stability of a solution of bupivacaine hydrochloride 0.125% and sufentanil citrate 0.5 µg/ml for filling syringes using a repeater pump.
Janssen K, Wisselo R, Geerlings C, Schouten J.P. |
2009 |
| 2113 |
Journal
Pharm World Sci 1999 ; 21, 6: 272-274. |
Stability of buprenorphine, haloperidol and glycopyrrolate mixture in a 0.9% sodium chloride solution.
Jäppinen A, Kokki H, Naaranlahti TJ, Rasi AS. |
1999 |
| 1835 |
Journal
Eur J Pharm Sci 2003 ; 19, 1: 31-36. |
Stability of sufentanil and levobupivacain solutions and a mixture in a 0.9% sodium chloride infusion stored in polypropylene syringes.
Jäppinen A, Turpeinen M, Kokki H, ,Rasi A, Ojanen T, Pelkonen O, Naaranlahti T. |
2003 |
| 1752 |
Journal
Int J Pharm Compound 1998 ; 2: 466-468. |
Stability of sufentanil in a syringe pump under simulated epidural infusion.
Jäppinen AL, Hokki H, Rasi AS, Naaranlathi TJ. |
1998 |
| 969 |
Journal
N Engl J Med 1991 ; 325: 1315-1316. |
Precipitation of ondansetron in alkaline solutions.
Jarosinski PF, Hirschfeld S. |
1991 |
| 442 |
Journal
Am J Hosp Pharm 1989 ; 46: 732-737. |
Stability of a concentrated trimethoprim-sulfamethoxazole admixtures.
Jarosinski PF, Kennedy PE, Gallelli JF. |
1989 |
| 4375 |
Journal
Int J Pharm Compound 2020 ;24,1:77-82 |
Stability of Metronidazole Free-base Oral Suspensions Formulated with United States Pharmacopeia-grade Metronidazole Powder and Commercial Metronidazole Tablets.
Jarouche M, Ibrahim M, Pearson J, Venkataya B, Low M, Rowe J. |
2020 |
| 3837 |
Journal
South Asian J Trop Med Pub Health 2003 ; 34: 627-629. |
Stability of meropenem in normal saline solution after storage at room temperature.
Jaruratanasirikul S, Sriwiriyajan S. |
2003 |
| 3210 |
Journal
Int J Pharm Compound 2011 ; 15, 3: 259-261. |
Compatibility of Parenteral Furosemide with Seventeen Secondary Drugs Used in Standard Concentrations.
Jasti Bhaskara R, Saraf Poonam. |
2011 |
| 398 |
Journal
Am J Hosp Pharm 1988 ; 45: 1556-1557. |
Visual compatibility of famotidine with commonly used critical-care medications during simulated Y-site injection.
Jay GT, Fanikos J, Souney PF. |
1988 |
| 1366 |
Journal
Am J Hosp Pharm 1981 ; 38: 462,464. |
Nafcillin sodium incompatibility with acidic solutions.
Jeglum EL, Winter E, Kotos M. |
1981 |
| 3413 |
Journal
Pharm Res 2004 ; 21, 5: 891-894. |
Oxaliplatin degradation in the presence of chloride: Identification and cytotoxicity of the monochloro monooxalato complex.
Jerremalm E, Hedeland M, Wallin I, Bondesson U, Ehrsson H. |
2004 |
| 113 |
Journal
Am J Hosp Pharm 1993 ; 50: 1918-1920. |
Stability of ondansetron hydrochloride stored in a disposable, elastomeric infusion device at 4°C.
Jhee SS, Jeong EW, Chin A, Inagaki K, Fox JL, Gill MA. |
1993 |
| 1259 |
Journal
Am J Hosp Pharm 1981 ; 38: 900-901. |
Compatibility of aminophylline with hydrocortisone sodium succinate or dexamethasone sodium phosphate in 5% dextrose injection.
Jhunjhunwala VP, Bhalla HL. |
1981 |
| 289 |
Journal
Ann Pharmacotherapy 1993 ; 27: 704-707. |
Physical and chemical compatibility of intravenous ciprofloxacin with other drugs.
Jim LK. |
1993 |
| 518 |
Journal
Am J Hosp Pharm 1988 ; 45: 1278. |
Visual compatibility of nalbuphine hydrochloride and promethazine hydrochloride.
Jimenez MD. |
1988 |
| 4041 |
Poster
SNPHPU Congress 12th 2017 |
Etude de stabilité d'un collyre de ceftazidime à 50mg/ml conditionné en flacon de polyéthylène basse densité.
Jobard M, Brandely-Piat M-L, El Deeb G, Labat L, Cros C, Chast F, Batista R. |
2017 |
| 2167 |
Journal
Cancer Chemother Pharmacol 1995 ; 37, 1: 117-124. |
Stability of the iv and oral formulations of etoposide in solution.
Joel SP, Clark PI, Slevin ML. |
1995 |
| 2676 |
Journal
Int J Pharm Compound 1998 ; 2: 314-317. |
Stability of ciprofloxacin in an extemporaneous oral liquid dosage form.
Johnson C.E, Wong D.V, Hoppe H.L, Bhatt-Mehta V. |
1998 |
| 1260 |
Journal
Am J Hosp Pharm 1981 ; 38: 871-875. |
Compatibility of azathioprime sodium with intravenous fluids.
Johnson CA, Porter WA. |
1981 |
| 86 |
Journal
Am J Hosp Pharm 1994 ; 51: 2812-2815. |
Stability of midazolam hydrochloride and morphine sulfate during simulated intravenous coadministration.
Johnson CE, Bhatt-Mehta V, Mancari SC, McKown JA. |
1994 |
| 220 |
Journal
Am J Health-Syst Pharm 1997 ; 54: 61-64. |
Compatibility of bupivacaine hydrochloride and morphine sulfate.
Johnson CE, Christen C, Perez MM, Ma M. |
1997 |
| 3185 |
Journal
Am J Health-Syst Pharm 2011 ; 68:519-521. |
Stability of extemporaneously prepared oxandrolone oral suspensions.
Johnson CE, Cober MP, hawkins KA, Julian JD. |
2011 |
| 2980 |
Journal
Ann Pharmacotherapy 2007 ; 41: 1954-1961. |
Stability of partial doses of omeprazole-sodium bicarbonate oral suspension.
Johnson CE, Cober MP, Ludwig JL. |
2007 |
| 3187 |
Journal
Am J Health-Syst Pharm 2011 ; 68:420-423. |
Stability of an extemporaneous alcohol-free melatonin suspension.
Johnson CE, Cober MP, Thome T, Rouse E. |
2011 |
| 390 |
Journal
Am J Hosp Pharm 1986 ; 43: 1482-1485. |
Compatibility of aminophylline and methylprednisolone sodium succinate intravenous admixtures.
Johnson CE, Cohen IA, Craft DA, Lizer MH. |
1986 |
| 391 |
Journal
Am J Hosp Pharm 1987 ; 44: 1620-1624. |
Compatibility of premixed theophylline and methylprednisolone sodium succinate intravenous admixtures.
Johnson CE, Cohen IA, Michelini TJ, McMahon RE. |
1987 |
| 2478 |
Journal
Am J Hosp Pharm 1993 ; 50: 2353-2355. |
Stability of an extemporaneously compounded baclofen oral liquid
Johnson CE, Hart SM. |
1993 |
| 72 |
Journal
Am J Hosp Pharm 1994 ; 51: 503-508. |
Stability of ganciclovir sodium and amino acids in parenteral nutrient solutions.
Johnson CE, Jacobson PA, Chan E. |
1994 |
| 262 |
Journal
Am J Hosp Pharm 1993 ; 50: 703-706. |
Stability and compatibility of fluconazole and aminophylline in intravenous admixtures.
Johnson CE, Jacobson PA, Pillen HA, Woycik CL. |
1993 |
| 372 |
Journal
Am J Hosp Pharm 1988 ; 45: 609-612. |
Compatibility of premixed theophylline and verapamil intravenous admixtures.
Johnson CE, Lloyd CW, Aviles AI, Rybarz KL. |
1988 |
| 364 |
Journal
Am J Hosp Pharm 1989 ; 46: 97-100. |
Compatibility of aminophylline and verapamil in intravenous admixtures.
Johnson CE, Lloyd CW, Mesaros JL, Rubley GJ. |
1989 |
| 2449 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 1798-1800. |
Stability of ursodiol in an extemporaneously compounded oral liquid
Johnson CE, Nesbitt J. |
1995 |
| 2209 |
Journal
Am J Health-Syst Pharm 2007 ; 64, 22: 2356-2358. |
Stability of vecuronium in sterile water for injection stored in polypropylene syringes for 21 days.
Johnson CE, Petrea Cober M. |
2007 |
| 2412 |
Journal
Am J Health-Syst Pharm 2001 ; 58: 577-579. |
Stability of norfloxacin in an extemporaneously prepared oral liquid
Johnson CE, Price J, Hession JM. |
2001 |
| 2410 |
Journal
Am J Health-Syst Pharm 2002 ; 59: 361-363. |
Stability of oral suspensions of ursodiol made from tablets
Johnson CE, Streetman DD. |
2002 |
| 1421 |
Journal
J Am Pharm Assoc 1999 ; 39: 505-509. |
Stability and compatibility of tacrolimus and fluconazole in 0.9% sodium chloride.
Johnson CE, Truong NM. |
1999 |
| 2925 |
Journal
Am J Health-Syst Pharm 2005 ; 62: 2518-2520. |
Stability of anhydrous theophylline in extemporaneously prepared alcohol-free oral suspensions.
Johnson CE, vanDe Koppel S, Myers E. |
2005 |
| 814 |
Journal
Am J Health-Syst Pharm 1999 ; 56: 164-169. |
Stability of tacrolimus with morphine sulfate, hydromorphone hydrochloride, and ceftazidime during simulated intravenous coadministration.
Johnson CE, VandenBussche HL, Chio CC, Jacobson PA. |
1999 |
| 2407 |
Journal
Am J Health-Syst Pharm 2004 ; 61: 54-57. |
Stability of tramadol hydrochloride--acetaminophen (Ultracet) in strawberry syrup and in a sugar-free vehicle
Johnson CE, Wagner DS, DeLoach SL, Cichon-Hensley BK. |
2004 |
| 1740 |
Journal
Int J Pharm Compound 1998 ; 2, 4: 314-317. |
Stability of ciprofloxacin in an extemporaneous oral liquid dosage form.
Johnson CE, Wong D, Hoppe HL, Bhatt-Mehta V. |
1998 |
| 2030 |
Journal
Am J Health-Syst Pharm 2005 ; 62: 2410-2412. |
Stability of pantoprazole in 0.9% sodium chloride injection in polypropylene syringes.
Johnson CE. |
2005 |
| 1088 |
Journal
JAMA 1984 ; 252: 2392. |
Drug trapping in intravenous infusion side arms.
Johnston A, McKenzie MA, Krasnow SH, Hood MA, Cohen MH. |
1984 |
| 4057 |
Journal
Hosp Pharm 2018 ; 53, 2: 125-127. |
Physical Compatibility of Micafungin With Sodium Bicarbonate Hydratation Fluids Commonly Used With High-Dose Methotrexate Chemotherapy.
Joiner L, Ynes C, Arnold J, Miller R, Gorman G. |
2018 |
| 293 |
Journal
Am J Hosp Pharm 1993 ; 50: 2364-2365. |
Stability of bupivacaine hydrochloride in polypropylene syringes.
Jones JW, Davis AT. |
1993 |
| 3363 |
Journal
J Pharm Pract and Res 2012 ; 42, 3: 213-217. |
Stability of Oral Cholecalciferol (Vitamin D3) Liquid Formulations in Olive Oil.
Joseph P.M, Hemmens V.J, Munns C.F. |
2012 |
| 3823 |
Journal
Pharmactuel 2015 ; 48, 3 : 146-152. |
Compatibilité physique de médicaments administrés dans l’unité de soins intensifs
Juan E.P, Palau M.M, Cerd? S.A, Rubert M.A, Nicolau B.R. |
2015 |
| 3069 |
Journal
Eur Hosp Pharm 1997 ; 3: 59-60. |
Stability of amphotericin B in water solution for inhalation.
Juarez JC, ,Lopez RM, Hucto M et al. |
1997 |
| 616 |
Journal
Am J Hosp Pharm 1982 ; 39: 841-843. |
Compatibility of nalbuphine hydrochloride with other preoperative medications.
Jump WG, Plaza VM, Poremba A. |
1982 |
| 365 |
Journal
Med Sci Monit 2015 ; 21:2528-2534. |
Long-Term Stability of Tramadol and Ketamine Solutions for Patient-Controlled Analgesia Delivery.
Junfeng Gu, Wengang Qin, Fuchao Chen, Zhongyuan Xia. |
2015 |
| 2321 |
Journal
Ann Pharmacotherapy 2009 ; 43,2: 390-391. |
Stability of Oxaliplatin Solution.
Junker A, Roy S, Desroches M.C, Moussay C, Berhoune M, Bellanger A, Fernandez C,Farinotti R. |
2009 |
| 1172 |
Journal
Am J Hosp Pharm 1981 ; 38: 377-378. |
Compatibility of amphotericin B with certain large-volume parenterals.
Jurgens RW, DeLuca PP, Papadimitriou D. |
1981 |
| 3963 |
Journal
Int J Pharm Compound 2017 ; 21, 2: 160-163. |
Stability of Extemporaneously Prepared Hydroxycarbamide Oral Suspensions.
Kabiche D,Balde I.B,Majoul E,Kabiche S,Bourguignon E,Fontan J-E,Cisternino S,Schlatter J. |
2017 |
| 2203 |
Journal
J Oncol Pharm Practice 2007 ; 13: 119-126. |
A sequential temperature cycling study for the investigation of carboplatin infusion stability to facilitate 'dose-banding'.
Kaestner S, Sewell G. |
2007 |
| 3110 |
Poster
Poster ADKA Congress May 2010 2010 |
Physikalisch-chemische Stabilität von Clofarabin-Zubereitungen.
Kaiser J, Krämer I. |
2010 |
| 3225 |
Journal
EJHP Science 2011 ; 17, 1: 7-12. |
Physico-chemical stability of nelarabine infusion solutions in EVA infusion bags.
Kaiser J, Krämer I. |
2011 |
| 3313 |
Journal
J Oncol Pharm Practice 2012 ; 18, 2: 218-221. |
Long-term stability study of clofarabine injection concentrate and diluted clofarabine infusion solutions.
Kaiser J, Krämer I. |
2012 |
| 3258 |
Journal
Int J Pharm Compound 2011 ; 15, 6 : 515-520. |
Physicochemical Stability of Diluted Trastuzumab Infusion Solutions in Polypropylene Infusion Bags.
Kaiser J, Krämer I. |
2011 |
| 2671 |
Journal
J Oncol Pharm Practice 2010 ; 16: 53-61. |
Stability of irinotecan-loaded eluting beads (DC Bead) used for transarterial chemoembolization.
Kaiser J, Thiesen J, Krämer I. |
2010 |
| 2201 |
Journal
EJHP Science 2007 ; 13, 3: 55-59. |
Chemical and physical stability of dexrazoxane, diluted with Ringer's lactate solution, in polyvinyl and polyethylene containers.
Kaiser J.D, Vigneron J, Zenier H, May I, Demor? B. |
2007 |
| 2028 |
Journal
EJHP Science 2005 ; 11, 4: 88-90. |
Sodium nitroprusside stability at 1 µg/ml in aqueous solutions.
Kaisserlian CE, Razzouq N, Astier A, Paul M. |
2005 |
| 3223 |
Journal
Am J Health-Syst Pharm 2011 ;68:1533-1536. |
Stability of diluted adenosine solutions in polyvinyl chloride infusion bags
Kaltenbach M, Hutchinson DJ, Bollinger JE, Zhao F. |
2011 |
| 1746 |
Journal
EJHP 2010 ; 16, 30-37. |
Stability studies of amoxicillin/clavulanic acid combinaison in polyolefin infusion bags.
Kambia N, Merite N, Dine T, Dupin-Spriet T, Gressier B, Luyckx M, Watinne C, Brunet C. |
2010 |
| 2311 |
Journal
J Clin Pharm Ther 2009 ; 34: 25-31. |
Nefopam hydrochloride compatibility and stability with selected proton pump inhibitors in bionolyte G5 injection for intravenous infusion.
Kambia N.K, Luyckx M, Dine T, Dupin-Spriet T, Gressier B, Brunet C. |
2009 |
| 1960 |
Journal
J Pharm Biomed Anal 2005 ; 37: 259-264. |
Compatibility of nitroglycerin, diazepam and chlorpromazine with a new multilayer material for infusion containers.
Kambia NK, Dine T, Dupin-Spriet T, Gressier B, Luycks M, Goudaliez F, Brunet C. |
2005 |
| 2140 |
Journal
EJHP Science 2006 ; 12, 5: 91-95. |
Stability and compatibility of the ready-to-use solution of paracetamol admixted with phloroglucinol for intravenous infusion.
Kambia NK, Luyckx M, Dine T, Dupin-Spriet T, Gressier B, Brunet C. |
2006 |
| 2122 |
Journal
EJHP Science 2006 ; 12, 4: 81-84. |
Stability and compatibility of paracetamol injection admixed with ketoprofen.
Kambia NK, Luyckx M, Dine T, Dupin-Sriet T, Gressier B, Brunet C. |
2006 |
| 2790 |
Journal
Int J COPD 2007 ; 1, 4: 599-607. |
Physicochemical compatibility of fluconasone-17-propionate nebulizer suspension with ipratropium and albuterol nebulizer solutions.
Kamin W, Schwabe A, Krämer I. |
2007 |
| 4056 |
Journal
Perit Dial Int 2017 |
Stability of ceftazidime and heparine in four different types of peritoneal dialysis solutions.
Kandel S, Zaidi S, Wanandy T, Ming L, Castelino R, Sud K, Patel R. |
2017 |
| 2159 |
Journal
Perit Dial Int 1994 ; 14: 79-81. |
Stability of erythromycin lactobionate in peritoneal dialysate solutions.
Kane MP, Bailie GR, Moon DG, Siu I, Eisele G. |
1994 |
| 2156 |
Journal
Perit Dial Int 1994 ; 14: 396-398. |
Stability of deferoxamine peritoneal dialysate solutions.
Kane MP, Bailie GR, Moon DG, Siu I. |
1994 |
| 4263 |
Journal
Am J Hosp Pharm 1994 ;51:373-377 |
Stability of ciprofloxacin injection in peritoneal dialysis solutions.
Kane MP, Bailie GR, Moon DG, Siu I. |
1994 |
| 857 |
Journal
Am J Hosp Pharm 1983 ; 40: 1323-1328. |
Binding of selected drugs to a “treated” inline filter.
Kanke M, Eubanks JL, DeLuca PP. |
1983 |
| 1646 |
Journal
Anaesthesia 2001 ; 56: 920. |
Incompatibility of prochlorperazine and ketoprofen.
Kannan S. |
2001 |
| 4264 |
Journal
Acta Ophtalmol 2008 |
Stability and antibacterial potency of ceftazidime and vancomycin eyedrops reconstituted in BSS against Pseudomonas aeruginosa and Staphylococcus aureus.
Karampatakis V, Papanikolaou T, Giannousis M, Goulas A, Mandraveli K, Kilmpasani M, Alexiou-Daniel S, Mirtsou-Fidani V. |
2008 |
| 3222 |
Journal
Am J Health-Syst Pharm 2011 ;68:1537-1540. |
Stability of midazolam hydrochloride injection 1-mg/mL solutions in polyvinyl chloride and polyolefin bags
Karlage K, Earhart Z, Green-Boesen K, . Myrdal PB |
2011 |
| 859 |
Journal
Nor Pharm Acta 1983 ; 45: 61-67. |
Stability of cytotoxic intravenous solutions subjected to freeze-thaw treatment.
Karlsen J, Thonnesen HH, Olsen IR, Sollien AH, Skobba TJ. |
1983 |
| 363 |
Journal
Am J Hosp Pharm 1989 ; 46: 101-104. |
Stability of esmolol hydrochloride and sodium nitroprussiate in intravenous admixtures.
Karnatz NN, Wong J, Baaske DM, Johnson JH, Speicher ER, Herbranson DE. |
1989 |
| 8 |
Journal
Am J Hosp Pharm 1988 ; 45: 368-371. |
Compatibility of esmolol hydrochloride with morphine sulfate and fentanyl citrate during simulated Y-site administration.
Karnatz NN, Wong J, Kesler H, Baaske DM, Speicher ER. |
1988 |
| 2490 |
Journal
Am J Hosp Pharm 1989 ; 46: 304-307. |
Concentration uniformity of extemporaneously prepared ranitidine suspension
Karnes HT, Harris SR, Garnett WR, March C. |
1989 |
| 2128 |
Journal
Pharmazie 2006 ; 10: 845-850. |
Untersuchungen zur Stabilität der Busulfan-Stammlösung (Busilvex®, Busulfex TM) in B/Braun Injekt® Einmalspritzen.
Karstens A, Krämer I. |
2006 |
| 2188 |
Journal
EJHP Science 2007 ; 13, 2: 40-47 |
Chemical and physical stability of diluted busulfan infusion solutions.
Karstens A, Krämer I. |
2007 |
| 3997 |
Journal
Am J Health-Syst Pharm 2017 ; 74:14 : 1099-1102 |
Visual compatibility of colistin injection with other antibiotics during simulated Y-site administration.
Katip W. |
2017 |
| 2174 |
Journal
EJHP Science 2006 ; 12, 6: 129-134. |
Long-term physical and chemical stability of a generic paclitaxel infusion under simulated storage and clinical-use conditions.
Kattige A. |
2006 |
| 446 |
Journal
Am J Hosp Pharm 1992 ; 49: 2782-2783. |
Stability of undiluted trimethoprim-sulfamethoxazole for injection in plastic syringes.
Kaufman MB, Scavone JM, Foley JJ. |
1992 |
| 3409 |
Journal
Am J Health-Syst Pharm 2013 ; 70:894-899. |
Stability of extemporaneously compounded diltiazem hydrochloride infusions stored in polyolefin bags
Kaushal G, Sayre B.E, Prettyman T. |
2013 |
| 3347 |
Journal
Drug Discov Ther 2012 ; 6, 1 : 49-54. |
Stability-indicating HPLC method for the determination of the stability of oxytocin parenteral solutions prepared in polyolefin bags.
Kaushal, G., Sayre, B.E., Prettyman, T. |
2012 |
| 3284 |
Journal
Yakugaku Zasshi 2008 ; 128, 8: 1221-1226. |
Effect of the Admixture of Tetracycline and Nadifloxacin Ointments on Their Stability and Their Antibacterial Activity.
Kawamoto T, Tayama Y, Sawa A, monde T, Sashima S, Yoshioka M, Miyake K, Morita S, Kihira K. |
2008 |
| 4189 |
Journal
Am J Health-Syst Pharm 2022 ;79,12: 1011-1018 |
Stability of Captisol-enabled versus propylene glycol–based melphalan at room temperature and after refrigeration.
Kawedia J, Ramchandran S, Liu X, Gulbis A, Titus M, Bashir Q, Qazilbash M, Champlin R, Ciur S, |
2022 |
| 3691 |
Journal
J Oncol Pharm Practice 2016 ; 22: 21-25 |
Physical and chemical stability of proflavine contrast agent solutions for early detection of oral cancer
Kawedia L.D, Zhang Y-P, Myers A.L, Richards-Kortum R.R, Kramer M.A, Gillenwater A.M, Culotta K.S. |
2016 |
| 589 |
Journal
J Pharm Sci 1989 ; 78: 73-77. |
Stability of parenteral ceftriaxone disodium solutions in frozen and liquid states: effect of freezing and microwave thawing.
Kedzierewicz F, Finance C, Nicolas A, Dixneuf P, Hoffman M. |
1989 |
| 816 |
Journal
Am J Health-Syst Pharm 1998 ; 55: 466-470. |
Stability of undiluted and diluted adenosine at three temperatures in syringes and bags.
Kektar VA, Kolling WM, Nardviriyakul N, VanDer Kamp K, Wurster DE. |
1998 |
| 4732 |
Journal
Am J Health-Syst Pharm 2023 80, 3;164–170 |
Compatibility of calcium chloride with milrinone, epinephrine, vasopressin, and heparin via in vitro testing and simulated Y-site administration.
Kenneally A, Agbana P, Gardner B, Bae Y, Mitchell T, Beckman E. |
2023 |
| 3096 |
Journal
Ann Pharmacotherapy 2010 ;44:295-301. |
Stability of Cyclophosphamide in Extemporaneous Oral Suspensions.
Kennedy R, Groepper D, Tagen M, Christensen R, Navid F, Gajjar A, Stewart CF. |
2010 |
| 317 |
Journal
Am J Hosp Pharm 1993 ; 50: 1360-1362. |
Visual compatibility of premixed theophylline or heparin with selected drugs for IV administration.
Kershaw BP, Monnier HL, Mason JH. |
1993 |
| 2815 |
Journal
EJHP 2009 ; 15, 4: 30-32. |
Assessment of stability in extemporaneously prepared venlafaxine solutions.
Kervale JG, Castagnet S, Chiadmi F, Schlatter J, Benabadji Z, Cisternino S, Fontan JE. |
2009 |
| 1237 |
Journal
Pharm Weekbl [Sci] 1986 ; 8: 194-197. |
Stability of solutions of doxorubicin and epirubicin in plastic minibags for intravesical use after storage at -20°C and thawing by microwave radiation.
Keusters L, Stolk LML, Umans R, Van Asten P. |
1986 |
| 215 |
Journal
Ann Pharmacotherapy 1993 ; 27: 422-426. |
Stability of famotidine in polyvinyl chloride minibags and polypropylene syringes and compatibility of famotidine with selected drugs.
Keyi X, Gagnon N, Bisson C, Desmarais M, LeBel M. |
1993 |
| 4012 |
Journal
EJHP 2018 ; 25, e2 |
Investigations into the physical and chemical stability of concentrated co-trimoxazole intravenous infusions.
Khaleel I, Tabish R Zaidi S, Shastri M, Suji Eapen M, Chiau Ming L, Wanandy T, P Patel R. |
2018 |
| 1671 |
Journal
Int J Pharm 1996 ; 139: 243-247. |
Compatibility and stability of vancomycin hydrochloride with PVC infusion material in various conditions using stability-indicating high-performance liquid chromatographic assay.
Khalfi F, Dine T, Gressier B, Luyckx M, Brunet C, Ballester L, Goudaliez F, Cazin M, Cazin JC. |
1996 |
| 1670 |
Journal
Pharmazie 1998 ; 53: 112-116. |
Compatibility of cefpirome and cephalotin with PVC bags during simulated infusion and storage.
Khalfi F, Dine T, Gressier B, Luyckx M, Brunet C, Ballester L, Goudaliez F, Kablan J, Cazin M, Cazin JC. |
1998 |
| 2661 |
Journal
Eye 2015 ; 29, 6: 820-827. |
Storage stability of bevacizumab in polycarbonate and polypropylene syringes
Khalili H, Sharma G, Froome A, Khaw P.T, Brocchini S. |
2015 |
| 4705 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2022 2022; 7(1): 20210010 |
Stability of voriconazole 10 mg/mL ophthalmic solution during 90 days
Khan A, Venet A, Bernadou J-M, Cresto S, Servant V, Boulestreau H, Xuereb F, Crauste-Manciet S. |
2022 |
| 2659 |
Journal
Int J Pharm Compound 2010 ; 14, 2: 160-164. |
Chemical stability of hydromorphone hydrochloride in patient-controlled analgesia injector.
Khondkar D, Chopra P, McArter JP, Rosen JA, Li SK. |
2010 |
| 4003 |
Journal
EJHP 2017 ; 25, 3: 157-164. |
Evaluation of the physicochemical and biological stability of reconstituted and diluted SB2 (infliximab).
Kim J, Chung J, Park S, Jung S, Kang D. |
2017 |
| 4043 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2017 ;2,4: 145-157. |
Physicochemical Stability of Reconstituted Decitabine (Dacogen®) Solutions and Ready-to-Administer Infusion Bags when Stored Refrigerated or Frozen.
Kim S, Heeb R, Krämer I. |
2017 |
| 3986 |
Journal
Krankenhauspharmazie 2017 ;38:377-82. |
Physikalisch-chemische Stabilität von Carfilzomib (Kyprolis®) im Originalbehältnis nach Erstanbruch und in applikationsfertigen Zubereitungen.
Kim S, Krämer I. |
2017 |
| 4047 |
Journal
J Oncol Pharm Practice 2017 ;25,2: 339-350 |
Physicochemical stability of carfilzomib (Kyprolis®) containing solutions in glass vials, ready-to-administer plastic syringes and infusion bags over a 28-day storage period.
Kim S.H, Krämer I. |
2017 |
| 3896 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2016 ;1,2:73-81 |
Physicochemical Stability of Mozobil® (Plerixafor) Solution for Injection in Glass Vials and Plastic Syringes over a Three-Month Storage Period
Kim S.H, Thiesen J, Krämer I. |
2016 |
| 4194 |
Journal
Bio Drugs 2018 32;619-625 |
In-Use Physichochemical and Biological Stability of the Trastuzumab Biosimilar CT-P6 Upon Preparation for Intravenous Infusion.
Kim S.J, Lee J.W, Kang H.Y, Kim S.Y, Shin Y.K, Kim K.W, Oh J.S, Lim K.J, Kim J.Y. |
2018 |
| 1961 |
Journal
Int J Pharm 2005 ; 293: 303-310. |
Investigation of the release behavior of DEHP from infusion sets by paclitaxel-loaded polymeric micelles.
Kim SC, Yoon HJ, Lee JW, Yu J, Park ES, Chi SC. |
2005 |
| 4367 |
Journal
J Glaucoma 2016 ; 25, 6: 477-481. |
The Degradation of Mitomycin C Under Various Storage Methods.
Kinast R.M, Akula K.K, DeBarber A.E, Barker G.T, Gardiner S.K, Whitson E, Mansberger S.L. |
2016 |
| 1664 |
Journal
J Clin Pharm Ther 1994 ; 19: 317-325. |
Stability of cefmetazole-doxycycline mixtures in sodium chloride and dextrose injections.
King AD, Stewart JT, Warren FW. |
1994 |
| 3779 |
Journal
Am J Health-Syst Pharm 2014 ; 71:2061-2065 |
Stability of i.v. admixture containing metoclopramide, diphenhydramine hydrochloride, and dexamethasone sodium phosphate in 0.9% sodium chloride injection
Kintzel P.E, Zhao T, Wen B, Sun D. |
2014 |
| 439 |
Journal
Am J Hosp Pharm 1991 ; 48: 283-285. |
Stability of amphotericin B in 5% dextrose injection at concentrations used for administration through a central venous line.
Kintzel PE, Kennedy PE. |
1991 |
| 497 |
Journal
Am J Hosp Pharm 1991 ; 48: 1681. |
Stability of amphotericin B in 5% dextrose injection at 25°C.
Kintzel PE, Kennedy PE. |
1991 |
| 892 |
Journal
Am J Hosp Pharm 1992 ; 49: 1156-1164. |
Practical guidelines for preparing and administering amphotericin B.
Kintzel PE, Smith GH. |
1992 |
| 1385 |
Journal
Pharm J 1985 ; 235: 171. |
Diamorphine injection BP incompatibility.
Kirk B, Hain WR. |
1985 |
| 558 |
Journal
Br J Parent Ther 1986 ; july/august : 86-92. |
Stability of reconstituted mustine injection BP during storage.
Kirk B. |
1986 |
| 3978 |
Journal
Am J Health-Syst Pharm 2017 ; 74,9: 202-210 |
Beyond-use dating of lidocaine alone and in two “magic mouthwash” preparations.
Kirk L.M, Brown S.D, Luu Y, Ogle A, Huffman J, O. Lewis P.O. |
2017 |
| 52 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 1557-1558. |
Stability of ondansetron hydrochloride in a total parenteral nutrient admixture.
Kirkham JC, Rutherford ET, Cumingham GN, Daneshmand KA, Falls AL. |
1995 |
| 628 |
Journal
Am J Hosp Pharm 1982 ; 39: 1923-1925. |
Stability of dobutamine hydrochloride in selected large-volume parenterals.
Kirschenbaum HL, Aronoff W, Perentesis GP, Piltz GW, Goldberg RJ, Cutie AJ. |
1982 |
| 619 |
Journal
Am J Hosp Pharm 1982 ; 39: 1013-1015. |
Stability and compatibility of lidocaine hydrochloride with selected large-volume parenterals and drugs additives.
Kirschenbaum HL, Aronoff W, Perentesis GP, Plitz GW, Cutie AJ. |
1982 |
| 1058 |
Journal
Am J Hosp Pharm 1983 ; 40: 1690-1691. |
Compatibility and stability of dobutamine hydrochloride with large-volume parenterals and selected additives.
Kirschenbaum HL, Aronoff W, Piltz GW, Perentesis GP, Cutie AJ. |
1983 |
| 3307 |
Journal
Hosp Pharm 2012 ; 47, 1: 27-30. |
Managing the intravenous calcium shortage: Evaluation of calcium chloride stability in 0.9% sodium chloride and dextrose 5% water polyvinyl chloride bags.
Kiser T.H, Barber G.R, Robinson A. |
2012 |
| 2194 |
Journal
Am J Health-Syst Pharm 2007 ; 64, 10: 1092-1095. |
Stability of phenylephrine hydrochloride injection in polypropylene syringes.
Kiser TH, Oldland AR, Fish DN. |
2007 |
| 2400 |
Journal
Am J Health-Syst Pharm 2007 ; 64: 762-766. |
Stability of acetylcysteine solution repackaged in oral syringes and associated cost savings
Kiser TH, Oldland AR, Fish DN. |
2007 |
| 3434 |
Journal
Can J Hosp Pharm 2013 ; 66, 3 : 167-170. |
Compatibility and Stability of Morphine Sulphate and Naloxone Hydrochloride in 0.9% Sodium Chloride for Injection.
Kistner C, Ensom M.H.H, Decarie D, Lauder G, Carr R.R. |
2013 |
| 1875 |
Journal
Acta Anaesthesiol Scand 2000 ; 44: 864-867. |
Stability of an epidural analgesic solution containing adrenaline, bupivacaine and fentanyl.
Kjonniksen I, Brustugun J, Breivik H, Anderssen E, Klem W. |
2000 |
| 1049 |
Journal
Am J Hosp Pharm 1984 ; 41: 303-305. |
Stability of nitroglycerin in intravenous admixtures.
Klamerus KJ, Ueda CT, Newton DW. |
1984 |
| 4304 |
Journal
Drugs R D 2014 ; 14:13?23. |
Stability of Etoposide Solutions in Disposable Infusion Devices for Day Hospital Cancer Practices.
Klasen K, Kessari R, Mercier L, Valade C, Grill J, Desmaris R, Paci A. |
2014 |
| 339 |
Journal
Am J Hosp Pharm 1990 ; 47: 377-381. |
Stability of heroin hydrochloride in infusion devices and containers for intravenous administration.
Kleinberg ML, Duafala ME, Nacov C, Flora KP, Hines J, Davis K, McDaniel A, Scott D. |
1990 |
| 141 |
Journal
Hosp Pharm 1989 ; 24: 929-934. |
Stability of gallium nitrate and mitoguazone dihydrochloride in commonly used intravenous fluids.
Kleinberg ML, Oberdier J, Muller RJ, Duafala M, Boylan JC. |
1989 |
| 574 |
Journal
Am J Hosp Pharm 1980 ; 37: 1087-1088. |
Stability of antibiotics frozen and stored in disposable hypodermic syringes.
Kleinberg ML, Stauffer GL, Prior RB, Latiolais CJ. |
1980 |
| 3235 |
Poster
ADKA Congress 2011 2011 |
Stabilität von Argatroban-Dauerinjektionslösungen in applikationsfertigen Konzentrationen.
Klemmer A, Krämer I. |
2011 |
| 3682 |
Journal
EJHP 2016 ;23:33-37 |
Extemporaneous sotalol hydrochloride oral solutions for use in paediatric cardiology: formulation and stability study.
Klovrzova S, Zahalka L, Kriz T, Zahalkova O, Matysova L, Sklubalova Z, Horak P. |
2016 |
| 476 |
Journal
Am J Hosp Pharm 1992 ; 49: 2960-2962. |
Incompatibility of ketorolac tromethamine with selected postoperative drugs.
Knapp AJ, Mauro VF, Alexander KS. |
1992 |
| 4762 |
Journal
EJHP 2021 Knoll L, et al. Eur J Hos |
Physicochemical stability of carmustine-containing medicinal products after reconstitution and after dilution to ready-to-administer infusion solutions stored refrigerated or at room temperature
Knoll L, Kraemer I, Thiesen J. |
2021 |
| 4784 |
Journal
EJHP 2023 |
In-use stability of ready-to- administer daratumumab subcutaneous injection solution in plastic syringes.
Knoll L, Thiesen J, Klassen .D, Reinders L.M.H, Türk J, Krämer I. |
2023 |
| 591 |
Journal
Can J Hosp Pharm 1993 ; 46: 13-16. |
Stability of ceftizoxime in 5 percent dextrose and 0.9 percent sodium chloride.
Knoppert DC, Freeman D, Webb D. |
1993 |
| 3705 |
Journal
EJHP 2014 ;21:161-166 |
Physicochemical compatibility of commonly used analgesics and sedatives in the intensive care medicine.
Knudsen L, Eisend S, Haake N, Kunze T. |
2014 |
| 252 |
Journal
Am J Hosp Pharm 1990 ; 47: 2528-2529. |
Stability of bleomycin sulfate reconstituted in 5% dextrose injection or 0.9% sodium chloride injection stored in glass vials or polyvinyl chloride containers.
Koberda M, Zieske PA, Raghavan NV, Payton RJ. |
1990 |
| 3289 |
Journal
Acta Pol Pharm 2011 ; 68, 1: 99-107. |
Stability of ceftazidime in 1% and 5% buffered eye drops determined by HPLC method.
Kodym A, Hapka-Zmich D, Golab M, Gwizdala M. |
2011 |
| 3182 |
Journal
Pharmazie 2011 ; 66, 1: 17-23. |
Stability of cefepime in eye drops.
Kodym A, PawLowska M, Ruminski JK, Bartosinska A, Kieliba A. |
2011 |
| 3290 |
Journal
Acta Pol Pharm 2011 ; 68, 4: 555-564. |
Stability of cefuroxime in 1% and 5% buffered eye drops determined with HPLC method.
Kodym A, Wisniewski A, Kniola D, Olejniczak M. |
2011 |
| 3041 |
Journal
Acta Pol Pharm 2006 ; 63: 293-299. |
Physicochemical and microbiological properties of eye drops containing cefuroxime.
Kodym A, Zawiswa T, Taberska J , Kukula H. |
2006 |
| 2050 |
Journal
Current Ther Res 2000 ; 61: 1-6 |
Stability of reconstituted urokinase solutions.
Kohles JD, Weld M, Asa?d H, Gunning P, Reid Sterrett J, Debari VA. |
2000 |
| 4490 |
Journal
Sci Pharm 2020 ; 88, 25 |
Medication Safety in Intravenous Therapy: A Compatibility Study and Analysis of Reaction Products of Dihydralazine and Metamizole.
Koller A.K, Fischer O, Krebs S. |
2020 |
| 4130 |
Journal
Pharmaceutics 2021 , 13, 21. |
Untersuchungen zur Kompatibilität von Clonidin mit häufig eingesetzen Arzneimittel auf Intensivstationen.
Koller AK, Krebs S, Dörje F. |
2021 |
| 2868 |
Journal
Int J Pharm Compound 2000 ; 4, 2: 146-149. |
Some Studies of the Stability of Compounded Cefazolin Ophthalmic Solution.
Kommanaboyina B, Lindauer RF, Rhodes CT, Grady LT. |
2000 |
| 4768 |
Journal
Journal of Nippon Medical school 2023 |
Y-site injection physical compatibility of remdesivr with select intravenous drugs used in palliative care and for treating coronavirus disease 2019.
Kondo M, Genpei M, Watanabe K, Yoshida M, Tagui N, Fukao S, Sugaya K, Takase H. |
2023 |
| 4545 |
Journal
Journal of Nippon Medical school 2021 |
Physical compatibility of nafamostat with analgesics, sedatives, and muscle relaxants for coronavirus disease treatment.
Kondo M, Nagano M, Yoshida M, Yoshida N, Tagui N, Yoshida M, Sugaya K, Takase H. |
2021 |
| 4723 |
Journal
Am J Health-Syst Pharm 2022 https://doi.org/10.1093/a |
Physical compatibility of remimazolam with opioid analgesics, sedatives, and muscle relaxants during simulated Y-site administration.
Kondo M, Yoshida N, Yoshida M, Tanaka C, Tagami T, Horik K, Sugaya K, Takase H |
2022 |
| 1168 |
Journal
Antimicrob Agents Chemother 1983 ; 23: 653-657. |
Tobramycin inactivation by carbenicillin, ticarcillin and piperacillin.
Konishi H, Goto M, Nakamoto Y, Yamamoto I, Yamashina H. |
1983 |
| 1733 |
Journal
Pharmazie 1999 ; 54: 542-544. |
HPTLC-based stability assay for determination of amiodarone in intravenous admixtures.
Kopelent-Frank H, Schimper A. |
1999 |
| 960 |
Journal
Can J Hosp Pharm 1990 ; 43: 57-60. |
Stability of aqueous solutions of deferoxamine.
Koren G, Tesoro A, Leeder JS, Bentur Y, Olivieri N. |
1990 |
| 1698 |
Journal
Krankenhauspharmazie 1997 ; 18: 474-478. |
Stabilität von dopaminhydrochlorid (Dopamine Solvay°) in mischungen mit infusionlösungen.
Körner A, Bonnacker I. |
1997 |
| 200 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 2340. |
Incompatibility of amiodarone hydrochloride and sodium bicarbonate injections.
Korth-Bradley JM, Ludwig S, Callaghan C. |
1995 |
| 223 |
Journal
Am J Hosp Pharm 1990 ; 47: 1584-1587. |
Stability of fentanyl citrate in glass and plastic containers and in a patient-controlled delivery system.
Kowalski SR, Gourlay GK. |
1990 |
| 1173 |
Journal
Am J Hosp Pharm 1981 ; 38: 1308-1314. |
Interactions between drugs and polyvinyl chloride infusion bags.
Kowaluk EA, Roberts MS, Blackburn HD, Polack AE. |
1981 |
| 2267 |
Journal
Am J Health-Syst Pharm 2008 ; 65, 7: 636-638. |
Stability of metoprolol tartrate injection 1 mg/ml undiluted and 0.5 mg/ml in 0.9% sodium chloride injection and 5% dextrose injection.
Kraft MD, Johnson CE, Chung C, Julian F. |
2008 |
| 3269 |
Journal
Am J Health-Syst Pharm 2012 ; 69:56-58. |
Stability of an extemporaneously prepared thalidomide suspension.
Kraft S, . Johnson C.E, Tyler R.P. |
2012 |
| 4004 |
Journal
Krankenhauspharmazie 2017 ;38,7:334?340. |
Physikalisch-chemische Stabilität von Oxaliplatin-beta-Infusionslösungskonzentrat und Infusionslösungen in 5 % Glucose in Polyolefin-Infusionsbeuteln.
Krämer I, Sarakbi I, Thiesen J, Mainz. |
2017 |
| 3472 |
Journal
Krankenhauspharmazie 2007 ; 28, 5: 170-178. |
Physikalisch-chemische kompatilibität von Mischinhalationslösungen und suspensionen zur simultanen feuchtinhalationstherapie bei Mukoviszidose Patienten.
Krämer I, Schwabe A, Kamin W. |
2007 |
| 2770 |
Journal
Pharmazie 2007 ; 62, 10: 760-766. |
Physicochemical compatibility of nebulizable drug mixtures containing dornase alfa and ipratropium and/or albuterol.
Krämer I, Schwabe A, Lichtinghagen R, Kamin W. |
2007 |
| 1425 |
Journal
J Oncol Pharm Practice 1999 ; 5: 75-82. |
Stability of topotecan infusion solutions in polyvinylchloride bags and elastomeric portable infusion devices.
Krämer I, Thiesen J. |
1999 |
| 3334 |
Journal
EJHP 2013 ;20:36-41 |
Physicochemical compatibility of nebuliser solution admixtures containing colistimethate and hypertonic saline or colistimethate, fluticasone-17-propionate, ipratropium bromide and salbutamol sulfate.
Krämer I, Walz-Jung H, Stanko C, Kamin W. |
2013 |
| 1639 |
Journal
Eur Hosp Pharm 1997 ; 3: 168-171. |
Stability of meropenem in elastomeric portable infusion devices.
Krämer I. |
1997 |
| 1274 |
Journal
TAP Pharmazeutische Zeitung 1997 ; 31: 30-33. |
Pharmazeutische aspekte von topotecan-infusionen.
Krämer I, Thiesen J. |
1997 |
| 2307 |
Journal
Palliative Med 1995 ; 9, 4: 315-318. |
Epidural diamorphine and bupivacaine stability study.
Kreeger L, Cowin P, Noble-Gresty J, Naysmith A. |
1995 |
| 2686 |
Journal
J Am Acad Dermatol 1989 ; 21: 979-984. |
Topical corticosteroid compounding: effects on physicochemical stability and skin penetration rate.
Krochm?al L, Wang JCT, Patel B. |
1989 |
| 2494 |
Journal
Am J Hosp Pharm 1986 , 43: 2225-2228. |
Stability of 1% rifampin suspensions prepared in five syrups
Krukenberg CC, Mischler PG, Massad EN, Moore LA, Chandler AD. |
1986 |
| 907 |
Journal
J Pharm Technol 1996 ; 12: 58-61. |
Stability of tacrolimus injection in total parenteral nutrition solution.
Ku YM, Min DI, Kumar V, Noormohamed SA. |
1996 |
| 207 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 2024-2025. |
Compatibility of tacrolimus injection with cimetidine hydrochloride injection in 0.9% sodium chloride injection.
Ku YM, Min DI, Kumar V, Noormohamed SE. |
1995 |
| 3745 |
Journal
Am J Hosp Pharm 1979 ; 36: 881. |
Sodium chloride residue provides potential for drug incompatibiities.
Kuenhle C, Moore |
1979 |
| 3960 |
Journal
Hosp Pharm 2017 ;52,2:132-137. |
Y-site Incompatibility Between Premix Concentrations of Vancomycin and Piperacillin-Tazobactam: Do Current Compatibility Testing Methodologies Tell the Whole Story?
Kufel W.D, Miller C.D, Johnson P.R, Reid K., Zahra J.J, Seabury R.W. |
2017 |
| 1236 |
Journal
Am J Hosp Pharm 1986 ; 43: 1241-1242. |
Stability of netilmicin sulfate in admixtures with calcium gluconate and aminophylline.
Kuhn RJ, Nahata MC. |
1986 |
| 3152 |
Journal
Am J Health-Syst Pharm 2010 ; 67: 1640-1644. |
Visual compatibility of oritavancin diphosphate with selected coadministered drugs during simulated Y-site administration.
Kumar A, Mann HJ. |
2010 |
| 2165 |
Journal
J Liquid Chrom Rel Technol 2006 ; 29, 16: 2353-2365. |
Development and validation of an HPLC method for oxytocin in Ringer’s lactate and its application in stability analysis.
Kumar V, Madabushi R, Derendorf H, Boothby LA, Breland BD, Hatton RC, Doering PL. |
2006 |
| 2228 |
Journal
Int J Pharm Compound 2008 ; 12,2: 170-173. |
Compatibility and stability of palonosetron hydrochloride with gentamicin, metronidazole, or vancomycin during simulated Y-site administration.
Kupiec T, Ben M, Trusley C, Trissel LA. |
2008 |
| 2279 |
Journal
Am J Health-Syst Pharm 2008 ; 65, 18: 1735-1759. |
Physical and chemical stability of palonosetron hydrochloride with five common parenteral drugs during simulated Y-site administration.
Kupiec T, Trusley C, Ben M, Trissel LA. |
2008 |
| 2270 |
Journal
Ann Pharmacotherapy 2008 ; 42, 9: 1247-1251. |
Physical and chemical stability of esomeprazole sodium solutions.
Kupiec TC, Aloumanis V, Ben M, Trissel LA, Chan P, Patterson J. |
2008 |
| 4458 |
Journal
Eur J Clin Microbiol Infec Dis 2017 36:2237–2242. |
Compatibility of fosfomycin with different commercial peritoneal dialysis solutions.
Kussmann M, Baumann A, Hauer S, Pichler P, Zeitlinger M, Wiesholzer M, Burgmann H, Poeppl W, Reznicek G. |
2017 |
| 4460 |
Journal
Scientific reports 2019 9:6512 |
Compatibility of ciprofloxacin with commercial peritoneal dialysis solutions.
Kussmann M, Ferth A, Obermüller M, Pichler P, Zeitlinger M, Wiesholzer , Burgmann H, Poeppl W, Reznicek G. |
2019 |
| 4255 |
Journal
J Pharm Anal 2013 ;3,6:408-414 |
Rapid, simple and stability-indicating determination of polyhexamethylene biguanide in liquid and gel-like dosage forms by liquid chromatography with diode-array detection.
Kusters M, Beyer S, Kutschera S, Schlesingera H, Gerhartzb M. |
2013 |
| 3350 |
Journal
Am J Health-Syst Pharm 2012 ; 69:1999-2001 |
Extended stability of intravenous acetaminophen in syringes and opened vials.
Kwiatkowski J.L, Johnson C.E, Wagner D.S. |
2012 |
| 3366 |
Journal
J Pharm Sci 2012 ; DOI 10.1002 / jps.23403 |
Compatibility and stability of pertuzumab and trastuzumab admixtures in i.v. infusion bags for coadministration.
Kwong Glover Z.W, Gennaro L, Yadav S, Demeule B, Wong P.Y, Sreedhara A. |
2012 |
| 4644 |
Journal
Adv Ther 2021 ; 38 : 5609–5622 |
Investigation of the Physicochemical and Biological Stability of the Adalimumab Biosimilar CT-P17.
Kyeong Shin Y, Yong Han W, Jung Kim S, Woo Kim K, Won Ro J, Bin Lee J, Seok Oh J, Astier A. |
2021 |
| 1080 |
Journal
Am J Hosp Pharm 1985 ; 42: 2652. |
Stability of cisplatin admixtures in polyvinyl chloride bags.
La Folette JM, Arbus MH, Lauper RD. |
1985 |
| 2083 |
Journal
J Pharm Pract and Res 2002 ; 32: 65-68. |
Stability and compatibility of morphine, midazolam and bupivacaine combinaisons for iontravenous infusion.
La Forgia SP, Sharley NA, Burgess NG, Doecke CJ. |
2002 |
| 1126 |
Journal
Am J Hosp Pharm 1983 ; 40: 97-101. |
Lidocaine stability in cardioplegic solution stored in glass bottles and polyvinyl chloride bags.
Lackner TE, Baldus D, Butler CD, Amyx C, Kessler G. |
1983 |
| 1937 |
Journal
Ann Pharmacotherapy 2004 ; 38: 1612-1616. |
Physical and chemical stability of daptomycin with nine medications.
Lai JJ, Brodeur SK. |
2004 |
| 338 |
Journal
Am J Hosp Pharm 1991 ; 48: 280-282. |
Stability of zidovudine in 5% dextrose injection and 0.9% sodium chloride injection.
Lam NP, Kennedy PE, Jarosinski PF, Galleli JF. |
1991 |
| 240 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 1904-1909. |
Stability and activity of alteplase with injectable drugs commonly used in cardiac therapy.
Lam XM, Ward CA, de C du M?e CPR. |
1995 |
| 4040 |
Journal
J Oncol Pharm Practice 2017 ;25,2: 269-278 |
The in-use stability of the rituximab biosimilar Rixathon®/Riximyo® upon preparation for intravenous infusion.
Lamanna W.C, Heller K, Schneider D, Guerrasio R, Hampl V, Fritsch C, Schiestl M. |
2017 |
| 1672 |
Journal
Anesthesiology 1998 ; 89: 1609. |
Incompatibility of propofol emulsion with anesthesic drugs.
Lamontagne C, Brouillette D, Hardy JF. |
1998 |
| 358 |
Journal
Am J Hosp Pharm 1986 ; 43: 921-925. |
Stability of ranitidine admixtures frozen and refrigerated in minibags.
Lampasona V, Mullins RE, Parks RB. |
1986 |
| 2500 |
Journal
Am J Hosp Pharm 1990 ; 47: 2716-2719. |
Stability of nizatidine in extemporaneous oral liquid preparations
Lantz MD, Wozniak TJ. |
1990 |
| 2148 |
Journal
Anal Biochem 2002 ; 309: 117-126. |
Analytical validation of a microplate reader-based method for the therapeutic drug monitoring of L-asparaginase in human serum.
Lanvers C, Pinheiro JPV, Hempel G, Wuerthwein G, Boos J. |
2002 |
| 3327 |
Journal
Am J Health-Syst Pharm 2012 ; 69:1405-1409 |
Compatibility and stability of telavancin and vancomycin in heparin or sodium citrate lock solutions.
LaPlante K.L, Woodmansee S, Mermel L.A. |
2012 |
| 1873 |
Journal
Clin Ther 2003 ; 25: 1219-1224. |
Assessment of the stability of dalteparin sodium in prepared syringes for up to thirty days/ In vitro study.
Laposata M, Johnson SM. |
2003 |
| 4342 |
Journal
Int J Pharm Compound 2019 ;23,5:434-437 |
Long-term Physicochemical Stability of Concentrated Solutions of Salbutamol (Albuterol) in Polypropylene Syringes for Use in the Intensive Care Unit and in Obstetrics.
Lardinois B, Baltzis A, Delcave C, Soumoy L, Jamart J, Bihin B, Hecq JD, Galanti L. |
2019 |
| 4252 |
Journal
Int J Pharm Compound 2019 ;23,2:163-166 |
Evaluation of the Physicochemical Stability of Amiodarone Hydrochloride in Syringes for the Intensive Care Unit.
Lardinois B, Dimitriou A, Delcave C, Jamart J, Bihin B, Soumoy L, Hecq JD, Galanti LM. |
2019 |
| 4374 |
Journal
Int J Pharm Compound 2020 ;24,1:64-68 |
Long-term Physicochemical Stability of Concentrated Solutions of Isosorbide Dinitrate in Polypropylene Syringes for Administration in the Intensive Care Unit.
Lardinois B, Dimitriou A, Delcave C, Soumoy L, Jamart J, Bihin B, Hecq J-H, Galanti L.M. |
2020 |
| 4642 |
Poster
SEFH Congress (Virtual) October 2021 2021 |
Compatibilidad en Y de atosiban y farmacois habitualmente utilizados en obstetricia.
Larossa garcia M, Jimenez-Lozano I, Boix-Montanés A, Mallandrich Miret M, Clemente Bautista M, cabanas Poy M.J., Gorgas Torner |
2021 |
| 1014 |
Journal
Clin Pharmacol Ther 1988 ; 43: 183. |
Lack of photodegradation but significant adsorption of nifedipine in administration systems.
Larsen JS, Uden DL, Zaske DE. |
1988 |
| 3917 |
Journal
Int J Pharm Compound 2016 ; 20, 6 : 521-525. |
Stability of Ribavirin for Inhalation Packaged in Syringes or Glass Vials when Stored Frozen, Refrigerated, and at Room Temperature.
Larson B L, Bushman L R, Casciano M L, Oldland A R, Kiser J J, Kiser T H. |
2016 |
| 28 |
Journal
PDA J Pharm Sci Technol 1996 ; 50: 261-267. |
Dexamethasone phosphate stability and contamination of solutions stored in syringes.
Lau DWC, Law S, Walker SE, Iazzetta J. |
1996 |
| 1864 |
Journal
Pain 1998 ; 75: 389-390. |
Compatibility of ketamine and morphin injections.
Lau MH, Hackman C, Morgan DJ. |
1998 |
| 4485 |
Journal
Can J Hosp Pharm 2021 ;74;1:57-69 |
Stability of Generic Formulations of Bortezomib 1.0 and 2.5 mg/mL in Vials and Syringes Stored 4°C and Room Temperature (23°C)
Law S, Charbonneau L, Iazetta J, Perks W, Ma N, Walker S.E. |
2021 |
| 4228 |
Poster
Prof Practice Conference - Canadian Society of PH 2017 |
Stability of 10 and 50 microg/mL Fentanyl Solutions in CADD Reservoirs, PVC containers and Ethylene/Propylene Co-Polymer (PAB) Bags at Refrigerated (4°C) and Room Temperature (23°C).
Law S, Perks W, Iazetta J, Walker S. |
2017 |
| 3431 |
Journal
Can J Hosp Pharm 2001 ; 54, 3: 214-215. |
Stability of preservative-free tobramycin in half-normal saline.
Law S. |
2001 |
| 4317 |
Journal
J Pharm Technol 2019 ;35,3:105-109 |
Comparative Stability of Oral Vitamin K Liquids Stored in Refrigerated Amber Plastic Syringes.
Lawson S, Lewis P, Peacock G, Brown S. |
2019 |
| 919 |
Journal
Anesth Analg 1998 ; 86: 422-426. |
Propofol and thiopental in a 1:1 volume mixture is chemically stable.
Lazar ER, Jolly DT, Tam YK, Hrazdil J, Tawfik SR, Clanachan AS. |
1998 |
| 3804 |
Journal
EJHP 2014 ;22:150-155. |
Physicochemical stability of cabazitaxel and docetaxel solutions.
Lazzarini R, Salvadori S, Trapella C, Guerrini R, Marzola E, Pasini G, Dalpiaz A. |
2014 |
| 4199 |
Journal
EJHP 2018 |
Long-term stability of 0.1% rapamycin hydrophilic gel in the treatment of facial angiofibromas.
Le Guyader G, Vieillard V, Andrieux K, Rollo M, Thirion O, Wolkenstein P, Paul M. |
2018 |
| 4505 |
Journal
Eur J Cancer 2020 ; 135: 192-202. |
Stability of nivolumab in its original vials after opening and handing in normal saline bag for intravenous infusion.
Le Guyader G, Vieillard V, Mouraud S, Do B, Marabelle A, Paul M. |
2020 |
| 4493 |
Journal
J Oncol Pharm Practice 2020 |
Physicochemical stability study of MYL-1401O, a biosimilar of trastuzumab, following a transient temperature excursion.
Le Guyader G, Vieillard V, Paul M. |
2020 |
| 515 |
Journal
J Pharm Clin 1998 ; 17: 35-39. |
Stability of morphine hydrochloride solutions in portable single-use PCA systems. Additives leaching into the morphine solutions.
Le Hoang MD, Sarbach C, Prognon P, Delvordre P, Mignot A, Pradeau D. |
1998 |
| 241 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 2639. |
Incompatibility between ceftriaxone sodium and labetolol hydrochloride.
Leader WG, Jones JM. |
1996 |
| 4729 |
Journal
Pharmaceutics 2023 ; 15, 208. |
Extemporaneous Preparation of 20 mg/mL Ganciclovir in Artificial Tears in Comparison with SterileWater for Ophthalmic Administration: Formulation and Stability Study.
Leanpolchareanchai J, Tangteerakoon P, Supapsophon P, Sukavatcharin S, Simaroj P, Suksiriworapong J. |
2023 |
| 1492 |
Journal
Can J Hosp Pharm 1995 ; 48: 155-160. |
Compatibility of morphine and midazolam or haloperidol in parenteral admixtures.
LeBelle MJ, Savard C, Gagnon A. |
1995 |
| 2361 |
Journal
J Clin Pharm Ther 2009 ; 34, 4 : 423-428. |
Effect of freeze-thawing on the long-term stability of calcium levofolinate in 5% dextrose stored on polyolefin infusion bags.
Lebitasy M, Hecq J.D, Athanassopoulos A, Vanbeckbergen D, Jamart J, Galanti L. |
2009 |
| 2814 |
Journal
Ann Pharm Fr 2009 ; 67: 272-277. |
Long-term stability of tramadol hydrochloride and droperidol mixture in 5% dextrose infusion polyolefin bags at 5 +/- 3°C.
Lebitasy M, Hecq JD, Vanbeckbergen D, Jamart J, Galanti L. |
2009 |
| 264 |
Journal
Pharm Hosp Fr 1997 ; 121: 124. |
Incompatibilité physico-chimique entre l’oméprazole et la vancomycine.
Leboucher G, Charpiat B. |
1997 |
| 4750 |
Journal
Pharmaceutics 2023 ,15, 755. |
Development and Stability of a New Formulation of Pentobarbital Suppositories for Paediatric Procedural Sedation.
Lebrat M, Bouattour Y, Gaudet C, Yessaad M, Jouannet M, Wasiak M, Dhifallah I, Beyssac E, Garrait G, Chennell P, Sautou V. |
2023 |
| 4561 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2021 ; 6(1): 20200013. |
New liquid oral formulations of hydroxychloroquine: a physicochemical stability study.
Lebreton V, Bourcier B, Cosson K, Lagarce F, Spiesser-Robelet L, Vrignaud S. |
2021 |
| 1892 |
Journal
Int J Pharm Compound 2004 ; 8, 2: 156-159. |
Effect of freezing, long-term storage and microwave thawing on the stability of tramadol in 5% dextrose infusion in polyvinyl chloride bags.
Lebrun J, Hecq JD, Vanbeckbergen D, Jalart J, Galanti LM. |
2004 |
| 1287 |
Journal
Pharm Ind 1991 ; 53: 90-94. |
Stability study of reconstituted and diluted solutions of calcium folinate.
Lecompte D, Bousselet M, Gayrard D, Poitou P. |
1991 |
| 828 |
Journal
J Pharm Clin 1990 ; 9: 159-165. |
Stability of mitoxantrone (Novantrone*) after dilution in PVC infusions.
Lecompte D, Bousselet M, Magnam J. |
1990 |
| 2242 |
Journal
Int J Pharm 1998 ; 167, 1-2: 223-228. |
A note on the solution chemistry of carboplatin in aqueous solutions.
Lederer M, Leipzig-Pagani E. |
1998 |
| 4666 |
Journal
J Anal Sci Tech 2020 ; 11: 32. |
Intravenous patient-controlled analgesia: in vitro stability profiles of mixtures containing fentanyl, hydromorphone, oxycodone, nefopam, ondansetron, and ramosetron.
Lee C.H, Kim A.R, Lee M.K, Oh J.S, Lee D.K, Choi S.S. |
2020 |
| 92 |
Journal
Am J Hosp Pharm 1990 ; 47: 606-608. |
Visual and spectrophotometric determination of compatibility of alteplase and streptokinase with other injectable drugs.
Lee CY, Mauro VF, Alexander KS. |
1990 |
| 87 |
Journal
Am J Hosp Pharm 1991 ; 48: 108-110. |
Compatibility of cefoperazone sodium and furosemide in 5% dextrose injection.
Lee DKT, Lee A, Wang DP. |
1991 |
| 1993 |
Journal
Am J Health-Syst Pharm 2005 ; 62: 1190-1192. |
Compatibility of fentanyl citrate, ketamine hydrochloride, and droperidol in 0.9% sodium chloride injection stored in polyvinyl chloride bags.
Lee DKT, Wang DP, Harsono R, Wong CY. |
2005 |
| 79 |
Journal
Am J Hosp Pharm 1991 ; 48: 111-113. |
Compatibility of cefoperazone sodium and cimetidine hydrochloride in 5% dextrose injection.
Lee DKT, Wang DP, Lee A. |
1991 |
| 237 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 432. |
Stability of cefmetazole and famotidine.
Lee DKT, Wong CY, Wang DP, Chang LC, Wu KH. |
1996 |
| 111 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 1608,1610. |
Stability of cefazolin sodium and meperidine hydrochloride.
Lee DKT, Wong CY, Wang DP. |
1996 |
| 1810 |
Journal
EJHP 2003 ; 1:1-3. |
Stability of morphine sulphate in P.C.A.s.
Lee G, Sabra K, Doyle N, Malley GO. |
2003 |
| 2123 |
Journal
EJHP Science 2006 ; 12, 4: 76-80. |
Stability of morphine sulphate in ANAPA Plus ambulatory infusion device and PEGA infusion sets.
Lee G, Sabra K. |
2006 |
| 4113 |
Journal
Am J Health-Syst Pharm 2018 ; 75, 10: 622-626. |
Stability of isoniazid injection in i.v. solutions.
Lee J, Moriyama B, Henning S, Danner R, Walsh T, Penzak S, Grimes G, Gopal K. |
2018 |
| 3842 |
Journal
Am J Health-Syst Pharm 2016 ; 73:137-142. |
Stability of tacrolimus solutions in polyolefin containers.
Lee J.H, Goldspiel B.R, Ryu S, Potti G.K. |
2016 |
| 283 |
Journal
Am J Hosp Pharm 1994 ; 51: 394-396. |
Stability of amphotericin B in 5% dextrose injection stored at 4 or 25°C for 120 hours.
Lee MD, Hess MM, Boucher BA, Apple AM. |
1994 |
| 1332 |
Journal
J Clin Hosp Pharm 1981 ; 6: 209-211. |
Absorption of isosorbide dinitrate by PVC infusion bags and administration sets.
Lee MG, Fenton-May V. |
1981 |
| 190 |
Journal
Am J Hosp Pharm 1986 ; 43: 1945-1950. |
Sorption of four drugs to polyvinyl chloride and polybutadiene intravenous administration sets.
Lee MG. |
1986 |
| 4569 |
Journal
Hosp Pharm 2021 ; 56, 4: 282-286. |
Y-Site Compatibility of Intravenous Levetiracetam With Commonly Used Critical Care Medications.
Lee T.M , Villareal C.L, Meyer L.M. |
2021 |
| 2787 |
Journal
Am J Health-Syst Pharm 2005 ; 62, 8: 828-833. |
Compatibility and osmolality of inhaled N-acetylcysteine nebulizing solution with fenoterol and ipratropium.
Lee TY, Chen CM, Lee CN, Chaing YC. |
2005 |
| 743 |
Journal
Am J Hosp Pharm 1980 ; 37: 803-808. |
Bretylium tosylate intravenous admixture compatibility. I: Stability in common large-volume parenteral solutions.
Lee YC, Baaske DM, Amann AH, Carter JE, Mooers MA, Wagenknecht DM, Lai CM. |
1980 |
| 705 |
Journal
Am J Hosp Pharm 1981 ; 38: 183-187. |
Bretylium tosylate admixture compatibility. II : Dopamine, lidocaine, procainamide, and nitroglycerin.
Lee YC, Malick W, Amann AH, Baaske DM, Shah JJ, Wagenknecht DM, Carter JE. |
1981 |
| 4573 |
Journal
Am J Health-Syst Pharm 2021 ;78, 9:806–812, |
Long-term physicochemical stability of acyclovir 5 mg/mL solution stored in polypropylene bags as a simulated hospital stock preparation.
Legeron R, Bougueon G, Berroneau A, De-Germay S, Bernadou JM, Djabarouti S, Crauste-Manciet S, Xuereb F. |
2021 |
| 3534 |
Journal
Am J Health-Syst Pharm 2013 ; 70:2137-2142 |
Chemical stability of azacitidine suspensions for injection after cold-chain reconstitution of powder and storage
Legeron R, Xuereb F, Djabarouti S, Saux M.C, Breilh D. |
2013 |
| 3767 |
Journal
Pharmactuel 2014 ; 47, 3 : 167-172. |
Compatibilité par évaluation visuelle du thiopental injectable lors de son administration en Y avec des médicaments usuels.
Legris M.E, Lavoie A, Forrest J.M, Hildgen P. |
2014 |
| 3216 |
Journal
Pharmactuel 2011 ; 44, 1 : 14-18 |
Compatibilité physique par évaluation visuelle du salbutamol injectable lors de son administration en Y.
Legris ME, Valiquette ME, Lavoie A, Forest JM, Leclair G. |
2011 |
| 1235 |
Journal
Br J Pharm Pract 1988 ; 10: 22-23. |
Pentamidine infusion stability.
Leigh PH, Buddle GC. |
1988 |
| 3953 |
Journal
Hemodial Int 2011 ; 15, 2 : 364-272. |
In vitro stability and compatibility of tenecteplase in central venous access devices.
Lentz Y.K, Joyce M, Lam X. |
2011 |
| 3205 |
Journal
AAPS Pharm Sci 2011 ; 15, 2 : 264-272. |
in vitro stability and compatibility of tenecteplase in central venous access devices.
Lentz, Y.K. , Joyce, M., Lam, X. |
2011 |
| 1613 |
Journal
Can J Hosp Pharm 2000 ; 53: 338-345. |
Stability and compatibility of etoposide in normal saline.
Lepage R, Walker SE, Godin J. |
2000 |
| 916 |
Journal
J Clin Pharm Ther 1993 ; 18: 343-345. |
Stability of quinine dihydrochloride in commonly used intravenous solutions.
Lerkiatbundit S. |
1993 |
| 4319 |
Journal
Hosp Pharm 2020 ; 55, 5: 332-337. |
Compatibility of Y-site Injection of Meropenem Trihydrate With 101 Other Injectable Drugs.
Lessard J-J, Caron E, Schérer H, Forest J-M, Leclair G. |
2020 |
| 517 |
Journal
Am J Hosp Pharm 1992 ; 49: 838-839. |
Visual compatibility of magnesium sulfate with narcotic analgesics.
Letourneau M. |
1992 |
| 3421 |
Journal
Am J Health-Syst Pharm 2013 ;70:1163-1166. |
Physical compatibility of vancomycin and piperacillin sodium–tazobactam at concentrations typically used during prolonged infusions.
Leung E, Venkatesan N, Ly S.C, Scheetz M.H. |
2013 |
| 1861 |
Journal
Int J Pharm 1996 ; 127: 255-259. |
Medical plastics: compatibility of alfentanil and propofol alone or mixed. Stability of the alfentanil-propofol mixture.
Levadoux E, Sautou V, Bazin JE, Schoeffler P, Chopineau J. |
1996 |
| 2502 |
Journal
Am J Hosp Pharm 1992 ; 49: 122-125. |
Stability of an extemporaneously compounded clonidine hydrochloride oral liquid
Levinson ML, Johnson CE. |
1992 |
| 1758 |
Journal
Can J Hosp Pharm 1999 ; 52: 90. |
Ampicillin and ciprofloxacin incompatibility.
Lewis GM, Donelly RF. |
1999 |
| 1392 |
Journal
Can J Hosp Pharm 1999 ; 52: 90. |
Ampicillin and ciprofloxacin incompatibility.
Lewis GM, Donnelly RF. |
1999 |
| 275 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 1461-1462. |
Cephalosporin-pentamidine isethionate incompatibilities.
Lewis JD, El-Gendy A. |
1996 |
| 4053 |
Journal
Am J Health-Syst Pharm 2017 ;74,24:2060-2064 |
Stability of a pyrimethamine suspension compounded from bulk powder.
Lewis P, Cluck D, Huffman J, Ogle A, Brown S. |
2017 |
| 1617 |
Journal
Am J Health-Syst Pharm 2002 ; 59: 539-544. |
Stability of irinotecan hydrochloride in aqueous solutions.
Li WY, Koda RT. |
2002 |
| 4352 |
Journal
J Clin Pharm Ther 2019 ; 44: 875-882. |
In vitro compatibility and stability of admixtures containing etoposide, epirubicin hydrochloride and vindesine sulphate in a single infusion bag.
Li J, Yao C, Xu Y, Ping P, Yin H, Sun Y. |
2019 |
| 3476 |
Journal
Am J Health-Syst Pharm 2013 ;70:1970-1972. |
Stability of cyclosporine diluted with 0.9% sodium chloride injection or 5% dextrose injection and stored in ethylene-vinyl acetate containers.
Li M, Coursol C, Leclair G. |
2013 |
| 3229 |
Journal
Am J Health-Syst Pharm 2011 ;68:1646-1650. |
Stability of cyclosporine solutions stored in polypropylene–polyolefin bags and polypropylene syringes.
Li M, Forest JM, Coursol C, Leclair G. |
2011 |
| 3399 |
Poster
EAHP Congress Paris 2013 |
Development of a hydrochlorothiazide 0.5 mg/mL oral solution for children.
Li Y.Y, Postma D.J, Wagenaar H.W.G. |
2013 |
| 4592 |
Journal
Antibiotics 2021 ; 10: 715. |
The Role of Non-Enzymatic Degradation of Meropenem—Insights from the Bottle to the Body.
Liebchen U, Rakete S, Vogeser M, Arend F.M, Kinast C, Scharf C, Zoller M, Schönermarck U, Paal M. |
2021 |
| 1413 |
Journal
Int J Pharm Compound 1999 ; 3: 67-68. |
Five-day stability of vinorelbine in 5% dextrose injection and in 0.9% sodium chloride injection at room temperature.
Lieu CL, Chin A, Gill MA. |
1999 |
| 1877 |
Journal
Br Ophtalmol 2000 ; 84: 117. |
Vancomycin and ceftazidime incompatibility upon vitreal injection.
Lifshitz T, Lapid-Gortzak R, Finkelman Y, Klemperer I. |
2000 |
| 794 |
Journal
Anaesthesia 1996 ; 51: 815-818. |
The effect of the addition of lignocaine on propofol emulsion stability.
Lilley EMM, Isert PR, Carasso ML, Kennedy RA. |
1996 |
| 2431 |
Journal
Am J Health-Syst Pharm 1997 ; 54: 2073-2078. |
Stability of phenoxybenzamine hydrochloride in various vehicles
Lim LY, Tan LL, Chan EW, Yow KL, Chan SY, Ho PC. |
1997 |
| 2091 |
Journal
J Pharm Pract and Res 2004 ; 34: 11-13. |
Stability of insulin aspart in normal saline infusion.
Lim SC, Roberts MJ, Paech MJ, Peng L, Jones A. |
2004 |
| 3895 |
Journal
Ann Pharmacotherapy 2016 ; 50: 790-792. |
Physicochemical Stability Study of Polymyxin B in Various Infusion Solutions for Administration to Critically Ill Patients
Lim Tze-Peng, Kim-Hor Hee D, Lee W, Qi-Min Teo J, Cai Y,Yu-Hng Chia S, Yee-Kiat Leaw J, Jing-Yi Lee S, Soon-U Lee L, Kwa A.L. |
2016 |
| 4522 |
Journal
J Pharm Biomed Anal 2020 |
Six months stability investigation of sufentanil and ropivacaine/levobupivacaine admixtures in plastic container by LC-UV.
Lin Q, Van Schepdael A, Adams E. |
2020 |
| 4547 |
Journal
EJHP 2021 |
Formulation and stability of an extemporaneously compounded propafenone hydrochloride oral suspension for children with arrhythmia.
Lin Y-S, Lin S-C, Hsieh Y-T,Liu L-Y,Lin C-H, Shen L-J, Huang C-F. |
2021 |
| 1805 |
Journal
Am J Health-Syst Pharm 2002 ; 59: 2362-2364. |
Stability of cefazolin sodium in icodextrin-containing peritoneal dialysis solution.
Lin YF, Wu CC, Lin SH, Wang DP, Wang CN. |
2002 |
| 3159 |
Journal
Acta Anaesthesiol Taiwan 2010 ; 48, 3 : 117-121. |
Compatibility and stability of binary mixtures of ketorolac tromethamine and tramadol hydrochloride injection concentrate and diluted infusion solution.
Lin, T.-F., Lin, F.-S., Chou, W.-H., Yeh, Y.-C., Lin, C.-P., Fan, S.-Z., Sun, W.-Z. |
2010 |
| 1626 |
Journal
Int J Pharm Compound 2001 ; 5: 151-152. |
Stability of cefepime hydrochloride after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric use.
Ling J, Das Gupta V. |
2001 |
| 1716 |
Journal
Int J Pharm Compound 2001 ; 5: 73-75. |
Stability of ethacrynate sodium after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric use.
Ling J, Das Gupta V. |
2001 |
| 1717 |
Journal
Int J Pharm Compound 2001 ; 5: 75-77. |
Stability of acyclovir sodium after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric use.
Ling J, Das Gupta V. |
2001 |
| 2352 |
Journal
Int J Pharm Compound 2000 ; 4, 6: 480-481. |
Stability of nafcillin sodium after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric use.
Ling J, Das Gupta V. |
2000 |
| 2593 |
Journal
Can J Hosp Pharm 2006 ; 59, 4: 194-200. |
Stability of sulfasalazine oral suspension.
Linger-Walsh K, Walker SE, Law S, Abesamis M, Sales P. |
2006 |
| 4142 |
Journal
Can J Hosp Pharm 2018 ;71,3:165-172 |
Stability of Extemporaneously Compounded Domperidone 5 mg/mL Suspension in Oral Mix in Plastinc and Glass Bottles and Plastic Syringes.
Lingertat-Walsh K, Law S, Walker S.E. |
2018 |
| 4397 |
Journal
J Oncol Pharm Practice 2021 ;27,1:78–87 |
Stability of extemporaneously compounded temozolomide 10 mg/mL suspensions in Oral Mix SF in glass and plastic syringes.
Lingertat-Walsh K, Weilnau J, Cober M P, Ostrenga A, Poon B, Pacita S, Law S, Dupuis LL, Walker SE. |
2021 |
| 4677 |
Poster
EAHP Congress Vienna 2022 |
Physicochemical stability of diluted "Thiotepa Riemser" infusion solutions in prefilled 5% glucose infusion bags.
Linxweiler H, Thiesen J, Krämer I. |
2022 |
| 4748 |
Journal
Pharmaceutics 2023 ,15, 309. |
Physicochemical Stability of Generic Thiotepa Concentrate and Ready-to-Administer Infusion Solutions for Conditioning Treatment.
Linxweiler H, Thiesen J, Krämer I. |
2023 |
| 3266 |
Manufacturer
Lipomed 2011 |
Dacarbazine solutions: In Use stability of dacarbazine lipomed®
Lipomed Laboratories |
2011 |
| 3267 |
Manufacturer
Lipomed 2011 |
Dacarbazine Lipomed - Summary of Product Characteristics
Lipomed Laboratories |
2011 |
| 4018 |
Journal
Krankenhauspharmazie 2017 ;38:423-429 |
Physikalisch-chemische Stabilität von rekonstituierten Trabectedin-haltigen Lösungen.
Lipp H-P, Gfrörer W |
2017 |
| 3537 |
Journal
Krankenhauspharmazie 2013 ; 34,11: 500-505. |
Bortezomib zur subkutanen Applikation.
Lipp HP, Gfrörer W, Riedmüller S. |
2013 |
| 1736 |
Journal
J Clin Pharm Ther 1999 ; 24: 145-150. |
Effects of sucrose, citric buffer and glucose oxidase on the stability of captopril in liquid formulations.
Liu J, Chan Y, Ho PC. |
1999 |
| 91 |
Journal
Am J Hosp Pharm 1993 ; 50: 1208-1210. |
Visual compatibility of gallium nitrate with selected drugs during Y-site injection.
Lober CA, Dollard PA. |
1993 |
| 3868 |
Journal
J Oncol Pharm Practice 2016 ; 22: 571-572 |
Incompatibility of busulfan with 1 ml Luer-Lock syringes.
Loboda C, Lider P, Vigneron J. |
2016 |
| 4634 |
Journal
Antibiotics 2022 ;11,4: 458 |
Stability studies of 16 Antibiotics for Continuous Infusion in Intensive Care Units and for Performing Outpatient Parenteral Antimicrobial Therapy.
Loeuille G, D'Huart E, Vigneron J, Nisse YE, Beiler B, Polo C, Ayari G, Sacrez M, Demoré B, Charmillon A. |
2022 |
| 4600 |
Journal
EJOP 2021 ; 4: 3. |
Physicochemical stability of lurbinectedin reconstituted at 500 µg/mL and diluted at 15, 30, and 70 µg/mL in 0.9% sodium chloride and 5% dextrose.
Loeuille G, Vigneron J, D’Huart E, Demoré B. |
2021 |
| 2078 |
Journal
J Ped Surg 2000 ; 35: 1775-1781. |
Polyvinylchloride infusion lines expose infants to large amounts of toxic plasticizers.
Loff S, Kabs F, Witt K, Sartoris J, Mandl B, Niessen KH, Waag KL. |
2000 |
| 2130 |
Journal
Bull Cancer 1999 ; 86, 11: 946-954. |
Stabilité du mélange 5-fluoro-uracil-acide fonique : influence des concentrations, du contenant et de la forme de l’acide folinique.
Lokiec F, Amirault P, Bonnans H, Gauzan MF, Sauvage N, Santoni J. |
1999 |
| 4179 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2018 ;3,4:207-218 |
Validation of an HPLC Assay Method for Routine QC Testing and Stability Study of Compounded Low-Dose Capsules of Acetylsalicylic Acid.
Lonca N, Maillard F, Leguelinel G, Sharkawi T, Soulairol I. |
2018 |
| 4283 |
Journal
Eur J Pharm Sci 2019 |
Pharmaceutical preformulation studies and paediatric oral formulations of sodium dichloroacetate.
Lopalco A, Curci A, Lopedota A, Cutrignelli A, Laquintana V, Franco M, Denora N. |
2019 |
| 4533 |
Journal
Int J Pharm Compound 2021 ;25,5:427-430 |
Stability of Diazepam Enema Extemporaneous Formulation in Manzoni Base.
Lopalco A, Lopedota A, Aurelio F, La Forgia F, Fontana S, Franco M, Denora N. |
2021 |
| 4362 |
Journal
EJHP 2018 Eur J Hosp Pharm 2018;0:1 |
Physicochemical stability of binary admixtures of paracetamol and dexketoprofen-trometamol for patient-controlled analgesia use.
Lopez Navarro AA, Martinez Gomez MA, Gras Colomer E, Campillos P, Climente Marti M. |
2018 |
| 1506 |
Journal
EJHP 2015 ;22:107-112. |
Physicochemical compatibility of high concentration drugs usually Y-site administered in intensive care units.
Lopez-Cabezas C, Guerrero L, Molas G, Anglada H, Soy D. |
2015 |
| 496 |
Journal
Am J Hosp Pharm 1991 ; 48: 744-746. |
Visual compatibility of fluconazole with commonly used injectable drugs during simulated Y-site administration.
Lor E, Sheybani T, Takagi J. |
1991 |
| 73 |
Journal
Am J Hosp Pharm 1990 ; 47: 157-159. |
Visual compatibility of foscarnet with other injectable drugs.
Lor E, Takagi J. |
1990 |
| 145 |
Journal
J Pharm Clin 1992 ; 11: 285-295. |
Photosensibility of 5-fluorouracile and methotrexate in translucent or opaque perfusers.
Lorillon P, Corbel JC, Mordelet MF, Basle B, Guesnier LR. |
1992 |
| 194 |
Journal
Am J Hosp Pharm 1990 ; 47: 1559-1562. |
Effect of vehicle ionic strength on sorption of nitroglycerin to a polyvinyl chloride administration set.
Loucas SP, Maager P, Mehl B, Loucas ER. |
1990 |
| 803 |
Journal
Diabetes Care 1997 ; 20: 1061-1065. |
Stability of insulin lispro in insulin infusion systems.
Lougheed WD, Weymouth AB, Zinman B, Bernstein EA, Strack TR, Korbas AM, Janis LJ, Frank BH. |
1997 |
| 1624 |
Journal
Am J Health-Syst Pharm 2000 ; 57: 760-762. |
Activity of dalteparin sodium in polypropylene syringes.
Louie S, Chin A, Gill MA. |
2000 |
| 3315 |
Poster
Communication orale Hopipharm 2012 |
Mise en évidence d'une incompatibilité physico-chimique entre la phénytoïne sodique et le paracétamol injectable en flacon.
Louvrier M, Dhennain S, Hocahrt S, Zawadski E, Bouffart S, Moquay E. |
2012 |
| 4683 |
Journal
J Pharm Pract and Res 2022 2022; 52, 34-41 |
Stability of omeprazole in a commercial calcium carbonate based oral suspension at 2, 5 and 10 mg/mL stored under refrigeration (4°C) for 70 days
Low M, Singh S, Venkataya B, Pearson J, Ibrahim M, Jarouche M, Khoo C, Rowe J, Li CG. |
2022 |
| 4353 |
Journal
J Clin Pharm Ther 2019 |
Physicochemical stability of extemporaneously prepared clonidine solutions for use in neonatal abstinence syndrome.
Lu D, Harmanjeet H, Wanandy T, Paine M, . PetersonG.M, Patel R. |
2019 |
| 4528 |
Journal
Int J Pharm Compound 2021 ;25,1:52-61 |
Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration.
Lu J, Liu Q, Kupiec T, Vail H, Lunch L, Fam D, Vu N. |
2021 |
| 546 |
Journal
Ann Pharmacotherapy 1994 ; 28: 1018-1019. |
Stability of diluted dexamethasone sodium phosphate injection at two temperatures.
Lugo RA, Nahata MC. |
1994 |
| 4309 |
Journal
J Am Pharm Assoc 2013 ; 53, 3: 304-306. |
Stability of U-500 regular
insulin in prefilled syringes
Lull M.E, Piacentino J.J, Traina A.N. |
2013 |
| 353 |
Journal
Am J Hosp Pharm 1987 ; 44: 2519-2524. |
Reductive destruction of dacarbazine, procarbazine hydrochloride, isoniazid, and iproniazid.
Lunn G, Sansone EB. |
1987 |
| 4544 |
Journal
Int J Pharm Compound 2021 ;25,3:236-240 |
Stability Evaluation of Minoxidil in FOAMIL Foam Base with Bracketing Study Design.
Lupatini , Sidhu R, Patel H, Bichar K. |
2021 |
| 3923 |
Journal
Am J Health-Syst Pharm 2017 ; 74, 1: e64-e71 |
Stability of sildenafil in combination with heparin and dopamine.
Luu Y, Thigpen J, Brown S.D. |
2017 |
| 1393 |
Journal
Pharm J 1987 ; 238: 290. |
Ciprofloxacin lactate infusion.
Lyall D, Blythe J. |
1987 |
| 2432 |
Journal
Am J Health-Syst Pharm 1997 ; 54: 2483-2487. |
Effects of ingredients on stability of captopril in extemporaneously prepared oral liquids
Lye MY, Yow KL, Lim LY, Chan SY, Chan E, Ho PC. |
1997 |
| 1688 |
Journal
Krankenhauspharmazie 1999 ; 20: 55-58. |
Stabilitätsstudie zu alizaprid im PVC-infusionbeutel.
M?ller H-J, Frank C. |
1999 |
| 2364 |
Poster
PharmSciFair 2009 |
Hydromorphone and dipyrone in PCA devices: Is still a therapy with hydromorphone?
M?ller S, Trittler R, Schubert R, Strehl E. |
2009 |
| 2363 |
Poster
ADKA Congress 2006 |
Morphin-Metamizol mischungen zur kontinuierlichen parenteralen applikation : Sind sie immer inkompatibel?
M?ller S, Trittler R, Schubert R, von Hornstein W.F, Strehl E. |
2006 |
| 2366 |
Poster
ADKA Congress 2009 |
Oxycodon-Metamizol in PCA pumpen : Kompatibel?
M?ller S, Trittler R, Schubert R. |
2009 |
| 3649 |
Journal
Am J Health-Syst Pharm 2014 ; 71:657-661. |
Stability of clonidine suspension in oral plastic syringes.
Ma C, Decarie D, Ensom M.H.H. |
2014 |
| 4229 |
Journal
Int J Pharm Compound 2017 ;24,6:519-527 |
Development of Stable and Simple Finasteride 333-μg/mL Suspensions that Minimize Occupational Exposure.
Ma N, Perks W, Law S, John I, Walker S. |
2017 |
| 4759 |
Poster
Sunnybrook Healt Science Centre 2023 |
Stability of 5-fluorouracil at 4°C, 25°C, and 33°C stored in NiproSureFuser+ Ambulatory Balloon Infusers.
Ma NH, Charbonneau LF, Law S, Walker S. |
2023 |
| 2289 |
Journal
Pharmazie 1994 ; 49, 10: 775-777. |
Stabilität von bendamustinhydrochloride in infusion lösungen.
Maas B, Huber C, Krämer I. |
1994 |
| 1959 |
Journal
Hosp Pharm 2005 ; 40, 2: 154-155. |
Precipitate formation after subconjonctival administration of ceftazidime and vancomycin.
Mac Lellan C, Papadopoulos A. |
2005 |
| 2523 |
Journal
Am J Hosp Pharm 1994 ; 51: 2409-2411. |
Stability of isradipine in an extemporaneously compounded oral liquid
MacDonald JL, Johnson CE, Jacobson P. |
1994 |
| 340 |
Journal
Am J Hosp Pharm 1985 ; 42: 1087-1094. |
Stability of morphine sulfate and meperidine hydrochloride in a parenteral nutrient formulation.
Macias JM, Martin WJ, Lloyd CW. |
1985 |
| 3195 |
Journal
EJHP 2011 ; 17, 2: 39-43. |
Physical and chemical stability of docetaxel infusions.
MacLeod S, Sewell G. |
2011 |
| 4200 |
Journal
EJHP 2018 |
Stability study of hydromorphone and bupivacaine mixture by HPLC-UV.
Macorigh C, Guibbert V, Casanova M, Haenni C. |
2018 |
| 4742 |
Journal
Pharmactuel 2022 ; 55, 4: 247-255. |
Compatibilité physique de l’acétaminophène injectable avec 102 autres médicaments lors d’une administration en Y.
Macoviciuc M, Nguyen C, Forest J-M, Leclair G. |
2022 |
| 4712 |
Poster
GERPAC Congrès - octobre 2022 2022 |
Développement de formulations buvables de vinorelbine à usage pédiatrique.
Macqueron L, Régnier L, Robinet P, Leroy AM, Lester MA, Boivin PN, Le Corre P. |
2022 |
| 4059 |
Journal
EJHP 2017 ; 25, e2 |
Physical and chemical stability of ceftaroline in an elastomeric infusion device.
Madfai F, Zaidi S, Ming L, Wanandy T, Patel R. |
2017 |
| 4109 |
Journal
Am J Health-Syst Pharm 2018 ;75,9:241-245 |
Stability of milrinone in continuous ambulatory delivery devices.
Madfai F, Zaidi S, Ming L, Wanandy T, Patel R. |
2018 |
| 1037 |
Journal
J Pharm Sci 1984 ; 73: 838-839. |
In vitro stability of sodium nitroprusside solutions for intravenous administration.
Mahony C, Brown JE, Stargel WW, Verghese CP, Bjornsson TD. |
1984 |
| 3120 |
Poster
Congrès HOPIPHARM 2010 |
Etude de stabilité de solutions intravitréennes de vancomycine à 10 mg/ml.
Maillot-Pyszczek V, Bourdeaux D, Sautou V, Chopineau J. |
2010 |
| 4724 |
Journal
Int J Pharm Compound 2022 ;26,6:522-526 |
Intravenous Physical Compatibility of Heparin Sodium and Furosemide.
Maktabi B, Howard MS, Baki G, Churchwell MD |
2022 |
| 3872 |
Journal
Hosp Pharm 2016 ; 51: 389-395. |
Stability of an Extemporaneously Compounded Oral Suspension of Bosentan.
Malik A, Gorman G, Coward L ,. Arnold J.J. |
2016 |
| 3985 |
Poster
Hopipharm Congress 2017 - Nancy 2017 |
Compatibilité physique entre médicaments injectables et nutrition parentérale pédiatrique : Evaluation in-vitro.
Manai M., Soussi M.A., Lazreg O., Drira C., Ben Tekaya S. et Razgallah Khrouf M. |
2017 |
| 177 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 2213-2216. |
Avaibility of lorazepam after simulated administration from glass and polyvinyl chloride containers.
Mancano MA, Boullata JI, Gelone SP, Zitterman RE, Borenstein MR. |
1995 |
| 4063 |
Journal
Int J Pharm Compound 2018 ;22,1:66-75 |
Stability of an Alcohol-free, Dye-free Hydrocortisone (2mg/mL) Compounded Oral Suspension.
Manchanda A, Laracy M, Savji T, Bogner R. |
2018 |
| 2450 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 2731 - 2734. |
Stability of ceftazidime sodium and teicoplanin sodium in a peritoneal dialysis solution
Manduru M, Fariello A, White RL, Fox JL, Bosso JA. |
1996 |
| 2163 |
Journal
Perit Dial Int 2002 ; 22: 419-422. |
Linezolid stability in peritoneal dialysis solutions.
Manley HJ, McClaran ML, Bedenbaugh A, Peloquin CA. |
2002 |
| 3262 |
Journal
J Oncol Pharm Practice 2011 ; 17, 4: 395-399. |
Conditions causing gemcitabine crystallization.
Manners S, Galettis P, de Souza P. |
2011 |
| 423 |
Journal
Am J Hosp Pharm 1985 ; 42: 332-335. |
Stability and cost analysis of clindamycin-gentamicin admixtures given every eight hours.
Mansur JM, Abramowitz PW, Lerner SA, Smith RB, Townsend RJ. |
1985 |
| 176 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 2567-2568. |
Visual compatibility of midazolam hydrochloride with selected drugs during simulated Y-site injection.
Mantong ML, Marquardt ED. |
1995 |
| 432 |
Journal
Am J Hosp Pharm 1986 ; 43: 1732-1736. |
Stability of clindamycin phosphate with aztreonam, ceftazidime sodium, ceftriaxone sodium, or piperacillin sodium in two intravenous solutions.
Marble DA, Bosso JA, Townsend RJ. |
1986 |
| 565 |
Journal
Drug Intell Clin Pharm 1986 ; 20: 960-963. |
Compatibility of clindamycin phosphate with amikacin sulfate at room temperature and with gentamicin sulfate and tobramycin sulfate under frozen conditions.
Marble DA, Bosso JA, Townsend RJ. |
1986 |
| 644 |
Journal
Drug Intell Clin Pharm 1988 ; 22: 54-57. |
Compatibility of clindamycin phosphate with aztreonam in polypropylene syringes and with cefoperazone sodium, cefonicid sodium, and cefuroxime sodium in partial-fill glass bottles.
Marble DA, Bosso JA, Townsend RJ. |
1988 |
| 4119 |
Poster
Hôpitaux Universitaire de Genève 2004 |
Stabilité et compatibilité de solutions injectables d'amiodarone (Cordarone®)
Marcoz N, Ing H, Sautter AM, Saadi JF, Roulin JF, Bonnabry P. |
2004 |
| 310 |
Journal
Am J Hosp Pharm 1991 ; 48: 510-514. |
Compatibility and pH variability of four injectable phenytoin sodium products.
Markowsky SJ, Kohls PR, Ehresman D, Leppik I. |
1991 |
| 63 |
Journal
Am J Hosp Pharm 1994 ; 51: 811-812. |
Visual compatibility of fentanyl citrate with selected drugs during simulated Y-site injection.
Marquardt Ed, Lam SSY. |
1994 |
| 331 |
Journal
Am J Hosp Pharm 1988 ; 45: 2127. |
Visual compatibility of hydroxyzine hydrochloride with various antineoplasic agents.
Marquardt ED. |
1988 |
| 4029 |
Journal
Int J Pharm Compound 2017 ; 21, 5: 436-439 |
Stability of Dexmedetomidine in 0.9% Sodium Chloride in Two Types of Intravenous Infusion Bags.
Marquis K, Hohlfelder B, Szumita Paul. |
2017 |
| 1475 |
Journal
J Pharm Biomed Anal 1996 ; 14: 395-399. |
Long-term stability of 5-fluorouracil stored in PVC bags and in ambulatory pump reservoirs.
Martel P, Petit I, Pinguet F, Poujol S, Astre C, Fabbro M. |
1996 |
| 350 |
Journal
Am J Hosp Pharm 1990 ; 47: 369-373. |
Sorption of various drugs in polyvinyl chloride, glass, and polyethylene-lined infusion containers.
Martens HJ, De Goede PN, Van Loenen AC. |
1990 |
| 2771 |
Journal
Skin Pharm Appl Skin Physiol 1999 ; 12: 266-270. |
Long-term stability of 8-methoxypsoralen in ointments for topical PUVA therapy (Cream PUVA).
Martens-Lobenhoffer J, Rinke M, Losche D. |
1999 |
| 2586 |
Journal
Br Assoc Dermatol 1998 ; 139 (suppl 52): 8-1. |
Chemical stability of adepalene and tretinoin when combined with benzoyl peroxyde in presence and in absence of visible light and ultraviolet radiation.
Martin B, Meunier C, Montels D. |
1998 |
| 552 |
Journal
Int J Pharm Compound 1997 ; 1: 356-358. |
Compatibility of warfarin sodium with selected drugs and large-volume parenteral solutions.
Martinez JF, Trissel LA, Gilbert DL. |
1997 |
| 966 |
Journal
JPEN 1991 ; 15: 536-539. |
In vitro assessment of vancomycin HCl compatibility after coinfusion with a specialized amino acid formulation.
Martins AM, McDougal A, Hamilton D, Igwemezie L, McErlane K. |
1991 |
| 2495 |
Journal
Am J Hosp Pharm 1986 ; 43: 380-383. |
Long-term stability study of histamine in sterile bronchoprovocation solutions
Marwaha RK, Johnson BF. |
1986 |
| 2053 |
Journal
Anesth Analg 2003 ; 97: 1646-1651. |
Physicochemical compatibility of propofol-lidocaine mixture.
Masaki Y, Tanaka M, Nishikawa T. |
2003 |
| 1182 |
Journal
Am J Hosp Pharm 1981 ; 38: 1449-1454. |
Factors affecting diazepam infusion: solubility, administration-set composition, and flow rate.
Mason NA, Cline S, Hyneck ML, Berardi RR, Ho NFH, Flynn GL. |
1981 |
| 2369 |
Journal
Am J Hosp Pharm 1992 ; 49: 1139 - 1142. |
Stability of ceftazidime and tobramycin sulfate in peritoneal dialysis solution
Mason NA, Johnson CE, O'Brien MA. |
1992 |
| 4007 |
Poster
Hopipharm Congress 2017-Nancy 2017 |
Etude de la stabilité de la vancomycine à 40 mg/ml au cours d'une perfusion de 24 heures.
Masse M, Genay S, Carta N, Delannoy-Rousseli?re C, Moreau F, Barthelemy C, Faure K, Decaudin B, Odou P. |
2017 |
| 4128 |
Poster
GRITA Symposium Perfusion 2017, Lille, France. 2017 |
Stabilité de la vancomycine à des doses méningées dans les seringues au cours d'une perfusion de 24 heures.
Masse M, Genay S, Carta N, Moreau F, Delannoy-Rousselière C, Barthélémy C, Décaudin B, Faure K, Odou P. |
2017 |
| 4373 |
Journal
EJHP 2020 ; 27(e1):e87-e92. |
Evaluation of the stability of vancomycin solutions at concentrations used in clinical services.
Masse M, Genay S, Martin Mena A, Carta N, Lannoy D, Barthélémy C, Décaudin B, Odou P. |
2020 |
| 75 |
Journal
J Clin Pharm Ther 1994 ; 19: 35-36. |
Stability of foscarnet sodium in 5% dextrose and 0.9% sodium chloride injections.
Mathew M, Das Gupta V, Bethea C. |
1994 |
| 666 |
Journal
J Clin Pharm Ther 1994 ; 19: 261-262. |
Stability of ciprofloxacin in 5% dextrose and normal saline injections.
Mathew M, Das Gupta V, Zerai T. |
1994 |
| 2702 |
Journal
J Clin Pharm Ther 1994 ; 19, 1: 31-34. |
Stability of metronidazole benzoate in suspensions
Mathew M, Gupta VD, Bethea C. |
1994 |
| 1270 |
Journal
J Pharm Belg 1980 ; 35: 389-393. |
IV infusion of glyceryl trinitrate. Study of the sorption on various plastic containers.
Mathot F, Bonnard J, Han P, Bosly J. |
1980 |
| 1271 |
Journal
J Pharm Belg 1982 ; 37: 153-156. |
Reliable continuous IV perfusion system for diazepam.
Mathot F, Bonnard J, Paris P, Bosly J. |
1982 |
| 2471 |
Journal
Am J Hosp Pharm 1982 ; 39: 309-310. |
Stability of disopyramide phosphate in cherry syrup
Mathur LK, Lai PK, Shively CD. |
1982 |
| 2489 |
Journal
Am J Hosp Pharm 1989 ; 46: 2040-2042. |
Stability of extemporaneously compounded spironolactone suspensions
Mathur LK, Wickman A |
1989 |
| 891 |
Journal
Hosp Pharm 1992 ; 27: 200, 202, 209. |
Visual compatibility of sargramostim (GM-CSF) during simulated Y-site administration with selected agents.
Matsuura G. |
1992 |
| 322 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 2639. |
More on compatibility of mannitol and sodium bicarbonate in injectable fluids.
Matuschka PR, Hill LJ. |
1996 |
| 298 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 320-321. |
Compatibility of mannitol and sodium bicarbonate in injectable fluids.
Matuschka PR, Smith WR, Vissing RS. |
1995 |
| 3715 |
Journal
Am J Health-Syst Pharm 2014 ; 71:1534-1535 |
Compatibility of conivaptan injection with select cardiovascular medications.
Mauro V.F, Howard M.S, Boddu S.H.S, Churchwell M.D. |
2014 |
| 2368 |
Journal
Am J Hosp Pharm 1992 ; 49: 2956 - 2959. |
Stability of ciprofloxacin in peritoneal dialysis solution
Mawhinney WM, Adair CG, Gorman SP, McClurg B. |
1992 |
| 2370 |
Journal
Am J Hosp Pharm 1992 ; 49: 137 - 139. |
Stability of vancomycin hydrochloride in peritoneal dialysis solution
Mawhinney WM, Adair CG, Gorman SP, McClurg B. |
1992 |
| 1414 |
Journal
J Pharm Technol 1999 ; 15: 13-17. |
Stability of low-dose vancomycin hydrochloride in heparin sodium 100 UI / ml.
Mayer JLR, Pascale VJ, Clyne LP, Malkus H, Santos FS, van Hoff J. |
1999 |
| 312 |
Journal
Am J Health-Syst Pharm 1997 ; 54: 570-571. |
Compatibility of iron dextran with neonatal parenteral nutrient solutions.
Mayhew SL, Quick MW. |
1997 |
| 57 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 294-304. |
Stability and compatibility of granisetron hydrochloride in IV solutions and oral liquids and during simulated Y-site injection with selected drugs.
Mayron D, Gennaro AR. |
1996 |
| 1026 |
Journal
Am J Health-Syst Pharm 1999 ; 56: 875-881. |
Stability and compatibility of topotecan hydrochloride with selected drugs.
Mayron D, Gennaro AR. |
1999 |
| 250 |
Journal
Am J Health-Syst Pharm 1997 ; 54: 566-569. |
Compatibility of docetaxel and paclitaxel in intravenous solutions with polyvinyl chloride infusion materials.
Mazzo DJ, Nguyen-Huu JJ, Pagniez S, Denis P. |
1997 |
| 598 |
Journal
J Clin Pharm Ther 1989 ; 14: 45-52. |
The stability of amoxycillin sodium in normal saline and glucose (5%) solutions in the liquid and frozen states.
Mc Donald C, Sunderland VB, Lau H, Shija R. |
1989 |
| 2559 |
Journal
Aust J Hosp Pharm 1993 ; 23: 83. |
The formulation of spironolactone solution for paediatric use.
Mc Knight DL. |
1993 |
| 2487 |
Journal
Am J Hosp Pharm 1991 ; 48: 507-509. |
Stability of gentamicin sulfate and tobramycin sulfate in extemporaneously prepared ophthalmic solutions at 8 degrees C
McBride HA, Martinez DR, Trang JM, Lander RD, Helms HA. |
1991 |
| 3536 |
Journal
Int J Pharm Compound 2013 ; 17, 6: 515-519 |
Stability of Nitroglycerin 100 mcg/mL Stored in Polypropylene Syringes
McCluskey S V, Vu N, Rueter J. |
2013 |
| 2206 |
Journal
Am J Health-Syst Pharm 2015 ; 72:1292-1297 |
Stability of chlorothiazide sodium in polypropylene syringes
McCluskey S.V, Gardner B, . Graner K.K, Nicole Vu N. |
2015 |
| 2334 |
Journal
Am J Health-Syst Pharm 2009 ; 66, 9: 860-863. |
Stability of fentanyl 5 µg/mL diluted with 0.9% sodium chloride injection and stored in polypropylene syringes
McCluskey S.V, Graner K.K, Kemp J, Aloumanis V, Ben M, Kupiec T, Nicole Vu N. |
2009 |
| 3756 |
Journal
Int J Pharm Compound 2014 ; 18, 5: 423-437. |
Stability of Tranexamic Acid in 0.9% Sodium Chloride, Stored in Type 1 Glass Vials and Ethylene/Propylene Copolymer Plastic Containers.
McCluskey S.V, Sztajnkrycer M.D, Jenkins D.A, Zietlow S P, Berns K.S, Park Myung S. |
2014 |
| 3961 |
Journal
Int J Pharm Compound 2017 ; 21, 2: 150-153. |
Stability of Alprostadil in 0.9% Sodium Chloride Stored in Polyvinyl Chloride Containers.
McCluskey S.V,Kirkham K,Munson J.M. |
2017 |
| 3206 |
Journal
Int J Pharm Compound 2011 ; 15, 2: 166-169. |
Nifedpine in Compounded Oral and Topical Preparations.
McCluskey Susan V, Brunn Gregory J. |
2011 |
| 3207 |
Journal
Int J Pharm Compound 2011 ; 15, 2: 170-173. |
Stability of Droperidol 0.625 mg/mL Diluted with 0.9% Sodium Chloride Injection and Stored in Polypropylene Syringes.
McCluskey Susan V, Lovely Jenna K . |
2011 |
| 246 |
Journal
Aust J Hosp Pharm 1996 ; 26: 560-561. |
The stability of foscarnet in the presence of potassium.
McDonald C, Boddy M, Garas G. |
1996 |
| 3702 |
Journal
J Pharm Pract and Res 2014 ; 44, 1: 26-28. |
Stability of buffered benzylpenicillin solutions for outpatient parenteral antimicrobial therapy.
McDougall D.A.J, McWhinney. |
2014 |
| 1158 |
Journal
Int J Pharm 1988 ; 47: 239-247. |
Stability of methotrexate and vinblastine in burette administration sets.
McElnay JC, Elliott DS, Cartwright-Shamoon J, D?Arcy PF. |
1988 |
| 25 |
Journal
Am J Hosp Pharm 1993 ; 50: 1410-1414. |
Compatibility and stability of ondansetron hydrochloride, dexamethasone, and lorazepam in injectable solutions.
McGuire TR, Narducci WA, Fox JL. |
1993 |
| 3993 |
Journal
Int J Pharm Compound 2017 ; 3: 251-254 |
Stability of Extemporaneously Prepared Hydroxychloroquine Sulfate 25-mg/mL Suspensions in Plastic Bottles and Syringes.
McHenry A.R,Wempe M.F., Rice P.J. |
2017 |
| 2894 |
Journal
J Dermatolog Treat 2004 ; 15: 295-302. |
A topical azythromycin preparation for the treatment of acne vulgaris and rosacea.
McHugh RC, Sangha ND, Mc Carty MA et al. |
2004 |
| 2774 |
Journal
Ann Pharmacotherapy 2004 ; 38: 967-972. |
Compatibility of Budesonide Inhalation Suspension with Four Nebulizing Solutions.
McKenzie J.E, Mario Cruz-Rivera M. |
2004 |
| 1233 |
Journal
Br J Pharm Pract 1990 ; 12: 328, 330, 334. |
The stability of reconstituted aztreonam.
McLaughlin JP, Simpson C. |
1990 |
| 1301 |
Journal
Hosp Pharm Pract 1992 ; 2: 59-62. |
The stability of reconstituted diethanolamine fusidate in a 5% dextrose infusion.
McLaughlin JP, Simpson C. |
1992 |
| 1494 |
Journal
Hosp Pharm Pract 1993 ; 3: 553-556. |
When is flucloxacillin stable ?
McLaughlin JP, Simpson C. |
1993 |
| 2482 |
Journal
Am J Hosp Pharm 1992 ; 49: 2784-2785. |
Stability of etoposide solution for oral use
McLeod HL, Relling MV. |
1992 |
| 185 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 2018-2020. |
Stability of midazolam hydrochloride in polyvinyl chloride bags under fluorescent light.
McMullin ST, Burns Schaiff RA, Dietzen DJ. |
1995 |
| 3535 |
Journal
Int J Pharm Compound 2013 ; 17, 6 : 508-511. |
Stability of Non-aqueous Topical Tetracaine and Clotrimazole Solutions in Polypropylene Droptainer Bottles
McPherson T. B, Neumann W L, Kolling W M. |
2013 |
| 1906 |
Journal
Am J Health-Syst Pharm 2004 ; 61: 38-45. |
Stability and compatibility of reconstituted ertapenem with commonly used iv infusion and coinfusion solutions.
McQuade MS, Van Nostrand V, Shariter J, Kanike JD, Forsyth RJ. |
2004 |
| 431 |
Journal
Am J Hosp Pharm 1975 ; 33: 1010-1013. |
Compatibility of antineoplastic, antibiotic and corticosteroid drugs in intravenous admixtures.
McRae MP, King JC. |
1975 |
| 4371 |
Journal
Journal of Parenteral and Enteral Nutrition 2018 |
Physicochemical Compatibility of Amiodarone with Parenteral Nutrition.
Mediavilla MM, Molina A, Navarro L, Grau L, Pujol MD, Cardenete J, Cardona D, Riera P. |
2018 |
| 2791 |
Journal
Int J Pharm 2015 ; 479 : 23-27. |
Stability of oxaliplatin in chloride-containing carrier solutions used in hyperthermic intraperitoneal chemotherapy.
Mehta A.M,.Van den Hoven J.M, Rosing H,.Hillebrand M.J.X, Nuijen B,. Huitema A.D.R, Beijnen J.H,.Verwaal V.J. |
2015 |
| 3008 |
Journal
Pharm J 1987 ; 238: 214-215. |
Stability of retinoic acid eye-drops.
Mehta AC, Calvert RT. |
1987 |
| 2951 |
Journal
J Clin Pharm Ther 1994 ; 19: 313-315. |
Stability of amoxicillin and potassium clavulanate in co-amoxiclav oral suspension.
Mehta AC, Hart-Davies S, Payne J, Lacey RW.. |
1994 |
| 448 |
Journal
Am J Hosp Pharm 1986 ; 43: 1760-1762. |
Stability of terbutaline sulfate admixtures stored in polyvinyl chloride bags.
Mehta J, Searcy CJ, Jung DT. |
1986 |
| 4388 |
Journal
Int J Pharm Compound 2020 ;24,2:140-147 |
The Effect of Manufacturer on the Compounding of Omeprazole Suspensions and Their Stability Assessment.
Meissner S, Bansal M, Donamae P, Hanning S, Svirskis D. |
2020 |
| 1500 |
Journal
Ann Pharmacotherapy 1996 ; 30: 87. |
Ciprofloxacin-ampicillin sulbactam incompatibility.
Melonakos TK. |
1996 |
| 1833 |
Journal
Ann Pharmacotherapy 2003 ; 37, 12: 1789-1792. |
Stability of cyclophosphamide and mesna admixtures in polyethylene infusion bags.
Menard C, Bourguignon C, Schlatter J, Vermerie N. |
2003 |
| 228 |
Journal
Am J Hosp Pharm 1994 ; 51: 2964. |
Incompatibility of ketorolac tromethamine with haloperidol lactate and triethylperazine maleate.
Mendenhall A, Hoyt DB. |
1994 |
| 4180 |
Journal
Perit Dial Int 2018 ;38,6:430-440 |
Stability of meropenem and piperacillin/tazobactam with heparin in various peritoneal dialysis solutions.
Mendes K, Harmanjeet H, Sedeeq M, Modi A, Wanandy T, Zaidi S, Ming L, Castelino R, Sud K, Peterson G, Patel R. |
2018 |
| 2120 |
Journal
J Pharm Biomed Anal 2006 ; 41: 1363-1366. |
Stability and degradation kinetics of meropenem in powder for injection and reconstituted sample.
Mendez A.S.L, Dalomo J, Steppe M; Schapoval E.E.S. |
2006 |
| 4096 |
Journal
Pharm Dev Technol 2014 |
Physicochemical stability of a new topical timolol 0.5% gel formulation for the treatment of infant hemangioma.
Merino-Bohorquez V, Casas M, Caracuel F, Camean M, Fernandez-Anguita M.J, Ramirez*Soto G, Lucero M.J. |
2014 |
| 4272 |
Journal
Pharm Dev Technol 2019 |
Physicochemical and microbiological stability of two news oral liquid formulations of clonidine hydrochloride for pediatric patients.
Merino-Bohorquez, Delgado-Valverde M, Garcia-Palomo M, Dàvila- Pousa MC, Canete C, Villaronga M, Rodriguez-Marrodan B, Lopez-Ro |
2019 |
| 1692 |
Journal
Krankenhauspharmazie 1998 ; 19: 226-228. |
Pharmazeutische kompatibilität von piperacillin mit metronidazol.
Messerschmidt W. |
1998 |
| 1481 |
Journal
Krankenhauspharmazie 1994 ; 9: 337-340. |
Kompatibilität von ofloxacin mit ampicillin.
Messerschmidt W. |
1994 |
| 1482 |
Journal
Krankenhauspharmazie 1992 ; 3: 98-100. |
Pharmazeutische kompatibilität der kombination cefotiam und ampicillin.
Messerschmidt W. |
1992 |
| 2501 |
Journal
Am J Hosp Pharm 1992 ; 49: 1720-1724. |
Stability of procainamide hydrochloride in an extemporaneously compounded oral liquid
Metras JI, Swenson CF, McDermott MP. |
1992 |
| 3984 |
Journal
Hosp Pharm 2017 ,52;3 : 221-228 |
Compatibility of Ceftazidime-Avibactam, Ceftolozane-Tazobactam and Piperacillin-Tazobactam with Vancomycin in Dextrose 5% in Water.
Meyer K, Santarossa M, Danziger L.H, Wenzler E. |
2017 |
| 1679 |
Journal
Int J Pharm 2001 ; 212: 93-99. |
Stability and sterility of meglumine gadoterate injection repackaged in plastic syringes.
Micard S, Rieutord A, Prognon P, Hassan M, Brion F. |
2001 |
| 660 |
Journal
Ann Pharmacotherapy 1996 ; 30: 228-232. |
Propofol compatibility with other intravenous drug products - Two new methods of evaluating IV emulsion compatibility.
Michaels MR, Stauffer GL, Haas DP. |
1996 |
| 3326 |
Journal
J Pharm Pract and Res 2012 ; 42, 2: 106-110. |
Chiral stability study of oral liquid clopidrogel formulations for infants.
Mihaila B, Ellis D, Rozek T, Milne R. |
2012 |
| 2181 |
Journal
Bull Cancer 1995 ; 82: 189-195. |
Etude de compatibilité physicochimique 5- fluoro-uracile (nouvelle préparation française) - acide folinique.
Milano G, Renée N. |
1995 |
| 479 |
Journal
Am J Hosp Pharm 1992 ; 49: 2964-2966. |
Visual compatibility of tacrolimus with commonly used drugs during simulated Y-site injection.
Min DI, Brown T, HWang GC. |
1992 |
| 4289 |
Journal
Photochemical & Photobiological Sciences 2018 |
Stability and degradation of indocyanine green in plasma, aqueous solution and whole blood.
Mindt S, Karampinis I, John M, Neumaier M, Nowak K. |
2018 |
| 436 |
Journal
Am J Hosp Pharm 1991 ; 48: 2635-2637. |
Chemical and visual stability of amphotericin B in 5% dextrose injection stored at 4°C for 35 days.
Mitrano FP, Outman WR, Baptista RJ, Palombo JD. |
1991 |
| 1727 |
Journal
Pharmazie 1999 ; 54: 625-626. |
Stability of vinblastine sulphate containing infusions.
Mittner A, Vincze Z, Jemnitz K. |
1999 |
| 1729 |
Journal
Pharmazie 1998 ; 53: 490-492. |
Stability of cisplatin containing infusion.
Mittner A, Vincze Z, Jemnitz K. |
1998 |
| 1728 |
Journal
Pharmazie 1999 ; 54: 224-225. |
Stability of cyclophosphamide containing infusions.
Mittner A, Vincze Z, Jemnitz. |
1999 |
| 4310 |
Journal
Kaohsiung J Med Sci 2017 ; 63, 1: E9-E16. |
Compatibility and Stability of Nab-Paclitaxel in Combination with Other Drugs.
Mizuta N, Nakagawa T, Yamamoto K, Nishioka T, Kume M, Makimoto H, Yano I, Minami H, Hiral M. |
2017 |
| 4413 |
Journal
J Pediatr Pharmacol Ther 2016 ; 21, 4: 322-326. |
Stability and Sterility of Enoxaparin 8 mg/mL Subcutaneous Injectable Solution.
Moffett B.S, Dinh K, Placencia J, Pelkey G, Rocky Hui S-K, Teruya J. |
2016 |
| 2468 |
Journal
J Pharm Sci 2023 ; 112: 963-973. |
In vitro Stability of Biosimilar Insulin Aspart SAR341402 in the Medtronic MiniMed Insulin Pumps.
Mohnicke M, Blecher A, Beichert K, Bidlingmaier B, Todt E-J, Dette C, Rotthaeuser B, Mukherjee B. |
2023 |
| 4635 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2021 ; 6(1): 20210005. |
Physicochemical stability of human insulin 1 I.U./mL infusion solution in 50 mL polypropylene syringes.
Mohr A, Erdnüß F, Krämer I. |
2021 |
| 4518 |
Journal
EJHP 2020 |
In-use stability of diluted thiamazole (methimazole) infusion solutions in prefilled 0.9% sodium chloride infusion bags for continuous infusion.
Mohr A, Krämer I. |
2020 |
| 3344 |
Poster
ECOP Congress, Budapest, Hungary 2012 |
Stabilité physicochimique du bevacizumab 5 mg/mL dilué dans le chlorure de benzalkonium 0.1 mg/mL.
Moine M, Vieillard V, Astier A, Paul M. |
2012 |
| 88 |
Journal
J Acquired Immune Defic Syndr 1992 ; 5: 354-358. |
Extended stability of ganciclovir for outpatient parenteral therapy for cytomegalovirus retinitis.
Mole L, Oliva C, O?Hanley P. |
1992 |
| 3464 |
Journal
Enferm Clin 2011 21:25-29. |
Compatibilidad física de la amiodarona en perfusión continua
Monica Maqueda-Palau, Eva Pérez-Juan, Maria Josep Arévalo-Rubert, Sylvia Monica Amoros-Cerda, Bàrbara Ribas-Nicolau. |
2011 |
| 4055 |
Journal
Am J Health-Syst Pharm 2018 , 75, 1:36-44 |
Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration.
Monogue M, Almarzoky Abuhussain S, Kuti J, Nicolau D. |
2018 |
| 4377 |
Journal
Radiology 1992 ; 184: 385-387. |
Ionic lodinated Contrast Medium and Amobarbital Sodium Mixtures: Potential for Precipitation.
Monsein L.H, Miller T.J, Kuwahara S.K, Sostre S, Debrun G.M. |
1992 |
| 3202 |
Journal
Am J Health-Syst Pharm 2011 ; 68: 900-908. |
Stability of compounded thioguanine oral suspensions
Montazeri Aliabadi H, Romanick M, Somayaji V, Mahdipoor P, Lavasanifar A |
2011 |
| 2496 |
Journal
Am J Hosp Pharm 1986 ; 43: 118-120. |
Stability of 5-aminosalicylic acid suspension
Montgomery HA, Smith FM, Scott BE, White SJ, Gerald KB. |
1986 |
| 818 |
Journal
Am J Health-Syst Pharm 1998 ; 55: 1042-1043. |
Stability of torsemide in 5% dextrose injection.
Montgomery PA, Cornish LA, Johnson CE, Fitzpatrick KA. |
1998 |
| 354 |
Journal
Am J Hosp Pharm 1989 ; 46: 2329-2332. |
Stability of famotidine 20 and 40 mg/L in total nutrient admixtures.
Montoro JB, Pou L, Salvador P, Pastor C, Cano SM. |
1989 |
| 274 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 999-1001. |
Stability of piperacillin sodium-tazobactam sodium in polypropylene syringes and polyvinyl chloride minibags.
Moon YSK, Chung KC, Chin A, Gill MA. |
1995 |
| 1120 |
Journal
Am J Hosp Pharm 1974 ; 31: 72-78. |
Interactions between drugs and plastic intravenous fluid bags. Part I: Sorption studies on 17 drugs.
Moorhatch P, Chiou WL. |
1974 |
| 2654 |
Journal
Int J Pharm 2007 ; 344, 1-2: 150-153. |
Liposomal amphotericin B eye drops to treat fungal keratitis: physico-chemical and formulation stability.
Morand K, Bartoletti AC, Bochot A, Barratt G, Brandely ML, Chast F. |
2007 |
| 2882 |
Poster
SFPO Congress 2009 |
Stabilité de solutions diluées de bévacizumab en fonction de la température.
Morand K, Paul M, Lahlou A, Blanchet B, Astier A. |
2009 |
| 4066 |
Poster
APHIF 2017 - Congress 2017 2017 |
Etude de stabilité physico-chimique et microbiologique des collyres de ciclosporine à 0.5 ; 5 et 20 mg/mL conditionnés en flacons de polyéthylène basse densité.
Mordohay A, Chanat C, Bezia C, Fresneau J, Jobard M, Brandely-Piat M.L, Batista R. |
2017 |
| 3796 |
Journal
Br Ophtalmol 1995 ; 79: 753-755. |
High dose intravitreal ganciclovir for CMV retinitis: a shelf life and cost comparison study.
Morlet N, Young S, Naidoo D et al. |
1995 |
| 731 |
Journal
Am J Hosp Pharm 1978 ; 35: 669-672. |
Compatibility and stability of diazepam injection following dilution with intravenous fluids.
Morris ME. |
1978 |
| 4307 |
Journal
J Pediatr Pharmacol Ther 2013 ;18(2):122-127. |
Stability of Extemporaneously Prepared Lansoprazole Suspension at Two Temperatures.
Morrison J.T, Lugo R.A, Thigpen J.C, Brown S.D. |
2013 |
| 2079 |
Journal
Can J Anesth 1987 ; 34: 87-89. |
The effect of pancuronium on the solubility of aqueous thiopentone.
Morton WD, Lerman J. |
1987 |
| 821 |
Journal
Am J Health-Syst Pharm 1998 ; 55: 1194,1197. |
Visual compatibility of fentanyl citrate with parenteral nutrient solutions.
Moshfeghi M, Ciuffo JD. |
1998 |
| 2825 |
Journal
Int J Pharm Compound 2015 ; 19, 3: 261-267. |
Physico-chemical Stability of MabThera Drug-product Solution for Subcutaneous Injection under In-use Conditions with Different Administration Materials.
Mueller C, Dietel E, Heynen S, Nalenz H, Goldbach P, Mahler H, Schmidt J, Grauschopf U, Schoenhammer K. |
2015 |
| 1685 |
Journal
Krankenhauspharmazie 1998 ; 19: 229-234. |
Stabilitätsstudie zu metamizol-natrium im PVC-infusionbeutel.
Müller H-J, Berg J. |
1998 |
| 1689 |
Journal
Krankenhauspharmazie 1997 ; 18: 468-473. |
Stabilitätsstudie zu apomorphin-hydrochlorid im PVC-infusionbeutel.
Müller H-J, Berg J. |
1997 |
| 1690 |
Journal
Krankenhauspharmazie 1997 ; 18: 75-79. |
Stabilitätsstudie zu tramadolhydrochlorid im PVC-infusionbeutel.
Müller H-J, Berg J. |
1997 |
| 1684 |
Journal
Krankenhauspharmazie 1998 ; 19: 469-472. |
Stabilitätsstudie zu pentoxifyllin im PVC-infusionbeutel.
Müller H-J, Frank C. |
1998 |
| 1687 |
Journal
Krankenhauspharmazie 2000 ; 21: 435-438. |
Stabilität von gemcitabin.
Müller H-J, Frank C. |
2000 |
| 1845 |
Journal
EJHP 2003 ; 6: 106-111. |
The stability of amoxicillin, ampicillin, benzylpenicillin, flucloxacillin, mezlocillin and piperacillin in isotonic saline solutions when stored in an innovative infusion container (Freeflex container).
Müller HJ, Haker I. |
2003 |
| 1452 |
Journal
Eur Hosp Pharm 2000 ; 6: 17-23. |
Stability of cefazolin, cefotiam, cefuroxime, cefotaxime, ceftriaxone and ceftazidime in normal saline solutions, stored in a new IV container made of Biofine*.
Muller HJ, Howe K, Frank C, Haker I. |
2000 |
| 4404 |
Poster
JFSPH 2019 2019 |
Compatibility studies of seven commonly used drugs for parenteral administration in palliative care.
Müller U, Haller F, Wiedemeier P, Steuer C. |
2019 |
| 74 |
Journal
Am J Hosp Pharm 1994 ; 51: 1348-1349. |
Stability of ganciclovir sodium in an infusion-pump syringe.
Mulye NV, Turco SJ, Speaker TJ. |
1994 |
| 489 |
Journal
Am J Hosp Pharm 1992 ; 49: 1137-1139. |
Stability of ifosfamide in 0.9% sodium chloride solution or water for injection in a portable IV pump cassette.
Munoz M, Girona V, Pujol M, Duran S, Vicente P, Solé LA. |
1992 |
| 850 |
Journal
Drug Intell Clin Pharm 1982 ; 16: 765-767. |
Cytosine arabinose stability in intravenous admixtures with sodium bicarbonate and in plastic syringes.
Munson J, Kubiak EJ, Cohon MS. |
1982 |
| 302 |
Journal
Am J Health-Syst Pharm 1997 ; 54: 2588-2591. |
Stability of thiotepa (lyophilized) in 0.9% sodium chloride injection.
Murray KM, Erkkila D, Gombotz WR, Pankey S. |
1997 |
| 1477 |
Journal
J Pharm Biomed Anal 1996 ; 15: 221-226. |
Stability of revex, nalmefene hydrochloride injection, in injectable solutions.
Murthy SS, Brittain HG. |
1996 |
| 1900 |
Journal
Int J Pharm Compound 2004 ; 8, 3: 236-239. |
Stability of zidovudine and ranitidine in 0.9% sodium chloride and 5% dextrose injections stored at ambient temperature (23°C±2°C) and 4°C in 50 ml polyvinylchloride bags up to 24 hours.
Musami P, Stewart JT, Taylor EW. |
2004 |
| 1878 |
Journal
Int J Pharm Compound 2004 ; 8, 1: 73-76. |
Stability of zidovudine and dobutamine hydrochloride injections in 0.9% sodium chloride and 5% dextrose injections stored at ambient temperature (23±2°C) and 4°C in 50 ml polyvinyl chloride bags up to 24 hours.
Musami P, Stewart JT, Will Taylor E. |
2004 |
| 4282 |
Journal
Drugs R D 2017 |
Solubilization and Stability of Mitomycin C Solutions Prepared for Intravesical Administration.
Myers A-L, Zhang Y-P, Kawedia J-D, Zhou X,. Sobocinski S-M, Metcalfe M-J, Kramer M-A, Dinney C.P.N, Kamat A-M. |
2017 |
| 3915 |
Journal
Am J Health-Syst Pharm 2016 ; 73,24: 2083-2088. |
Stability of tacrolimus injection diluted in 0.9% sodium chloride injection and stored in Excel bags
Myers A.L, Zhang Y, . Kawedia J.D, Shank B.R, Deaver M.A, Kramer M.A. |
2016 |
| 3830 |
Journal
J Oncol Pharm Practice 2016 ; 22: 31-36. |
Stability study of carboplatin infusion solutions in 0.9% sodium chloride in polyvinyl chloride bags.
Myers A.Ls, Zhang Y-P, Kawedia L, Trinh V.A, Tran H, Smith J.A, Kramer M.A. |
2016 |
| 3866 |
Journal
Int J Pharm Compound 2016 ; 30, 3 : 247-249. |
Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children.
Nahata M C. |
2016 |
| 3792 |
Journal
J Ped Pharm Pract 1999 ; 4: 186-189. |
Stability of amiodarone in extemporaneous oral suspension prepared from commercially available vehicles.
Nahata M.C, Morosco R.S, Hipple T.F. |
1999 |
| 3793 |
Journal
Drug Intell Clin Pharm 1991 ; 25: 465-469. |
Stability of labetalol hydrochloride in distilled water, simple syrup, and three fruit juices.
Nahata M.C. |
1991 |
| 3856 |
Journal
Int J Pharm Compound 2016 ; 20, 2:164-166. |
Long-term Stability of Zonisamide, Amitriptyline, and Glycopyrrolate in Extemporaneously Prepared Liquid-dosage Forms at Two Temperatures
Nahata M.C. |
2016 |
| 2372 |
Journal
Am J Hosp Pharm 1991 ; 48: 291 - 292. |
Stability of cefazolin sodium in peritoneal dialysis solutions
Nahata MC, Ahalt PA. |
1991 |
| 503 |
Journal
Am J Hosp Pharm 1985 ; 45: 1987-1988. |
Stability of tobramycin sulfate in admixtures with calcium gluconate.
Nahata MC, Durrell DE. |
1985 |
| 267 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 1046-1048. |
Stability of metronidazole and ceftizoxime sodium in ready-to-use metronidazole bags stored at 4 and 25°C.
Nahata MC, Edmonds JJ, Morosco RS. |
1996 |
| 349 |
Journal
Am J Hosp Pharm 1986 ; 43: 384-385. |
Stability of phenobarbital sodium diluted in 0.9% sodium chloride injection.
Nahata MC, Hipple TF, Strausbaugh SD. |
1986 |
| 1486 |
Journal
Hosp Pharm 1987 ; 22: 1131-1132. |
Stability of gentamicin diluted in 0.9% sodium chloride injection in glass syringes.
Nahata MC, Hipple TF, Strausbaugh SD. |
1987 |
| 2486 |
Journal
Am J Hosp Pharm 1991 ; 48: 992-993. |
Stability of cefadroxil in reconstituted suspension under refrigeration and at room temperature
Nahata MC, Jackson DS. |
1991 |
| 428 |
Journal
Am J Hosp Pharm 1987 ; 44: 802-804. |
Stability of vancomycin hydrochloride in various concentrations of dextrose injection.
Nahata MC, Miller MA, Durrell DE. |
1987 |
| 2548 |
Journal
Ann Pharmacotherapy 2003 ;37:506-509. |
Stability of Sotalol in Two Liquid Formulations at Two Temperatures
Nahata MC, Morosco RS. |
2003 |
| 2549 |
Journal
Ann Pharmacotherapy 2004 ;38:396-399. |
Stability of Lisinopril in Two Liquid Dosage Forms
Nahata MC, Morosco RS. |
2004 |
| 2545 |
Journal
Ann Pharmacotherapy 2000 ;34:848-850. |
Stability of dapsone in two oral liquid dosage forms.
Nahata MC, Morosco RC, Trowbridge JM. |
2000 |
| 2416 |
Journal
Am J Health-Syst Pharm 1999 ; 56: 240-242. |
Stability of lamotrigine in two extemporaneously prepared oral suspensions at 4 and 25 degrees C
Nahata MC, Morosco RS, Hipple TF. |
1999 |
| 2425 |
Journal
Am J Health-Syst Pharm 1998 ; 55: 1155-1157. |
Stability of enalapril maleate in three extemporaneously prepared oral liquids
Nahata MC, Morosco RS, Hipple TF. |
1998 |
| 2415 |
Journal
Am J Health-Syst Pharm 2000 ; 57: 1141-1143. |
Stability of propylthiouracil in extemporaneously prepared oral suspensions at 4 and 25 degrees C
Nahata MC, Morosco RS, Trowbridge JM. |
2000 |
| 2926 |
Journal
Am J Health-Syst Pharm 2006 ; 63: 254-257. |
Extemporaneous sildefanil citrate oral suspensions for the treatment of pulmonary hypertension in children.
Nahata MC, Morosco RS, Brady MT. |
2006 |
| 46 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 1588-1590. |
Stability of ranitidine hydrochloride in water for injection in glass vials and plastic syringes.
Nahata MC, Morosco RS, Fox JL. |
1996 |
| 477 |
Journal
Am J Hosp Pharm 1992 ; 49: 2954-2956. |
Stability of ceftazidime (with arginine) stored in plastic syringes at three temperatures.
Nahata MC, Morosco RS, Fox JL. |
1992 |
| 2704 |
Journal
J Clin Pharm Ther 1994 ; 19, 4: 263-265. |
Stability of rifampin in two suspensions at room temperature
Nahata MC, Morosco RS, Hippie TF. |
1994 |
| 2534 |
Journal
Ann Pharmacotherapy 1993 ;27:1198-1199. |
Stability of spironolactone in an extemporaneously prepared suspension at two temperatures
Nahata MC, Morosco RS, Hipple TF. |
1993 |
| 115 |
Journal
Am J Hosp Pharm 1992 ; 49: 2785-2786. |
Stability of morphine sulfate in bacteriostatic 0.9% sodium chloride injection stored in glass vials at two temperatures.
Nahata MC, Morosco RS, Hipple TF. |
1992 |
| 80 |
Journal
Am J Hosp Pharm 1993 ; 50: 2559-2561. |
Stability of cimetidine hydrochloride and of clindamycin phosphate in water for injection stored in glass vials at two temperatures.
Nahata MC, Morosco RS, Hipple TF. |
1993 |
| 212 |
Journal
Am J Hosp Pharm 1994 ; 51: 2157-2159. |
Stability of diluted methylprednisolone sodium succinate injection at two temperatures.
Nahata MC, Morosco RS, Hipple TF. |
1994 |
| 478 |
Journal
Am J Hosp Pharm 1992 ; 49: 2962-2963. |
Stability of aminophylline in bacteriostatic water for injection stored in plastic syringes at two temperatures.
Nahata MC, Morosco RS, Hipple TF. |
1992 |
| 2423 |
Journal
Am J Health-Syst Pharm 1998 ; 55: 2511-2513. |
Stability of granisetron hydrochloride in two oral suspensions
Nahata MC, Morosco RS, Hipple TF. |
1998 |
| 2447 |
Journal
Am J Health-Syst Pharm 1997 ; 54: 2714-2716. |
Stability of pyrimethamine in a liquid dosage formulation stored for three months
Nahata MC, Morosco RS, Hipple TF. |
1997 |
| 2522 |
Journal
Am J Hosp Pharm 1994 ; 51: 1707-1708. |
Stability of captopril in liquid containing ascorbic acid or sodium ascorbate
Nahata MC, Morosco RS, Hipple TF. |
1994 |
| 2634 |
Journal
Hosp Pharm 1997 ; 32: 691-693. |
Stability of metolazone in a liquid dosage form.
Nahata MC, Morosco RS, Hipple TF. |
1997 |
| 2689 |
Journal
J Am Pharm Assoc 1999 ; 39: 375-377. |
Stability of amlodipine mesylate in two liquid dosage form.
Nahata MC, Morosco RS, Hipple TF. |
1999 |
| 2690 |
Journal
J Am Pharm Assoc 2000 ; 40: 257-259. |
Stability of mexiletine in two extemporaneously liquid formulations stored under refrigeration and et room temperature
Nahata MC, Morosco RS, Hipple TF. |
2000 |
| 2721 |
Journal
J Pad Ophtalmol Strabismus 2000 ; 37, 6: 333-337. |
Development of Two Stable Oral Suspensions of Levodopa-Carbidopa for Children With Amblyopia
Nahata MC, Morosco RS, Leguire LE. |
2000 |
| 2454 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 1558-1560. |
Stability of pyrazinamide in two suspensions
Nahata MC, Morosco RS, Peritore SP. |
1995 |
| 2691 |
Journal
J Am Pharm Assoc 2002 ; 42: 865-867. |
Stability of nifedipine in two oral suspensions stored at two temperatures.
Nahata MC, Morosco RS, Willhite EA. |
2002 |
| 691 |
Journal
J Clin Pharm Ther 1989 ; 14: 53-55. |
Stability of caffeine citrate injection in intravenous admixtures and parenteral nutrition solutions.
Nahata MC, Zingarelli JR, Durell DE. |
1989 |
| 698 |
Journal
Ann Pharmacotherapy 1989 ; 23: 466-467. |
Stability of caffeine injection in intravenous admixtures and parenteral nutrition solutions.
Nahata MC, Zingarelli JR, Durell DE. |
1989 |
| 990 |
Journal
Ann Pharmacotherapy 1989 ; 23: 1035. |
Stability of caffeine injection stored in plastic and glass syringes.
Nahata MC, Zingarelli JR, Hipple TF. |
1989 |
| 2541 |
Journal
Ann Pharmacotherapy 1997 ;31:851-852. |
Stability of amiodarone in an oral suspension stored under refrigeration and at room temperature.
Nahata MC. |
1997 |
| 2759 |
Journal
Pediatr Neurol 1999 ; 20: 195-197. |
Development of two stable oral suspensions of gabapentin.
Nahata MC. |
1999 |
| 3002 |
Journal
J Ped Pharm Pract 1997 ; 2: 82-84. |
Stability of trimethoprim in an extemporaneous liquid dosage form.
Nahata MC. |
1997 |
| 3811 |
Journal
Int J Pharm Compound 2015 ; 19, 5 : 428-431. |
Stability of Levothyroxine, Doxycycline, Hydrocortisone, and Pravastatin in Liquid Dosage Forms Stored at Two Temperatures.
Nahata Milap C. |
2015 |
| 132 |
Journal
Am J Health-Syst Pharm 1997 ; 54: 181-184. |
Compatibility of commonly used bone marrow transplant drugs during Y-site delivery.
Najari Z, Rusho WJ. |
1997 |
| 4163 |
Journal
Int J Pharm Compound 2018 22;5:417-423 |
Prolonged In-Use Stability of Reconstituted Herceptin in Commercial Intravenous Bags.
Nalenz H, K?pf E, Dietel E. |
2018 |
| 2975 |
Poster
ESCP 2014 2014 |
In-Use stability of herceptin for subcutaneous injection with different administration materials.
Nalenz H, Schoenhammer K, Dietel E, Heynen S.R, Grauschopf U, Mahler H.C. |
2014 |
| 4383 |
Journal
Crit Care Resusc 2020 ;22(1):83-85. |
Stability of bicarbonate in normal saline: a technical report.
Naorungroj T, Neto AS, Fujii T, Jude B, Udy A, Bellomo R. |
2020 |
| 2166 |
Journal
J Liquid Chrom Rel Technol 2003 ; 26, 17: 2909-2929. |
HPLC-DAD methods for studying the stability of solutions containing hydromorphone, ketorolac, haloperidol, midazolam, famotidine, metoclopramide, dimenhydrinate and scopolamine.
Nassr S, Dubuc MC, Lavoie P, Brazier JL. |
2003 |
| 1189 |
Journal
Am J Hosp Pharm 1983 ; 40: 1692-1693. |
Uptake of clonazepam by plastic intravenous infusion bags and administration sets.
Nation RL, Hackett LP, Dusci LJ. |
1983 |
| 820 |
Journal
Am J Health-Syst Pharm 1998 ; 55: 1161-1164. |
Stability of adenosine 6 microg/ml in 0.9% sodium chloride solution.
Naud C, Marti B, Fernandez C, Astier A, Paul M. |
1998 |
| 1804 |
Journal
Am J Health-Syst Pharm 2003 ; 60: 464-468. |
Stability of multidose, preserved formulation epoetin alfa in syringes for three and six weeks.
Naughton CA, Duppong LM, Forbes KD, Sehgal I. |
2003 |
| 4611 |
Journal
J Pharm Anal 2021 ;10 532e545. |
Use of subcutaneous tocilizumab to prepare intravenous solutions for COVID-19 emergency shortage: Comparative analytical study of physicochemical quality attributes.
Navas N, Hermosilla J, Torrente-Lopez A, Hernandez-Jimenez J, Cabeza J, Perez-Robles R, Salmeron-García A. |
2021 |
| 4105 |
Journal
Ann Pharmacotherapy 2008 ;42:962-966 |
Stability of Sunitinib in Oral Suspensions.
Navid F, Christensen R, Minkin P, Stewart C, Furman W, Baker S. |
2008 |
| 3198 |
Journal
Farm Hosp 2008 ; 32, 6 : 344-348. |
Estabilidad en suero fisiológico del busulfán intravenoso en un envase de poliolefinas.
Nebot Martinez J, Alos Alminana M, Diez Sales O. |
2008 |
| 221 |
Journal
Am J Hosp Pharm 1992 ; 49: 2149. |
Compatibility of bupivacaine hydrochloride with hydromorphone hydrochloride or morphine sulfate.
Neels JT. |
1992 |
| 3132 |
Journal
J Palliat Med 2010 ; 13, 3: 273-277. |
Compatibility and stability of ternary admixtures of tramadol, haloperidol, and hyoscine.
Negro S, Martin A, Azuara L, Sanchez Y, Barcia E. |
2010 |
| 2024 |
Journal
J Pain Symptom Manage 2005 ; 30: 192-199. |
Stability of tramadol and haloperidol for continuous infusion at home.
Negro S, Martin A, Azuara ML, Sanchez Y, Barcia E. |
2005 |
| 2205 |
Journal
Arzneimittel Forschung 2006 ; 56, 10: 714-720. |
Compatibility and stability of furosemide and dexamethasone combined in infusion solutions.
Negro S, Rendon AL, Azuara ML, S?nchez Y, Fern?ndez-Carballido A, Barcia E. |
2006 |
| 2055 |
Journal
Int J Pharm 2006 ; 307: 278-284. |
Morphine, haloperidol and hyoscine N-butyl bromide combined in sc infusion solutions : compatibility and stability evaluation in terminal oncology patients.
Negro S, Reyes R, Azuara ML, Sanchez Y, Barcia E. |
2006 |
| 2211 |
Journal
J Clin Pharm Ther 2007 ; 32: 441-444. |
Compatibility and stability of tramadol and dexamethasone in solution and its use in terminally ill patients.
Negro S, Salama A, S?nchez Y, AzuaraM.L, Barcia B. |
2007 |
| 4624 |
Journal
EJHP 2023 ; 30: e2-e9. |
Stability of pemetrexed disodium in sodium chloride 0.9% w/v intravenous Viaflo infusion bags.
Nelson L, Dwier P, Corris M, Santillo M, Davies L, Milligan K, Rahman R, Clarke I. |
2023 |
| 860 |
Journal
Am J Hosp Pharm 1987 ; 44: 2028. |
Visual incompatibility of dacarbazine and heparin.
Nelson RW, Young R, Lamnin M. |
1987 |
| 2325 |
Journal
Pharmazie 2009 ; 64, 2: 94-97. |
The effect of nimodipine, fentanyl and remifentanil intravenous products on the stability of propofol emulsions.
Nemec K, Germ E, Schulz-Siegmund M, Ortner A. |
2009 |
| 3308 |
Journal
Antimicrob Agents Chemother 2012 ; 56: 3435-3437; |
Stability of Extemporaneously Prepared 0.5-Percent Caspofungin Eye Drops: a Potential Cost-Savings Exercise.
Neoh C.F, Jacob J, Leung L, Li J, Stathopoulos A, Stewart K, Kong D.C.M. |
2012 |
| 311 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 167-169. |
Compatibility and activity of enoxaparin sodium in 0.9% sodium chloride injection for 48 hours.
Newborn AL, Kessler JM, Joyner KA. |
1996 |
| 2294 |
Journal
Can J Hosp Pharm 2008 ; 61, 5: 356-357. |
Stability of magnesium sulfate 20% in Viaflex bags.
Newby B.D, Benes C, Palmer L, Cleve R. |
2008 |
| 2346 |
Journal
Am J Health-Syst Pharm 2009 ; 66: 986-987. |
Physical compatibility of metoprolol tartrate injection with selected cardiovascular agents
Newland A.M, Mauro V.F, Alexander K.S. |
2009 |
| 4488 |
Journal
Pharmaceutics 2020 ; 12, 677. |
Y-Site Physical Compatibility of Numeta G13E with Drugs Frequently Used at Neonatal Intensive Care.
Nezvalova-Henriksen K, Niklas Nilsson N, Tomine Østerberg C, Staven Berge V, Tho I. |
2020 |
| 2071 |
Journal
Anesth Analg 2002 ; 95: 785. |
Precipitation of protamine by cefazolin.
Ng HP, Koh KF. |
2002 |
| 928 |
Journal
Int J Pharm Compound 1998 ; 2: 246-248. |
Stability of milrinone lactate in 5% dextrose injection and 0.9% sodium chloride injection at concentrations of 400, 600 and 800 microg/mL.
Nguyen D, Gill MA, Wong F. |
1998 |
| 4670 |
Journal
Molecules 2022 ; 27(3): 1070. |
Stability and Formulation of Erlotinib in Skin Creams.
Nguyen D, Secrétan P-H, Cotteret , Jacques-Gustave E, Greco C, Bodemer C, Schlatter J, Cisternino S. |
2022 |
| 2064 |
Journal
Int J Pharm Compound 2006 ; 10: 69-73. |
Stability of morphine sulfate in polypropylene infusion bags for use in patient-controlled analgesia pumps for postoperative pain management.
Nguyen-Xuan Tho, Griffiths W, Kern C, Van Gessel E, Bonnabry P. |
2006 |
| 3841 |
Journal
Am J Health-Syst Pharm 2016 ; 73:241-246 |
Visual and absorbance analyses of admixtures containing vancomycin and piperacillin–tazobactam at commonly used concentrations.
Nicholas O?Donnell J, Venkatesan N, Manek M, Rhodes N.J, Scheetz M.H. |
2016 |
| 3365 |
Journal
Hosp Pharm 2013 ; 1: 44-47 |
Y-Site Compatibility of Vancomycin and Piperacillin/Tazobactam at Commonly Utilized Pediatric Concentrations.
Nichols K.R, DeMarco M.W, Vertin M.D, Knoderer C.A. |
2013 |
| 3428 |
Journal
Hosp Pharm 2013 ; 48, 1: 44-47. |
Y-site compatibility of vancomycin and piperacillin/tazobactam at commonly utilized pediatric concentrations.
Nichols K.R, DeMarco M.W, Vertin M.D, Knoderer C.A. |
2013 |
| 3243 |
Poster
ECCO Congress Stockholm 2011 |
Stability of diluted L-asparaginase in normal saline solution.
Nicolson O, d'Hayer B, Vieillard V, Dollet S, Astier A, Paul M. |
2011 |
| 291 |
Journal
Am J Hosp Pharm 1993 ; 50: 470-472. |
Stability of cyclosporine with magnesium sulfate in 5% dextrose injection.
Nieforth KA, Shea BF, Souney PF, Scavone JM. |
1993 |
| 1188 |
Journal
Am J Hosp Pharm 1983 ; 40: 428-432. |
Stability of aminophylline injection in three parenteral nutrient solutions.
Niemiec PW, Venderveen TW, Hohenwarter MW, Gadsden RH. |
1983 |
| 405 |
Journal
Am J Hosp Pharm 1985 ; 42: 1108-1109. |
Compatibility of narcotic analgesic solutions with various antibiotics during simulated Y-site injection.
Nieves-Cordero AL, Luciw HM, Souney PF. |
1985 |
| 1029 |
Journal
Am J Health-Syst Pharm 1999 ; 56: 983-985. |
Stability of sumatriptan succinate in polypropylene syringes.
Nii LJ, Chin A, Cao TM, Gill MA. |
1999 |
| 4331 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2019 |
Emulsion Stability of Different Intravenous Propofol Formulations in Simulated Co-Administration with Remifentanil Hydrochloride.
Nilsson N, Nezvalova-Henriksen K, Tho I. |
2019 |
| 4526 |
Journal
EJOP 2021 4: 1. |
Stability of mitomycin in polypropylene syringes for use in glaucoma surgery.
Nisse, Y.E, Vigneron J, Zenier H, D'Huart E, Demoré B. |
2021 |
| 3980 |
Journal
Am J Health-Syst Pharm 2017 ; 74,9: e211-e223 |
Stability study of methotrexate in 0.9% sodium chloride injection and 5% dextrose injection with limit tests for impurities.
Nissen K.B, Jorgensen L.B, Berg D.L, Andersen G. |
2017 |
| 1353 |
Journal
Am J Hosp Pharm 1984 ; 41: 1835-1837. |
Effects of presaturation on nitroglycerin delivery by polyvinyl chloride infusion sets.
Nix DE, Tharpe WN, Francisco GE. |
1984 |
| 1495 |
Journal
Pharm J 1995 ; 254: 153-155. |
The stability of morphine sulphate and metoclopramide hydrochloride in various delivery presentations.
Nixon AR, O?Hare MCB, Chisakuta AM. |
1995 |
| 2103 |
Journal
Farm Hosp 1999 ; 23: 103-108. |
Estabilidad y compatibilidad del metamizol en jeringa y en mezclas intravenosas.
Noguera Rodriguez A, Sancho Chust V, Medina Hernandez C, Medina Hernandez MJ, Jimenez Torrez NV. |
1999 |
| 208 |
Journal
Am J Health-Syst Pharm 1997 ; 54: 1304-1306. |
Stability of ranitidine hydrochloride and human insulin in 0.9% sodium chloride injection.
Nolan PE, Hoyer GL, Ledoux JH, Fox JL. |
1997 |
| 1116 |
Journal
Am J Hosp Pharm 1982 ; 39: 471-474. |
Stability of thiamine hydrochloride repackaged in disposable syringes.
Nolly RJ, Stach PE, Latiolais CJ, Sokoloski TD, Nahata MC. |
1982 |
| 1935 |
Journal
Am J Health-Syst Pharm 2004 ; 61: 1039-1041. |
Stability of lorazepam in 0.9% sodium chloride stored in polyolefin bags.
Norenberg JP, Achusim LE, Steel TH, Anderson TL. |
2004 |
| 2147 |
Journal
Ann Pharmacotherapy 2006 ; 40, 11: 1950-1954. |
Stability of vancomycin in icodextrin peritoneal dialysis solution.
Nornoo AO, Elwell RJ. |
2006 |
| 484 |
Journal
J Clin Pharm Ther 1991 ; 16: 123-129. |
The stability of carboplatin, diamorphine, 5-fluorouracil and mitozantrone infusions in an ambulatory pump under storage and prolonged “in use” conditions.
Northcott M, Allsopp MA, Powell H, Sewell GJ. |
1991 |
| 561 |
Journal
Current Ther Res 1976 ; 20: 359-368. |
Physical compatibility and chemical stability of amikacin sulfate in large-volume parenteral solutions. Part II.
Nunning BC, Granatek AP. |
1976 |
| 32 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 1171-1173. |
Stability of doxorubicin and vincristine sulfate in two portable infusion-pump reservoirs.
Nyhammar EK, Johansson SG, Seiving BE. |
1996 |
| 1638 |
Journal
Eur Hosp Pharm 1996 ; 2: 47-48. |
Stability of reconstituted ceftriaxone solution in polypropylene syringes.
O'Connell C, Sabra K, Scott K. |
1996 |
| 4548 |
Journal
Clin Ther 2020 ; 42, 8: 1580-1586. |
Intravenous Compatibility of Ceftazidime/Avibactam and Aztreonam Using Simulated and Actual Y-site Administration.
O'Donnell J.N, Xu A, Lodise T.P. |
2020 |
| 4606 |
Journal
Int J Pharm Compound 2021 ;25,3:258-262 |
Study on the Optimal Conditions for Long-term Storage of Melatonin Powder as an In-hospital Preparation.
Odanak K, Kojima H, Nakagawa N. |
2021 |
| 1987 |
Journal
Am J Health-Syst Pharm 2005 ; 62: 289-291. |
Stability of roxatidine acetate in parenteral nutrient solutions containing different amino acid formulations.
Oh J, Gwak H, Moon H, Choi I. |
2005 |
| 3286 |
Journal
Yakugaku Zasshi 2010 ; 130, 10: 1369-1374. |
Light-induced Deterioration Test of Carboplatin under Clinical Settings.
Okamoto Y, Tazumi K, Sanada Y, Tsugane M, Uejima E. |
2010 |
| 2836 |
Journal
Int J Pharm Compound 2003 ; 7, 4: 313-319. |
Stability of Hydralazine Hydrochloride in Both Flavored and Nonflavored Extemporaneous Preparations
Okoka CC, Modwick T, Naira G, Khuspo S, Grady LT. |
2003 |
| 2682 |
Journal
Int J Pharm Pract 1991 ; 1: 19-22. |
Formulation and stability of cefuroxime eye-drops.
Oldham GB. |
1991 |
| 1725 |
Journal
Can J Hosp Pharm 2001 ; 54: 112-113. |
Compatibility of oxytocin, zidovudine, and penicillin G.
Oliver C, Law S. |
2001 |
| 187 |
Journal
Am J Hosp Pharm 1993 ; 50: 1907-1912. |
Stability of flumazenil with selected drugs in 5% dextrose injection.
Olsen KM, Gurley BJ, Davis GA, Christensen R, Monaghan MS. |
1993 |
| 506 |
Journal
J Pharm Pharmacol 1989 ; 41: 275-277. |
Diamorphine stability in aqueous solution for subcutaneous infusion.
Omar OA, Hoskin PJ, Johnston A, Hanks W, Turner P. |
1989 |
| 4440 |
Journal
Ann Nutr Metab 2018 ; 73: 227-233. |
Compatibility of Intravenous Fat Emulsion with Antibiotics for Secondary Piggyback Infusion.
Omotani S, Aoe M, Esaki S, Nagai K, Hatsuda Y, Mukai J, Teramachi H, Myotoku M. |
2018 |
| 3316 |
Journal
Chem Pharm Bull 2012 ; 60, 1: 86-93. |
A 5% Glucose Infusion Fluid Provokes Significant Precipitation of Phenytoin Sodium Injection via Interruption of the Cosolvent Effect of Propylene Glycol.
Onuki Y, Ikegami-Kawai M, Ishitsuka K, Hayashi Y, Takayama K. |
2012 |
| 4360 |
Journal
Hosp Pharm 2019 |
Formulation and Stability Study of Omeprazole Oral Liquid Suspension for Pediatric Patients.
Oriana Boscolo, Francesco Perra, Leandro Salvo, Fabiàn Buontempo, and Silvia Lucangioli. |
2019 |
| 3665 |
Journal
Am J Health-Syst Pharm 2014 ; 71:956-959 |
Stability of daptomycin 5 mg/mL and heparin sodium 100 units/mL combined in lactated Ringer’s injection and stored in polypropylene syringes at 4 and -20°C.
Ortega R, Salmer?n-Garc?a A, Cabeza J, Capit?n-Vallvey L.F, Navas N. |
2014 |
| 805 |
Journal
Hosp Pharm 1997 ; 32: 1013-1020. |
An automated process for determining the physical compatibility of drugs.
Oskroba DM, Leissing NC, Trissel LA. |
1997 |
| 1665 |
Journal
J Clin Pharm Ther 2002 ; 21: 39-45. |
Compatibility of ropivacaine with morphine, sufentanil, fentanyl, or clonidine.
Öster Svedberg K, McKenzie J, Larrivee-Elkins C. |
2002 |
| 3384 |
Journal
Farm Hosp 2013 ;37,1:10-14 |
Estudio de estabilidad de tiaprida en disolución para administración en perfusión intravenosa continua.
Otero F.M |
2013 |
| 219 |
Journal
J Clin Pharm Ther 1997 ; 22: 283-290. |
Study protocol : stability of morphine injected without preservative, delivered with a disposable infusion device.
Oustric-Mendes AC, Huart B, Le Hoang MD, Perrin-Rosset M, Pailler FM, Darbord JC, Prognon, Gard C, Pradeau D. |
1997 |
| 67 |
Journal
Am J Hosp Pharm 1991 ; 48: 1538-1539. |
Visual compatibility of ganciclovir sodium and parenteral nutrient solution during simulated Y-site injection.
Outman WR, Mitrano FP, Baptista RJ. |
1991 |
| 403 |
Journal
Am J Hosp Pharm 1991 ; 48: 1539-1541. |
Visual compatibility of haloperidol lactate with 0.9% sodium chloride injection or injectable critical-care drugs during simulated Y-site injection.
Outman WR, Monolakis J. |
1991 |
| 12 |
Journal
Am J Health-Syst Pharm 1997 ; 54: 683-686. |
Stability of amphotericin B 0.05 and 0.5 mg/ml in 20% fat emulsion.
Owens LC, Fleming RA, Restino MS, Cruz JM, Hurd DD. |
1997 |
| 549 |
Journal
Int J Pharm Compound 1997 ; 1: 121-122. |
Compatibility of common respiratory therapy drug combinations.
Owsley HD, Rusho WJ. |
1997 |
| 2168 |
Journal
Cancer Chemother Pharmacol 2005 ; 56, 5: 529-534. |
Spectrophotometric investigation of the chemical compatibility of the anticancer irinotecan-HCl and epirubicin-HCl in the same infusion solution.
Ozdemir FA, Anilanmert B, Pekin M. |
2005 |
| 3849 |
Journal
Curr Pharm Biotech 2013 ; 14, 2: 220-225. |
Physical and structural stability of the monoclonal antibody, trastuzumab (Herceptin®), intravenous solutions.
Pabari R.M, Ryan B, Ahmad W, Ramtoola Z. |
2013 |
| 1388 |
Journal
Pharm J 1982 ; 228: 238-239. |
Diamorphine hydrochloride compatibility with saline.
Page J, Hudson S. |
1982 |
| 4069 |
Journal
EJHP 2018 ; 25, e2 |
Stability of prostaglandin E1 solutions stored in polypropylene syringes for continuous intravenous administration to newborns.
Palmero D, Chavan E, Berger-Gryllaki M, Tolsa J-F, Di Paolo E, Pannatier A, Henry H, Sadeghipour F. |
2018 |
| 460 |
Journal
Am J Hosp Pharm 1987 ; 44: 358-360. |
Stability of acetazolamide sodium in 5% dextrose and 0.9% sodium chloride injection.
Parasrampuria J, Das Gupta V, Stewart KR. |
1987 |
| 76 |
Journal
Am J Hosp Pharm 1992 ; 49: 116-118. |
Stability of ganciclovir sodium in 5% dextrose injection and in 0.9% sodium chloride injection over 35 days.
Parasrampuria J, Li LC, Stelmach AH, Sykes TR, Gordon GA. |
1992 |
| 4123 |
Journal
J Oncol Pharm Practice 2018 ;24,3:201-208 |
Storage and transport of reconstituted omacetaxine mepesuccinate: Considerations for home administration.
Parikh A, Van de Rijn J, Melville C, Sarkari M, Peltier S, McKean R. |
2018 |
| 4525 |
Journal
Adv Ther 2020 ; 37: 4308–4324. |
Evaluation of the Physico-Chemical and Biological
Stability of SB8 (Aybintio), a Proposed Biosimilar to Bevacizumab, Under Ambient and In-Use Conditions.
Park D, Kim J, Yun J, Park S.J. |
2020 |
| 4627 |
Journal
Adv Ther 2019 36:442–450 |
Evaluation of Physicochemical and Biological Stability of 36-Months-Aged SB5 (Adalimumab Biosimilar) for 4 Weeks at Room Temperature.
Park D, Yun J, Hwang S-J, Park SJ. |
2019 |
| 3937 |
Journal
Biomat Res 2015 ; 19, 2 |
Stability study of docetaxel solution (0.9% saline) using Non-PVC and PVC tubes for intravenous administration.
Park K.H, Chung D.J. |
2015 |
| 2451 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 2022 - 2024. |
Stability of piperacillin sodium-tazobactam sodium in peritoneal dialysis solutions
Park TW, Le-Bui LP, Chung KC, Rho JP, Gill MA. |
1995 |
| 712 |
Journal
Am J Hosp Pharm 1980 ; 37: 496-500. |
Compatibility of diazepam with intravenous fluid containers and administration sets.
Parker WA, MacCara ME. |
1980 |
| 58 |
Journal
Can J Hosp Pharm 1985 ; 38: 160-161. |
Physical compatibility of ranitidine HCl with preoperative injectable medications.
Parker WA. |
1985 |
| 1234 |
Journal
Br J Pharm Pract 1989 ; 11: 34-36. |
Stability of low-dosage heparin in pre-filled syringes.
Parkinson R, Wilson JV, Ross M, Denyer SP. |
1989 |
| 1302 |
Journal
Drug Intell Clin Pharm 1988 ; 22: 173-174. |
Cyclosporine binding to components in medication administration sets.
Parr MD, Barton SD, Haver VM, Porter WH. |
1988 |
| 3439 |
Journal
Perit Dial Int 2013 ; 33:458-461 |
Effect of Glucose Concentration on the Stability of Daptomycin in Peritoneal Solutions.
Parra M.A, Campanero M.A, S?daba B, Irigoyen A, Garc?a-L?pez L,Fernandez-Reyes M.J, Ramon Azanza J. |
2013 |
| 276 |
Journal
Am J Hosp Pharm 1994 ; 51: 92-94. |
Stability of ceftriaxone sodium and aminophylline or theophylline in intravenous admixtures.
Parrish MA, Bailey LC, Medwick T. |
1994 |
| 2878 |
Journal
Can J Hosp Pharm 2009 ; 62, 5: 375-380. |
Buffered Lidocaine Hydrochloride Solution With and Without Epinephrine: Stability in Polypropylene Syringes.
Pascuet E, Donnelly RF, Garceau D, Vaillancourt R. |
2009 |
| 375 |
Journal
Am J Hosp Pharm 1991 ; 48: 1511-1514. |
Activity of urokinase diluted in 0.9% sodium chloride injection or 5% dextrose injection and stored in glass or plastic syringes.
Patel JP, Tran LT, Sinai WJ, Carr LJ. |
1991 |
| 823 |
Journal
Am J Health-Syst Pharm 1998 ; 55: 1584-1587. |
Microbial inhibitory properties and stability of topotecan hydrochloride injection.
Patel K, Craig SB, McBride MG, Palepu NR. |
1998 |
| 2004 |
Journal
Am J Health-Syst Pharm 2005 ; 62: 1381-1384. |
Compatibility of argatroban with abciximab, eptifibatide, or tirofiban during simulated Y-site administration.
Patel K, Hursting MJ. |
2005 |
| 3293 |
Journal
EJHP 2012 ; 19: 52-56. |
Stability of dobutamine 500 mg in 50 ml syringes prepared using a Central Intravenous Additive Service
Patel N, Taki M, Tunstell P, Forsey P, Forbes B. |
2012 |
| 10 |
Journal
Am J Health-Syst Pharm 1997 ; 54: 412-421. |
Stability of meropenem in intravenous solutions.
Patel PR, Cook SE. |
1997 |
| 266 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 2853-2855. |
Compatibility of meropenem with commonly used injectable drugs.
Patel PR. |
1996 |
| 4247 |
Journal
Clin Ther 2018 ;40,4:664-667 |
Stability of Cefazolin in Polyisoprene Elastomeric Infusion Devices.
Patel R, Jacob J, Sedeeq M, Ming L.C, Wanandy T, Zaidi S.T.R, Peterson G.M. |
2018 |
| 3777 |
Journal
Am J Health-Syst Pharm 2015 ; 72:13-14 |
Stability of ampicillin and amoxicillin in peritoneal dialysis solutions
Patel R.P, Li K, Shastri M, Wanandy T, Jose M.D. |
2015 |
| 3651 |
Journal
Perit Dial Int 2014 ; 34:212-218 |
Stability of the Combination of Ceftazidime and Cephazolin in Icodextrin or pH Neutral Peritoneal Dialysis Solution.
Patel R.P, Shastri M.D, Bakkari M, Wanandy T, Jose M.D. |
2014 |
| 3443 |
Journal
J Pharm Pract and Res 2013 ; 43: 112-116. |
Stability of Diluted Iron Polymaltose in PVC Infusion Bags.
Patel R.P, Wanandy T, Loring S, Johns C, Hutchinson J, Shastri M. |
2013 |
| 3860 |
Journal
J Pharm Pract and Res 2016 ; 46: 10-14. |
Stability of trimethoprim in newly formulated liquid dosage form.
Patel R.P, Wanandy T, Zani R, Jose M.D, Shastri M, Zaidi S.T.R. |
2016 |
| 4137 |
Journal
Newsletter Stabilis 2018 41;2-6 |
Short Report : Extended Stability Studies on Bortezomib Injection and Infusions of Cisplatin and Pemetrexed (all Accord Healthcare).
Patel T, Sewell G. |
2018 |
| 2795 |
Journal
J Pharm Pharm Sci 2004 ; 7, 1: 84-87. |
Stability of sulfadiazine oral liquids prepared from tablets and powder.
Pathmanathan U, Halgrain D, Chiadmi F, Schlmatter J, Vermerie N. |
2004 |
| 2003 |
Journal
EJHP Science 2005 ; 2: 31-36. |
Stability of prostaglandin E1 (PGE1) in aqueous solutions.
Paul M, Razzouq N, Tixier G, Astier A. |
2005 |
| 3386 |
Journal
Int J Pharm 2013 ; 448: 101-104. |
Long-term physico-chemical stability of diluted trastuzumab.
Paul M, Vieillard V, Da Silva Lemos R, Escalup L, Astier A. |
2013 |
| 3323 |
Journal
Int J Pharm 2012 ; 436, 1-2: 282-290. |
Long-term stability of diluted solutions of the monoclonal antibody rituximab.
Paul M, Vieillard V, Jaccoulet E, Astier A. |
2012 |
| 3312 |
Journal
Ann Pharm Fr 2012 ; 70, 3: 139-154. |
Long-term stability of bevacizumab repackaged in 1 mL polypropylene syringes for intravitreal administration.
Paul M, Vieillard V, Roumi E, Cauvin A, Despiau M.C, Laurent M, Astier A. |
2012 |
| 3843 |
Journal
Int J Pharm Compound 2016 ; 20, 1: 81-85 |
Evaluation of the Stability of Mercaptopurine Suspension Compounded in a Commercial Vehicle and the Determination of an Appropriate Beyond-use Date.
Peacock G.F, Sauvageot J, Hill A, Killian A. |
2016 |
| 3345 |
Journal
Int J Pharm Compound 2012 ; 16, 5: 428-430. |
Evaluation of the Stability of Acetaminophen in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-Use Date.
Peacock G.F, Sauvageot J. |
2012 |
| 3667 |
Journal
Int J Pharm Compound 2014 ; 18, 3: 253-255. |
Evaluation of the Stability of Fluoxetine in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date
P |
